Archiv verlassen und diese Seite im Standarddesign anzeigen : UPS und DOWNS bei den AMI-Werten!
Seiten :
1
2
3
4
5
6
[
7]
8
9
10
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Google kommt nicht so recht aus dem Seitwärtstrend heraus - 455 T und 513 Hoch, dort liegt der Deckel!
20.02.2007 19:45
Bekommt Google Konkurrenz?
von Jochen Steffens
Ein paar Tage ausspannen, etwas das nie falsch sein kann. Und doch habe ich immer wieder das Gefühl, es schießt einen geradezu aus dem Börsenuniversum, wenn man nicht jeden Tag 100 % dabei ist. Und eins ist sicher: Je länger man der Börse fern geblieben ist, desto länger braucht man auch, um wieder einzusteigen.
Da gestern in den USA Feiertag war, wird auch die weitere Richtung erst heute entschieden, zumal am Freitag kleiner Verfallstag war. Morgen wird dann auch noch das Fed-Protokoll veröffentlicht, das dem Markt weitere Impulse geben sollte. Etwas längerfristig betrachtet, wird es dem Markt in den nächsten Wochen darum gehen, ob wieder Zinssenkungsphantasie aufkommt.
Das kann durch schlechtere Konjunkturdaten geschehen, sollte aber unbedingt durch einen fallenden oder zumindest gleichbleibenden Ölpreis untermauert werden.
Soweit zu den groben Faktoren, die den Markt in den nächsten Tagen bis Wochen beeinflussen werden. Bis die Amis aber wieder den Takt vorgeben, bleibt etwas Zeit, über ein anderes höchst spannendes Thema zu schreiben.
Eine der besten Suchmaschinen
Ich kann mich noch daran erinnern, dass mich eine Bekannte vor Jahren auf die Suchmaschine Google (Nachrichten/Aktienkurs) hingewiesen hat. Und tatsächlich, Google war besser. Das hat zwar mittlerweile meines Erachtens etwas nachgelassen, aber Google ist immer noch die Suchmaschine mit den meisten Nutzern. Dagegen konnte selbst Microsoft nichts machen und musste sämtliche Ambitionen, eine Konkurrenz zu Google aufzubauen, aufgeben.
Jetzt könnte Google aber doch Konkurrenz bekommen; aus einer Ecke, der ich zum ersten Mal wirklich zutraue, Google vom Thron zu stürzen. Wobei ich ehrlich bin, ich hatte die Hoffnung schon fast aufgegeben, dass es einmal dazu kommen wird.
Wikipedia will nun eine eigene Suchmaschine etablieren. Es seien bereits einige namhafte Investoren interessiert. Gut, das allein reicht natürlich nicht, Suchmaschinen gibt es viele. Es ist die Idee, die dahinter steht, und die auch schon Wikipedia zu einem unglaublichen Internetnachschlagewerk gemacht hat.
Der Mensch beurteilt besser als der Computer
So soll bei Wiki Search auch kein Algorithmus die Suchergebnisse bestimmen, sondern der Mensch selbst. Die Nutzer sollen bewerten und ordnen, so hört man.
Würde das funktionieren, dann könnte das tatsächlich zu einer wichtigen Revolution auf dem Suchmaschinenmarkt werden. Schließlich ist es tatsächlich kein unbedingtes Qualitätsmerkmal mehr, die Webseiten nach Verweisen zu sortieren. Mittlerweile haben sich zu viele Anbieter darauf eingestellt und versuchen mit allen möglichen Tricks, sich bei bestimmten Suchworten weit nach vorne zu bringen.
Würde jedoch eine menschliche Bewertung die Seiten beurteilen, und das in der Masse, würde eine wesentlich objektivere Sortierung der Ergebnisse möglich sein. Somit wäre es auch wesentlich schwieriger, hier Ergebnisse zu fälschen beziehungsweise zu beeinflussen.
Die Umsetzung ist kaum möglich?
Allerdings weiß ich noch nicht, wie das umgesetzt werden soll. Wer will schon bei seiner Suche im Internet beständig alle Seiten, die er findet, bewerten? Zudem gibt es Millionen verschiedener Seiten im Internet. Hier würde eine Kontrolle und Bewertung extrem schwer. Ich kann mir noch nicht vorstellen, wie das im Detail funktionieren soll, ich habe mich damit aber natürlich auch noch nicht auseinander gesetzt. Man muss dem Mitgründer der Online-Enzyklopädie Jimmy Wales eins lassen: An Wikipedia hat auch zunächst keiner geglaubt. Also ich werde mich überraschen lassen.
Da ich keine Monopolisierungen mag, bin ich der Auffassung, dass es dem Internet gut täte, wenn Google eine ernst zunehmende Konkurrenz erhält. Und so wie ich damals schon recht früh zu Google gewechselt bin, würde ich auch ebenso schnell zu Wiki Search wechseln wenn es sich lohnt.
Was das für die Aktie von Google bedeuten würde, kann man sich vorstellen. Nein, nicht wenn ich zu Wiki Search wechsle, sondern wenn Wiki Search es tatsächlich schaffen würde, Google größere Marktanteile abzuluchsen. Sobald sich das abzeichnet, wäre es ein guter Zeitpunkt, Google zu shorten. Aber, wie gesagt, dazu muss erst einmal abgewartet werden, was schlussendlich aus dieser Idee wird und ob sie sich tatsächlich als alltagstauglich erweist.
20. Februar 2007, 08:43
Hat Google GoYellow im Visier?
(chs) Google zeigt offenbar Interesse an einer Übernahme des deutschen Auskunftsportals GoYellow. Das Unternehmen ist auf die lokale Suche nach Firmen, Geschäften und Adressen spezialisiert.
Hintergrund des Interesses scheint aber eine Nebentätigkeit zu sein. GoYellow zeichnet Geschäfte und Restaurants seiner Inserenten in Stadtpläne ein, die mit Luftbildern versehen sind. Die dafür benötigten Daten bezieht das Unternehmen vom Schweizer Anbieter Endoxon, den Google im Dezember 2006 übernommen hat. GoYellow besitzt bis Ende 2009 die alleinigen Nutzungsrechte für die Deutschland-Luftbilder, was das Interesse von Google erklären könnte.
Quellen: Die Welt, FINANCE
JetBlue Airways Corporation
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=JBLU.NAS&lColors=0x000000&sSym=JBLU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=JBLU.NAS&lColors=0x000000&sSym=JBLU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=JBLU.NAS&lColors=0x000000&sSym=JBLU.NAS&hcmask=
Bei solchen News kommen dann solche Folgen:rolleyes::rolleyes::rolleyes:
JetBlue's woes spawn 'customer bill of rights'
Feb 20, 2007 (Newsday - McClatchy-Tribune Business News via COMTEX) -- After six of the most wrenching days in its history, JetBlue Airways Corp. said yesterday it plans to unveil today a "customer bill of rights" that is to detail what the low-cost airline will do to help out passengers in the event of another storm such as the one that has crippled service since Wednesday.
Forest Hills-based JetBlue said it is on the road to straightening out its schedule after hundreds of flights were canceled after the Valentine's Day storm. But early yesterday morning, the airline said it canceled an additional 139 flights. JetBlue had originally scheduled 600 flights for Presidents Day, more than the 550 to 575 flights scheduled for a typical Monday.
Alison Eshelman, a JetBlue spokeswoman, said the airline will announce details of its "customer bill of rights" early today.
"It's going to detail what customers can expect of JetBlue," Eshelman said. "We're going to include what penalties we will assume as well as what passengers can expect from us."
She said JetBlue Chairman and Chief Executive David Neeleman and top airline executives are working on the document.
"It's going to be more meaningful, broader and deeper than anything in the industry today and it's going to restore the faith of our customers," Eshelman said. She declined to disclose any other details.
A report in yesterday's New York Times described an emotional Neeleman saying he is "humiliated and mortified" by the breakdown in the operations of the 6-year-old airline, which had been highly popular among customers. Neeleman said in the interview that in the future JetBlue will pay penalties to customers if they are stranded on a plane for too long.
Neeleman said the part of the company that coordinates flight assignments for pilots and flight attendants is not large enough and that 100 existing employees will be trained to work in that area when needed.
Yesterday, all JetBlue flights were canceled out of 11 airports: Richmond, Va; Pittsburgh; Charlotte and Raleigh-Durham, N.C; Jacksonville, Fla; Austin and Houston in Texas; Columbus, Ohio; Nashville, Tenn; Portland, Maine; and Bermuda.
Meanwhile, airlines in general are again trying to head off congressional regulation that would govern what carriers must do in the event of lengthy delays.
Sen. Barbara Boxer (D-Calif.) has said she intends to propose a bill giving passengers the right to get off planes after a set amount of time. A group called the Coalition for an Airline Passengers' Bill of Rights wants a mandatory three-hour cap on wait times as part of an 11-point list of requirements, including adequate food and water, and working toilets.
The Air Transport Association, a Washington, D.C.-based group representing major airlines, opposes such legislation. David Castelveter, a spokesman for the association, said if a flight had to return to a gate after, say, three hours, but could take off in another 15 minutes, "it creates a true hardship for passengers."
SULPHCO INC
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
Sie braucht eine ordentliche Konsolidierung!!
SulphCo(R) Provides Status Report on Probes
SPARKS, Nev., Feb 13, 2007 /PRNewswire-FirstCall via COMTEX/ -- SulphCo(R), Inc. (Amex: SUF) announced today an update on the improvement and shipping status of the probes.
Four probes were recently tested and successfully passed screening tests in Sparks, Nevada in preparation for shipment to NTG. The probes were sent on February 7th to NTG to start the protocol for pressure and wet testing of the skid to be sent to Austria. It is expected that the preparation will take two to three weeks. Two SulphCo(R) engineers are at NTG this week to oversee the probe wiring, installation, and testing.
Dr. Larry Ryan, CEO of SulphCo(R) stated, "I am pleased to announce the status of the probes and to further validate our efforts to remain transparent with our shareholders. We are continuing to work with our external probe vendors and are receiving and testing prototype probes on a weekly basis. It is imperative that we continue to perfect the probes as we draw nearer to running them in the first large scale test application."
Currently, no probes have been shipped to Fujairah; however a SulphCo(R) team is in Fujairah this week and will return with an update.
About SulphCo(R), Inc.
SulphCo(R) has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The Company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel.
Overstock.com, Inc.
20.02.07 22:00 Uhr
19,03 USD
+4,33 % [+0,79
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=OSTK.NAS&lColors=0x000000&sSym=OSTK.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=OSTK.NAS&lColors=0x000000&sSym=OSTK.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=OSTK.NAS&lColors=0x000000&sSym=OSTK.NAS&hcmask=
Es schreit direkt nach Konsolidierung.
Sonus Networks, Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
Schöner Aufwärtstrend! Überkauft-Signal total abgebaut. Widerstand bei 8,00.
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
Der Staat, die Airlines und die Lobby
Wer den Schaden hat, braucht für den Spott nicht zu sorgen. Der Billig- und Überflieger JetBlue ist wegen Schnee, Eis und Miss-Management zum Gespött an der Wall Street und im Late-Night-TV geworden. Doch das Schlimmste: Man muss den Millionen-Schaden selbst tragen, kann sich nicht auf weitere Hilfe der Regierung verlassen.
Das ist ungewöhnlich für die sonst so verwöhnte Airline-Branche, denn in den letzten Jahren hatte es sich geradezu eingebürgert, dass die Regierung angeschlagenen Unternehmen zur Seite sprang. Der Grund: Die Branche war direkt nach und auch wegen der Terror-Anschläge auf das World Trade Center am 11. September 2001 in Schwierigkeiten geraten die Folgen einer nationalen Katastrophe wollte Uncle Sam nicht den Unternehmen selbst aufbürden.
Doch war die Branchenkrise, die zahlreiche Traditions-Carrier an den Rand oder in den Ruin trieb, nur teilweise von 9/11 bedingt. Die Katastrophe kostete American und United Airlines nicht nur jeweils zwei Flugzeuge, zahlreiche Mitarbeiter und sorgte für ein schwer zu bewältigendes Trauma. Sie verdarb dem halben Land auch zunächst einmal die Lust aufŽs Fliegen die Buchungen nahmen rapide ab.
Doch auch der steigenden Ölpreis und damit immer teureres Flugbenzin erschwerten den Unternehmen die Geschäfte. Ebenso die unflexiblen Verträge mit Piloten, Besatzung und Bodenpersonal. Dazu kamen der schlechte Service an Bord und weitere Management-Pannen, wie ein Millionen-Bonus, den sich der damalige AMR-Boss Don Carty genehmigte, kaum dass er die Gehälter der Mitarbeiter erfolgreich gedrückt hatte. Alles in allem gelang der Branche in den letzten Jahren nicht allzuviel, doch nicht alles konnte man auf 9/11 schieben.
Die Regierung sprang den Unternehmen dennoch zur Seite und gab in den letzten Jahren eine Finanzspritze von mehr als 15 Milliarden Dollar. Ob das sinnvoll war, ist unter Experten und Wählern! noch immer umstritten. Doch ein kleiner Passus, den die Autoren des damaligen Airline-Unterstützungs-Gesetzes in die Vorlage aufnahmen, lässt den Staat zumindest zum Teil an der Erholung der Branche teilhaben.
Jon Corzine, Demokrat aus New Jersey, und Peter Fitzgerald, Republikaner aus Illinois, die Autoren des Gesetzes, haben beide Erfahrung im Finanzsektor: Corzine als ehemaliger CEO von Goldman Sachs und Fitzgerald als Berater einer Privatbank. Die beiden sorgten dafür, dass die unterstützten Airlines Uncle Sam Optionen überschreiben mussten. Kauf und Verkauf der entsprechenden Papiere für Frontier und America West haben bisher 119 Millionen Dollar in die Staatskasse gebracht, weitere 130 Millionen Dollar liegen in Papieren von World Airways.
Stellt sich die Frage: Warum wird Uncle Sam nicht regelmäßig für Zahlungen an Unternehmen mit Optionen bedacht? Immerhin hat sich das System schon in der Vergangenheit ausgezahlt. Als die Regierung 1979 Chrysler aus der Klemme half, bekam man Optionen, die später 300 Millionen Dollar einbrachten. Schießt der Staat hingegen 21 Millionen Dollar in die HIV-Forschung, wie neulich beim Pharmazeuten Argos geschehen, ist von einer Beteiligung nirgends die Rede nicht einmal, wenn die staatlich finanzierte Forschung zu Rekordgewinnen für das Unternehmen führt.
Nun, warum lässt sich Uncle Sam nicht regelmäßig am Unternehmenserfolg beteiligen? Laut Experten in Washington fehlt es nicht an Ideen und Gelegenheit. Vielmehr scheinen die mächtigen Lobbyisten den Politikern regelmäßig solche Spielchen auszureden. Die Unternehmen wollen im Erfolgsfall alleine kassieren, und dank großzügiger Wahlkampfspenden haben sie genug Macht, das auch durchzubringen.
Im Falle der Airline-Branche hatte Uncle Sam letztlich auch nur Glück. Gesetzes-Autor Fitzgerald, der 2005 seinen Seatsposten aufgegeben hat, erinnert sich: Die Fluggesellschaften waren so unorganisiert, sie konnten sich selbst nicht einigen, was für sie am besten wäre. Von diesem Miss-Management profitierte der Staat.
Lars Halter
GRACE W R CO NEW %)
Sedol: 2232685 Exch: NYSE Sym: GRA.NYS
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GRA.NYS&lColors=0x000000&sSym=GRA.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=GRA.NYS&lColors=0x000000&sSym=GRA.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GRA.NYS&lColors=0x000000&sSym=GRA.NYS&hcmask=
Der Deckel muß erst weg, bevor es wieder hochgehen kann.
Börse
NYSE
Aktuell
25,75 USD
Zeit
21.02.07 22:02
Diff. Vortag
+5,40 %
Tages-Vol.
30,73 Mio.
Gehandelte Stück
1,2 Mio.
bellwetherreport.com: Shareholder Alert for W. R. Grace & Co.
Feb 07, 2007 (M2 PRESSWIRE via COMTEX) -- W. R. Grace & Co. has embraced Thoreau's call to simplify. The company has restructured from six product groups into two major units, each accounting for about half of sales. Grace's Davison Chemicals unit makes silica-based products, chemical catalysts, and refining catalysts that help produce refined products from crude oil. Its Performance Chemicals unit makes concrete and cement additives, packaging sealants, and fireproofing chemicals. The company's customers include chemicals companies, oil refiners, and construction firms. Grace filed for bankruptcy protection in 2001 after an unexpected increase in asbestos litigation (injury claims nearly doubled in 2000); the company no longer makes such products.
Shares were down 3% swings to a fourth quarter profit.
Sirius Satellite Radio Inc.
21.02.07 22:00 Uhr
3,92 USD
+0,00 % [+0,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Börse
NASDAQ
Aktuell
3,92 USD
Zeit
21.02.07 22:00
Diff. Vortag
+0,00 %
Tages-Vol.
429,65 Mio.
Gehandelte Stück
114 Mio
Sales of satellite radio receivers remain steady
Feb 21, 2007 (Post-Bulletin - McClatchy-Tribune Business News via COMTEX) -- What kind of reception is a proposed merger between the two satellite radio providers picking up from Rochester music and sports fans?
Sirius Satellite Radio and XM Satellite Radio announced the plan earlier this week, and it doesn't seem to have hurt sales of each company's equipment.
Sales of both are still steady, says Rochester Best Buy sales representative Mike Conard. Neither one seems more popular than the other.
"Both are very, very competitive," he says.
The companies do not release subscriber numbers for specific areas such as Rochester or Minnesota.
The main differences between the two is XM's focus on music along with Oprah Winfrey, Bob Dylan and major league baseball while Sirius has an edge in the sports area with pro football and racing, along with Howard Stern.
Sports is why Greg Nicholay of Rochester subscribes to Sirius, which he listens to in his car.
"The reason I went out and got it was that I could listen to all of the NFL games," he said. "And I'm a graduate of the Naval Academy, and they carry all the Navy games.
However the merger plays out, Nicholay wants to keep listening.
"I use it a lot," he said. " Hopefully down the road ... in my next car, I'd have it installed."
XM previously carried NASCAR races, but Sirius picked that up in January. Now that race season is in full swing, listeners are really noticing.
"Lately, I've had a lot people coming in who had XM to listen to NASCAR saying, 'Switch me to Sirius,'" Conard said.
The proposed merger, however, has clouded the issue of which company offers which -- sports or music.
"Some people are buying (equipment) because they say it will be lumped together," Conard said. "They say it won't matter (which system you choose) eventually."
XM radio receivers can't receive signals from Sirius and vice versa. The companies are working on developing a receiver that could receive both signals.
In the meantime, they said, assuming the deal goes through, the companies would make other arrangements to provide programming that's currently exclusive to one provider to listeners of the other, such as getting Major League Baseball games -- currently only available on XM -- to Sirius listeners.
By Jeff Kiger
Google: (K)ein Angriff auf Microsoft
Seit Google in einer beeindruckenden Zwei-Jahres-Rallye den Aktienkurs von 80 auf über 500 Dollar gesteigert hat, hatte es die Suchmaschine zunehmend schwer, sich als harmloser Internet-Wert dazustellen. Ab sofort ist das gar nicht mehr möglich, denn mit einem Frontalangriff auf Microsoft zeigt das Unternehmen Zähne.
Dabei hatte Google-CEO Eric Schmidt in den letzten Monaten wiederholt beteuert, dass Google keineswegs in Konkurrenz zu Microsoft treten wolle. Analysten hatten das immer wieder vermutet. Immerhin hat die Suchmaschine immer mehr Internet-basierte Software aufgenommen, die User zumindest theoretisch dazu hätten bewegen können, Windows den Rücken zu kehren.
Doch das kostenlose Textverarbeitungsprogramm, das nun den Namen Google Docs trägt, sollte nicht Windows ersetzen, so Schmidt. Und die Tabellenkalkulation, die nun Google Spreadsheet heißt, auch nicht Excel. Doch seit beide Programm und noch einige mehr, darunter ein Email-Server, ein Kalenderdienst, zehn Gigabyte Speicher und eine Telefon-Hotline für den Kundendienst, am Donnerstag für 50 Dollar pro Jahr und Kunde im Profi-Pack erhältlich sind, lässt sich kaum mehr leugnen, dass sich Google an Bill GatesŽ Software-Riesen orientiert.
Bei Microsoft muss man sich deswegen nicht fürchten. Es ist kaum anzunehmen, dass Google mit seinen Internet-Programm einen auch nur spürbaren Bissen aus dem Windows-Kuchen beißen wird. Rund 450 Millionen User weltweit arbeiten immerhin mit den Office-Programmen, während die Geschäftssparte von Google gerade einmal 100 000 Kunden für das bisher kostenlose Paket hatte.
Selbst wenn alle 100 000 Kunden kostenpflichtig zu Google wechseln würden, wäre das kein Verlust für Microsoft. Und für Google zunächst kein großer Gewinn, denn die 5 Millionen Dollar Umsatz, die das einspielen würde, sind gemessen am Gesamtumsatz des Konzerns von zuletzt 10,6 Milliarden Dollar in 2006 geradezu verschwindend gering.
Dass die Aktie von Google dank der Pro-Apps am Donnerstag dennoch ins Plus kletterte, ist den Aussichten zu verdanken, die Anleger in bezug auf die Geschäftspolitik des Unternehmens haben. Dass der konsequente Wechsel von Microsoft- auf Google-Programme einem Unternehmen pro Lizenz gute 600 Dollar jährlich sparen könnte, ist nämlich nur in zweiter Linie für Großkunden interessant. Vielmehr aber öffnet das neue Service-Paket den kleinen und mittleren Betrieben Türen, die bislang gar nicht im Internet vertreten waren.
Um diesen Markt um die Restaurants, Schuhverkäufer, Schreibwarenläden und Massage-Salons kämpft Google schon seit Jahren, unter anderem in komplett anzeigen-unterstützten Programmen wie Google Earth. Der Erfolg war bisher bescheiden: Bis heute hat etwa die Hälfte der amerikanischen Arbeitsnehmer keinen Email-Anschluss in Büro oder Betrieb. Hier liegt Wachstumspotenzial, das Microsoft und andere Anbieter bisher vernachlässigt haben.
Googles neues Paket ist also ein Knüller nicht so sehr in bezug auf die aktuelle Gestalt des Angebots. Vielmehr ist die Google Apps Premier Edition ein weiterer Indikator für die visionäre Geschäftsführung im Googleplex und die ist, worauf Anleger mit jeder gekauften Aktie setzen.
Lars Halter
Ahead of the Bell: Merck Up on Upgrade
Monday February 26, 9:11 am ET
Merck Upgraded to "Buy" at Citigroup Based on Diabetes and Cervical Cancer Drug Sales
NEW YORK (AP) -- A Citigroup analyst upgraded shares of drug maker Merck & Co. Inc. to "Buy" before the start of trading Monday, predicting strong sales of its type II diabetes drug Januvia.
Analyst George Grofik increased his sales predictions for Januvia, and raised his target price to $50 per share from $45. Grofik said his research shows physicians expect to prescribe Januvia for 10 percent of their patients within a year.
Grofik also forecast solid sales for Gardasil, a cervical cancer vaccine.
"While adoption in mandatory state vaccination programs is critical for the product's uptake, we also see an interesting upside opportunity in mid-adult women," he said.
Whitehouse Station, N.J.-based Merck is also keeping its expenses down, he said.
Merck shares gained $1.47, or 3.4 percent, to $44.41 in premarket electronic trading, from their close at $42.94 Friday on the New York Stock Exchange.
Übernahmegerüchte treiben AMD-Aktie in die Höhe
Di Feb 27, 2007 7:22 MEZ
New York (Reuters) - Übernahmespekulationen haben am Montag die Aktien des US-Chipkonzerns AMD um mehr als fünf Prozent in die Höhe getrieben.
Am Markt kursierten Gerüchte, Beteiligungsgesellschaften hätten Interesse an AMD, sagte Paul Foster vom Web-Informationsdienst theflyonthewall.com. Die Gerüchte seien aber nicht bestätigt. Ein AMD-Sprecher lehnte einen Kommentar dazu ab. Das AMD-Handelsvolumen für im März fällige Optionen sei ungewöhnlich hoch, sagte auch Steve Sosnick von Timber Hill. Zumindest kurzfristig schenke der Markt den Gerüchten über eine Übernahme Glauben.
AMD ist der weltweit zweitgrößten Chiphersteller nach Intel und beschäftigt in Deutschland mehr als 3000 Mitarbeiter - vor allem in seinen Chipfabriken in Dresden.
Ahead of the Bell: Sherwin-Williams
Tuesday February 27, 9:10 am ET
Market Overreacted to Ruling That Could Force Sherwin-Williams to Remove Lead Paint - Analyst
NEW YORK (AP) -- The market overreacted when it batted down Sherwin-Williams Co.'s stock Monday after a judge's ruling made it more likely the paint maker would have to pay to clean up lead paint in Rhode Island, a KeyBanc analyst wrote in a research report.
ANZEIGE
A Providence Superior Court judge on Monday denied Sherwin-Williams' request to revisit a jury's ruling finding the company liable for lead contamination in paint. The judge, Michael Silverstein, affirmed the jury's ruling and said he will appoint an adviser to help decide how to force Sherwin-Williams and two other paint makers to clean the lead.
While paint manufacturers stopped making paint with lead almost 30 years ago, lead-contaminated paint is still in 250,000 older homes in the state. Lawyers for the state estimated the cleanup could cost more than $1 billion.
But KeyBanc Capital Markets analyst Saul H. Ludwig said that's only if the companies strip the paint out of all 250,000 homes. That won't be necessary, he said. There's a process called lead safe, which means managing the lead contamination rather than removing the paint entirely.
The lead safe process would cost less than $20 million to implement in Rhode Island, he said. Based in Cleveland, Sherwin-Williams operates more than 3,000 stores and booked $7.81 billion sales last year.
Plus, Sherwin-Williams can appeal Silverstein's ruling to the state Supreme Court, which would take at least a year and a half.
"It will be quite some time before all appeals are exhausted, and it remains uncertain as to how much, if any, liability Sherwin-Williams will bear," Ludwig said.
Ludwig said the 3.2 percent drop in Sherwin-Williams' stock Monday was "an inappropriate but not surprising overreaction by the market."
Sherwin-Williams shares closed at $67.77 on the New York Stock Exchange Monday.
Dallas-based NL Industries Inc., and Millennium Holdings LLC, owned by Lyondell Chemical Co., are co-defendents in the suit.
Tenet Healthcare 4Q Losses $386 Million Vs $286 Million2-27-07 8:59 AM EST |
DOW JONES NEWSWIRES
Tenet Healthcare Corp. (THC) said Tuesday its fourth-quarter loss widened to $ 386 million, or 82 cents a share, from a loss of $286 million, or 61 cents, a year earlier.
The average estimated loss of 18 analysts surveyed by Thomson Financial was 4 cents a share.
The Dallas company said revenue for the three months ended Dec. 31 rose 2.6% to $2.18 billion from $2.12 billion.
-Thomas Middleton; 415-439-6400
Wall Street News Alert: UCPI Is on the Move! February 27, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, Feb 27, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Unicorp, Inc. (OTCBB: UCPI),
Chesapeake Energy Corporation (NYSE: CHK),
TXU Corp. (NYSE: TXU) and
Evergreen Solar, Inc. (NASDAQ: ESLR)
News just released by Unicorp Inc., (OTCBB: UCPI), may get the attention of investors this morning. Yesterday after the markets closed, the company (engaged in the acquisition, development, exploration and production of crude oil and natural gas) issued a press release announcing that the drilling of its South Creole Prospect located in Cameron Parish, Louisiana has been completed and that electric logs indicate approximately 35 feet of pay.
This could be a big deal for the company! Operations to complete the well will begin within the next several weeks and when brought online will double Unicorp's existing revenue. The South Creole Prospect was drilled to a depth of approximately 11,300 feet to test the Planulina A formation. Total reserves are estimated to be 2.5 Bcf of natural gas with associated condensate production. Unicorp has a 28.3% working interest and approximately a 21% net revenue interest in the well.
"This is a good find for our company and will significantly enhance our revenue," stated Kevan Casey, CEO of Unicorp. "We hope to have this well completed and producing during our next fiscal quarter."
Unicorp is not just your average "prospecting" company. The company actually has oil-producing wells. The Walley Estate #1 has been producing an average of approximately 85 barrels of oil per day and has produced over $200,000 in gross oil revenue since first production in November 2006. Unicorp has a 60% working interest and a 47.55% net revenue interest in this prospect.
The company recently announced its participation in the North Cayuga Prospect located in Henderson County, Texas. This prospect has the potential for eight wells and potential gross reserves of 1,000,000 barrels of oil and 4 Bcf of gas. Unicorp will have a 21% working interest and an approximate 16% working interest after payout in this prospect.
Wall Street News Alert is continuing to alert investors to monitor the progress of Unicorp as the company continues to release positive news. Near the end of last year, the company announced that it expected to triple its gross profit in fiscal 2007 to approximately $3,000,000 versus 2006 of approximately $760,000 and to be profitable from operations during the first quarter of 2007, excluding non-cash charges.
Before the news hit the wires, Unicorp's stock closed yesterday at around Thirty Seven cents a share.
In case you are not familiar with the company: Unicorp, Inc is primarily engaged in the acquisition, development, exploration and production of crude oil and natural gas. Its focus is on aggressively acquiring working interests in crude oil and natural gas properties with the intent of exploration and development or by enhancing production through the use of modern development techniques such as horizontal drilling, satellite technology and 3-D seismic. The company's goal is to achieve a high return on its investment by limiting its up-front acquisition costs, by quickly developing its acquisitions and by practicing a sound and smart approach to oil and gas exploration and development.
Chesapeake Energy Corporation (NYSE: CHK) up 2.5% on 17.1 million shares traded.
Chesapeake Energy Corporation is one of the largest independent producers of natural gas in the U.S. Headquartered in Oklahoma City.
TXU Corp. (NYSE: TXU) up 13.1% on 48.4 million shares traded.
TXU Corp., a Dallas-based energy company, manages a portfolio of competitive and regulated energy businesses primarily in Texas.
Evergreen Solar, Inc. (NASDAQ: ESLR) up 6% on 7 million shares traded Evergreen Solar, Inc. develops, manufactures and markets solar power products using proprietary, low-cost manufacturing technologies.
ICE Futures ADV Increases 93%; NYBOT ADV up 18% With Record Monthly Volume; ICE OTC Average Daily Commissions Grow 90% in February
ATLANTA, March 2, 2007 /PRNewswire-FirstCall via COMTEX/ -- IntercontinentalExchange (NYSE: ICE), the leading electronic energy marketplace and soft commodity exchange, today reported significant increases in volume and commissions during the month of February 2007 compared to February 2006. Average daily volume (ADV) for ICE Futures, ICE's U.K. based regulated futures subsidiary, was 492,353 contracts, an increase of 92.8% over ADV in February 2006. Volume at the New York Board of Trade (NYBOT), ICE's wholly-owned U.S. based regulated futures subsidiary, totaled a record 4,886,508 contracts in February 2007, for an ADV of 256,447 contracts, an increase of 17.9% over February 2006. Electronic trading accounted for 32.4% of the total NYBOT soft commodities futures contracts. Average daily commissions in ICE's over-the- counter (OTC) business segment in February 2007 were $800,446, a 90.0% increase over February 2006.
ICE Futures Volume
Total monthly volume at ICE Futures in February 2007 rose 92.8% to 9,847,062 contracts, compared to 5,107,913 contracts in February 2006. ADV for the month also rose 92.8% to 492,353 contracts compared to ADV of 255,396 contracts in February 2006. Excluding trading on President's Day, a U.S. holiday during which the ICE Futures markets were open for trading, average daily volume for the month was 510,186 contracts. Monthly and average daily volume exchange-wide figures in February 2007 represented the second highest totals in the history of the exchange. ICE Brent Crude futures and ICE WTI Crude futures individually recorded their second best volume months in February.
ICE UK Natural Gas futures set a new monthly record of 97,635 contracts in February 2007, surpassing the previous January 2003 monthly record of 95,945; ADV was a record 4,882 contracts, exceeding by 11.9% the January 2003 ADV record.
During the month of February 2007, ICE Futures established several open interest records, including exchange-wide and in ICE Brent Crude, ICE WTI Crude and ICE Gas Oil futures.
In February 2007, the ICE Futures rate per contract (RPC) averaged $1.28, compared to $1.12 in February 2006, when a fee waiver for the ICE WTI Crude futures contract, as well as the previous futures rate structure, were in place. In January 2007, ICE Futures' RPC was $1.30, compared to $1.33 in December 2006 and $1.33 in the fourth quarter of 2006.
About IntercontinentalExchangeIntercontinentalExchange(R ), (NYSE: ICE) operates the leading global, electronic
marketplace for trading both futures and OTC energy contracts and the leading
soft commodity exchange. ICE's markets offer a range of contracts based on crude
oil and refined products, natural gas, power and emissions, as well as soft
commodities including cocoa, coffee, cotton, ethanol, orange juice, wood pulp
and sugar, in addition to currency and index futures and options. ICE(R)
conducts its energy futures markets through its U.K. regulated London-based
subsidiary, ICE Futures, Europe's leading energy exchange. ICE Futures offers
liquid markets in the world's leading oil benchmarks, Brent Crude futures and
West Texas Intermediate (WTI) Crude futures, trading nearly half of the world's
global crude futures by commodity volume. ICE conducts its soft commodity
futures markets through its U.S. regulated subsidiary, the New York Board of
Trade(R). For more than a century, NYBOT(R) has provided global markets for
food, fiber and financial products. ICE was added to the Russell 1000(R) Index
on June 30, 2006. Headquartered in Atlanta, ICE also has offices in Calgary,
Chicago, Houston, London, New York and Singapore. For more information, please
visit www.theice.com and www.nybot.com.
Microsoft Rewards Technology Innovation at KSS with Presentation of Retail Application Developer (RAD) Award KSS PriceStrat Takes Top Honors in Business Insight Category
FLORHAM PARK, N.J., Mar 02, 2007 (BUSINESS WIRE) -- KSS, a global leader in retail price optimization solutions, announced today that Microsoft has awarded the KSS PriceStrat price optimization solution with the Europe/Middle East/Asia (EMEA) Retail Application Development (RAD) award, in the Business Insight category. Microsoft presented KSS with the award Feb 27, 2007, at the RAD award ceremony at the CCD Congress Center in Dusseldorf, Germany.
The awards, which attracted entries from all over the EMEA region including Belgium, France, Israel, South Africa, Sweden, Turkey and the United Kingdom, are designed to reward independent software vendors (ISVs) and retailer IT departments that can successfully demonstrate innovation and excellence by delivering business value using Microsoft(R) technologies in the retail sector. This year's panel of judges was made up of some of the leading figures from the European retail industry: Paivi Hokkanen (Stockmann, Finland), Hansjoerg Bausch (Kaufhof, Germany), Neil Ashworth (Tesco.com, UK), Martin White (Primark, Ireland) and Michael Gerling (EHI Retail Institute, Germany).
"We are excited to receive this prestigious honour from Microsoft in recognition of our PriceStrat solution," said Mark Hawtin, KSS vice president of business development. "PriceStrat, built on the .NET platform, provides retailers around the world with the ability to accurately model and forecast the effects of pricing and promotions decisions, before they are implemented. The business insight that this solution brings to our customers allows them to consistently develop and execute the optimum mix of prices and promotions that satisfy their customers needs and generate desired performance across the store."
About KSS
KSS is the leading supplier of comprehensive pricing intelligence, optimization and execution solutions to the grocery, chain drug, general retail, convenience retail and petroleum industries. The company helps retailers manage more than $70 billion in annual revenue from more than 22,000 outlets. Retailers use KSS software to model, forecast and optimize the effects of pricing and promotional decisions. PriceStrat and other KSS software are available as an on-site, fully integrated system. For more information, visit www.kssg.com. For media inquiries in Europe, contact Mark Hawtin at 0161 228 0040 or hawtinm@kssg.com. For all other media inquiries, contact Roy Miller at (903) 422-5117, or at roy@roygmiller.com.
Schon sehr lange nichts mehr gehört von der!
Genta Incorporated
08.03.07 19:10 Uhr
0,4981 USD
+1,65 % [+0,0081]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
Börse
NASDAQ
Aktuell
0,4981 USD
Zeit
08.03.07 19:10
Diff. Vortag
+1,65 %
Tages-Vol.
534.359,12
Gehandelte Stück
1,1 Mio
Genta and IDIS Announce Global Ex-U.S. Agreement for Named Patient/Compassionate Use Distribution of Ganite(R) and Genasense(R)
BERKELEY HEIGHTS, N.J. and WEYBRIDGE, U.K., Mar 07, 2007 /PRNewswire via COMTEX/ -- BERKELEY HEIGHTS, N.J. and WEYBRIDGE, U.K., March 7 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) and IDIS today announced the signing of an agreement whereby IDIS will distribute two of Genta's oncology products, Ganite(R) (gallium nitrate injection) and Genasense(R) (oblimersen sodium) Injection, on a named patient/compassionate use basis. The global agreement covers all territories except the United States. "Named patient" distribution refers to the distribution or sale of a product to a specific healthcare professional for the treatment of an individual patient. IDIS, a privately owned company based in the United Kingdom, will manage the named patient programs for Genta.
Ganite is approved and marketed by Genta in the U.S. for treatment of cancer-related hypercalcemia that is resistant to hydration. Early Phase 2 studies using Ganite as an investigational drug to reduce accelerated bone resorption have been completed in patients with bone metastases and in Paget's disease of bone. The drug is currently being tested at higher doses as a direct anticancer agent in patients with relapsed or refractory non-Hodgkin's lymphoma. A Marketing Authorization Application for Genasense plus dacarbazine in patients with advanced melanoma is currently pending review in Europe. Genta is testing Genasense in ongoing clinical trials with other chemotherapy drugs in patients with melanoma and other diseases. The Company expects to allocate a percentage of net proceeds from the IDIS program to support compassionate use in indigent patients; the remainder will support further clinical research.
Natalie Douglas, Managing Director of IDIS, commented: "We are delighted to be working with Genta to manage access to Genasense and Ganite for oncology patients who have the potential to benefit from the Company's innovative therapies."
"Genta is committed to securing regulatory approval of its drugs on a global basis, and we welcome IDIS's assistance with this key program," said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer. "We are pleased to be able to provide these drugs that address critical unmet medical needs to seriously ill patients in response to prescriber requests."
On Wednesday March 7, 2007, management from Genta and IDIS will host a joint conference call and live audio webcast to provide an overview of the agreement at 4:30 pm EST.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Atheros Communications, Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ATHR.NAS&lColors=0x000000&sSym=ATHR.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ATHR.NAS&lColors=0x000000&sSym=ATHR.NAS&hcmask=
Sehr gut! Abprall von den unteren Bollingerbänder nach oben!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ATHR.NAS&lColors=0x000000&sSym=ATHR.NAS&hcmask=
Ivanhoe Energy, Inc. - Common Shares
08.03.07 19:43 Uhr
2,11 USD
+0,48 % [+0,01]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
Nach solch einemAnstieg wird die Luft immer dünner!
http://isht.comdirect.de/charts/large.chart?hist=3m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,11 USD
Zeit
08.03.07 19:43
Diff. Vortag
+0,48 %
Tages-Vol.
7,31 Mio.
Gehandelte Stück
3,5 Mio
Ivanhoe Energy Inc. (NASDAQ: IVAN) up 6% on 6 million shares traded Ivanhoe Energy is an independent international oil and gas development and production company focused on pursuing long-term growth in its reserves and production using advanced technologies, including its proprietary heavy oil upgrading process (HTL).
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Ganz schön weit entfernt von ihrem Hoch!! Dem Markt gefält der Merger nicht!
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Karmazin Says XM/Sirius Subscriptions Will be Discounted
(financialwire.net via COMTEX) -- March 8, 2007 (FinancialWire) Sirius (NASDAQ: SIRI) CEO Mel Karmazin said that subscription service for the combined XM and Sirius satellite radio merger would be substantially discounted for customers.
The service costs $12.95 each. When asked if the programming of the combined conglomerate would cost $26 per month Karmazin said that there would be a substantial discount that would likely be in the range of $10 off.
XM and Sirius are trying to merge but the proposal may be against US antitrust restrictions. Karmazin has maintained that the deal will be good for subscribers, who will benefit from both companies but will not have to pay substantially more for the deal.
CKE RESTAURANTS
08.03.07 20:04 Uhr
18,99 USD
+2,37 % [+0,44]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CKR.NYS&lColors=0x000000&sSym=CKR.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=CKR.NYS&lColors=0x000000&sSym=CKR.NYS&hcmask=
Das Ergebnis hat geholfen! Jetzt ist wieder Platz auf die 20.
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CKR.NYS&lColors=0x000000&sSym=CKR.NYS&hcmask=
Börse
NYSE
Aktuell
18,99 USD
Zeit
08.03.07 20:04
Diff. Vortag
+2,37 %
Tages-Vol.
20,89 Mio.
Gehandelte Stück
1,1 Mio.
CKE Restaurants, Inc. Reports Period One Blended Same-Store Sales Both Brands Report Historically High Period One Average Unit Volumes
CARPINTERIA, Calif., March 7, 2007 /PRNewswire-FirstCall via COMTEX/ -- CKE Restaurants, Inc. (NYSE: CKR) announced today period one same-store sales for the four weeks ended Feb. 26, 2007, for Carl's Jr.(R) and Hardee's(R).
Brand Period 1
FY 2008 FY 2007
Carl's Jr. -2.7% +10.2%
Hardee's +1.5% +4.3%
Blended -0.5% +7.3%Commenting on the Company's performance, Andrew F. Puzder, president and chief
executive officer, said, "Despite the 16th consecutive period of positive
same-store sales for our Hardee's brand, blended same-store sales for period one
declined 0.5 percent due to a negative 2.7 percent period for Carl's Jr. We
remain very optimistic about the potential future near- and long-term
performance of both our brands based upon our continued focus on innovative
premium products, cutting-edge advertising, customer service, remodels and
dual-branding conversions.""Obviously, we would love to report same-store sales increases every period for
all of our concepts. This becomes very difficult when rolling over strong
product introductions and favorable weather conditions resulting in strong
same-store sales (+10.2% at Carl's Jr.). However, through the first week of
period two, Carl's Jr. same-store sales appear to be rebounding.""One reason for this rebound is the Buffalo Chicken Sandwich(TM) which Carl's
Jr. introduced on Feb. 21. However, media support for the product only began
during the final two days of period one. Featuring a crispy chicken breast
fillet dipped in Frank's(R) RedHot(R) buffalo wing sauce, and topped with ranch
dressing, tomato and lettuce, the spiciness of the sandwich is only matched by
the television commercial that debuted during the Academy Awards in most
markets. The spot, starring model/actress Ashley Hartman, is another example of
the cutting-edge advertising for which our brands are known. Consumers can view
the commercial at the micro-website http://www.spicybuffalo.com," said Puzder
"Carl's Jr. also featured the Chipotle Chicken Salad(TM) during the period. On a
two-year cumulative basis, same-store sales at Carl's Jr. have increased
approximately seven and a half percent. Further, average unit volume for period
one was higher than any comparable period one in the brand's history." Revenue
for period one from company-operated Carl's Jr. restaurants (exclusive of
franchise-related revenue and royalties) was approximately $44.1 million."The Hardee's brand, which continued its positive same-store sales trend despite
less favorable weather in the current year, also launched the Buffalo Chicken
Sandwich and Ashley Hartman television spot during the period. As with Carl's
Jr., media began only during the last few days of the period. In addition,
Hardee's continued to promote the Big Twin(R), the Southwest Chicken Salad(TM),
and the aptly named Monster Biscuit(TM) during the breakfast daypart," Puzder
continued. "On a two-year cumulative basis, Hardee's same- store sales have
increased more than five and a half percent. In addition, Hardee's period one
average unit volume was higher than any comparable period one since fiscal 1994,
which is as far back as we can check." Revenue for period one from
company-operated Hardee's restaurants (exclusive of franchise- related revenue
and royalties) was approximately $48.2 million
Salix Pharmaceuticals, Ltd.
08.03.07 21:05 Uhr
12,80 USD
-0,16 % [-0,02]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SLXP.NAS&lColors=0x000000&sSym=SLXP.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=SLXP.NAS&lColors=0x000000&sSym=SLXP.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SLXP.NAS&lColors=0x000000&sSym=SLXP.NAS&hcmask=
Börse
NASDAQ
Aktuell
12,80 USD
Zeit
08.03.07 21:05
Diff. Vortag
-0,16 %
Tages-Vol.
6,79 Mio.
Gehandelte Stück
532.155
CHICAGO, Mar 05, 2007 (BUSINESS WIRE) --
Seeking Visibility on Salix Programs
Although we expect Salix Pharmaceuticals (Nasdaq: SLXP) to post decent top-line and bottom-line growth over the next few years, we remain concerned about the growth prospects of Colazal, the company's lead product. Colazal is likely to face intense competition with the entry of Shire's (Nasdaq: SHPGY) Lialda, and is also in danger of facing generics.
We believe that investor focus will remain on Salix's ability to execute on its life-cycle extension program for Colazal. Valuation is attractive in our view, but we would like more visibility on the Colazal life-cycle extension program before we recommend the shares. We rate the stock a Hold, with a $15 target.
We also believe that Salix offers average risk for the biotech group, but would like to see more proof that its antibiotic Xifaxan will drive shareholder value once the posted sales begin to match the prescription trends. While the company succeeded in bringing down inventory levels for Xifaxan and Colazal, it is still a long way from achieving normal inventory levels. This remains a matter of concern. The inventory situation together with the low visibility on Colazal will probably continue to keep the shares in check. Salix shares should be protected on the downside based on the potential to post 25% top-line growth over the next several years.
Halliburton´s Flucht nach Dubai
Mit der katastrophalen Pleite des einstigen Energieriesen Enron hat Houston, Texas, vor sechs Jahren seinen größten Arbeitgeber verloren. Jetzt zieht die Nummer Zwei ab: Halliburton, einer der größten Dienstleitser für die Öl- und Kriegsbranche, verlegt seinen Sitz nach Dubai. Für einige Manager wird es höchste Zeit.
Die jüngste Geschichte von Halliburton ist erstaunlich von vorne bis hinten. Das Unternehmen, das von 1995 bis 1999 vom heutigen amerikanischen Vize-Präsidenten Dick Cheney geführt wurde, hat in den letzten Jahren massiv von seiner Nähe zur Politik in Washington profitiert – und konnte ungestört walten. Es dauerte nicht lange, bis man seine Ausnahmeposition schonungslos ausnutzte und missbrauchte.
Das begann mit dem Einzug der amerikanischen Truppen im Irak. Von Anfang an war Halliburton mit dabei – das Unternehmen war für die Infrastruktur vor Ort verantwortlich, versorgte die Soldaten mit Unterkünften, Essen und Trinken, unterhielt Waschküchen und stellte schusssichere Westen und ähnliche Rüstung zur Verfügung. Dafür wurde Halliburton vom Steuerzahler entlohnt, den man nach allen Regeln der Kunst schröpfte.
Während das Unternehmen den Soldaten nämlich verdorbenes Essen servierte und verunreinigtes Flusswasser aus dem Euphrat anbot, stellte man Washington Fantasie-Rechnungen. Pro Cola-Dose wurden 45 Dollar abgerechnet, pro Wäsche-Sack 100 Dollar. Und mehrfech wurde berichtet, wie Halliburton-Mitarbeiter alte Trucks nach einer Panne am Straßenrand einfach stehen ließen und das Unternehme auf Staatskosten einen neuen anschaffte.
Ähnlich verhielt es sich mi Personalkosten: Hunderte von Arbeitern hatte Halliburton im Irak stationiert, für die es nichts zu tun gab. Sie saßen folglich untätig herum, mussten auf Anweisung aus dem Management aber zwölf Arbeitsstunden täglich abrechnen, für sieben Tage in der Woche.
Eine unabhängige Untersuchung ergab vor zwei Jahren, dass Halliburton mehr als 2,7 Milliarden Dollar in Washington direkt ergaunerte – das entspricht mehr als 10 Prozent des gesamten Auftragswertes von etwa 25 Milliarden Dollar, den Halliburton im Irak hatte. Möglich war das dank der Rückendeckung von Bush, Cheney und Co. Tom Davis, der republikanische Senator aus Virginia und Vorsitzender im Kommittee für Regierungsreformen in Washington, hatte offizielle Anfragen der Demokraten stets abgewiesen.
Die Geschäfte im Irak sind nicht der einzige Grund, warum Halliburton immer wieder in die Schusslinie gerät. Seit Jahren unterhält der Konzern beste Beziehungen in den Iran, mit dem amerikanische Firmen offiziell keine Geschäfte tätigen dürfen. Dass Halliburton ebendies über eine Tochtergesellschaft auf den Cayman Islands tat, machte die regelmäßigen Millionen-Deals legal – wenn auch nicht legitim.
Mit dem Regierungswechsel in Washington wären die nächsten Jahre ungemütlich geworden für Halliburton. Zahlreiche demokratische Politiker haben sich Untersuchungen gegen den Konzern auf die Fahnen geschrieben – dem entgeht man nun durch einen Schritt, der sich nur als Flucht klassifizieren lässt. Flucht vor der Verantwortung und den Folgen. Denn dass illegale Machenschaften auch Top-Manager ins Gefängnis bringen, das hat man beim Nachbarn Enron gesehen.
Lars Halter
WCI COMMUNITIES INC
13.03.07 16:21 Uhr
22,23 USD
+17,19 % [+3,26]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=WCI.NYS&lColors=0x000000&sSym=WCI.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=WCI.NYS&lColors=0x000000&sSym=WCI.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=WCI.NYS&lColors=0x000000&sSym=WCI.NYS&hcmask=
Börse
NYSE
Aktuell
22,23 USD
Zeit
13.03.07 16:21
Diff. Vortag
+17,19 %
Tages-Vol.
90,37 Mio.
Gehandelte Stück
4,8 Mio.
Icahn Affiliates to Make Tender Offer for Shares of WCI Communities, Inc. at $22.00 Per Share
NEW YORK, March 13, 2007 /PRNewswire via COMTEX/ -- Carl Icahn today announced that his affiliated entities, High River Limited Partnership and entities managed by Icahn Management LP, intend to initiate an "any and all" tender offer, not subject to any minimum condition, for the common stock of WCI Communities, Inc. at $22.00 per share.
Closing of the tender offer will be subject to, among other things, the redemption of the Company's recently adopted "poison pill" by the board. Mr. Icahn indicated that to the extent the current board prevents the conditions from being satisfied, he intends to leave the tender offer open and intends that our proposed nominees, if elected, would, subject to their fiduciary duties, cause the conditions to be met so that the $22.00 "any and all" tender offer can be consummated. The tender offer will not be subject to due diligence or financing.
Mr. Icahn stated that, "we believe that the board and CEO of WCI have not enabled the Company to maximize the potential of its unique set of assets which trade at a discount to their GAAP book value. If elected, we expect our slate, in a manner consistent with their fiduciary duties, to ensure these unique assets are properly marshaled through the current residential housing industry downturn."
WCI's board and CEO have stated emphatically and more than once that now is not the time to sell the Company. Mr. Icahn commented, "This is one of the very few times that management has been correct about anything." Mr. Icahn continued, "While clearly now is not the right time to sell, in my opinion Mr. Starkey and the current board are not qualified to navigate WCI through the difficult industry conditions that lie ahead. We question whether Mr. Starkey and the current board have the ability or the expertise to take advantage of the complex strategic opportunities that I believe may present themselves. Additionally, mergers, including the possible sale of the company in the future at the right time and price, may be overlooked by the current board."
Carl Icahn concluded that "this tender offer will be in the best interests of all shareholders in that it would provide immediate liquidity at a premium for those shareholders who are concerned with the current housing industry downturn while also providing the opportunity for those shareholders who, like us, believe in the long-term prospects of the company to realize any potential upside."
Accredited Home Lenders Holding Co.
13.03.07 16:42 Uhr
5,029 USD
-55,89 % [-6,371]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=LEND.NAS&lColors=0x000000&sSym=LEND.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=LEND.NAS&lColors=0x000000&sSym=LEND.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=LEND.NAS&lColors=0x000000&sSym=LEND.NAS&hcmask=
Börse
NASDAQ
Aktuell
5,029 USD
Zeit
13.03.07 16:42
Diff. Vortag
-55,89 %
Tages-Vol.
90,85 Mio.
Gehandelte Stück
18 Mio.
Accredited Pursuing Strategic Options
SAN DIEGO, Mar 13, 2007 (BUSINESS WIRE) -- Accredited Home Lenders Holding Co. (NASDAQ: LEND) ("Accredited" or "Company") announced today that it is currently exploring various strategic options, including raising additional capital to enhance liquidity and provide the Company with the flexibility to retain or sell originated loans based on an assessment of the best overall return. Accredited's available cash resources have been affected primarily by margin calls under its warehouse and repurchase facilities since January 1, 2007, all of which have been met to date, as well as ongoing loan repurchases. The Company reported that it has paid approximately $190 million in margin calls on its facilities since January 1, 2007. Approximately two-thirds of those margin calls have been received and paid since February 15, 2007.
In addition, Accredited is seeking waivers and extensions of waivers of certain financial and operating covenants under its warehouse and repurchase facilities, including waivers relating to required levels of net income. The Company has been operating under various waivers under these facilities since December 31, 2006. There can be no assurance that the Company will be successful in receiving any of the required waivers.
Accredited also reported that it is pursuing certain cost restructuring initiatives, including further workforce reductions.
The Company continues to evaluate impairment of the goodwill established in its acquisition of Aames Investment Corporation ("Aames") in the fourth quarter of 2006. In light of this evaluation, along with work that must be completed for the Company's year-end audit, it is unlikely that the Company will file its Annual Report on Form 10-K by March 16, 2007 as previously contemplated in its Notification of Late Filing on Form 12b-25 filed with the Securities and Exchange Commission on March 1, 2007.
j2 Global Communications Inc
13.03.07 16:56 Uhr
27,96 USD
+13,20 % [+3,26]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=JCOM.NAS&lColors=0x000000&sSym=JCOM.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=JCOM.NAS&lColors=0x000000&sSym=JCOM.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=JCOM.NAS&lColors=0x000000&sSym=JCOM.NAS&hcmask=
Börse
NASDAQ
Aktuell
27,96 USD
Zeit
13.03.07 16:56
Diff. Vortag
+13,20 %
Tages-Vol.
82,94 Mio.
Gehandelte Stück
3,1 Mio.
bellwetherreport.com: Shareholders alert for J2 Global Communications, Inc
Mar 13, 2007 (M2 PRESSWIRE via COMTEX) -- Shareholders alert for J2 Global Communications, Inc (NASDAQ: JCOM)
j2 Global Communications, Inc. provides outsourced, value added messaging and communications services to individuals and businesses worldwide. It offers an array of faxing solutions, including Web-based fax and fax broadcasting at eFax.com; and a suite of unified communications services, including fax, Web-based voicemail, and conference calling at j2.com; as well as a conference calling service to its business services at consensus.com and a unified communications service through Onebox.com. The company�s customer support services include support to its customers through a combination of on-line self-help, email messages, interactive chat sessions, and telephone calls. As of December 31, 2005, it had 54 physical points of presence, as well as delivered its services through its global telephony/Internet protocol network that covered approximately 2,000 cities in 26 countries across 5 continents. The company serves various customers, including individuals, small to medium-sized businesses, and enterprises and government organizations. j2 Global Communications was co-founded by Jaye Muller and Jack Riley in 1995 and is headquartered in Los Angeles, California.
Shares were up 6% after the outsourcing company brought its filings up to date.
Shares of J2 Global Communications Inc. rose in premarket trading Tuesday after the outsourcing company brought its filings up to date and said a price increase hasn't scared away many customers.
J2 Global, which delayed filing earnings reports because of an investigation into the timing of its stock options, filed two quarterly reports and an annual report Monday.
Based in Los Angeles, J2 Global provides faxing, voicemail and e-mail to companies looking to outsource communications processes. With $181 million in annual sales, J2 Global had 907,000 subscribers at the end of 2006.
Jefferies & Co. analyst Youssef Squali upgraded J2 Global to "Buy" from "Hold." He said the filings bring the investigation into options pricing to a close, which will focus investors on the company's promising prospects.
J2 Global raised prices 31 percent, Squali said, yet only 2.9 percent of customers let their subscriptions lapse. That's a little higher than normal, he said, but encouraging considering the price hike.
Squali raised his price target to $31 from $27. The new target is 25.5 percent higher than the stock's closing trade of $24.70 on the Nasdaq Stock Market Monday.
Google Inc.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Google hat den Abwärtstrend nicht verlassen!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Genta Incorporated
23.03.07 21:00 Uhr
0,402 USD
+1,85 % [+0,0073]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
Zur Bedeutungslosigkeit geschrumpft! Bei anderen Charts sieht man das genae Gegenteil. Aber es schaut nach einer Bodenbildung aUS1
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&ind0=VOLUME&¤cy=&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
Börse
NASDAQ
Aktuell
0,402 USD
Zeit
23.03.07 21:00
Diff. Vortag
+1,85 %
Tages-Vol.
792.551,94
Gehandelte Stück
2 Mio.
15.03.2007 14:01
Genta Announces Closing of Common Stock Offering
BERKELEY HEIGHTS, N.J., March 15 /PRNewswire-FirstCall/ -- Genta Incorporated (Nachrichten) announced that the Company has closed the previously announced offering of 30 million shares of common stock for gross proceeds totaling approximately $11 million before fees and expenses. The shares were sold pursuant to the Company's registration statement on Form S-3 declared effective by the Securities and Exchange Commission on May 11, 2004. Rodman&Renshaw, LLC served as the placement agent for the offering.
"The Company is looking forward to several key regulatory milestones, including the regulatory opinion from Europe on the Genasense marketing application for patients with advanced melanoma", said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer. "We are also on track to file this month our appeal of the initial decision by the U.S. Food and Drug Administration on Genasense in patients with relapsed and refractory chronic lymphocytic leukemia. Proceeds from this offering will be used to support general corporate activities, including product sales from the recently announced named-patient distribution programs for Ganite and Genasense, and we expect to ship the initial inventory for that program next week."
This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The shares of common stock may only be offered by means of a prospectus. Copies of the final prospectus supplement and accompanying base prospectus can be obtained from Rodman&Renshaw, LLC at 1270 Avenue of the Americas, New York, NY 10017. Fax # 212-356-0536
About Genta
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS on a program whereby both Ganite and Genasense are available to cancer patients on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com/.
Yahoo! Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
Bei Yahoo sehe ich mehr Potential als bei Google!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
Sonus Networks, Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
Hat sich super erholt!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
GrowthStockAlert.net: Stocks to Watch for Tuesday, March 27, 2007: (OTCBB: PGNE) , (NYSE:LUM), (PinkSheets: RCAU),. (NASDAQ: SONS), (PinkSheets: BIPH)
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- Stocks To Watch: PrimeGen Energy Corporation(OTCBB: PGNE) , Luminent Mortgage Capital, Inc (NYSE:LUM), SGT GROUP INC (PinkSheets: RCAU), Sonus Networks, Inc. (NASDAQ: SONS), Biophan Technologies (PinkSheets: BIPH)
FEATURED STOCK: PrimeGen Energy Corporation (OTCBB: PGNE) Current Price (1.50) www.growthstockalert.net
PrimeGen Energy's (OTCBB: PGNE) High Expectations for Upcoming Shale Gas Venture
The Fayetteville Shale play located in Van Buren, Stone and Cleburne Counties, has the potential to become a significant on-shore natural gas play.
PrimeGen Energy Corporation (OTCBB: PGNE) works to acquire interests in leaseholds that either are in production, near to production, or demonstrate significant exploration potential. PrimeGen Energy Corporation owns a 10% working interest in roughly 40,000 acres, where the geological characteristics are analogous to other successful projects in the area. PrimeGen is delighted to have attained membership in this upcoming shale gas venture.
Luminent Mortgage Capital, Inc (NYSE:LUM) Current Price (9.05) SAN FRANCISCO, March 21 -- Luminent Mortgage Capital, Inc. (NYSE: LUM - News) announced today that Dimitrios Papatheoharis, CFA will join Luminent Mortgage Capital, Inc. in April 2007 as Senior Vice President and Chief Investment Officer. Luminent Mortgage Capital, Inc., a real estate investment trust (REIT), invests primarily in the United States agency and other single-family, adjustable-rate, and fixed rate mortgage-backed securities. The company has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income tax purposes, provided that it distributes at least 90% of its REIT taxable income to its shareholders. Luminent Mortgage was founded in 2003 and is headquartered in San Francisco, California.
SGT GROUP INC (PinkSheets: RCAU) Current Price (1.70) ORLANDO, Fla.----CompleteAuto, an RCAU Company (Pink Sheets:RCAU - News), announced today that they have received certification from eBay Motors to operate as a Solutions Provider in eBay Motors' Local Market Program. Through their state-of-the-art vehicle listing software, CompleteAuto currently offers automobile dealers the ability to reach buyers all across the country through online auctions via eBay Motors. Certification by eBay Motors in the Launch of their new Local Market Program will now allow dealers to utilize the CompleteAuto software to bring more local buyers directly into their dealerships, making the eBay selling process more simplistic.
Sonus Networks, Inc.
(NASDAQ: SONS) Current Price (8.56) WESTFORD, Mass., March 22 -- Sonus Networks, Inc. (Nasdaq: SONS - News), a leading supplier of service provider Voice over IP (VoIP) infrastructure solutions, announced today that some of the industry's most innovative companies have joined the Sonus Interoperability Certification Program at the University of New Hampshire InterOperability Lab (UNH-IOL), which is designed to help promote successful interoperability in multi-vendor networks. The Sonus Certification program was launched as part of the Open Services Partner Alliance, the industry's pioneer Session Initiation Protocol (SIP) interoperability testing organization, to advance further network operators' ability to deploy solutions from multiple vendors within their networks.
Sonus Networks, Inc. is a leading provider of Voice over IP (VoIP) infrastructure solutions for wireline and wireless service providers. With its comprehensive IP Multimedia Subsystem (IMS) solution, Sonus addresses the full range of carrier applications, including residential and business voice services, wireless voice and multimedia, trunking and tandem switching, carrier interconnection and enhanced services. Sonus' voice infrastructure solutions are deployed in service provider networks worldwide.
Founded in 1997, Sonus is headquartered in Westford, Massachusetts. Additional information on Sonus is available at http://www.sonusnet.com
Biophan Technologies (PinkSheets: BIPH) Current Price (0.37) EL DORADO HILLS, Calif.---Dutton Associates updates its coverage of Biophan Technologies (OTCBB:BIPH - News) maintaining a Neutral rating. The 12-page report by Dutton senior analyst Richard W. West, CFA is available at www.jmdutton.com, and from First Call, Bloomberg, Zacks, Reuters, Knobias, and other leading financial portals. Biophan Technologies, Inc. engages in the development and commercialization of technologies for use with medical procedures and biomedical devices. Its technologies enable medical systems, such as pacemakers; interventional surgical devices, including catheters and guidewires; and implants, such as stents to be implantable, safe, and image compatible with magnetic resonance imaging (MRI). The company is also developing and marketing an image compatible ceramic motor; a system for generating power for implantable devices from body heat; and a series of implantable devices, including MRI-visible vascular implants, such as a vena cava filter, a heart valve, and an occluder for the treatment of atrial septal defects, a hole in the wall separating the left and right chambers of the heart. In addition, Biophan Technologies has interest in MYOTECH, LLC that develops and commercializes the MYO-VAD, MRI-compatible ventricular assist device for the treatment of heart disease. Further, it has joint development and licensing agreements with Boston Scientific Corporation, NASA Ames Center for Nanotechnology, and Nanoset, LLC, as well as has a cooperative research and development agreement with the U.S. FDA to develop standards for making pacemakers, defibrillators, and neurostimulators safe with MRI. The company was founded in 1963. It was formerly known as Idaho Copper and Gold, Inc. and changed its name to Idaho Technical, Inc. in 1999. Further, the company changed its name to GreatBio Technologies, Inc. in 2000 and to Biophan Technologies, Inc. in 2001. Biophan Technologies is headquartered in Pittsford, New York.
BUYINS.NET: PCYC, PGIC, NTRZ, CCCFF, FOLGF Have Also Been Removed From Naked Short List Today
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list:
Pharmacyclics Inc. (NASDAQ: PCYC),
Progressive Gaming International Corporation (NASDAQ: PGIC),
Nutracea (OTCBB: NTRZ),
Chai-Na-Ta Corp. (OTCBB: CCCFF),
Falcon Oil & Gas Ltd (OTC: FOLGF)
Pharmacyclics Inc. (NASDAQ: PCYC) a pharmaceutical company, is developing drugs to treat cancer and other diseases. Its pharmaceutical agents are synthetic small molecules designed to target key biochemical pathways in diseased cells. The company's principal development products include Xcytrin injection, an anti-cancer agent that is in phase II clinical trials; and Histone Deacetylase Inhibitor, a phase I clinical trial product that targets histone deacetylase enzymes and inhibits their function. Its other development products comprise HDAC-8 selective inhibitor, a preclinical stage drug for the treatment of cancer; a small molecule inhibitor of Factor VIIa, which has demonstrated anti-angiogenic and anti-cancer activity in the laboratory and inhibitors of tyrosine kinase enzymes; and B cell associated tyrosine kinase inhibitors for the treatment of lymphomas and autoimmune diseases. The company has a collaboration and license agreement with the National Cancer Institute. Pharmacyclics was founded in 1991 and is headquartered in Sunnyvale, California. With 25.94 million shares outstanding and 4.15 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of PCYC.
Progressive Gaming International Corporation (NASDAQ: PGIC) supplies integrated casino and jackpot management solutions for the gaming industry worldwide. It operates in two segments, Slot and Table Games, and Systems. The Slot and Table Games segment develops, acquires, licenses, and distributes proprietary branded and non-branded table games, such as World Series of Poker Texas Hold Em Bonus, Texas Hold Em Bonus, Caribbean Stud, Two-Card Joker Poker, Progressive Blackjack, Progressive Baccarat, and various blackjack and poker derivatives; and slot games, including licensed branded game offerings based upon popular brands, including KISS, Garfield, The Beach Boys, and Wink Martindale, as well as non-branded games and mystery concepts, such as Graveyard Bash and Office Daze. The System segment offers a suite of software systems under the Casinolink Enterprise Edition umbrella. The Casinolink Enterprise Edition comprises Casinolink Patron Suite, which offers reception, player tracking, and marketing functionality; Casinolink Intelligence Suite that provides casinos with products to manage cage and pit operations, cashless gaming, and slot accounting and security functionality; and Casinolink Gaming Suite, which provides casinos with slot jackpot management tools, player bonusing, and media management functionality, as well as sports wagering and server-based gaming products. This integrated suite of software products centralizes gaming management, including functions, such as slots and tables monitoring, reporting, and accounting across various casino properties. Progressive Gaming International's customers include casinos, other gaming suppliers, operators of wide-area gaming networks, and lottery authorities. The company was founded in 1986. It was formerly known as Mikohn Gaming Corporation and changed its name to Progressive Gaming International Corporation in 2006. The company is headquartered in Las Vegas, Nevada. With 34.67 million shares outstanding and 8.13 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of PGIC.
Nutracea (OTCBB: NTRZ) a health science company, engages in the development and distribution of stabilized rice bran and rice bran-based products for the consumer food and animal feed sectors. Its products include food supplements and medical foods for humans and animals, as well as cosmetics and beauty aids based on stabilized rice bran, rice bran derivatives, and rice bran oils. The company's customers include consumer nutrition and healthcare companies, domestic and international food companies, and companion animal feed manufacturers. NutraCea was founded in 2000. The company was formerly known as NutraStar Incorporated and changed its name to NutraCea in 2003. NutraCea is based in El Dorado Hills, California. With 87.12 million shares outstanding and 1.91 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of NTRZ.
Chai-Na-Ta Corp. (OTCBB: CCCFF) , based in Richmond, British Columbia, is the world's largest supplier of North American ginseng. The Company farms, processes and distributes North American ginseng as bulk root, and supplies processed material for the manufacture of value-added ginseng-based products. With 34.70 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of CCCFF.
Falcon Oil & Gas Ltd (OTC: FOLGF) is a British Columbia corporation which is in the business of oil and gas exploration and production. It has operations in Hungary through its wholly-owned subsidiary TXM Oil and Gas Exploration, LLC, and in Romania through its wholly-owned subsidiary JVX Energy Corporation. With 322.68 million shares outstanding and 25 shares declared short as of February 2007, there is no longer a failure to deliver in shares of FOLGF.
BUYINS.NET: MYS, IMX, CPWM, DCGN, GMXR, LMRA Have Been Removed From Naked Short List Today
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list:
Masisa S.A. (NYSE: MYS),
Implant Sciences Corporation (AMEX: IMX),
Cost Plus, Inc. (NASDAQ: CPWM),
deCODE genetics Inc (NASDAQ: DCGN),
GMX Resources Inc (NASDAQ: GMXR),
Lumera Corporation (NASDAQ: LMRA).
Masisa S.A. (NYSE: MYS) a vertically integrated forestry and wood products company, produces sawn lumber, saw and pulp logs wood boards, and solid wood products. Its principal board products include medium density fiberboard (MDF), particle board, and oriented strand board that are principally sold in the Latin American region. The company also produces products, such as MDF mouldings, finger-joint mouldings, and solid wood doors. Its other products comprise wood shavings, wood chips, sawdust, door parts, fiberboard doors, and pine veneer wood plies. Masisa sells its products primarily to the construction and furniture industries, primarily in Latin America and the United States, as well as to customers in other markets, such as Europe and Asia. The company was formerly known as Terranova S.A. and changed its name to Masisa S.A. in 2005. Masisa is headquartered in Santiago, Chile. Masisa S.A. is a subsidiary of Grupo Nueva S.A. With 113.36 million shares outstanding and 50,677 shares declared short as of February 2007, there is no longer a failure to deliver in shares of MYS.
Implant Sciences Corporation (AMEX: IMX) engages in the development, manufacturing, and marketing of products using ion implantation and thin film coatings for medical device applications and semiconductor wafer processing. It offers a range of medical products, including I-Plant Iodine-125 radioactive seed for the treatment of prostate cancer; treatment planning software that enables the physician in making two and three dimensional maps of the stage, grade, and location of cancer within the prostate gland; Ytterbium-192 for breast cancer therapy; orthopedic hip and knee total joint replacements; and biocompatible radiopaque and other coatings. The company also offers ion implantation and analytical services, and disk refurbishment services, as well as source conditioning equipment to semiconductor manufacturers, research laboratories, and research universities. In addition, it supplies trace explosives detection equipment, which detects the vapor from trace amounts of explosive compounds, including plastic explosives, such as RDX, the compound commonly found in C4 explosives. The company was incorporated in 1984 and is based in Wakefield, Massachusetts. With 11.8 million shares outstanding and 194,996 shares declared short as of February 2007, there is no longer a failure to deliver in shares of IMX.
Cost Plus, Inc. (NASDAQ: CPWM) and its subsidiaries operate as a specialty retailer of casual home furnishings and entertaining products in the United States. It offers a range of home decorating items, such as furniture, rugs, pillows, lamps, window coverings, frames, and baskets; furniture products, including ready-to-assemble living and dining room pieces, unusual handcrafted case goods, and occasional pieces; and outdoor furniture made from various materials, such as rattan, hardwood, and wrought iron. The company sells various tabletop and kitchen items, including glassware, ceramics, textiles, and cooking utensils. It also provides various gift and decorative accessories, including collectibles, cards, wrapping paper, and holiday and other seasonal items. In addition, the company offers a selection of gourmet foods and beverages, including wine, microbrewed and imported beer, coffee, tea, and bottled water. As of March 31, 2006, Cost Plus operated 271 stores under World Market, Cost Plus World Market, Cost Plus Imports, and World Market Stores names in 34 states. The company was founded in 1946 and is headquartered in Oakland, California. With 22.08 million shares outstanding and 6.24 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of CPWM.
deCODE genetics Inc. (NASDAQ: DCGN) operates as a biopharmaceutical company in the United States and Iceland. It applies its discoveries in human genetics to the development of drugs for common diseases. The company involves in human genetics, and integrated drug discovery and development activities to offer products and services in various areas, including DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery, and clinical development. It develops DG031 for the prevention of heart attack that completed a series of Phase II clinical trials in Iceland; and DG041 for peripheral artery disease, a form of atherosclerosis that constricts blood flow to the legs and arms, which completed the Phase I clinical program, as well as conducts a Phase II trial on behalf of the developer of a compound for asthma. deCODE genetics has a strategic alliance with Illumina, Inc. for the development and commercialization of DNA-based diagnostic tests in various disease areas; a collaboration with F. Hoffmann-La Roche for the codevelopment of inhibitors of PDE4 for the prevention and treatment of vascular disease; and an alliance with Merck & Co, Inc. to develop treatments for obesity. The company was co-founded by Kari Stefansson and Jeffrey Gulcher in 1996 and is headquartered in Reykjavik, Iceland. With 61.54 million shares outstanding and 5.13 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of DCGN.
GMX Resources Inc. (NASDAQ: GMXR) and its subsidiaries engage in the acquisition, exploration, and development of properties for the production of crude oil and natural gas in Texas, Louisiana, and New Mexico. Its drilling, development, and production activities primarily focus on the Cotton Valley Sands in the Carthage, North Field of Harrison and Panola counties of east Texas. As of December 31, 2006, the company had proved reserves of 258,403 million cubic feet of natural gas equivalent and 95.8 net producing wells. It also has a joint development agreement with Penn Virginia Oil & Gas, L.P. for the development of properties in Carthage, North Field. The company was founded in 1998 and is headquartered in Oklahoma City, Oklahoma. With 11.24 million shares outstanding and 1.69 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of GMXR.
Lumera Corporation (NASDAQ: LMRA) engages in the development, manufacture, and marketing of devices using proprietary polymer materials primarily in the United States. It offers proprietary polymer materials and products based on these materials for bioscience and electro-optics markets. The company's products include biotechnology disposables, which are manufactured with a proprietary polymer coating and process to provide high sample spot density for cost effective solutions for bioassay testing; and electro-optic devices, which translates and encodes data from electronic signals into optical signals that can be used in communications systems and in optical interconnects for high-speed data communication. Its bioscience products are used for DNA and protein analysis, drug development, screening and drug toxicity testing. The company's electro-optic device is used in satellite communications, optical switching for telecom components, high speed signal processing, terahertz imaging, and defense/aerospace. In addition it develops customized polymer-based applications for government agencies. Lumera Corporation was founded in 2000 and is headquartered in Bothell, Washington. With 16.95 million shares outstanding and 3.41 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of LMRA.
Wall Street News Alert: Breaking News Alert - UCPI! March 27, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, Mar 27, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Unicorp Inc., (OTCBB: UCPI),
Anadarko Petroleum Corporation (NYSE: APC),
Exxon Mobil Corporation (NYSE: XOM) and
Baker Hughes Incorporated (NYSE: BHI).
Investors should be watching Unicorp Inc., (OTCBB: UCPI) for activity this morning. Yesterday after the markets closed, the company (engaged in the acquisition, development, exploration and production of crude oil and natural gas) issued a press release announcing that operations to complete its South Creole Prospect located in Cameron Parish, Louisiana have been initiated and expects that the well will be perforated within the next several days.
This is expected to be good news! Expectations are for this prospect to double Unicorp's existing revenue. The electric logs indicated approximately 35 feet of pay and the expectations are for this well to come online at approximately 3 Mmcfpd gross gas production.
The South Creole Prospect was drilled to a depth of approximately 11,300 feet targeting the Planulina A formation. Total reserves are estimated to be 2.5 Bcf of natural gas with associated condensate production. Unicorp has a 28.3% before payout working interest and approximately a 21% net revenue interest in the well.
Last Week Unicorp announced results of operations including revenue up over 280% for 2006 and the expectations that revenue for 2007 will be up over 300% versus 2006. Based upon the current projects to which Unicorp is participating, the company is projecting revenue for fiscal 2007 in excess of $4,000,000 and gross profit from oil and gas operations excluding depletion in excess of $3,000,000.
The company had previously provided guidance that gross profit for 2007 would triple based upon its current prospects and reaffirms this projection. Unicorp previously reported it would be profitable from operations excluding non-cash charges during the first quarter of 2007 but now expects to achieve this during the second quarter of 2007.
Unicorp is not just prospecting; this company is generating revenue from oil! It is still anticipated that gross oil production, from the North Laurel Ridge Prospect will be approximately 400 barrels of oil per day. Unicorp has a 21% working interest and an approximate 16% net revenue interest in the well.
Before the news hit the wires, Unicorp's stock closed yesterday at Thirty Five cents a share.
In case you are not familiar with the company:
Unicorp, Inc. is primarily engaged in the acquisition, development, exploration and production of crude oil and natural gas. Its focus is on aggressively acquiring working interests in crude oil and natural gas properties with the intent of exploration and development or by enhancing production through the use of modern development techniques such as horizontal drilling, satellite technology and 3-D seismic. The company's goal is to achieve a high return on its investment by limiting its up-front acquisition costs, by quickly developing its acquisitions and by practicing a sound and smart approach to oil and gas exploration and development.
Anadarko Petroleum Corporation (NYSE: APC) up 2.4% on 7.9 million shares traded. Anadarko Petroleum Corporation's mission is to deliver a competitive and sustainable rate of return to shareholders by exploring for, acquiring and developing oil and natural gas resources vital to the world's health and welfare.
Exxon Mobil Corporation (NYSE: XOM) up 0.5% on 27.5 million shares traded. Exxon Mobil Corporation is an international energy company whose subsidiaries have operations in many countries and territories.
Baker Hughes Incorporated (NYSE: BHI) up 0.4% on 3.2 million shares traded. Baker Hughes is one of the leading providers of drilling, formation evaluation, completion and production products and services to the worldwide oil and gas industry.
US-Touristenbranche sorgt sich um Einwanderungs-Schikanen
Es wird Frühling in New York, und mit den Kirschblüten im Central Park erwacht eine Industrie aus dem Winterschlaf: die Tourismus-Branche. In den nächsten Monaten werden Millionen Menschen kamera-behängt in der Weltstadt am Hudson, bei den Niagara-Fällen, im Grand Canyon und in L.A. einfallen – hoffentlich.
Denn die Zeiten sind vorbei, in denen der Zustrom internationaler Touristen in den USA stetig zunahm. Von einem dramatischen Einbruch unmittelbar nach den Terror-Attacken auf das World Trade Center hat sich die Branche zwar weitgehend erholt. Im vergangenen Jahr wurden US-weit 51,1 Millionen Touristen gezählt und damit etwa so viele wie im Rekord-Jahr 2000. Doch von den einst vom Handelsministerium prognostizierten 60 Millionen ist man weit entfernt.
Darum sorgt sich die „Discover America Partnership“, ein Branchenverband, in dem sich Vertreter zahlreicher Touri-orientierten Unternehmen zur gemeinsamen Lobby-Arbeit zusammengeschlossen haben. Im Gremium sitzen die CEO von Hotelketten und Casinos, von Freizeitparks, Messezentren und Mietwagen-Firmen. Sie alle haben ein Ziel vor Augen: Jedes Jahr mehr internationale Touristen ins Land der unbegrenzten Möglichkeiten zu locken. Doch das wird immer schwieriger.
Dabei ist es gar nicht einmal das politische Umfeld, dass die USA in den letzten Jahren für Besucher unattraktiver gemacht hätte. Republikanische Hardliner hin, Irakkrieg her, Touristen können laut einer groß angelegten Studie über solche Probleme hinwegsehen. Auch eine etwaige Terror-Gefahr nehmen die Besucher in Kauf – was sie abschreckt, ist vielmehr der Terror-Schutz. Der hat nämlich dazu geführt, dass die Einreise am New Yorker und an anderen Flughäfen in den letzten Jahren zu einem wahren Albtraum geworden ist.
39 Prozent der befragten internationalen Touristen erklären, die Einreise in die USA ist die schwierigste überhaupt – angefangen von der Beschaffung des Visums bis hin zu langen Schlangen und unfreundlichen Beamten am Einreise-Schalter. 66 Prozent der Touristen haben Angst, schon wegen eines klitzekleinen Fehlers auf einem Dokument stundenlang festgehalten oder gar zurückgeschickt zu werden.
Nur magere 12 Prozent der Touristen – befragt wurden Reisende aus 16 Ländern von China und Russland über Deutschland und Frankreich bis hin zu Argentinien und Kolumbien – halten den Einreise-Service in die USA für „einladend und freundlich“. Doppelt so viele sprechen sich für die Einreise in ein europäisches Land aus.
Entsprechend hat sich das Reiseverhalten angepasst: Die Zahl britischer Touristen in den USA ist in den letzten sechs Jahren von 4,7 aus 4,2 Millionen gefallen. Aus Japan kamen einst 5 Millionen und heute nur noch 37 Millionen, unter den Franzosen zieht es jährlich 790 000 in die Vereinigten Staaten, wohin einst 1 Million reisten.
Für einen kleinen Ausgleich sorgen steigende Touristenzahlen aus China, Indien, Südkorea und Mexiko – doch macht eben diese Verschiebung der Branche Sorgen. Denn Besucher aus den genannten Ländern geben weniger Geld aus als Europäer und Japaner.
Entsprechend fordert man nun Maßnahmen, den Trend umzukehren. Der Branchenverband denkt an ein Programm für „registrierte Reisende“, die am Flughafen schneller abgewickelt werden könnten. Oder an eine Visum-Bearbeitung von unter dreißig Tagen für Touristen. „Wir wollen auf keinen Fall die Sicherheit mindern“, meint Verbandssprecher Geoff Freeman. „Wir können und müssen aber effizienter arbeiten.“
Lars Halter -
27.03.2007 19:59
Merck & Co. erzielt erneut Erfolg in Vioxx-Prozess
Whitehouse Station, NJ (aktiencheck.de AG) - Der US-Pharmakonzern Merck&Co. Inc. (ISIN US5893311077 (Nachrichten/Aktienkurs)/ WKN 851719) hat am Dienstag einen weiteren Prozesserfolg gegen einen Vioxx-Kläger erzielt.
Demnach hat ein Geschworenengericht in Edwardsville im Bundesstaat Illinois den Pharmakonzern von dem Vorwurf freigesprochen, für den tödlichen Herzinfarkt einer 52-jährigen Frau im Jahr 2003 verantwortlich zu sein. Nach Aussagen der Jury war nicht die Einnahme von Vioxx sondern andere Ursachen wie etwa das starke Übergewicht der Auslöser für den tödlichen Herzinfarkt.
Dieser Prozessgewinn ist der zehnte von bisher 15 Verfahren. Merck&Co. hatte Vioxx im Jahr 2004 vom Markt genommen, nachdem entsprechende Risiken aufgetreten waren.
Die Aktie von Merck&Co. verliert derzeit an der NYSE 0,58 Prozent auf 43,81 Dollar. (27.03.2007/ac/n/a)
Nuvelo, Inc.
27.03.07 20:03 Uhr
4,01 USD
+29,77 % [+0,92]
KGVe:
--
DIVe:
0,00%
https://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NUVO.NAS&lColors=0x000000&sSym=NUVO.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NUVO.NAS&lColors=0x000000&sSym=NUVO.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&&lSyms=NUVO.NAS&lColors=0x000000&sSym=NUVO.NAS&hcmask=
Ein WAHNSINNSCHART!!!!!!!!!!!!!!!!
Absolut brutal!
Börse
NASDAQ
Aktuell
4,01 USD
Zeit
27.03.07 20:03
Diff. Vortag
+29,77 %
Tages-Vol.
72,77 Mio.
Gehandelte Stück
23 Mio.
Biotech News: Morning Alert for Nuvelo Inc
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- Morning Alert for Nuvelo Inc (NASDAQ: NUVO)
Nuvelo, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for acute cardiovascular and cancer therapy. Its development pipeline includes three acute cardiovascular programs: alfimeprase, a direct-acting thrombolytic that is in Phase III clinical trials for the treatment of thrombotic-related disorders; rNAPc2, an anticoagulant that inhibits the factor VIIa and tissue factor protease complex that is in Phase II clinical development for acute coronary syndromes; and a thrombin inhibiting aptamer for anticoagulation during medical procedures. In addition, the company is developing NU206 for the treatment of chemotherapy/radiation therapy-induced mucositis, as well as rNAPc2 for use as a cancer therapy. Further, the company has two ongoing drug discovery programs focused on the identification of human genes that encode proteins with therapeutic potential. The company has strategic alliances with Amgen, Inc.; Dendreon Corporation; Kirin Brewery Co., Ltd.; Bayer HealthCare AG; and Archemix Corporation. Nuvelo was founded in 1991 and is headquartered in San Carlos, California.
Shares were up 30% after the Food and Drug Administration has granted "fast-track" status to its colon cancer drug candidate.
Electronic Clearing House, Inc.
27.03.07 20:08 Uhr
12,45 USD
-33,10 % [-6,16]
https://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ECHO.NAS&lColors=0x000000&sSym=ECHO.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ECHO.NAS&lColors=0x000000&sSym=ECHO.NAS&hcmask=
https://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ECHO.NAS&lColors=0x000000&sSym=ECHO.NAS&hcmask=
Börse
NASDAQ
Aktuell
12,45 USD
Zeit
27.03.07 20:08
Diff. Vortag
-33,10 %
Tages-Vol.
23,06 Mio.
Gehandelte Stück
2,1 Mio.
ECHO Terminates Intuit Merger Agreement, Cooperates In Federal Online Gambling Probe
Mar 27, 2007 (financialwire.net via COMTEX) -- March 27, 2007 (FinancialWire) Electronic Clearing House Inc. (NASDAQ: ECHO), a provider of electronic payment and transaction processing services, has mutually agreed with Intuit Inc. (NASDAQ: INTU) to terminate the merger agreement entered into by the companies on December 14, 2006. In connection with the termination, ECHO and Intuit agreed to release each other from all claims arising under or related to the terminated merger agreement.
Additionally, ECHO has revealed that it has been cooperating as a witness in a federal investigation relating to its Internet wallet customers that provided services to online gaming web sites. Pursuant to a non-prosecution agreement expected to be executed shortly, the government will assure ECHO that it will not pursue any action against the company. ECHO has in turn agreed to disgorge $2.3 million, which represents management's estimate of the company's profits from processing and collection services provided to its Internet wallet customers since 2001, and to continue cooperating as a witness in that investigation.
The company expects to incur additional legal expenses related to the federal investigation. Earlier in 2007, ECHO ceased all processing and collection services for its remaining Internet wallet customers.
CV Therapeutics, Inc.
27.03.07 20:19 Uhr
8,04 USD
+19,11 % [+1,29]
https://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CVTX.NAS&lColors=0x000000&sSym=CVTX.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CVTX.NAS&lColors=0x000000&sSym=CVTX.NAS&hcmask=
https://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CVTX.NAS&lColors=0x000000&sSym=CVTX.NAS&hcmask=
Börse
NASDAQ
Aktuell
8,04 USD
Zeit
27.03.07 20:19
Diff. Vortag
+19,11 %
Tages-Vol.
96,85 Mio.
Gehandelte Stück
13 Mio.
Von GESTERN:
Biotech News: CV Therapeutics, Inc. is Added to Watch List
Mar 26, 2007 (M2 PRESSWIRE via COMTEX) -- CV Therapeutics is a development-stage company specializing in small-molecule drugs to treat chronic cardiovascular diseases. The firm's FDA-approved Ranexa, licensed from a Roche subsidiary, treats chronic angina for select patients by altering metabolism. Products in development include Tecadenoson, which potentially treats heart arrhythmias, and Regadenoson, which is a potential cardiac imaging agent. The company has decided to end a co-promotion agreement with Solvay Pharmaceuticals, through which it had marketed hypertension drug ACEON, to focus on commercializing Ranexa.
Shares were down 20% on analyst downgrade.
04.04.2007 20:11
Monster Worldwide: Kurseinbruch übertrieben - sagt Broker
Der Aktienkurs von Monster Worldwide (Nachrichten) ist derzeit massiv unter Druck. Die Muttergesellschaft des Online-Jobvermittlers Monster.com hatte heute eine scharfe Umsatzwarnung abgegeben und dafür geringere Einnahmen aus der Internet-Werbung und dem E-Commerce verantwortlich gemacht.
Die Aktie bekommt jetzt aber Rückendeckung vom Brokerhaus Thomas Weisel. Der Job-Titel sei jetzt überverkauft, heißt es. Das Unternehmen sei in der Lage, seine Kosten aggressiv auf das niedrigere Umsatzniveau zu drücken.
Langfristig sollte die Internationalisierungsstrategie des Online-Dienstleisters zu einem robusten Umsatzswachstum führen. Da sich die Margen dabei auch allmählich wieder verbesserten, sollten die Gewinne in den kommenden Quartalen steigen. Thomas Weisel rät daher, die aktuelle Kursschwäche für Schnäppchenkäufe zu nutzen.
Die Aktie fällte dennoch im Moment 13,5% auf 41,97 Dollar.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MNST.NAS&lColors=0x000000&sSym=MNST.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MNST.NAS&lColors=0x000000&sSym=MNST.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MNST.NAS&lColors=0x000000&sSym=MNST.NAS&hcmask=
Biogenerics Limited Provides Company Update
TYLER, Texas, Apr 11, 2007 (PrimeNewswire via COMTEX) -- Biogenerics Limited (Other OTC:BIGN) Board of Directors is pleased to provide its shareholders with the following company update.
James Lancaster, CEO, is pleased to report that, "All previously announced transactions are proceeding and updates on these will be placed on the Company's web site and announced in detail in future press releases."
The WW Oil and Gas Inc. dividend shares have been issued by the Transfer Agency and, in some cases, have already been received by shareholders. Shares that have to clear the Deposit Transfer Corporation to be further credited to brokerage firms may take up to 90 days to complete. Shareholders will receive 1 (one) WW Oil and Gas Inc. common restricted share for every 19 (nineteen) Biogenerics Ltd. shares held as of the January 2, 2007 record date.
Biogenerics is actively continuing its finalization of the Winfield Oil Field transaction. Mr. Lancaster stated, "This transaction is proceeding nicely within the time frame as indicated by the Company's previous press release."
Website: http:/www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc and Hydroslotter Corp.
BUYINS.NET: APNO, EDNE, SWRI, TPLM, WITM, ILKG Have Also Been Added To Naked Short List Today
Apr 11, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list:
Alpha Innotech Corporation (OTCBB: APNO),
Eden Energy Corp. (OTCBB: EDNE),
Seawright Holdings (OTCBB: SWRI),
Triangle Petroleum Corporation (OTCBB: TPLM),
Wits Basin Precious Minerals, Inc (OTCBB: WITM),
Interlink Global (OTC: ILKG).
Alpha Innotech Corporation (OTCBB: APNO) engages in the development, manufacture, and marketing of digital imaging and analysis systems for the life science research and drug discovery markets in the United States and internationally. It primarily offers two product lines, macroimaging and microimaging. Macroimaging product line consists of digital imaging systems that are used to detect, archive, and analyze fluorescent, chemiluminescent, and visible signals from biological samples, such as DNA, proteins and bacterial colonies; and other products comprising a multicolor illuminator module for the company's imaging systems; software for analysis of 2-D' protein gels; reagents for use in chemiluminescent applications; and software packages for electronic document security. Microimaging product line includes AlphaScan laser scanner and the NovaRay detection platform for researchers to analyze slides or multiwell microplates printed' with genomic, proteomic, or cellular samples, as well as fixed cell cultures. This product line also comprises ArrayVision data collection software for use with the AlphaScan laser scanner and the NovaRay detection platform. The company's products are used by the pharmaceutical companies, academic/medical institutions, biotechnology companies, and government institutes in various applications, including laboratory tests or assays in markets consisting of lead optimization, cell-based assays, enzyme assays, protein kinase, in-vitro toxicology, functional assays, antiviral assays, and novel targets panel. The company markets its products through a network of direct sales representatives and independent manufacturers' representatives in the United States, as well as through a network of independent distributors internationally. The company was founded in 1992 and is headquartered in San Leandro, California. With 9.89 million shares outstanding and 32 shares declared short as of March 2007, there is a failure to deliver in shares of APNO.
Eden Energy Corp. (OTCBB: EDNE) focuses on large-scale oil and gas projects with significant resource potential. Its Noah project in eastern Nevada contains exceptionally rich source rocks, large thrusted fault blocks, and an excellent potential reservoir rock. The Chinchaga prospect in Northern Alberta also targets dolomitized Devonian reservoirs and its large resource potential fits well with the Company's goals. These high-potential projects are balanced by the lower-risk development project at White River Dome in Colorado. With 42.04 million shares outstanding and 216,968 shares declared short as of March 2007, there is a failure to deliver in shares of EDNE.
Seawright Holdings (OTCBB: SWRI) a development stage company, through its subsidiary, Seawright Springs, LLC, engages in developing, bottling, and distributing spring water in the United States. The company was founded in 1999 and was formerly known as Pre-Settlement Funding Corporation and changed its name to Seawright Holdings, Inc. in 2003. Seawright Holdings is based in Alexandria, Virginia. With 9.1 million shares outstanding and 3,801 shares declared short as of March 2007, there is a failure to deliver in shares of SWRI.
Triangle Petroleum Corporation (OTCBB: TPLM) is an exploration company focused on the Fayetteville Shale project in Arkansas, the Barnett Shale project in Texas, and resource plays in select areas of the western United States. An experienced team comprising technical and business skills has been formed to optimize the Company's opportunities through its operating subsidiaries, Triangle USA Petroleum Corporation in the United States and Elmworth Energy Corporation in Canada. With 22.2 million shares outstanding and 1,098 shares declared short as of March 2007, there is a failure to deliver in shares of TPLM.
Wits Basin Precious Minerals, Inc. (OTCBB: WITM) an exploration stage company, together with its subsidiaries, engages in the exploration and development of mineral properties in South Africa; Canada; and Colorado, the United States. It holds indirect interests in the FSC Project, an exploration project adjacent to the Witwatersrand goldfields in South Africa. The company also owns exploration rights in the Holdsworth Project, a property consisting of 19 contiguous patented mining claims covering approximately 304 hectares in the Wawa area near the town of Hawk Junction, Ontario, Canada; and in the Bates-Hunter Gold Mine in Central City, Colorado. In addition, Wits Basin has an option to earn a 70% interest in five mining claims covering approximately 1,295 hectares in the McFaulds Lake area of the James Bay Lowlands, Attawapiskat Region of northern Ontario. The company was incorporated as Meteor Industries, Inc. in 1992 and changed its name to Active IQ Technologies, Inc. in 2001. Further, it changed its name to Wits Basin Precious Minerals, Inc. in 2003. Wits Basin Precious Minerals is headquartered in Minneapolis, Minnesota. With 91.39 million shares outstanding and 54,668 shares declared short as of March 2007, there is a failure to deliver in shares of WITM.
Interlink Global (OTC: ILKG) founded in 2002, provides telecommunication solutions around the world. As a leader in hosted VoIP telephony services, Interlink Global is currently doing business in North America, South America, the Middle East, and, soon in the Pacific. Interlink Global provides SIP-based broadband telephony solutions, WiFi applications, IV-PBX (Interlink Virtual PBX), Videophone Services, and other enterprise solutions, nationally and internationally. Interlink Global, using VoIP technology, provides long distance telephone services, with full features, at prices that are greatly reduced in comparison with traditional telephone companies. With 29.21 million shares outstanding and an undisclosed short position, there is a failure to deliver in shares of ILKG.
Dow muss feindliche Offerte fürchten
von Michael Gassmann und James Politi (New York) und Guido Warlimont (Hamburg)
Die Gefahr einer feindlichen Übernahme ist für Dow Chemical noch nicht gebannt. Nach dem Rauswurf zweier Topmanager, die hinter dem Rücken des Verwaltungsrats mit Kaufinteressenten verhandelt haben sollen, erwarten Kenner der Branche nun erst recht Angebote für den US-Chemiekonzern.
http://www.ftd.de/asset/Image/2007/01/30/dow1.jpg
Eine Fabrik von Dow Chemical in Midland, Michigan
Konzernchef Andrew Liveris hatte die zwei Manager vorigen Donnerstag abrupt abgesetzt. Nach Informationen der Financial Times sollen sie Gespräche mit einer Gruppe von Interessenten geführt haben, die von Investoren aus dem Sultanat Oman angeführt wurde. Analysten und Fondsmanager rechnen damit, dass deren Kaufinteresse fortbesteht.
Eine Übernahme des größten amerikanischen Chemiekonzerns könnte auch Folgen für Weltmarktführer BASF haben. Beide Unternehmen haben eine ähnliche Struktur mit der Kombination aus Massenchemie, Pflanzenschutz, Spezialchemie und Kunststoffen. Bei einer Aufspaltung von Dow Chemical würden die Karten in der Branche neu verteilt. Der Börsenwert des US-Konzern liegt derzeit bei etwas mehr als 44 Mrd. $. Ein Übernahmeangebot dürfte einschließlich Prämie voraussichtlich bei rund 50 Mrd. $ liegen.
Der entlassene Spitzenmanager Romeo Kreinberg wies die Anschuldigungen entschieden zurück. "Sie beschädigen meinen Ruf, nachdem ich 30 Jahre für das Unternehmen gearbeitet habe", sagte Kreinberg der Agentur Bloomberg. Er und sein Kollege Pedro Reinhard seien als Sündenböcke geopfert worden, um die seit Monaten anhaltenden Gerüchte um eine feindliche Übernahme zu beenden. Der Konzern habe keinerlei Beweise vorgelegt.
Machtkampf um Strategie vermutet
http://www.ftd.de/asset/Image/2007/04/15/dowchemicalsparten.gif
Anteil der Dow-Chemical-Sparten am Etat
"Die Informationen stammen aus einer äußerst zuverlässigen Quelle, in die wir großes Vertrauen haben", sagte ein Dow-Sprecher. Die Entlassungen erfolgten nach einem Gespräch zwischen Vorstandschef Liveris und Jamie Dimon, dem Chef der Investmentbank JP Morgan erfuhr die FT. Das Vorgehen der Investmentbank erscheint problematisch, zumal sie parallel an Gesprächen mit den Investoren aus dem Oman beteiligt gewesen sein soll. Weder Dow Chemical noch JP Morgan wollten sich dazu äußern.
Hinter den spektakulären Entlassungen könnte ein Machtkampf um die strategische Ausrichtung des Konzerns stecken. Dabei wird die bisherige Integration der Geschäftsbereiche infrage gestellt. Bereits Mitte März hatten indische und amerikanische Medien über Verhandlungen zwischen Dow Chemical und dem indischen Konzern Reliance zur Bildung eines Joint Ventures für die Massenchemie berichtet.
Google läuft allen davon
Da mögen die amerikanischen Börsen noch so klettern, es gibt eine Aktie, die unter allen aufstrebenden Papieren einen besonderen Stand hat: Google. Die Suchmaschine wächst und wächst, und straft Kitiker Lügen, die einmal geglaubt haben, dass man außerhalb der Online-Suche kaum Marktchancen haben werde.
Seit einigen Wochen scheint sich Google regelrecht neu zu erfinden. So wie einst Amazon.com vom überschaubaren Online-Buchhändler zum größten Internet-Retailer geworden ist, so befreit sich Google von der Bezeichnung Suchmaschine und mutiert immer mehr zum König aller Medien.
Bereits vor einigen Wochen hat das Unternehmen mit dem Verkauf von Fernseh-Werbung begonnen, ganz aktuell kommt über einen Deal mit Clear Channel Radio auch Hörfunk-Werbung dazu. Auch mit Zeitungen kooperiert das Unternehmen. Damit ist Google gelungen, was kaum einer dem Hightech-Startup zugetraut hatte: der Sprung in die alten Medien.
Doch dürfte der für Google äußerst lukrativ sein. Denn nicht nur in der Online-Werbung liegt gewaltiges Umsatzpotenzial. Im Gegenteil: Seit Jahren bemüht sich die Internetbranche mit überschaubarem Erfolg um lokale und regionale Werbekunden. Doch für den örtlichen Bäcker und die Kneipe um die Ecke hat es sich bislang nur in Ausnahmefällen bezahlt gemacht, im Netz auf Kundenfang zu gehen oder auch nur eine eigene Website zu unterhalten.
Seit aber Google die Internetsuche – beispielsweise über Google Earth und dessen Ableger für Mobilfunk-Geräte – regionalisiert hat und Werbung entsprechend ortsgebunden verlinken kann, hat sich die Situation geändert. Die Kombo-Schaltung mit lokalen Fernseh- und Radiosendern und der Heimatzeitung macht das World Wibe Web für alle Unternehmen interessant, nicht nur für diejenigen, die tatsächlich „world wide“ werben wollen.
Google ist wohlgemerkt nicht das einzige Unternehmen, dem der Spagat zwischen alten und neuen Medien gelingt. Auch der größte Konkurrent Yahoo hat gerade eine Kooperation mit Zeitungen angekündigt.
Doch ist Google mit Abstand die Nummer Eins am Markt, und durch die jüngst bekannt gewordene Übernahme des Abzeigen-Vermittlers DoubleClick hat man den Vorsprung ausgebaut. Zu weit, wie die Konkurrenten meinen. Microsofts Internet-Tochter MSN, der Time-Warner-Ableger AOL und weitere Online-Provider fürchten, von einem allzu starken Google-Service in die Ecke gedrängt zu werden. Das könnte durchaus passieren, weil sich diese Unternehmen seit Jahren erstaunlich konservativ zeigen und kaum Innovationen gebracht haben, während Google dem Internet fast wöchentlich neue Applikationen und Umsatzmärkte entlockt.
Die Konkurrenz wendet sich nun an die Wettbewerbsbehörden. Die werden einen Deal zwischen Google und DoubleClick nicht auf die leichte Schulter nehmen, denn immerhin kontrollieren die Partner gemeinsam 80 Prozent des Online-Anzeigenmarktes. Durchgehen dürfte die Übernahme allerdings, zumal Google durch die Ausweitung seiner Geschäfte in Print, Radio und TV natürlich nicht mehr als reiner Online-Dienst gilt und in anderen Bereichen keineswegs marktführend ist.
Damit wiederum bleibt Microsoft, AOL und Co. nur eines übrig: Eigene Ideen müssen her. Es wird wohl nicht gelingen, Google auszubremsen, vielmehr sollten die Konkurrenten einen Zwischensprint einlegen.
Lars Halter -
Antigenics Inc.
16.04.07 21:26 Uhr
4,35 USD
+18,53 % [+0,68]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
Börse
NASDAQ
Aktuell
4,35 USD
Zeit
16.04.07 21:26
Diff. Vortag
+18,53 %
Tages-Vol.
53,12 Mio.
Gehandelte Stück
12 Mio.
Biotech News: Shareholders alert for Antigenics Inc
Apr 16, 2007 (M2 PRESSWIRE via COMTEX) -- Shareholders alert for Antigenics Inc (NASDAQ: AGEN)
Antigenics, Inc., a biotechnology company, through its subsidiaries, engages in the development of technologies and products to treat cancers, infectious diseases, and autoimmune disorders, primarily based on immunological approaches. It offers Oncophage, a personalized therapeutic cancer vaccine candidate, which is in Phase 3 clinical trials for the treatment of renal cell carcinoma and for metastatic melanoma. The company also offers AG-858, which is in Phase 2 clinical trial for the treatment of chronic myelogenous leukemia; AG-707, a therapeutic vaccine program that is in Phase 1 clinical trial for the treatment of genital herpes; Aroplatin, a liposomal chemotherapeutic, which is in Phase 1 clinical trial for the treatment of solid tumors and non-Hodgkin�s lymphoma; and QS-21, an adjuvant used in various vaccines, including hepatitis, lyme diseases, human immunodeficiency virus, influenza, cancer, and malaria. The company was founded as Antigenics L.L.C. in 1994 and changed its name to Antigenics, Inc. in 2000. Antigenics is headquartered in New York City.
Shares were up 17% as vaccine shows promise in brain cancer.
United PanAm Financial Corporation
16.04.07 21:31 Uhr
13,84 USD
+5,33 % [+0,70]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=UPFC.NAS&lColors=0x000000&sSym=UPFC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=UPFC.NAS&lColors=0x000000&sSym=UPFC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=UPFC.NAS&lColors=0x000000&sSym=UPFC.NAS&hcmask=
Solarfun Power Holdings Co., Ltd.
16.04.07 21:42 Uhr
16,72 USD
+28,22 % [+3,68
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SOLF.NAS&lColors=0x000000&sSym=SOLF.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SOLF.NAS&lColors=0x000000&sSym=SOLF.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SOLF.NAS&lColors=0x000000&sSym=SOLF.NAS&hcmask=
Börse
NASDAQ
Aktuell
16,72 USD
Zeit
16.04.07 21:42
Diff. Vortag
+28,22 %
Tages-Vol.
66,69 Mio.
Gehandelte Stück
4,3 Mio
About Solar EnerTech Corp http://www.solarenertech.com/ Solar EnerTech is a photovoltaic (''PV'') solar energy cell manufacturing enterprise based in Shanghai, China, where the Company has established a sophisticated 42,000-square foot manufacturing plant in Shanghai's Jinqiao Modern Technology Park. This facility is capable of producing 25Mw of solar cells from its current production line and 50Mw when upon completion of the second line slated for Q4 of this year. Solar EnerTech has also established a Joint R&D Lab at Shanghai University to research and develop higher efficiency cells and to put the results of that research to use immediately in its manufacturing processes. Led by one of the industry's top scientists, the Company's R&D program will work to bring Solar EnerTech to the forefront of advanced solar technology research and production. The Company has also established a marketing, purchasing and distribution arm in Northern California's Silicon Valley
Visa and MasterCard Approve VeriFone's QX100 for Contactless Payment System Provides Easy Upgrade for Merchants Seeking to Cash in on Contactless Wave
LAS VEGAS, Apr 17, 2007 (BUSINESS WIRE) -- VeriFone Holdings, Inc. (NYSE: PAY) announced today that its first external contactless card acceptance device, the QX100, has been certified by Visa and MasterCard as conforming with their respective contactless payment systems, Visa Contactless and MasterCard PayPass.
The QX100 easily attaches to VeriFone's Vx Solutions, Omni 3700 and NURIT payment solutions, as well as any stand-alone payment device or POS system for quick merchant upgrades. It provides merchants with a cost-effective migration to accept the increasingly popular "tap and pay" payment cards now being offered by major banks. Backed by VeriFone's reputation for quality, reliability and customer service, the QX100 represents the first in a line of contactless card readers that is unsurpassed in the industry for versatility and quality.
"The QX100 sets a new standard in contactless payment convenience," said Paul Rasori, VeriFone vice president of global product marketing. "Contactless payment is ideal for speeding up checkout lines and we've designed a system that is ideal for merchants in a range of venues, from quick service restaurants and convenience stores, to retail outlets, movie theatres and sports arenas."
With over 100,000 contactless installations across the globe, VeriFone is the industry leader in supporting contactless payment at the point of sale. The stylish QX100 is the model of convenience and can be used on the countertop or wall-mounted to reduce clutter and enhance ease of use. The QX100 is capable of high speed encryption using modern encryption algorithms and utilizes downloadable software to meet evolving contactless card payment security specifications.
The QX100 is an external contactless card acceptance system designed to meet Visa Contactless, MasterCard PayPass, American Express ExpressPay, and Discover specifications for magnetic stripe equivalent applications. With four standard inclination angles and a large landing zone, the QX100 allows easy card or fob reading in any retail or service environment
Ariba Expands Capabilities of Ariba Supplier Network Advanced Discount Management and RFX Functionality in Latest Version of Leading on-Demand Trading Platform Drives Greater Collaboration and Supply Chain Value
SUNNYVALE, Calif., Apr 17, 2007 (BUSINESS WIRE) -- Ariba, Inc. (Nasdaq: ARBA), the leading spend management solutions provider, today announced the release of Ariba Supplier Network(TM) 44, the latest version of its industry-leading on-demand business collaboration platform. Building on the robust capabilities of previous versions, the release features advanced discount management and RFX functionality that enables buyers and suppliers to enhance their business by better managing trading relationships and working capital.
"More than simply managing transactions and costs, successful spend management is about responding quickly to changes in business and market conditions to maximize opportunities for growth," said Bob Shecterle, Vice President, Solutions Marketing, Ariba. "With the advanced features in the latest release of Ariba Supplier Network, buyers and suppliers can take advantage of opportunities to access capital, eliminate risk from their supply chain, lower costs, and ultimately, deliver greater results."
Improve Working Capital and Supply Chain Value
To remain competitive, companies must continually look for new ways to cut costs and streamline business processes. With Ariba Discount Management(TM), organizations of all types and sizes can take advantage of a variety of supply chain financing tools that promote cost savings, including purchasing cards, early payment discounts, dynamic discounting and third-party supplier financing.
A flexible combination of software, services and analysis delivered via Ariba Supplier Network, Ariba Discount Management enables buyers and suppliers to optimize activities throughout the entire procure-to-pay process and realize maximum value from their supply chain.
17.04.2007 23:19
IBM-Aktie nach Zahlen gefragt
Das groß in der Technologiewelt nicht gleich schlecht bedeuten muss zeigt heute IBM. Das Unternehmen steigerte seinen Gewinn im zurückliegenden ersten Quartal um 8%. Zwar wuchsen die angestammten Bereiche des Unternehmens nur moderat. Zukäufe im Softwarebereich zahlten sich aber doppelt aus: Sie trugen im letzten Quartal am stärksten zum Wachstum IBMs (Nachrichten/Aktienkurs) bei.
Der Gewinn lag bei 1,84 Milliarden Dollar oder 1,21 Dollar je Aktie, nach 1,71 Milliarden Dollar oder 1,08 Dollar je Aktie im Vorjahr. Damit lag IBM im Rahmen der Analystenerwartungen. Der Umsatz wuchs um 7% auf 22 Milliarden Dollar und lag damit leicht über dem, was Analysten sich im Vorfeld ausgemalt hatten. Sie rechneten mit einem Umsatz von 21,9 Milliarden Dollar.
Die IBM Aktie stieg heute im regulären Handel um 0,98% auf 97,12 Dollar. Nachbörslich geht es weiter aufwärts, und zwar um 1,3% auf 98,37 Dollar.
Intel mit höherem Gewinn im Quartal - Aktie steigt
Mi Apr 18, 2007 6:58 MESZ
San Francisco (Reuters) - Der weltgrößte Chiphersteller Intel hat im abgelaufenen Quartal seinen Gewinn gesteigert und damit die Markterwartungen erfüllt.
Das Unternehmen gab am Dienstag nach US-Börsenschluss eine Umsatzprognose unterhalb der Markterwartungen ab, hob aber den Ausblick für die Brutto-Gewinnmarge für das Gesamtjahr an. An der Börse stiegen die Intel-Aktien nachbörslich gut zwei Prozent.
Der Nettogewinn sei im ersten Quartal auf 1,6 Milliarden Dollar von 1,36 Milliarden Dollar im Vorjahreszeitraum gestiegen, teilte das Unternehmen am Dienstag nach US-Börsenschluss mit. Einen Steuersondereffekt herausgerechnet betrug der Gewinn je Aktie etwa 22 Cent, was im Rahmen der Analystenerwartungen lag. Der Umsatz schrumpfte dagegen um knapp ein Prozent auf 8,85 Milliarden Dollar zu. Von Reuters befragte Analysten hatten im Durchschnitt mit einem etwas höheren Umsatz von 8,96 Milliarden Dollar gerechnet.
Intel rechnete für das zweite Quartal mit einem Umsatz zwischen 8,2 und 8,8 Milliarden Dollar, die Markterwartungen lagen hier nur bei 88,86 Milliarden Dollar. Die Gewinnmarge werde im Gesamtjahr wohl bei 51 Prozent liegen - und nicht wie zuvor prognostiziert bei 50 Prozent.
Intel hatte zuvor mitgeteilt, noch im laufenden Jahr gut 40 Prozent schnellere Prozessoren auf den Markt bringen zu wollen.
Offenbar will der Konzern damit seinem Erzrivalen AMD zuvorkommen. Letzterer hatte vor mehr als einer Woche angekündigt, dass der Quartalsgewinn wohl deutlich unter den Markterwartungen ausfallen werde. AMD soll am 19. April Quartalszahlen vorlegen.
18.04.2007 08:37
Licht und Schatten bei US-Hightechs
Liebe Leser,
gestern Abend kam der erste größere Schub Quartalszahlen aus den USA, darunter einige der großen Hightech-Werte. Der erhoffte Schub für die Börsen bleibt jedoch aus, zumindest vorerst – zu durchwachsen fielen die Zahlen aus.
Während die Zahlen von Intel und IBM im Rahmen der Analystenprognosen ausfielen, überraschte Yahoo mit einem Gewinnrückgang von 160 auf 142 Mio. Dollar. Das sind 10 Cent pro Aktie, 1 Cent unter den Erwartungen. Die Bestrafung folgte auf dem Fuße: Im nachbörslichen Handel brach die Aktie um über 7% ein.
Für die positive Überraschung des Abends sorgte EMC. Der Hersteller von Speichersystemen steigerte Umsatz und Gewinn unerwartet hoch. Mit 15 Cent pro Aktie (Vorjahresquartal 11 Cent) schlug das Unternehmen die Analystenprognosen um 2 Cent. EMC begründete den starken Geschäftsverlauf mit einem sehr guten Asiengeschäft.
EMC unterstreicht mit diesen Zahlen abermals, dass man auf einem guten Weg ist. Ich möchte nicht so weit gehen und von „zurück zu alter Stärke“ sprechen, denn davon ist das Unternehmen noch zu weit entfernt. Im Jahr 2000 notierte der Wert bei 100 Dollar, nur drei Jahre später waren es nur noch 4 Dollar. Nun hat sich die Aktie immerhin schon wieder auf 15 Dollar vor gearbeitet. Weitere Kursgewinne sind wahrscheinlich. Erstens wird der Konzern 2007 seinen Wachstumskurs fortsetzen. Zweitens lässt die aktuelle Bewertung noch Spielraum nach oben zu. Und drittens hat die Aktie gerade einen wichtigen charttechnischen Widerstand erfolgreich überwunden.
Blackberry-Panne lässt die Wall Street zittern
Manchen Marken gelingt es, sich mit genialen Produkten nicht nur in die Läden und in die Herzen der Verbraucher zu spielen, sondern auch in die Wörterbücher. Der „Walkman“ war in den Achtzigern einer der ersten Markenbegriffe im allgemeinen Sprachgebrauch, heute „googelt“ die ganze Welt, und unter Medizinern ist der „Blackberry-Daumen“ ein fester Begriff – wenn auch negativ besetzt.
Der „Blackberry-Daumen“ ist eine sehr spezielle Art der Sehnenscheidenentzündung. Sie befällt weniger das Handgelenk als die Finger- respektive die Daumengelenke und ist bei Leuten zu finden, die tagein tagaus auf den Kleinst-Tastaturen ihrer Mini-Computer – eben vor allem dem Blackberry – Emails tippen und verschicken.
Der „Blackberry-Daumen“ ist mittlerweile so verbreitet, dass die Hotelkette Hyatt ein neues Spa-Programm entwickelt hat: eine spezielle Hand-Massage mit wohltuenden Cremes, die unter dem Namen „Blackberry Balm“ angeboten wird. Dreißig Minuten Massage kosten 30 Dollar, viele Manager auf Geschäftsreisen nutzen den Service regelmäßig, um Verschleiß an den Gelenken vorzubeugen, die bei der Benutzung des Kleincomputers unersetzlich sind.
An der Wall Street lässt sich oberhalb der Türsteher-Ebene niemand ohne Blackberry erwischen. Wer sich im Zentrum der Finanzwelt, wo die schnelle Übermittlung von Informationen über Millionengewinne und -verluste entscheiden kann, noch gegen die Handy-Computer-Email-Organizer-Kombo wehrt (wie beispielsweise der Schreiber dieser Zeilen!), wird fast mitleidig angesehen.
So groß die Abhängigkeit der Trader und Manager von ihrem Blackberry mittlerweile geworden ist, so katastrophal ist es, wenn das liebgewordene System auf einmal nicht funktioniert. Seit Dienstagabend ist das der Fall: Der Email-Server von Blackberry hat den Geist aufgegeben. Bei sämtlichen Abonennten – ob sie nun über AT&T oder Verizon, über Sprint oder T-Mobile Zugang haben – versanden Emails im virtuellen Nirgendwo.
Research in Motion, der Hersteller des Blackberry, spricht ganz offen von einem „katastrophalen Fehler in der Infrastruktur“ und kündigt schon einmal an, das Problem nicht vor Mittwochabend behoben zu haben. Damit würde der Service, der die wichtigsten Entscheider Amerikas mit elektronischer Post versorgt, für mehr als 24 Stunden brach liegen.
Solche Service-Einbrüche können teuer werden. Mit Schadenersatzforderungen muss sich Research in Motion zwar noch nicht herumschlagen. Wer aber den immer unverzichtbareren Email-Dienst nicht rund um die Uhr garantieren kann – und Blackberry-User müssen nicht zum ersten Mal auf den Service verzichten – der kann in der Publikumsgunst schnell absacken. An der Wall Street sind die Folgen des Systemfehlers am Mittwochmorgen gleich doppelt zu sehen: Manchem Manager zittern nervös die Hände, weil der Mini-Computer nicht läuft. Und die Aktie von Research in Motion begann den Handel mit einem Minus von 2 Prozent.
Lars Halter -
Wednesday's ETF Winners & Losers
By Robert Holmes
TheStreet.com Staff Reporter
4/18/2007 2:32 PM EDT
Semiconductor-related exchange-traded funds were among the big winners Wednesday, thanks to positive earnings news out of
Intel (INTC - Cramer's Take - Stockpickr - Rating) and
Linear Technology (LLTC - Cramer's Take - Stockpickr - Rating).
Intel matched expectations for first-quarter earnings, but the chipmaker bumped up its profit margin outlook for the full year. Linear posted fiscal third-quarter earnings that were also in line with estimates, but shares jumped after the company announced a $3 billion accelerated stock repurchase plan. Intel was rising 0.7%, and Linear soared 12%.
The Ultra Semiconductor ProShares (USD - Cramer's Take - Stockpickr) ETF was adding 3.9% at $74.98. The Semiconductor HOLDRs (SMH - Cramer's Take - Stockpickr - Rating) ETF was recently up 2.9% to $35.61. The SPDR S&P Semiconductor (XSD - Cramer's Take - Stockpickr) ETF gained 2.4% to $50.86. The iShares Goldman Sachs Semiconductor (IGW - Cramer's Take - Stockpickr - Rating) ETF was higher by 2.2% at $63.66. The PowerShares Dynamic Semiconductors (PSI - Cramer's Take - Stockpickr - Rating) ETF climbed 2% to $18.86.
Bundled securities tracking financials were also higher, thanks to a 5% rise in Washington Mutual (WM - Cramer's Take - Stockpickr - Rating), which topped Wall Street's estimates after reporting earnings late Tuesday. Elsewhere, Dow component JPMorgan Chase (JPM - Cramer's Take - Stockpickr - Rating) beat estimates by a wide margin and set plans for a $10 billion stock buyback.
The Ultra Financials ProShares (UYG - Cramer's Take - Stockpickr) ETF was up 1.7% to $69.33. The KBW Bank (KBE - Cramer's Take - Stockpickr) ETF gained 1.4% at $58.21. The Regional Bank HOLDRs (RKH - Cramer's Take - Stockpickr - Rating) was higher by 1.3% at $162.02. The Financial Select Sector SPDR (XLF - Cramer's Take - Stockpickr - Rating) was climbing 1.2% to $36.99.
On the other hand, Yahoo! (YHOO - Cramer's Take - Stockpickr - Rating) sank Internet-related ETFs after the Web search engine disappointed investors with its earnings report after the prior close. Recently, Yahoo! was falling 11.5% to $28.39.
The Internet HOLDRs (HHH - Cramer's Take - Stockpickr - Rating) ETF was falling $2.33, or 4%, to $56.56. The First Trust Dow Jones Internet Index (FDN - Cramer's Take - Stockpickr) was losing 38 cents, or 1.6%, to $24.07.
Meanwhile, a loss of 2.4% in holding IBM (IBM - Cramer's Take - Stockpickr - Rating) sent the Internet Architecture HOLDRs (IAH - Cramer's Take - Stockpickr - Rating) ETF down 51 cents, or 1.2%, to $42.76. Following Tuesday's close, IBM posted earnings that matched estimates, prompting Goldman Sachs and Credit Suisse to downgrade their ratings on the stock.
Lang&Schwarz Daily Trader: IBM
19.04.2007 (10:52)
IBM:(News/Kurs/Chart/Board) Die Zahlen für das erste Quartal lagen in der Summe leicht über der Markterwartung. Der Umsatz erhöhte sich um 6,6% (4,0% währungsbereinigt) auf 22,03 (20,66; Marktkonsens: 22,0) Mrd. USD und der operative Gewinn kletterte um 9,6% auf 8,9 Mrd. USD (8,09 Mrd. USD; operative Marge von 39,1% auf 40,2%). Das Nettoergebnis verzeichnete einen 8,0%-igen Anstieg auf 1,84 (1,71; Marktkonsens: 1,85) Mrd. USD und das EpS rangierte, wie von Analysten erwartet, mit einem Anstieg von 12,0% bei 1,21 (1,08; Marktkonsens: 1,21; Aktienzahl: von 1,59 Mrd. auf 1,53 Mrd. gesunken) USD. Das Management erwartet für 2007 einen EpS-Anstieg aus dem fortgeführten Geschäft um 11,0% auf 6,83 (Marktkonsens: 6,72) USD. In Q1 profitierte IBM von der relativen Schwäche des US-Dollars aus dem starken Auslandsgeschäft und verbuchte daher Wechselkursgewinne. Außerdem tätigte IBM Aktienrückkäufe und realisierte einen Rückgang der Steuerquote um 1,5%.
Lang&Schwarz Daily Trader: Coca-Cola
19.04.2007 (10:48)
Coca-Cola:(News/Kurs/Chart/Board) Der Getränkekonzern steigerte im ersten Quartal 2007 den Nettoumsatz um 17% auf 6,10 (5,22; Marktkonsens: 5,63) Mrd. USD. Mit einem Anstieg des Mengenvolumens von konzernweit 6% verzeichnete Coca-Cola einen deutlichen Wachstumsschub gegenüber dem Vorquartal (Q4 2006: +4%) . Hier zeigen sich aus Analystensicht deutlich die positiven Effekte aus der Einführung innovativer Produkte, insbesondere der Einführung von Coca-Cola Zero. Positiv werten Branchenbeobachter den deutlichen Anstieg des Mengenvolumens in der EU (+11%), während die Entwicklung in den USA mit einem Absatzrückgang von 3% weiterhin schwach verlief. Das operative Ergebnis verbesserte sich um 17% auf 1,63 (1,40) Mrd. USD. Beim Ergebnis vor Steuern verzeichnete Coca-Cola ebenfalls einen Anstieg um 17% auf 1,73 (1,48) Mrd. USD. Das Nettoergebnis legte auf Grund einer höheren Steuerquote (27%; Q1 2006: 25,0%) unterproportional um 14% auf 1,26 (1,11) Mrd. USD bzw. verwässert um 15% auf 0,54 (0,47) USD je Aktie zu. Bereinigt um Sondereffekte belief sich das EpS auf 0,56 (Marktkonsens: 0,53) USD. Die vorgelegten Zahlen fielen Aktienstrategen zufolge insgesamt überzeugend aus.
69 PROZENT GEWINN-PLUS
Google übertrifft alle Erwartungen
Der kalifornische Internetkonzern bilanziert für das erste Quartal des Jahres einen beeindruckenden Gewinn von einer Milliarde US-Dollar. Damit zementiert Google seine Position als das profitabelste Unternehmen im Internet.
New York - Google hat seinen Gewinn und Umsatz kräftig gesteigert. Für das erste Quartal gab der Internetkonzern aus Mountain View nach Börsenschluss einen Nettogewinn von einer Milliarde Dollar bekannt. Im Vorjahreszeitraum hatte Google noch einen Nettogewinn von 592 Millionen Dollar erzielt.
Der Umsatz stieg um 63 Prozent auf 3,66 Milliarden US-Dollar. Google-Aktien legten im nachbörslichen Handel um 3,2 Prozent zu. Google gewann nach eigenen Angaben Marktanteile im Suchmaschinen-Bereich hinzu und erhöhte so seine Einnahmen aus der Online-Werbung.
Mit seinem Resultat hat Google die Erwartungen der Analysten übertroffen. Die neuerliche Erfolgsmeldung untermauert die Stellung des kalifornischen Unternehmens als das erfolgreichste und vielleicht auch mächtigste Unternehmen im Internet. Am Vortag hatte Yahoo im Kampf gegen seinen ärgsten Rivalen den Verlust weiterer Marktanteile einräumen müssen. Zudem enttäuschte er die Anleger mit einem Gewinnrückgang. Daten der Marktforscher von comScore zufolge kontrolliert Google mittlerweile fast die Hälfte des Online-Werbemarkts in den USA.
"Ihre Gewinne haben einen Punkt jenseits dessen erreicht, den die meisten für möglich gehalten haben", sagte Rick Meckler von LibertyView Capital Management. "Im Moment haben sie ein phänomenal solides Wachstum." Martin Pyykkonen von Global Crown Management erklärte, Google habe wie im vergangenen Quartal die Erwartungen für das Quartal nicht haushoch übertroffen, aber daran gewöhne sich der Markt. "Und der Konzern zeigt gute Gewinne verglichen mit Yahoo."
Yahoos Anteil sank dagegen auf 27,5 Prozent. Der Abstand vergrößert sich seit eineinhalb Jahren kontinuierlich.
Google hatte jüngst mit dem geplanten Kauf von Doubleclick für 3,1 Milliarden Dollar die größte Übernahme seiner Geschichte angekündigt.
van/Reuters
Platinum Energy Resources, Inc. to Present at IPAA OGIS Conference
NEW YORK, NY, Apr 23, 2007 (MARKET WIRE via COMTEX) -- Platinum Energy Resources, Inc. ("Platinum Energy") (OTCBB: PGRIU) (OTCBB: PGRI) (OTCBB: PGRIW) announced today that Chief Executive Officer Barry Kostiner will present at the IPAA OGIS conference on Wednesday, April 25, 2007 at 2:50 pm ET. The conference will be held at the Sheraton New York Hotel & Towers at 811 7th Ave. in New York.
The IPAA Oil & Gas Investment Symposium New York (OGIS New York) has become the premier outlet for publicly traded independent Exploration and Production and Service and Supply companies to present their company profiles to the investment community. Last year's Symposium attracted over 1500 attendees, including more than 600 buy/sell-side analysts and portfolio managers and 80 presenting companies.
On October 4, 2006, Platinum Energy restructured its previously announced transaction to acquire Tandem Energy Corporation. Tandem is an independent oil and gas exploration and production company headquartered in Midland, Texas.
For additional information, please visit the Platinum Energy Resources web site at http://www.platenergy.com/.
About Platinum Energy
Platinum Energy Resources, based in Montvale, New Jersey, is a special purpose acquisition corporation seeking to acquire assets or operating businesses in the global oil and gas exploration and production industry. Platinum Energy will seek to build a portfolio of assets using multiple acquisitions subsequent to its first. Platinum Energy's strategy calls for the use of hedge financing to maximize profit and reduce risk resulting from volatile energy markets.
Platinum Energy was incorporated in April 2005 to acquire an operating business in the energy industry. Platinum Energy completed its initial public offering on October 24, 2005, receiving net proceeds of approximately $106 million through the sale of 14.4 million units of its securities at $8.00 per unit. Each unit is comprised of one share of Platinum Energy common stock and one redeemable and convertible common stock purchase warrant with an exercise price of $6.00. Platinum Energy currently holds over $109 million in a trust account maintained by an independent trustee, which will be released to Platinum upon the closing of a business combination.
Microsoft erklärt sich EU-Kommission
23. Apr 19:52
Gerade noch rechtzeitig hat Microsoft eine Frist im Streit mit der EU-Kommission eingehalten. Es geht um den Vorwurf überhöhter Lizenzgebühren - und 900 Millionen Euro.
Microsoft hat im Streit um EU-Strafmaßnahmen eine von der EU-Kommission gesetzte Frist eingehalten. Wie die Kommission am Montag in Brüssel mitteilte, ging ein Schreiben des weltgrößten Software-Konzerns rechtzeitig ein. Die Frist lief am Montag um Mitternacht aus.
Die Behörde hatte am 1. März gegen den Konzern ein neues Verfahren wegen überhöhter Lizenzgebühren für Schnittstelleninformationen eröffnet. Sollte Microsoft die Bedenken der Kommission nicht ausräumen können, könnte ein Bußgeld von bis zu 900 Millionen Euro verhängt werden. Die Brüsseler Wettbewerbshüter erklärten, das Schreiben nun prüfen zu wollen.
Schon seit Jahren gibt es Streit darüber, wie das Betriebssystem Windows für Arbeitsgruppenrechner mit Anwendungen anderer Hersteller dialogfähig gemacht werden kann. Dazu kam der Vorwurf überhöhter Preise.
Die Kommission hatte bereits vor drei Jahren ein Rekordbußgeld von 497 Millionen Euro gegen Microsoft verhängt und das Unternehmen zur Öffnung von Windows für mehr Wettbewerb verurteilt. Seitdem läuft ein erbitterter Streit um die Umsetzung der Sanktionen. Im vergangenen Juli gab es bereits ein weiteres Bußgeld wegen Nichterfüllung der Strafmaßnahmen von 280,5 Millionen Euro. Der Wettbewerbsfall Microsoft ist der mit Abstand schwierigste in Brüssel. Das Unternehmen hatte beim EU-Gericht in Luxemburg gegen die Sanktionen aus dem Jahr 2004 geklagt. (dpa)
MedImmune, Inc.
23.04.07 21:23 Uhr
56,63 USD
+17,95 % [+8,62
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MEDI.NAS&lColors=0x000000&sSym=MEDI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MEDI.NAS&lColors=0x000000&sSym=MEDI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MEDI.NAS&lColors=0x000000&sSym=MEDI.NAS&hcmask=
Börse
NASDAQ
Aktuell
56,63 USD
Zeit
23.04.07 21:23
Diff. Vortag
+17,95 %
Tages-Vol.
6,30 Mrd.
Gehandelte Stück
139 Mio
Biotech News: Shareholders alert for MedImmune Inc
Apr 23, 2007 (M2 PRESSWIRE via COMTEX) -- Shareholders alert for MedImmune Inc (NASDAQ: MEDI)
MedImmune, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of products for prevention and treatment in therapeutic areas of infectious diseases, inflammatory diseases, and cancer in the United States. The company markets three products: Synagis, a humanized monoclonal antibody for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in pediatric patients; Ethyol for the treatment of unwanted side effects of specific types of chemotherapies and radiotherapies that are used to treat cancer; and FluMist, a vaccine for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents. The company also provides NeuTrexin, a trimetrexate glucuronate for injection; and RespiGam. In addition, MedImmune has various products under development stages. The company's customers include pharmaceutical wholesalers, distributors, and specialty distributors. MedImmune, Inc. has strategic alliances with Critical Therapeutics, Inc. and Micromet AG. The company was founded in 1987 under the name Molecular Vaccines, Inc. and changed its name to MedImmune, Inc. in 1990. MedImmune is headquartered in Gaithersburg, Maryland.
Shares were up 18% after A buyout of MedImmune Inc. boosted shares
Alanco Technologies Inc.
23.04.07 21:28 Uhr
3,32 USD
+29,08 % [+0,748]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ALAN.NAS&lColors=0x000000&sSym=ALAN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ALAN.NAS&lColors=0x000000&sSym=ALAN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ALAN.NAS&lColors=0x000000&sSym=ALAN.NAS&hcmask=
Börse
NASDAQ
Aktuell
3,32 USD
Zeit
23.04.07 21:28
Diff. Vortag
+29,08 %
Tages-Vol.
22,12 Mio.
Gehandelte Stück
6,3 Mio
Alanco's Third Quarter Sales up 300% Nine Months YTD Sales Exceed $15 Million
SCOTTSDALE, Ariz., Apr 23, 2007 (BUSINESS WIRE) -- Alanco Technologies, Inc. (NASDAQ: ALAN) reported today that it expects sales revenues for the third quarter ended March 31, 2007, to exceed $4.4 million, an increase of over 300% versus comparable revenues of $988,000 in the prior year period. Sales revenue for the first nine months of fiscal year ending June 30, 2007 is expected to be approximately $15 million, an increase in excess of $11 million compared to $3.8 million in comparable revenue for the prior year nine months. The record sales results are primarily attributable to the Company's new Wireless Asset Management business segment, created by the acquisition of StarTrak Systems, LLC, ("StarTrak") on June 30, 2006. StarTrak is the world's leading supplier of wireless tracking and subscription asset management services to the refrigerated or "Reefer" segment of the transportation industry, including trailers, containers, and railcars.
Robert R. Kauffman, Alanco Chairman and Chief Executive Officer, commented, "While our record third quarter StarTrak-generated sales result was gratifying, we also experienced a high level of new business development activity in both of our wireless tracking businesses which we expect to result in continued sales growth for our fourth quarter and beyond."
"StarTrak is actively engaged in pilot evaluations and field trials with approximately 25 new prospects for ReeferTrak(R) applications in refrigerated containers, intermodal trailers, and truck/trailer fleets totaling about 45,000 units, representing hardware sales of approximately $27,000,000 and additional monthly subscription data service revenues in the range of $800,000 to $900,000. StarTrak's current deployed subscriber service base totals in excess of 20,000 units."
"Our TSI PRISM RFID tracking business has also experienced a high level of customer activity, including major new RFID inmate tracking Request for Proposal (RFP) solicitations from Kansas, Minnesota, and Florida, totaling approximately $15,000,000 in potential contract awards, which, if we are successful bidders, would dramatically impact near-term sales results."
Alanco Technologies, Inc. (NASDAQ: ALAN), headquartered in Scottsdale, Arizona, is a rapidly growing provider of wireless tracking and asset management solutions through its StarTrak Systems and Alanco/TSI PRISM subsidiaries. Corporate website: www.alanco.com
StarTrak Systems is a leading provider of GPS tracking and wireless asset management services to the transportation industry and the dominant provider of tracking, monitoring and control services to the refrigerated or "Reefer" segment of the transportation marketplace. StarTrak products increase efficiency and reduce costs of the refrigerated supply chain through the wireless monitoring and control of critical Reefer data, including GPS location, cargo temperatures and Reefer fuel levels. StarTrak offers complete integrated solutions for refrigerated trailers, trucks, railcars, and containers. Additional information is available at www.StarTrak.com.
Alanco/TSI PRISM is the leading provider of RFID real-time tracking technologies for the corrections industry. TSI PRISM systems track and record the location and movement of inmates and officers, resulting in enhanced facility safety and security and significant staff productivity improvements. Utilizing proprietary RFID (Radio Frequency Identification) tracking technology, TSI PRISM provides real-time inmate and officer identification, location and tracking both indoors and out. TSI PRISM is currently utilized in prisons in Michigan, California, Illinois, Ohio, Missouri, and Virginia. Additional information is available at www.TSIPRISM.com.
The Company also participates in the data storage industry through its wholly owned subsidiary, Excel/Meridian Data, Inc., a manufacturer of Network Attached Storage (NAS) systems. Excel delivers uniquely scalable, manageable and cost-effective storage solutions for all network storage customers. For further information, visit www.emdstorage.com.
Applied Micro Circuits Corporation
23.04.07 21:33 Uhr
2,7391 USD
-22,41 % [-0,7909]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AMCC.NAS&lColors=0x000000&sSym=AMCC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AMCC.NAS&lColors=0x000000&sSym=AMCC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AMCC.NAS&lColors=0x000000&sSym=AMCC.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,7391 USD
Zeit
23.04.07 21:33
Diff. Vortag
-22,41 %
Tages-Vol.
146,51 Mio.
Gehandelte Stück
56 Mio
Large Cap News: Shareholder Alert for Applied Micro Circuits Corp.
Apr 23, 2007 (M2 PRESSWIRE via COMTEX) -- Applied Micro Circuits Corporation (AMCC) applies most of its microchip expertise to communications, but does more than a micro business in storage as well. Customers use AMCC's chips -- which include controllers, host bus adapters, network processors, and switch fabrics -- to control the flow of voice and data transmissions in LANs, WANs, and storage networks. Having shut down its own wafer fabrication plant (or fab), the fabless semiconductor company outsources manufacturing to IBM, TSMC, and UMC. Its top customers include Alcatel-Lucent, Avnet (21% of sales), Cisco, Hitachi, Nortel Networks (12%), Sanmina-SCI (10%), and Siemens.
Shares were down 19% seeing weaker Q4 sales.
Gentex Corporation
23.04.07 21:37 Uhr
18,75 USD
+13,77 % [+2,27]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GNTX.NAS&lColors=0x000000&sSym=GNTX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GNTX.NAS&lColors=0x000000&sSym=GNTX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GNTX.NAS&lColors=0x000000&sSym=GNTX.NAS&hcmask=
Börse
NASDAQ
Aktuell
18,75 USD
Zeit
23.04.07 21:37
Diff. Vortag
+13,77 %
Tages-Vol.
80,92 Mio.
Gehandelte Stück
4,3 Mio.
bellwetherreport.com: Current Research on Gentex Corp
Apr 23, 2007 (M2 PRESSWIRE via COMTEX) -- Current Research on Gentex Corp (NASDAQ: GNTX)
Gentex Corporation engages in the design, development, manufacture, and marketing of electro-optic products, including automatic-dimming rearview mirrors for the automotive industry, and fire protection products for the commercial building industry worldwide. The company's electro-optic products include auto-dimming headlamp control mirror that automatically turns car head- and taillamps 'on' and 'off' at dusk and dawn; auto-dimming compass mirror, an electronic compass that automatically compensates for changes in the earth's magnetic field; auto-dimming mirror that digitally displays either a compass or outside temperature reading; compass mirrors with light-emitting diode map lamps; auto-dimming mirror with remote keyless entry and auto-dimming telematics mirrors; auto-dimming HomeLink mirrors; and auto-dimming mirrors with SmartBeam, a high-beam headlamp control feature. Gentex Corporation's fire protection products include smoke alarms and smoke detectors combined with signaling appliances to office buildings, hotels, motels, military bases, college dormitories, and various commercial establishments. It also offers single-station alarms for both commercial and residential applications. The company sells its products to distributors, electrical wholesale houses, and to original equipment manufacturers. Gentex Corporation was founded in 1974 and is headquartered in Zeeland, Michigan.
Shares were up 14% after reporting that sharpened European demand for its automotive mirrors helped lift first-quarter profit
23.04.07 21:45 Uhr
11,80 USD
+0,00 % [+0,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=TFSL.NAS&lColors=0x000000&sSym=TFSL.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=TFSL.NAS&lColors=0x000000&sSym=TFSL.NAS&hcmask=
Börse
NASDAQ
Aktuell
11,80 USD
Zeit
23.04.07 21:45
Diff. Vortag
+0,00 %
Tages-Vol.
173,94 Mio.
Gehandelte Stück
14 Mio.
About Third Federal Savings and Loan Association (TFSL):This news release was distributed by PrimeNewswire, www.primenewswire.comSOURCE: The Nasdaq Stock Market, Inc.Third Federal Savings and Loan Association, named for five years to the Fortune
list of "100 Best Companies to Work for," is a leading provider of savings and
mortgage products. Founded in Cleveland in 1938 as a mutual association by Ben
and Gerome Stefanski, Third Federal is dedicated to serving consumers with
competitive rates and outstanding customer service. Third Federal, an equal
housing lender, serves customers in Northeast Ohio from 26 branches and eight
lending offices in Central and Southern Ohio, and from 14 branches throughout
Florida. As of December 31, 2005, Third Federal had total assets of $8.6
billion. Third Federal can be reached toll-free by calling 1-888-844-7333, or
visit us on the internet at www.thirdfederal.com.
Juniper Networks mit Gewinnrückgang im ersten Quartal
Di Apr 24, 2007 7:25 MESZ
New York (Reuters) - Der US-Netzwerkausrüster Juniper Networks hat im ersten Quartal wegen gestiegener Kosten einen Gewinnrückgang verbucht. Das Nettoergebnis sei auf 66,6 Millionen Dollar von 75,8 Millionen Dollar im Vorjahreszeitraum gefallen, teilte das Unternehmen am Montag nach Börsenschluss mit. Der Umsatz stieg dagegen um elf Prozent auf 626,9 Millionen Dollar.
Juniper stellt Router und andere Geräte für den Datenverkehr her.
BioDelivery Sciences International, Inc.
25.04.07 16:23 Uhr
7,83 USD
+68,75 % [+3,19]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=BDSI.NAS&lColors=0x000000&sSym=BDSI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=BDSI.NAS&lColors=0x000000&sSym=BDSI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=BDSI.NAS&lColors=0x000000&sSym=BDSI.NAS&hcmask=
Börse
NASDAQ
Aktuell
7,83 USD
Zeit
25.04.07 16:23
Diff. Vortag
+68,75 %
Tages-Vol.
33,76 Mio.
Gehandelte Stück
5,5 Mio
Biotech News: Morning Alert for BioDelivery Sciences International Inc
Apr 25, 2007 (M2 PRESSWIRE via COMTEX) -- Morning Alert for BioDelivery Sciences International Inc (NASDAQ: BDSI)
BioDelivery Sciences International, Inc. operates as a specialty biopharmaceutical company in the United States. It uses its licensed and patented drug delivery technologies to develop and commercialize new formulations of proven therapeutics aimed at acute conditions occurring in cancer and surgical patients, such as pain, nausea and vomiting, insomnia, and fungal infections. The company's lead product, BEMA Fentanyl, is in the Phase III clinical trials for the treatment of breakthrough cancer pain. Its products also include BEMA Long Acting Analgesic, a Phase I completed clinical trial product for the treatment of pain conditions, including post operative and, potentially, chronic pain due to osteoarthritis, lower back disorders, and rheumatoid arthritis; BEMA Zolpidem, a preclinical stage product for the treatment of insomnia; and Bioral Amphotercin B, a Phase I clinical trial product for the treatment of fungal infections. The company's product pipeline also includes Bioral formulation, which is an encochleated version of Amphotericin B; and a second formulation for intranasal administration Amphotericin B to treat chronic rhinosinusitis. The company is also developing Emezine, a formulation of prochlorperazine, which is used for the treatment of nausea and vomiting. It has a clinical development and license agreement with Clinical Development Capital, LLC relating to its BEMA Fentanyl product. BioDelivery Sciences International was founded in 1997 and is based in Morrisville, North Carolina.
Shares were up 62% after Positive Study Data.
Amazon.com, Inc.
25.04.07 16:35 Uhr
53,88 USD
+20,40 % [+9,13]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
Börse
NASDAQ
Aktuell
53,88 USD
Zeit
25.04.07 16:35
Diff. Vortag
+20,40 %
Tages-Vol.
1,44 Mrd.
Gehandelte Stück
34 Mio.
bellwetherreport.com: Market Commentary on Amazon.com Inc
Apr 25, 2007 (M2 PRESSWIRE via COMTEX) -- Market Commentary on Amazon.com Inc (NASDAQ: AMZN)
Amazon.com, Inc. operates retail Web sites, as well as provides programs that enable third parties to sell products on its Web sites. The company sources and sells a range of products to its customers. It offers Amazon Marketplace and Merchants programs, which enable third parties to sell their products on its Web sites; allow customers to shop for products owned by third parties using its features and technologies; and enable individuals to complete transactions that include multiple sellers in a single checkout process. The company, together with third parties, sells various product categories, such as books, music, DVDs, unbox video downloads, VHS, magazines and newspapers, video games, software, amazon shorts, electronics, audio and video, cameras and photos, cell phones and service, computers and PC hardware, office products, musical instruments, outlet, home and garden products, bed and bath products, furniture and decor, gourmet food, kitchen and housewares, pet supplies, automotives, tools and hardware, industrial and scientific, apparel and accessories, shoes, jewelry and watches, grocery, beauty, health and personal care, sports and outdoors, toys and games, and baby products. Its retail Web sites include amazon.com, amazon.ca, amazon.de, amazon.fr, amazon.co.jp, amazon.co.uk, joyo.com, shopbop.com, and endless.com. The company also provides merchant services for third-party retailers; marketing and promotional services; and Web services comprising Amazon simple storage service, Amazon elastic compute cloud, Amazon simple queue service, Amazon mechanical turk, and Amazon e-commerce service for developers. In addition, it operates other Web sites, including a9.com and alexa.com that enable search and navigation; and www.imdb.com, a movie database. The company was founded in 1994 and is headquartered in Seattle, Washington.
Shares were up 18% after blowing away the Street's first-quarter earnings expectations and ratcheted up revenue guidance.
Travelzoo Inc
25.04.07 17:04 Uhr
28,09 USD
-23,83 % [-8,79]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=TZOO.NAS&lColors=0x000000&sSym=TZOO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=TZOO.NAS&lColors=0x000000&sSym=TZOO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=TZOO.NAS&lColors=0x000000&sSym=TZOO.NAS&hcmask=
Börse
NASDAQ
Aktuell
28,09 USD
Zeit
25.04.07 17:04
Diff. Vortag
-23,83 %
Tages-Vol.
41,39 Mio.
Gehandelte Stück
1,5 Mio
Small Cap News: Shareholder Alert for Travelzoo Inc.
Apr 25, 2007 (M2 PRESSWIRE via COMTEX) -- Travelzoo displays travel deals and specials and related information on its Web sites. Travel companies, such as airlines, cruise lines, hotels, and travel agencies, pay Travelzoo to publicize fares and promotions on Travelzoo's eponymous Web site, through its Travelzoo Top 20 newsletter, and across its Newsflash e-mail alert service. Travelzoo also operates SuperSearch, a pay-per-click search engine specializing in travel content. Clients Expedia and Travelport collectively accounted for 30% of the company's revenues in 2006. Travelzoo commenced its UK operations in mid-2005, looking to expand even further into the European market. CEO Ralph Bartel owns 50% of the company, which was founded in 1998.
Shares were down 24% announcing flat 1Q.
HANDELSBLATT, Mittwoch, 25. April 2007, 21:30 Uhr
Flugzeugbauer bleibt trotz Gewinnanstiegs bei Geschäftsprognosen
Bei Boeing floriert das Geschäft
Der US-Flugzeughersteller Boeing hat im ersten Quartal aufgrund deutlich zunehmender Aufträge für Rüstungs- und Passagiermaschinen Umsatz und Ergebnis stärker als erwartet gesteigert. Seine Geschäftsprognosen will der Konzern aber nicht anheben.
HB NEW YORK. Zwischen Januar und März verdiente Boeing mit 877 Mill. Dollar gut ein Viertel mehr als vor einem Jahr. Auch der Umsatzanstieg fiel mit acht Prozent auf 15,4 Mrd. Dollar höher aus als erwartet. Der Airbus-Konkurrent flog 106 Zivilflugzeuge zu seinen Kunden - vor einem Jahr waren es erst 98. Im Gesamtjahr will Boeing weiterhin zwischen 440 und 445 Verkehrsflugzeuge ausliefern.
Boeing verkaufte im vergangenen Jahr mehr Verkehrsflugzeuge als Airbus. Die Umsätze der Zivilflugzeug-Sparte von Boeing legten im ersten Quartal um sieben Prozent auf 7,6 Mrd. Dollar zu. Boeing bekräftigte den Zeitplan für seinen neuen 787 „Dreamliner“, für den mittlerweile über 500 Bestellungen vorliegen. Das Modell soll im August seinen Erstflug absolvieren und im kommenden Mai in den Dienst gestellt werden. In seiner Rüstungssparte steigerte Boeing den Umsatz ebenfalls um sieben Prozent auf 7,7 Mrd. Dollar. Boeing ist der zweitgrößte Lieferant der US-Armee.
Börsianer zeigten sich etwas enttäuscht, dass Boeing angesichts des guten Starts ins Jahr seine Geschäftsprognosen nicht anhob. Branchenexperten gehen im Schnitt davon aus, dass Boeing in diesem Jahr seine eigenen Prognosen übertreffen wird. Im Gesamtjahr peilt der Konzern einen Umsatz von 64,5 Mrd. bis 65 Mrd. Dollar an. Boeing-Aktien notierten in einem kräftigeren Gesamtmarkt leicht im Minus.
25.04.2007 22:11
Eilmeldung: Qualcomm über Erwartungen
Qualcomm verdiente im abgelaufenen Quartal 50 cents je Aktie und übertraf damit die Erwartungen um 2 cents. Der Umsatz lag bei 2,22 Milliarden Dollar und somit über den erwarteten 2,19 Milliarden Dollar.
25. April 2007
GEWINNSPRUNG UM 88 PROZENT
Apple-Aktie legt kräftig zu
Der US-Computerkonzern Apple hat im zweiten Quartal des laufenden Geschäftsjahres mehr verdient und umgesetzt als erwartet. Die Aktie sprang nach Bekanntgabe des Ergebnisses im nachbörslichen Handel nach oben.
Cupertino - Der Nettogewinn je Aktie (EPS) sei von 0,47 US-Dollar im entsprechenden Vorjahreszeitraum auf 0,87 Dollar geklettert, teilte das Unternehmen heute in Cupertino mit. Analysten hatten hingegen nur mit 0,64 Dollar gerechnet. Der Gesamtgewinn stieg von 410 auf 770 Millionen Dollar (plus 88 Prozent).
http://www.spiegel.de/img/0,1020,855893,00.jpg
AP
Apple-iPod: 24 Prozent mehr verkauft als im Vorjahr
Der Umsatz kletterte von 4,36 Milliarden auf 5,26 Milliarden Dollar. Hier hatten die Erwartungen lediglich bei 5,17 Milliarden Dollar gelegen. Die Bruttogewinnspanne verbesserte sich von 29,8 Prozent auf 35,1 Prozent.
Die Zahl der ausgelieferten Rechner erhöhte sich um 36 Prozent auf 1,517 Millionen. Mit 10,549 Millionen iPods wurden 24 Prozent mehr verkauft als im Vorjahr. Die Apple-Aktien legten am Abend im nachbörslichen US-Handel um 8,06 Prozent auf 103,03 US-Dollar zu.
pav/dpa-AFX
27.04.2007 06:10
Microsoft 3Q profit jumps 65 percent
SEATTLE (AP) - Microsoft Corp.'s fiscal third-quarter profit jumped 65 percent, buoyed by sales of its new versions of Windows and Office and by upgrade coupons for the operating system issued over the holidays.
Earnings for the quarter ended March 31 rose to $4.93 billion, or 50 cents per share, from $2.98 billion, or 29 cents per share in same period last year.
Results included legal charges amounting to 1 cent per share, but tax benefits boosted profit by 2 cents per share.
Analysts surveyed by Thomson Financial forecast a profit of 46 cents per share.
Revenue for the quarter rose 32 percent to $14.4 billion. Wall Street was looking for $13.89 billion in sales.
Microsoft started selling its newest operating system, Windows Vista, (Nachrichten/Aktienkurs) to consumers at the end of January. Its 'client' division, responsible for Windows, brought in $5.27 billion in sales, 67 percent higher than a year ago.
Microsoft said it deferred $1.2 billion in Windows Vista revenue to the third quarter, to account for upgrade coupons given to PC buyers during the holiday season before the consumer launch of the new operating system. Excluding this figure, client revenue totaled $4.1 billion, 30 percent higher than last year.
Business division revenue, which includes sales of Office 2007, rose 34 percent to $4.83 billion.
Microsoft Chief Financial Officer Chris Liddell said the 'excellent quarter' was due to better-than-expected sales of Vista and Office.
Liddell said Vista beat internal forecasts by $300 million to $400 million, and Office 2007 sales were $200 million better than expected.
The client division sales 'are surprisingly ahead of where we thought they would come in,' said Sid Parakh, an analyst at McAdams Wright Ragen. 'They might indicate Vista is doing fine.'
Microsoft's entertainment and devices division, which includes the Xbox 360 game console and the Zune music player, posted a 21 percent sales drop to $929 million in an expected post-holiday slump.
Liddell said the company is still on track to sell 1 million Zunes this fiscal year, and reach the 12 million mark in Xbox 360 units sold since the product hit store shelves in November 2005.
Microsoft trails Google Inc. and Yahoo Inc. in making money from Web searches, but online services revenue edged up 11 percent to $623 million in the quarter. Online advertising revenue grew 23 percent year-over-year, and Liddell said 'revenue per search' is higher than a year ago, when the company was still using a third-party ad platform.
'Monetization of search is increasing with our new adCenter platform,' said the CFO. 'It's still a small base, but it's growing very well.'
Microsoft also said it repurchased more than $6.7 billion in stock during the quarter.
For the fiscal fourth quarter, which ends June 30, Microsoft said it will earn 37 cents to 39 cents per share, with revenue of $13.1 billion to $13.4 billion. Wall Street currently expects a profit of 40 cents per share on $13.31 billion in sales.
For the full 2007 fiscal year, the company raised its guidance, forecasting a profit of $1.48 to $1.50 per share on sales from $50.9 billion to $51.2 billion. Analysts are looking for $1.47 per share on revenue of $50.56 billion.
Microsoft forecast earnings of $1.68 to $1.72 per share for fiscal 2008, with revenue of $56.5 billion to $57.5 billion. Analysts are predicting a profit of $1.69 per share on $56.24 billion in sales.
'I think it's a very good quarter, but more importantly, guidance is essentially in line with what the Street is expecting,' said Sarah Friar, an analyst at Goldman Sachs. 'Everyone was so terrified guidance would have some sort of issue.'
Shares of Microsoft jumped $1.20, or 4.1 percent, to $30.30 in after-hours electronic trading, after adding 11 cents to close at $29.10 on the Nasdaq Stock Market.
Friday's Tech Winners & Losers
By Mark Martinez
TheStreet.com Staff Reporter
4/27/2007 11:45 AM EDT
The tech sector was mixed Friday, but several names moved higher after posting solid earnings reports.
CommScope (CTV - Cramer's Take - Stockpickr - Rating) jumped 10% after the maker of fiber-optic cable products posted blowout first-quarter results and boosted its 2007 revenue forecast. The company earned $45.9 million, or 63 cents a share, on revenue of $435.5 million. Analysts expected earnings of 52 cents a share on revenue of $420.1 million. During the year-earlier period, the company earned $12.7 million, or 19 cents a share, on revenue of $352.3 million.
Looking ahead, CommScope now sees full-year revenue of $1.84 billion to $1.89 billion, up from an earlier forecast of $1.72 billion to $1.76 billion. Analysts project revenue of $1.8 billion. Shares were trading up $4.75 to $50.20.
Elsewhere, Microsoft (MSFT - Cramer's Take - Stockpickr - Rating) rose 5% after the software giant posted third-quarter results that topped expectations. For the quarter ended March 31, the company earned $4.93 billion, or 50 cents a share, on revenue of $14.4 billion. Results included legal charges of a penny a share and tax benefits of 2 cents a share. Analysts expected earnings of 46 cents a share on revenue of $13.89 billion. During the year-earlier quarter, the company earned $2.98 billion, or 29 cents a share, on revenue of $10.9 billion.
Looking ahead, Microsoft issued initial 2008 earnings guidance of $1.68 to $1.72 a share on revenue of $56.5 billion to $57.5 billion. Analysts project earnings of $1.69 a share on revenue of $56.2 billion. Shares were trading up $1.37 to $30.47.
Meanwhile, ON Semiconductor (ONNN - Cramer's Take - Stockpickr - Rating) rose 8% after the chipmaker posted in-line first-quarter earnings on better-than-expected revenue. The company earned $54 million, or 18 cents a share, on revenue of $374.2 million. Analysts expected earnings of 18 cents a share on revenue of $373.3 million. During the year-earlier quarter, the company earned $40.4 million, or 12 cents a share, on revenue of $334 million.
Looking ahead, ON Semiconductor sees second-quarter revenue of $375 million to $385 million. Analysts project revenue of $383.5 million. Shares were trading up 85 cents to $11.23.
Varian Semiconductor Equipment Associates (VSEA - Cramer's Take - Stockpickr - Rating) soared 19% after the company posted second-quarter results that were better than expected and issued third-quarter guidance that exceeded expectations. For the quarter ended March 30, the company earned $38.4 million, or 69 cents a share, on revenue of $241.8 million. Analysts expected earnings of 66 cents a share on revenue of $239 million. During the year-earlier quarter, the company earned $14.8 million, or 26 cents a share, on revenue of $170.5 million.
Looking ahead, Varian Semiconductor sees third-quarter earnings of 89 cents to 98 cents a share on revenue between $271 million and $286 million. Analysts project earnings of 68 cents a share on revenue of $240.8 million. Shares were trading up $10.99 to $67.99.
On the losing side, MEMC Electronic Materials (WFR - Cramer's Take - Stockpickr - Rating) slumped 12% after the maker of silicon wafers posted mixed first-quarter results and offered in-line revenue guidance, but said that wafer inventory issues remain. The company reported adjusted earnings of $164.3 million, or 71 cents a share, on revenue of $440.4 million. Analysts polled by Thomson Financial expected earnings of 69 cents a share on revenue of $443.9 million. During the year-earlier quarter, the company earned $67.3 million, or 29 cents a share, on revenue of $341.5 million.
Looking ahead, MEMC sees second-quarter revenue of $460 million to $470 million, in line with the $464.8 million that analysts project. "Although the demand environment for some of our semiconductor customers is improving compared to a soft first quarter, the wafer inventory recovery seems to be lagging that improvement a bit because of their days of inventory," the company said. "In addition, other customers seem to have remnant inventory issues from the holiday season. Demand from the solar market, however, continues to be healthy." Shares were trading down $8.25 to $58.90.
As for the broader technology sector, the Nasdaq 100 was recently trading down about 2 points to 1888.
Other technology movers included Sun Microsystems (SUNW - Cramer's Take - Stockpickr - Rating), down 1 cent to $5.24; Cisco Systems (CSCO - Cramer's Take - Stockpickr - Rating), up 28 cents to $26.83; Sirius Satellite Radio (SIRI - Cramer's Take - Stockpickr - Rating), up 8 cents to $3.04; and Intel (INTC - Cramer's Take - Stockpickr - Rating), down 15 cents to $21.94; Broadcom (BRCM - Cramer's Take - Stockpickr - Rating), down $1.58 to $33.28; and Level 3 Communications (LVLT - Cramer's Take - Stockpickr - Rating), up 3 cents to $5.76.
Appliance Recycling Centers of America, Inc.
30.04.07 21:33 Uhr
4,90 USD
+111,21 % [+2,58]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ARCI.NAS&lColors=0x000000&sSym=ARCI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ARCI.NAS&lColors=0x000000&sSym=ARCI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ARCI.NAS&lColors=0x000000&sSym=ARCI.NAS&hcmask=
Börse
NASDAQ
Aktuell
4,90 USD
Zeit
30.04.07 21:33
Diff. Vortag
+111,21 %
Tages-Vol.
1,11 Mio.
Gehandelte Stück
240.117
ARCA Announces $25 Million Expansion of Its Recycling Contract With the Southern California Public Power Authority to Replace and Recycle 50,000 Refrigerators for the Los Angeles Department of Water and Power
MINNEAPOLIS, April 30, 2007 /PRNewswire-FirstCall via COMTEX/ -- Appliance Recycling Centers of America (Nasdaq: ARCI) today announced that its recycling contract with the Southern California Public Power Authority (SCPPA) has been expanded to include the Los Angeles Department of Water and Power (LADWP), for whom ARCA will replace and recycle 50,000 old, inefficient refrigerators owned by low-income residents in the city. The 12-month program is expected to generate revenues for ARCA of approximately $25 million.
SCPPA is a consortium of municipal utilities operating in Southern California.
Under this program, ARCA will remove 50,000 refrigerators at least 10 years old from the homes of low-income LADWP customers and replace them with new, high-efficiency units. ARCA will also dispose of the old, inefficient refrigerators in an environmentally sound manner.
About ARCAARCA is one of the nation's largest recyclers of major household appliances for
the energy conservation programs of electric utilities. Through its
ApplianceSmart operation, ARCA also is one of the nation's leading retailers of
special-buy household appliances, primarily those manufactured by Maytag, GE,
Frigidaire and Whirlpool. These special-buy appliances, which include
close-outs, factory overruns and scratch-and-dent units, typically are not
integrated into the manufacturer's normal distribution channel. ApplianceSmart
sells these virtually new appliances at a discount to full retail, offers a 100%
money-back guarantee and provides warranties on parts and labor. As of April
2007, ApplianceSmart was operating 15 factory outlets: five in the
Minneapolis/St. Paul market; three in the Columbus, Ohio, market; four in the
Atlanta market; two in San Antonio, Texas; and one in Los Angeles.Statements about ARCA's outlook are forward-looking and involve risks and
uncertainties, including but not limited to: the strength of recycling programs,
the growth of appliance retail sales, the speed at which individual retail
stores reach profitability, and other factors discussed in the Company's filings
with the Securities and Exchange Commission.Visit our web site at http://www.arcainc.comSOURCE Appliance Recycling Centers of America, Inc.
Ionatron, Inc.
30.04.07 21:40 Uhr
6,01 USD
+18,07 % [+0,92]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=IOTN.NAS&lColors=0x000000&sSym=IOTN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=IOTN.NAS&lColors=0x000000&sSym=IOTN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=IOTN.NAS&lColors=0x000000&sSym=IOTN.NAS&hcmask=
Börse
NASDAQ
Aktuell
6,01 USD
Zeit
30.04.07 21:40
Diff. Vortag
+18,07 %
Tages-Vol.
107,99 Mio.
Gehandelte Stück
20 Mio.
Upward Momentum: Ionatron, Inc. Awarded Contract from U.S. Navy
Apr 30, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NASDAQ market has brought this company to the attention of our research team. Ionatron, Inc., (NASDAQ: IOTN), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
Ionatron, Inc., (NASDAQ: IOTN) a Laser Guided Energy (LGE(TM)) company developing next generation Directed Energy Weapons, today announced that the U.S. Navy has posted a notification on the Federal Business Opportunities website (www.fbo.gov) regarding the award of a sole source contract regarding Ionatron's proprietary Counter IED (CIED) technology. The posting of this information is a federal contracting requirement prior to contract award. The contract value is approximately $0.5 million dollars.
As described in the Solicitation Notice released by the U.S. Navy on April 26, 2007 this contract funded the initial development of a Dual Effects, Stand-Off IED Neutralization System (DESINS) to be used by the United States Marine Corps (USMC) in their effort to improve current and future naval expeditionary warfare capabilities across the spectrum of conflict for current and future operating forces. This effort encompassed defining preliminary specifications and requirements for all subsystems, integrated system and performance requirements.
The contract also included factory testing and demonstration, as well as field testing and demonstration of the developmental system. As previously disclosed by the Company, this independent testing of Ionatron's latest CIEDS products by USMC/USN team was directed by Congress in late 2006 and the tests were completed in mid-Q1 2007. Ionatron continues to support the Marine Corps and U.S. military in their effort to address the problem of Improvised Explosive Devices.
About Ionatron Inc.
Ionatron, Inc. is a solution provider that develops and markets Laser Guided Energy (LGE(TM)) and related products to defense and security customers for unique applications worldwide. Ionatron has significant expertise in the application of high-power lasers, optics and energy management technologies. Headquartered in Tucson, Arizona, Ionatron is focused on solving technology problems directly for its government and security-conscious customers
During mid-morning trading shares are up 26% to $6.40 with over 12,000,000 in volume. The Market Gainer Research Team will continue to gauge the short and long term affects that this announcement will have on the company
3M COMPANY (ex. MINNESOTA MINING) : Die Kurse nähern sich den ...
http://www.fimatex.de/includes/news/attachement_news.phtml?id=944147
3M COMPANY (ex. MINNESOTA MINING) : Die Kurse nähern sich den Widerstandsniveaus
ZUSAMMENFASSUNG
Der MACD ist positiv und liegt über seiner Signallinie. Diese Konstellation unterstreicht die gute Ausrichtung des Papiers.Dennoch befindet sich der RSI in der Überkaufzone - kurzfristig ist mit einer technischen Korrektur zu rechnen.Außerdem ist die Stochastik sehr hoch, was ebenfalls auf ein hohes Risiko im Falle einer abrupten Umkehr hindeutet.Die gehandelten Volumen liegen über dem Durchschnitt der Volumen der letzten 10 Tage.
BEWEGUNGEN UND AKTIENSTÄNDE
Das Papier erlebt eine Hausse. Es liegt über seinem beweglichen Durchschnitt über 50 Tage. Der Stand des beweglichen Durchschnitts über 20 Tage (höher als der bewegliche Durchschnitt über 50 Tage) stimmt optimistisch hinsichtlich der mittelfristigen Aussichten. Die ersten Kaufniveaus sind die Unterstützungslinien bei 78,12 USD, und dann bei 75,8 USD - nur die Widerstandslinien bei 87,44 USD, dann bei 89,77 USD, könnten die Kurse dämpfen.
Letzter Kurs : 84.42
Einschätzung : Neutral
Tendenz : kurzfristiges Ausbruchspotential
Unterstützung : 78.12 / 75.8
Widerstand : 87.44 / 89.77
VERIZON COMMUNICATIONS : Die Kurse nähern sich den Widerstandsniveaus
http://www.fimatex.de/includes/news/attachement_news.phtml?id=944145
ZUSAMMENFASSUNG
Der MACD ist positiv und liegt über seiner Signallinie. Diese Konstellation unterstreicht die gute Ausrichtung des Papiers.Dennoch befindet sich der RSI in der Überkaufzone - kurzfristig ist mit einer technischen Korrektur zu rechnen.Außerdem ist die Stochastik sehr hoch, was ebenfalls auf ein hohes Risiko im Falle einer abrupten Umkehr hindeutet.Die gehandelten Volumen liegen über dem Durchschnitt der Volumen der letzten 10 Tage.
BEWEGUNGEN UND AKTIENSTÄNDE
Das Papier erlebt eine Hausse. Es liegt über seinem beweglichen Durchschnitt über 50 Tage. Der Stand des beweglichen Durchschnitts über 20 Tage (höher als der bewegliche Durchschnitt über 50 Tage) stimmt optimistisch hinsichtlich der mittelfristigen Aussichten. Die ersten Kaufniveaus sind die Unterstützungslinien bei 36,85 USD, und dann bei 36,35 USD - nur die Widerstandslinien bei 39,85 USD, dann bei 40,84 USD, könnten die Kurse dämpfen.
Letzter Kurs : 39.6
Einschätzung : Neutral
Tendenz : kurzfristiges Ausbruchspotential
Unterstützung : 36.85 / 36.35
Widerstand : 39.85 / 40.84
Dow Jones wehrt sich gegen Murdoch
Rupert Murdoch hat schon immer nach den Sternen gegriffen. Nachdem er einst von der Lokalzeitungs-Ebene aus die gesamte australische Medienlandschaft veränderte und dann den Sprung zum Medienzar in den USA schaffte, greift der 76-Jährige nun nach einem Heiligtum: dem Wall Street Journal.
Rupert Murdochs News Corp. hat ein Übernahmeangebot an Dow Jones eingereicht, den Traditionsverlag, der hinter dem Wall Street Journal und dem Anlegermagazin Barron´s steht – beide Blätter gelten als Wall-Street-Bibeln. Entsprechend sind sie nicht billig, doch übertrifft Murdochs Angebot alle Spekulationen. Die News Corp. will rund 5 Milliarden Dollar für das Unternehmen zahlen. Das entspricht 60 Dollar pro Aktie und einem Aufschlag von mehr als 50 Prozent auf den Durchschnittskurs der letzten zwölf Monate.
Ein solches Angebot kann eigentlich keiner ablehnen, mögen sich Anleger gedacht haben, die den Kurs von Dow Jones umgehend um 53 Prozent klettern ließen. Doch falsch gedacht: Nach der Rallye am Dienstag dürfte ein rascher Ausstieg die größte Rendite bringen, denn es finden sich ganz viele, die einen Verkauf von Dow Jones an News Corp. nicht in Erwägung ziehen. Allen voran die Familie Bancroft, die etwas mehr als 50 Prozent der stimmberechtigten Aktien hält.
Die Familie – Nachfahren von Hugh Bancroft, der vor fast 100 Jahren Dow Jones von seinem Großvater Clarence Barron übernahm – hat bereits erklärt, dass man an einem Verkauf des Unternehmens nicht interessiert sei. Es geht den Bancrofts, die allesamt unter den 400 reichsten Amerikanern gelistet sind, nicht um den Preis, sondern um das Prinzip. Schließlich gehört man zum exklusiven Zirkel der internationalen Medienmogule – so wie die Sulzburgers bei der New York Times oder, in Deutschland, die Familie Mohn bei Bertelsmann. Solch einen Status verkauft man nicht.
Abgesehen davon, dass ein Verkauf von Dow Jones ohne die Zustimmung der Bancrofts ohnehin unvorstellbar ist, stemmen sich auch die Gewerkschaften und zahlreiche Politiker gegen einen solchen Schritt. Vor allem Demokraten wehren sich lautstark gegen die jüngste Konsolidierung auf dem amerikanischen Medienmarkt, die zu immer weniger ausgewogener Berichterstattung führt.
Um jene fürchten wohl auch die Mitarbeiter von Dow Jones. Wer bisher bei Wall Street Journal und Barron´s schrieb, wird sich künftig nicht Rupert Murdoch fügen wollen. Dessen politische Linie ist ebenso bekannt wie der Umstand, dass er sie in seinen Medien knallhart durchsetzt. Da nennt er den demokratischen Präsidentschaftkandidaten Barack Obama in Kommentaren „Osama“ oder macht sich über einen liberalen TV-Moderator lustig, nachdem der eine Anthrax-Drohung erhalten hatte.
Umstritten ist auch, wie Murdochs „New York Post“ die Präsidentschaft von George W. Bush und den Irakkrieg dokumentiert: Da stellte man einst aus Ärger über die mangelnde Kriegsbegeistertung in Europa Deutschland und Frankreich in die „Achse der Weicheier“. Vor einem halben Jahr bildete man die Chefs einer parteiübergreifenden Untersuchungskommission über den Irak als Affen ab, nachdem diese Bushs Kriegsführung kritisiert und einen Abzug der Truppen gefordert hatte.
Mit solchen Machenschaften will keiner zu tun haben, der vorher bei einem der angesehensten Blätter in der amerikanischen Medienlandschaft beschäftigt war. Zu groß wäre der Verlust der Glaubwürdigkeit, und den können auch rosige Wachstumsaussichten nicht wett machen.
Doch die gäbe es: Aller Vorraussicht nach würde Murdoch mit Dow Jones und Fox in einem Boot gerne einen neuen TV-Sender für Finanznachrichten gründen wollen, der den bisherigen Marktführer CNBC ebenso in Schwierigkeiten bringen könnte wie Fox News den seriösen Wettbewerber CNN im News-Bereich.
Die Wall Street – sonst stets im Merger-Fieber – dürfte sich in diesem Fall auf die Seite der Bancrofts schlagen. Aus Eigennutz, denn auf die objektive Berichterstattung des Wall Street Journal will man nicht verzichten. Und vielleicht auch aus Nostalgie. Denn Dow Jones ist eine Legende im Finanzviertel, nicht zuletzt wegen des gleichnamigen Index, der vom Verlag verwaltet wird. Der soll nicht eines Tages zur „Murdoch-Marke“ umbenannt werden.
Lars Halter
04.05.07 16:27 Uhr
33,16 USD
+17,67 % [+4,98]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
Börse
NASDAQ
Aktuell
33,16 USD
Zeit
04.05.07 16:27
Diff. Vortag
+17,67 %
Tages-Vol.
1,99 Mrd.
Gehandelte Stück
106 Mio.
Im Mittelpunkt des Interesses steht am Freitag eine mögliche Übernahme von Yahoo. Die „New York Post“ berichtet, dass der Software-Riese Microsoft in Übernahmeverhandlungen treten und bis zu 50 Milliarden Dollar bieten will. Yahoo hat zur Zeit einen Marktwert von etwa 38 Milliarden Dollar. Microsoft könnte über eine Partnerschaft Yahoo den Anschluss an das Internet-Business wieder gewinnen, in dem man trotz starker Geschäfte mit Betriebssystemen den Anschluss verloren hat.
Außerdem würden Microsoft und Yahoo gemeinsam einen größeren Teil der Online-Werbung einstreichen können und näher an den Internet-Marktführer Google rücken.
21st Century Holding Company
04.05.07 16:33 Uhr
11,27 USD
-43,62 % [-8,72]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=TCHC.NAS&lColors=0x000000&sSym=TCHC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=TCHC.NAS&lColors=0x000000&sSym=TCHC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=TCHC.NAS&lColors=0x000000&sSym=TCHC.NAS&hcmask=
Börse
NASDAQ
Aktuell
11,27 USD
Zeit
04.05.07 16:33
Diff. Vortag
-43,62 %
Tages-Vol.
10,85 Mio.
Gehandelte Stück
988.533
21st Century Holding Company Reports First Quarter Earnings of $0.11 Per Share
LAUDERDALE LAKES, Fla., May 03, 2007 (BUSINESS WIRE) -- 21st Century Holding Company (Nasdaq: TCHC), today reported results for the quarter ended March 31, 2007 (see attached tables).
For the three months ended March 31, 2007, the Company reported net income of $842,805, or $0.11 per share on 7,958,366 average undiluted shares outstanding, as compared to net income of $6,013,312, or $0.88 per share on 6,844,859 average undiluted shares outstanding in the same three-month period last year. On a diluted share basis, the Company reported earnings of $0.10 per share, based on 8,187,310 average diluted shares outstanding, as compared to $0.83 per share on 7,238,311 average diluted shares outstanding for the three months ended March 31, 2006.
Net premiums earned increased $0.6 million or 2.6% to $22.4 million for the three months ended March 31, 2007, as compared to $21.8 million for the same three-month period last year.
Total revenues increased $0.5 million or 1.9% to $25.6 million for the three months ended March 31, 2007, as compared to $25.1 million for the same three-month period last year.
Edward J. (Ted) Lawson, Chairman, CEO, and President, said, "While these earnings are not as robust as we had anticipated for our first quarter, our management team and I believe that the company remains strong and well positioned for future growth and profitability. However, after considering significant factors that are expected to impact our earnings for calendar year 2007, annual Company guidance is hereby amended from $4.50 per share to $2.00 to $2.50 per share."
Mr. Lawson continued, "In my opinion, the primary factors considered for lowering guidance at this time are 1) the State of Florida has politicized the entire rate making process and 2) the State's insurance carrier, Citizens Property Insurance Corporation, is now using rates that do not take into consideration the cost of private reinsurance and income tax expense while at the same time attracting new business since they are no longer considered the carrier of last resort, thereby hurting us in our ability to compete in a free enterprise system."
The Company will hold an investor conference call at 4:30 PM (ET) today, May 3, 2007. Mr. Lawson and Mr. J. Gordon Jennings III, CFO, will discuss the financial results and review the outlook for the Company. Messrs. Lawson and Jennings invite interested parties to participate in the conference call. Listeners can access the conference call by dialing toll free 888-460-6235, conference ID 7067460. Please call at least five minutes in advance to ensure that you are connected prior to the presentation. A replay of the conference call will be available for 7 days at 800-642-1687.
About the Company
The Company, through its subsidiaries, underwrites general liability insurance homeowners' property and casualty insurance, flood insurance and personal automobile insurance in the State of Florida. The Company underwrites general liability coverage as an admitted carrier in the States of Louisiana, Texas and Alabama for more than 300 classes of business, including special events. The Company also operates as an approved (non-admitted) carrier in the States of Georgia, Kentucky, Virginia, South Carolina, Missouri and Arkansas offering the same general liability products. The Company is licensed and has the facilities to market and underwrite other insurance carriers' lines of business, as well as to process and adjust claims for third party insurance carriers. In addition to insurance services, the Company offers premium finance services to its insureds as well as insureds of certain third party insurance companies.
Crocs, Inc.
04.05.07 16:39 Uhr
67,51 USD
+17,59 % [+10,10]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CROX.NAS&lColors=0x000000&sSym=CROX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CROX.NAS&lColors=0x000000&sSym=CROX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CROX.NAS&lColors=0x000000&sSym=CROX.NAS&hcmask=
Börse
NASDAQ
Aktuell
67,51 USD
Zeit
04.05.07 16:39
Diff. Vortag
+17,59 %
Tages-Vol.
402,19 Mio.
Gehandelte Stück
6,7 Mio.
Making The Watchlist: Crocs, Inc. Announces Financial Results for First Quarter
May 04, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NASDAQ market has brought this company to the attention of our research team. Crocs, Inc. (NASDAQ: CROX), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
Crocs, Inc. (NASDAQ: CROX) reported the following record financial results for the quarter ended March 31, 2007.
Revenues for the quarter ended March 31, 2007 increased 217% to $142.0 million compared to $44.8 million for the first quarter ended March 31, 2006. Net income for the quarter ended March 31, 2007 was $24.9 million, or $0.61 per diluted share, compared to $6.4 million, or $0.17 per diluted share, for the same period in 2006. Gross profit for the quarter of 2007 was $84.5 million, or 59.5% of revenues, compared to $23.7 million, or 52.9% of revenues for the quarter of 2006. Selling, general and administrative expenses for the first quarter ended March 31, 2007 was $47.3 million, or 33.3% of revenues, compared to $13.7 million, or 30.6% of revenues in the first quarter ended March 31, 2006.
Ron Snyder, President and Chief Executive Officer of Crocs, Inc. commented, "Our strong first quarter performance was driven by the growing worldwide demand for our entire portfolio of products. Domestically, we benefited from robust sell through of our Crocs footwear, including our new spring/summer collection, in addition to our new licensed and Jibbitz businesses. At the same time, our international business continues to rapidly expand fueled by sales of our classic models, as well as our more recent introductions. We are pleased with our start to 2007 and we remain extremely optimistic about the many growth opportunities that lie ahead as evidenced by our heightened outlook for the year."
Stock Split
Crocs announced that on May 2, 2007, its Board of Directors declared a two-for-one stock split of the Company's common shares, to be effected in the form of a common stock dividend. All shareholders of record at the close of business on May 31, 2007, will receive one additional share of common stock for each share held on that date. The additional share common stock will be distributed on June 14, 2007. Information pertaining to shares and earnings per share does not reflect this split.
Guidance
For the second quarter of 2007, the Company currently anticipates total revenues to range from $180 million to $190 million and projects its net income per diluted share to range from $0.80 to $0.85.
Crocs also raised its fiscal 2007 guidance. The Company now expects total revenues to range from $670 million to $680 million and net income per diluted share to range from $2.90 to $2.95.
About Crocs, Inc:
Crocs, Inc. is a rapidly growing designer, manufacturer and retailer of footwear for men, women and children under the Crocs(TM) brand.
All Crocs(TM) brand shoes feature Crocs' proprietary closed-cell resin, Croslite(TM), which represents a substantial innovation in footwear. The Croslite(TM) material enables us to produce soft, comfortable, lightweight, superior-gripping, non-marking and odor-resistant shoes. These unique elements make Crocs(TM) footwear ideal for casual wear, as well as for professional and recreational uses such as boating, hiking, hospitality and gardening. The versatile use of the material has enabled us to successfully market our products to a broad range of consumers.
In 2006, the company acquired Jibbitz LLC, a unique accessory brand with colorful snap-on products specifically suited for Crocs shoes. Today, more than 1,100 Jibbitz designs are available to consumers for personalizing and customizing their Crocs(TM) footwear.
Crocs(TM) are sold in more than 80 countries and come in a wide array of colors and styles. Please visit www.crocs.com for additional information During pre-market trading shares are up 18% to $68.25 with over 200,000 in volume.
Dow-Jones-Großaktionär gegen Murdoch-Offerte - Politische Gründe
Mo Mai 7, 2007 7:59 MESZ
New York (Reuters) - Einer der größten Aktionäre des US-Medienkonzerns Dow Jones lehnt das Übernahmeangebot des umstrittenen Milliardärs Rupert Murdoch ab.
Die redaktionelle Unabhängigkeit der Dow-Jones-Zeitung "Wall Street Journal" wäre unter Murdoch gefährdet, begründete Jim Ottaway Jr. seine Position am Sonntag.
"Murdoch verspricht redaktionelle Unabhängigkeit und Nicht-Einmischung ins Nachrichtengeschäft, wenn er Eigentümer von Dow Jones wäre", schrieb Ottaway. "Er hat diese einfachen Versprechen eines eifrigen Käufers in der Vergangenheit gemacht, aber sie nicht immer eingehalten."
Murdoch benutze seine Medien, um seine eigenen politischen und geschäftlichen Interesse zu verfolgen. "Wir sehen dies jeden Tag hier in Amerika in der 'New York Post', die regelmäßig parteiische Nachrichten und Schlagzeilen bringt, die seine Freunde, politischen Kandidaten und Ziele unterstützt und Menschen angreift, die er persönlich ablehnt." Das lasse sich auch bei Murdochs Fernsehsender Fox beobachten, der als besonders konservativ gilt.
Dow Jones hatte am Dienstag mitgeteilt, eine unerbetene Offerte von Murdochs News Corp erhalten zu haben. Die Firma erklärte, ihr Führungsgremium werde nicht auf die fünf Milliarden Dollar schwere Übernahmeofferte reagieren, da der Mehrheitsaktionär Bancroft das Gebot abgelehnt habe. Die Bancroft-Familie hält 64,2 Prozent der Stimmrechte an Dow Jones.
07.05.2007 14:43
8X8 - Bullischer Druckaubau deutet auf...
8x8 Inc. (Nachrichten) - Kürzel: EGHT - ISIN: US2829141009
Börse: Nasdaq in USD / Kursstand: 1,48 $
Kursverlauf vom 30.06.2002 bis 07.05.2007 (log. Kerzenchartdarstellung / 1 Kerze = 1 Woche)
Rückblick: Die 8X8 Aktie startete im August 2006 an der Unterstützung bei 0,68 $ eine Aufwärtsbewegung bis an den mittelfristigen Abwärtstrend, wo sie nach unten hin abprallte und in eine Seitwärtsbewegung überging. Diese Seitwärtsbewegung hat nach dem vorangegangenen Kursanstieg zunächst bullischen Charakter und deutet eine weitere Aufwärtswelle an. Das kurzfristige Chartbild hat leicht bullische Tendenzen, das mittelfristige ist absolut neutral zu werten.
Charttechnischer Ausblick: Die Aktie sollte in den kommenden Monaten einen Ausbruch nach oben hin und eine mittelfristige Aufwärtsbewegung starten. Die entscheidende Marke liegt jetzt bei 1,56 $. Bereits ein Anstieg über 1,56 $ bietet eine kleine Longchance mit Ziel bei 1,96 $. Erst ein Anstieg per Tages- und Wochenschluss über das Hoch aus 2006 bei 1,96 $ generiert ein großes Kaufsignal mit Zielen bei 3,39 und 8,06 $. Fällt die Aktie hingegen per Tages- und Wochenschluss unter 1,00 $ zurück, wird eine Abwärtsbewegung bis 0,68 $ wahrscheinlich.
https://ssl.godmode-trader.de/charts/46/2005/ddb4918.gif
IBM, Grundstein für Aufwärtstrend ist gelegt
07.05.2007 - 12:37:43 Uhr
HSBC Trinkaus & Burkhardt
Frankfurt (derivatecheck.de) - Die Marktexperten bei der HSBC Trinkaus & Burkhardt blicken auf die gegenwärtige Entwicklung und die Tendenzen bei der IBM-Aktie.
Im Verlauf des Aufwärtstrends der IBM-Aktie seit Oktober 2002 bei aktuell 77,78 US-Dollar sei es der Aktie zuletzt nicht nur gelungen, den seit September 2000 gültigen Baissetrend bei aktuell 97,28 US-Dollar zu überwinden, sondern es konnten nach Angaben der Marktbeobachter auch die verschiedenen Hochpunkte im Dunstkreis der 100-Dollar-Marke aus dem Weg geräumt werden. Diese beiden positiven Chartsignale würden dabei durch die Trend folgenden Indikatoren bestätigt.
Auf Monatsbasis signalisierten MACD und Aroon intakte Aufwärtstrends, wobei ersterer bei wöchentlicher Berechnungsweise gerade seine Signallinie von unten nach oben durchschneide. Damit dürfte der Grundstein gelegt sein, um den flacheren, im Juli 1999 begonnenen Abwärtstrend bei 113,03 US-Dollar in Angriff zu nehmen. Als Absicherung neuer Long-Positionen bietet sich nach Meinung der Strategen bei der HSBC Trinkaus & Burkhardt die Unterstützungszone aus den genannten ehemaligen Hochpunkten zwischen 100,90 und 99,10 US-Dollar an.
http://194.97.1.200/charts/1520000/20070507_1526592_1.gif
Ohio Casualty Corporation
07.05.07 16:17 Uhr
43,18 USD
+29,59 % [+9,86]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=OCAS.NAS&lColors=0x000000&sSym=OCAS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=OCAS.NAS&lColors=0x000000&sSym=OCAS.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=OCAS.NAS&lColors=0x000000&sSym=OCAS.NAS&hcmask=
Börse
NASDAQ
Aktuell
43,18 USD
Zeit
07.05.07 16:17
Diff. Vortag
+29,59 %
Tages-Vol.
80,29 Mio.
Gehandelte Stück
2,4 Mio.
Liberty Mutual Group to Acquire Ohio Casualty Corporation Ohio Casualty Generated $1.4 Billion in Net Written Premium in 2006 and pre-tax income of $300 million
BOSTON & FAIRFIELD, Ohio, May 07, 2007 (BUSINESS WIRE) -- Liberty Mutual Group ("Liberty Mutual") and Ohio Casualty Corporation ("Ohio Casualty") (NASD: OCAS) today announced that they have entered into a definitive agreement pursuant to which Liberty Mutual will acquire all outstanding shares of common stock of Ohio Casualty for $44.00 per share in cash. Ohio Casualty Corporation is the holding company of The Ohio Casualty Insurance Company and five other property and casualty insurance companies, which are referred to under the marketing brand Ohio Casualty Group. Ohio Casualty Group ranks 50th among property and casualty insurers based upon net premiums written (Best's Review, July 2006), and sells personal, commercial and bond insurance products through independent agents and brokers.
The transaction is valued at approximately $2.7 billion. Liberty Mutual intends to fund the purchase with cash on hand and short-term debt; the transaction is not subject to any financing contingencies. The proposed transaction, which has been approved by the Boards of Directors of both companies, is subject to approval by Ohio Casualty shareholders and customary regulatory approvals and conditions, and is expected to close in the third quarter of 2007.
Following the acquisition, Ohio Casualty will be part of Liberty Mutual Group's Agency Markets business unit. The 11 companies in Liberty Mutual Agency Markets have more than 6,800 employees and approximately 6,500 appointed agencies. In 2006, Liberty Mutual Agency Markets' net written premium was $5.9 billion. Ohio Casualty, which has approximately 2,100 employees and operations in 48 states, has approximately 3,400 appointed agencies. In 2006, Ohio Casualty's net written premium was $1.4 billion.
"Under Dan Carmichael's leadership, Ohio Casualty has been transformed into a premier regional property and casualty company and is a great fit with our Agency Markets business," said Edmund F. Kelly, Liberty Mutual Group chairman, president and chief executive officer. "Through the addition of Ohio Casualty, our regional-company independent agency business is significantly stronger and our agency relationships are strengthened. With combined net written premium exceeding $7.3 billion following this transaction, we will become the largest regional provider of property and casualty products distributed through independent agents in the United States."
Dan Carmichael, president and chief executive of Ohio Casualty, said, "I am very proud of the accomplishments of our employees, agents and management at Ohio Casualty in creating a leading super-regional property and casualty insurance company. We look forward to being an important component of Liberty Mutual Agency Markets' continuing success. We believe this transaction will benefit our key constituents and enable our shareholders to realize significant value for their investment in Ohio Casualty."
Gary Gregg, president of Liberty Mutual Agency Markets, said, "I look forward to working with Dan and the leadership of Ohio Casualty, who will play a key role in the joint integration team tasked with combining the best of both organizations to create a stronger Liberty Mutual Agency Markets. We share Ohio Casualty's commitment to employees, customers and agents. The combined organization intends to maintain a significant presence in the Cincinnati area and will continue to support local charities in the communities in which we do business."
About Liberty Mutual Group
Boston-based Liberty Mutual Group is a diversified global insurer and sixth largest property and casualty insurer in the United States based on 2005 direct written premium. The Company also ranks 95th on the Fortune 500 list of largest corporations in the United States based on 2006 revenue of $23.5 billion. As of December 31, 2006, Liberty Mutual Group had $85.5 billion in consolidated assets.
Liberty Mutual Group offers a wide range of insurance products and services, including personal automobile, homeowners, commercial multiple peril, commercial automobile, general liability, workers compensation, global specialty, group disability, assumed reinsurance, fire and surety.
Liberty Mutual Group (www.libertymutual.com) employs over 39,000 people in more than 900 offices throughout the world.
About Ohio Casualty Corporation
Ohio Casualty Corporation is the holding company of The Ohio Casualty Insurance Company and five other subsidiary insurance companies. Headquartered in Fairfield, OH, Ohio Casualty Corporation trades on the NASDAQ Stock Market under the symbol OCAS. With approximately 2,100 employees in five major locations countrywide, Ohio Casualty Group is ranked among the top 50 U.S. property/casualty insurance groups based on net premiums written (Best's Review, July 2006).
Ohio Casualty Group is the marketing brand for our six property/casualty insurance companies, which are licensed to write auto, home and business insurance. Policies are written through the independent agency system. The oldest company, The Ohio Casualty Insurance Company, was founded in 1919.
Rated A (Excellent) for financial strength by the A.M. Best Company, Inc., the Group has written premiums of approximately $1.42 billion as of Dec. 31, 2006. OCG products are marketed through approximately 3,400 independent agencies. Policies may be underwritten by The Ohio Casualty Insurance Company, West American Insurance Company, American Fire and Casualty Company, Ohio Security Insurance Company, Avomark Insurance Company or Ohio Casualty of New Jersey, Inc.
ALCAN INC
07.05.07 16:50 Uhr
81,86 USD
+34,13 % [+20,83]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
Börse
NYSE
Aktuell
81,86 USD
Zeit
07.05.07 16:50
Diff. Vortag
+34,13 %
Tages-Vol.
1,11 Mrd.
Gehandelte Stück
18 Mio.
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
ALCOA INC
07.05.07 16:53 Uhr
37,77 USD
+5,92 % [+2,11]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AA.NYS&lColors=0x000000&sSym=AA.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AA.NYS&lColors=0x000000&sSym=AA.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AA.NYS&lColors=0x000000&sSym=AA.NYS&hcmask=
Börse
NYSE
Aktuell
37,77 USD
Zeit
07.05.07 16:53
Diff. Vortag
+5,92 %
Tages-Vol.
1,26 Mrd.
Gehandelte Stück
41 Mio.
DOMINOS PIZZA INC
07.05.07 16:59 Uhr
19,85 USD
+5,19 % [+0,98]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=DPZ.NYS&lColors=0x000000&sSym=DPZ.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=DPZ.NYS&lColors=0x000000&sSym=DPZ.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DPZ.NYS&lColors=0x000000&sSym=DPZ.NYS&hcmask=
Börse
NYSE
Aktuell
19,85 USD
Zeit
07.05.07 16:59
Diff. Vortag
+5,19 %
Tages-Vol.
30,51 Mio.
Gehandelte Stück
1,6 Mio.
DJ Mexican Fast-Food Co Alsea Sells Domino's Pizza Ops In Brazil
MEXICO CITY, May 03, 2007 (Dow Jones Commodities News via Comtex) -- Mexican fast-food operator Alsea (ALSEA.MX) said Thursday it sold its remaining 50% stake in DeLibra Ltd., the company that operates Domino's Pizza franchises in Brazil.
Alsea, which runs Domino's Pizza (DPZ), Burger King (BKC), Starbucks Coffee (SBUX) and other franchises in Mexico, said the effect on earnings of its exit from DeLibra will be negligible.
Alsea sold 50% of Delibra in 2004 and stopped consolidating its results, listing them as discontinued operations as of the fourth quarter of 2006.
The company plans to open 100 coffee shops and restaurants this year, bringing its total to 963. Alsea reported 23 Domino's Pizza shops in Brazil at the end of 2006.
-By Anthony Harrup, Dow Jones Newswires; (5255) 5080 3450; anthony.harrup@dowjones.com
(END) Dow Jones Newswires
05-03-07 1144ET
Wall Street: Rückläufige Kurse am Tag vor der Fed-Sitzung
Die amerikanischen Börsen sind am Dienstag morgen mit leichten Verlusten gestartet, nachdem aus Europa und Asien rückläufige Kurse gemeldet wurden. Der letzte Handelstag vor der Sitzung der Fed am Mittwoch bewegt die Gemüter. Zehn Minuten nach Handelsbeginn fällt der Dow-Jones-Index um 0,34 Prozent auf 13.267,79 Punkte.
Der marktbreite S&P-500-Index fällt kurz nach Ertönen der Glocke um 0,30 Prozent auf 1.504,88 Zähler, die Nasdaq fällt um 0,38 Prozent auf 2.561.26 Punkte.
Rohöl-Futures notierten vorbörslich bei 61,71 $ pro Barrel, das entspricht einem Preisanstieg von 0,24 $.
Ökonomisch erwartet der Markt heute keine Überraschungen bis auf die Zahlen des Großhandels vom März. Die Börsianer sind gespannt, welche Zinsentscheidung und welches Statement zur politischen Lage Ben Bernanke morgen abgeben wird.
Im Mittelpunkt des Interesses steht am Dienstag der Hanyhersteller Motorola, dessen Aktiekurs vorbörslich um 1,8 Prozent sank, nachdem der Großinvestor Carl Icahn gestern nicht in den Aufsichtsrat gewählt wurde. Icahn sagte, er habe die Unterstützung vieler Kleinanlegern bekommen, ihm fehle aber der Rückhalt der großen Investment-Fonds.
Die Medienkonzerne Reuters und Thomson bekennen sich zu einer möglichen Fusion. Thomson möchte Reuters für 17,4 Milliarden $ übernehmen, der Vorstandsvorsitzende von Reuters, Tom Glocer, soll die Firma leiten.
Die Fast-Food-Kette McDonald’s Corp. erklärte, dass während die Verkäufe vergleichbarer Ketten im April weltweit um 4,8 Prozent zunahmen, die Verkaufszahlen der eigenen Restaurants um überdurchschnittliche 9,6 Prozent anstiegen.
Bei den Anbietern von Sportbekleidung berichtete Adidas von einem 11prozentigen Rückgang des Umsatzes, aber von steigenden Verkaufszahlen in der Turnschuh-Sparte und bei der Tochter Reebok. Wettbewerber Nike konnte vorbörslich zulegen.
Der Mischkonzern Tyco International’s übertraf die Erwartungen der Analysten um 1 Cent pro Aktie, während die Aktie des Musikunternehmens Time Warner Music’s um 1 Cent niedriger schloss, als von den Analysten erwartet.
Nach gestrigem Börsenschluss legten der Unterhaltungskonzern Walt Disney & Co. sowie der Netzwerkausrüster Cisco Quartalszahlen vor.
WSC -
08.05.2007 19:44
Wall Street am Mittag mit Gewinnmitnahmen etwas leichter
NEW YORK (Dow Jones)--Im Zuge von Gewinnmitnahmen zeigen sich die Notierungen an Wall Street am Dienstagmittag (Ortszeit) weiterhin etwas leichter. Bis 18.33 Uhr MESZ verliert der Dow Jones Index für 30 Industriewerte 0,4% bzw 48 auf 13.265 Punkte, der S&P-500 gibt um 0,4% bzw 6 Punkte auf 1.503 nach. Der Nasdaq-Composite notiert mit einem Minus von 0,4% bzw 11 Punkten bei 2.560. Die meisten Anleger hielten sich im Vorfeld der Zinsentscheidung der Federal Reserve am Mittwoch zurückhaltend, heißt es. Das Thema Übernahmen setze am Berichtstag keine entscheidenden Akzente. Nachrichten von Unternehmensseite gibt es nur wenige und auch die veröffentlichten Konjunkturdaten spielen nur eine untergeordnete Rolle.
Weiter im Blick stehen Alcoa, nachdem das Unternehmen am Vortag ein feindliches Übernahmeangebot für den kanadischen Wettbewerber Alcan über etwa 26,9 Mrd USD vorgelegt hat. BHP Billiton wollte sich zu einem möglichen Gegen-Gebot für Alcan nicht äußern. "Es gehört zur Unternehmenspolitik, Spekulationen und Marktgerüchte nicht zu kommentieren", sagte BHP-Billiton-Sprecher Illtud Harri auf Nachfrage. Zu einer möglichen Übernahmeofferte des in Melbourne ansässigen Unternehmens für den US-Aluminiumkonzern Alcoa wollte sich der Sprecher ebenfalls nicht äußern. Alcoa verlieren 0,1% auf 38,58 USD, Alcan 2,1% auf 80,41 USD.
ALCOA INC
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AA.NYS&lColors=0x000000&sSym=AA.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AA.NYS&lColors=0x000000&sSym=AA.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AA.NYS&lColors=0x000000&sSym=AA.NYS&hcmask=
ALCAN INC
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AL.NYS&lColors=0x000000&sSym=AL.NYS&hcmask=
Derweil geht es für die Aktie von AK Steel Holding um 9,8% auf 35,19 USD nach oben, nachdem die "Financial Times" berichtet hat, Arcelor Mittal plane eine 4,5-Mrd-USD-Übernahme des Stahlkonzerns, was einem Gebot von 40 USD je Aktie entspricht. Mit einem Aufschlag von 1,9% auf 44,62 USD reagiert die Aktie von Hewlett-Packard (HP) positiv auf die Anhebung der Unternehmensziele für das zweite Quartal. HP erwartet nun einen Umsatz von 25,5 Mrd bis 25,55 Mrd USD nach zuvor 24,5 Mrd USD. Der Gewinn je Aktie soll sich nun auf 0,64 bis 0,65 USD belaufen nach 0,59 bis 0,61 USD.
A K STEEL HLDG CORP
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AKS.NYS&lColors=0x000000&sSym=AKS.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AKS.NYS&lColors=0x000000&sSym=AKS.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AKS.NYS&lColors=0x000000&sSym=AKS.NYS&hcmask=
Daneben stehen Motorola im Blick. Die Aktie verliert vor dem Hintergrund der Hauptversammlung des Unternehmens 2,3% auf 17,66 USD. In deren Mittelpunkt stand die umstrittene Bewerbung des Milliardärs Carl Icahn für einen Sitz im Aufsichtsrat von Motorola. Laut dem "WSJ" wird Icahn keinen Sitz erhalten. Die Aktionäre wollten damit dem CEO Ed Zander offenbar mehr Zeit einräumen, das Unternehmen wieder auf Kurs zu bringen. Der US-Konzern leidet derzeit unter dem Preiskampf in der Branche.
MOTOROLA INC
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MOT.NYS&lColors=0x000000&sSym=MOT.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MOT.NYS&lColors=0x000000&sSym=MOT.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MOT.NYS&lColors=0x000000&sSym=MOT.NYS&hcmask=
DJG/DJN/reh
McDonald’s April same-store sales rise 4.8%
Tuesday, May 08, 2007 3:19:16 PM ET
newratings.com
NEW YORK, May 8 (newratings.com) – Fast food restaurant chain operator McDonald’s Corp (MCD.NYS) Tuesday reported that sales at its restaurants open for more than a year rose 4.8% in April, driven by strength in the Asia Pacific region.
McDonald’s said its US as well as European sales rose 3.5%. In the company's Asia-Pacific business, same-store sales were up 10.3%. The company attributed its robust sales performance to extended hours as well as breakfast and local menu offerings. McDonald’s said its same-store sales have grown by 5.9% so far in the current year.
MCDONALDS CP
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MCD.NYS&lColors=0x000000&sSym=MCD.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MCD.NYS&lColors=0x000000&sSym=MCD.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MCD.NYS&lColors=0x000000&sSym=MCD.NYS&hcmask=
08.05.2007 22:56
Walt Disney steigert in Q2 überraschend Gewinn - Umsatzerwartung erfüllt
Der US-Medienkonzern Walt Disney <DIS.NYS> <WDP.ETR> (Nachrichten/Aktienkurs) hat im zweiten Quartal den Gewinn überraschend gesteigert und die Umsatzerwartungen grob erfüllt. Der Gewinn je Aktie (EPS) sei von 37 US-Cent im entsprechenden Vorjahreszeitraum auf 44 Cent geklettert, teilte das Unternehmen am Dienstag in Burbank mit. Analysten hatten hingegen mit einem leichten Rückgang auf 36 Cent gerechnet.
Der Umsatz stieg von 8,027 Milliarden Dollar im zweiten Quartal auf 8,073 Milliarden Dollar. Experten hatten hier mit 8,08 Milliarden gerechnet./he
ISIN US2546871060
AXC0292 2007-05-08/22:52
Dendreon Corporation
09.05.07 15:43 Uhr
7,12 USD
-59,86 % [-10,62]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=DNDN.NAS&lColors=0x000000&sSym=DNDN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=DNDN.NAS&lColors=0x000000&sSym=DNDN.NAS&hcmask=
Börse
NASDAQ
Aktuell
7,12 USD
Zeit
09.05.07 15:43
Diff. Vortag
-59,86 %
Tages-Vol.
64,03 Mio.
Gehandelte Stück
28 Mio
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DNDN.NAS&lColors=0x000000&sSym=DNDN.NAS&hcmask=
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
SEATTLE, May 9, 2007 /PRNewswire-FirstCall via COMTEX/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that it received a Complete Response Letter, commonly referred to as an "approvable" letter, on May 8, 2007 from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for PROVENGE (sipuleucel-T) for the treatment of asymptomatic, metastatic, androgen-independent (also known as hormone refractory) prostate cancer.
The FDA has requested additional clinical data in support of the efficacy claim contained in the BLA. The Company is seeking a clarification from the FDA as to the nature of the data that is being requested. The FDA has also requested additional information with respect to the chemistry, manufacturing and controls (CMC) section of the BLA, which the Company believes it can supply to the FDA in a timely manner.
"Given our strong belief in the survival benefit and safety profile of PROVENGE, coupled with the positive outcome of the Advisory Committee meeting, we are disappointed that this decision will cause a delay in the availability of PROVENGE for patients who suffer from advanced prostate cancer," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "We are committed to working closely with the FDA to resolve these questions in a timely and efficient manner to bring PROVENGE to patients with advanced prostate cancer who currently have few appealing treatment options."
On March 29, 2007, the FDA's Office of Cellular, Tissue and Gene Therapies Advisory Committee was asked if the submitted data established that PROVENGE is reasonably safe and whether there is substantial evidence that the product is efficacious. The Advisory Committee voted 17 to 0 in favor of the safety of PROVENGE and 13 to 4 in favor of the efficacy of PROVENGE.
PROVENGE Biologics License Application
Dendreon's BLA was submitted under a Fast Track designation and was accepted for filing by the FDA in January 2007. The BLA was based primarily on a multi-center, randomized, double-blind, placebo-controlled Phase 3 study (D9901) that showed that the group of men with asymptomatic, metastatic, androgen-independent prostate cancer who received PROVENGE had a median survival time 4.5 months longer than the median survival seen in the group that had been assigned to receive placebo. For the men who received PROVENGE, there was a 41 percent overall reduction in the risk of death (p-value = 0.010; HR = 1.7). In addition, 34 percent of patients receiving PROVENGE were alive 36 months after treatment compared to 11 percent of patients randomized to receive placebo.
Treatment with PROVENGE was generally well tolerated. The majority of side effects were mild, including infusion-related fever and chills that were usually of low grade and typically lasted for one to two days following infusion.
Ongoing Clinical Study
IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) also known as D9902B, is an ongoing Phase 3 clinical trial measuring overall survival in men with hormone-refractory prostate cancer receiving PROVENGE versus those receiving placebo.
In order to be eligible to participate in the IMPACT study, a person must meet certain criteria, such as having cancer that has spread outside the prostate (metastatic) or cancer that has worsened while on hormone therapy among other additional criteria. Interested patients should contact the Dendreon Prostate Cancer Information line at 1-866-4PROSTATE (1-866-477-6782).
About Prostate Cancer
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than one million men in the United States have prostate cancer, with an estimated 218,890 new cases expected to be diagnosed in 2007, and more than 27,000 men expected to die this year from the disease. Currently there are limited treatment options for men with advanced, metastatic prostate cancer.
About PROVENGE
PROVENGE is the first in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to stimulate a patient's own immune system. Approximately 95% of prostate cancer cells express an antigen called prostatic acid phosphatase, or PAP. PROVENGE is designed to help the man's immune cells recognize cells that carry PAP as a foreign antigen and attack those cells.
About Active Cellular Immunotherapy
Active cellular immunotherapy is an approach that uses live human cells to re-engage the patient's own immune system. The goal of active cellular immunotherapy is to turn the immune system "back on" to elicit a specific long-lasting response against cancer. While ACIs are being studied in various cancers, prostate cancer is the first to be treated with them.
Activated T cells may be the immune system's most potent defense against cancer. Although a variety of immune cells participate in the surveillance and elimination of cancer cells, T cells are uniquely endowed to kill specific tumor cell types. When activated to recognize tumor-associated antigens, T cells proliferate and attack cells bearing those antigens. For this reason, the goal of many investigational ACIs is to stimulate and optimize activation of T cells.
The cellular orchestrators of T cell activation are antigen presenting cells (APCs). When encountering tumor-associated antigens in the body, APCs process and display the antigens, and then present them to T cells. When activated by APCs, T cells may recognize and lyse cells bearing those antigens.
PROVENGE's approach entails ex vivo activation of APCs with tumor-associated antigens. Dendreon's proprietary Antigen Delivery Cassette(TM) is a protein that enhances antigen binding and entry into APCs. The Antigen Delivery Cassette targets each engineered antigen to a receptor on APCs and provides a common key to unlock the potential of these cells to process antigen. The APCs process antigen along pathways that stimulate cell-mediated immunity.
About Dendreon
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.
Arrow International, Inc.
09.05.07 17:12 Uhr
38,57 USD
+17,45 % [+5,73]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ARRO.NAS&lColors=0x000000&sSym=ARRO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ARRO.NAS&lColors=0x000000&sSym=ARRO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ARRO.NAS&lColors=0x000000&sSym=ARRO.NAS&hcmask=
Börse
NASDAQ
Aktuell
38,57 USD
Zeit
09.05.07 17:12
Diff. Vortag
+17,45 %
Tages-Vol.
68,95 Mio.
Gehandelte Stück
2 Mio.
Arrow International, Inc. Announces Formation of a Special Committee of the Board to Explore Strategic Alternatives
READING, Pa., May 9, 2007 /PRNewswire-FirstCall via COMTEX/ -- Arrow International, Inc. (Nasdaq: ARRO) announced today that its Board of Directors has formed a Special Committee comprised of independent directors, who are John H. Broadbent, T. Jerome Holleran, R. James Macaleer, Marlin Miller, Jr. and Raymond Neag, to explore and evaluate strategic alternatives aimed at enhancing shareholder value. Marlin Miller, Jr., will serve as Chairman of the Special Committee, which has hired the investment banking firm of Lazard Freres & Co LLC to provide financial advisory services and Dechert LLP to provide legal services to it in connection with its review.
There can be no assurance regarding the timing of or whether the Board will elect to pursue any of the strategic alternatives it may consider, or that any such alternatives will result in changes to the Company's plans or will be consummated. The Company does not intend to provide updates or make any further comment until the outcome of the process is determined or until there are significant developments.
In addition, on Friday, May 4, 2007, the Board of Directors received a letter of resignation from director Richard T. Niner.
About Arrow
Arrow International, Inc. develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The Company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists and other healthcare providers. Arrow International's news releases and other company information can be found on the World Wide Web at http://www.arrowintl.com. The Company's common stock trades on the NASDAQ Global Select Market(TM) under the symbol ARRO.
Emageon Inc.
09.05.07 17:38 Uhr
8,43 USD
-25,86 % [-2,94]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=EMAG.NAS&lColors=0x000000&sSym=EMAG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=EMAG.NAS&lColors=0x000000&sSym=EMAG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=EMAG.NAS&lColors=0x000000&sSym=EMAG.NAS&hcmask=
Börse
NASDAQ
Aktuell
8,43 USD
Zeit
09.05.07 17:38
Diff. Vortag
-25,86 %
Tages-Vol.
19,55 Mio.
Gehandelte Stück
2,3 Mio.
Biotech News: Afternoon Alert for Emageon Inc.
May 09, 2007 (M2 PRESSWIRE via COMTEX) -- When you go to the hospital to get a picture taken of your gall bladder, Emageon wants to make sure that picture leaves nothing to your doctor's imagination. The company develops clinical analysis and medical image management software that helps doctors view, manipulate, and store medical images for diagnosis, disease screening, and therapy planning. In case two dimensions of your gall bladder aren't enough, Emageon's Web-enabled software lets physicians view it in 3-D and compare the picture with other images. Counting more than 250 hospitals as customers, the company targets health care organizations ranging from stand-alone imaging centers to large hospital systems.
Shares were down 17% as the company posts quarterly results.
RIO TINTO PLC ADS
09.05.07 17:40 Uhr
296,00 USD
+11,85 % [+31,35]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=RTP.NYS&lColors=0x000000&sSym=RTP.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=RTP.NYS&lColors=0x000000&sSym=RTP.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=10d&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=RTP.NYS&lColors=0x000000&sSym=RTP.NYS&hcmask=
Börse
NYSE
Aktuell
296,00 USD
Zeit
09.05.07 17:40
Diff. Vortag
+11,85 %
Tages-Vol.
340,45 Mio.
Gehandelte Stück
1,2 Mio.
DJ Mining Stocks Open Higher In London On Bid Speculation
LONDON, May 09, 2007 (Dow Jones Commodities News Select via Comtex) -- Mining stocks, led by Rio Tinto PLC (RIO.LN), rose sharply on open in London Wednesday buoyed by speculation about possible bid activity.
The rise came despite an earlier statement from Rio Tinto denying market rumors in Australia that it had received a friendly takeover offer from rival miner BHP Billiton PLC (BHP).
(MORE TO
Cisco Systems, Inc.
09.05.07 17:53 Uhr
26,57 USD
-6,31 % [-1,79]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CSCO.NAS&lColors=0x000000&sSym=CSCO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CSCO.NAS&lColors=0x000000&sSym=CSCO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CSCO.NAS&lColors=0x000000&sSym=CSCO.NAS&hcmask=
Börse
NASDAQ
Aktuell
26,57 USD
Zeit
09.05.07 17:53
Diff. Vortag
-6,31 %
Tages-Vol.
2,02 Mrd.
Gehandelte Stück
87 Mio.
Cisco scheitert an hohen Erwartungen
Die weltweite Nachfrage nach Internet-Videos treibt den Gewinn von Cisco Systems - allerdings nicht stark genug. Der weltgrößte Computernetz-Ausrüster erfüllte die hohen Erwartungen der Börsianer im dritten Quartal nicht.
Allerdings scheint sich jetzt bei Cisco das deutlich schwächere US-Wirtschaftswachstum bemerkbar zu machen. Cisco erwartet für das Schlussquartal nur noch ein Umsatzwachstum von 15 bis 16 Prozent, nachdem es zuvor erheblich höhere Steigerungsraten gegeben hatte. Die Cisco-Aktien fielen nachbörslich um 5,2 Prozent auf 26,88 $.
Analysten führten den Verlust auf die hohen Erwartungen der Investoren zurück. "Die Erwartungen steigen offensichtlich", sagte Tim Daubenspeck von Pacific Crest Securities zu dem nachbörslichen Kursrückgang. Auch andere Fachleute bestätigten diese Einschätzung: "Es sieht so aus, als ob die Zahlen nicht aufregend genug waren", sagte Ehud Gelblum von J.P. Morgan.
Das Unternehmen erhöhte den Gewinn in dem am 28. April beendeten Dreimonatsabschnitt um 33,9 Prozent auf 1,9 Mrd. $ oder 30 Cent je Aktie. Der Umsatz stieg um 21,1 Prozent auf 8,9 Mrd. $, teilte Cisco in San Jose im US-Bundesstaat Kalifornien am Dienstag nach Börsenschluss mit. Unter Ausklammerung von Sonderfaktoren erhöhte sich der Quartalsgewinn auf 34 Cent je Aktie und übertraf damit die Wall-Street-Erwartungen geringfügig.
Auf und Ab am Aktienmarkt
profitierte in der Berichtszeit von der starken Nachfrage von Unternehmenskunden, Telekom-Konzernen und Internet-Dienstleistern, die ihre Netze im Hinblick auf das rasante Internet-Wachstum und die rasant steigende Nachfrage nach mehr Bandbreite für Videoübertragungen weiter ausbauen. Die Verbraucher, die Cisco-Produkte für ihre drahtlos vernetzten Computer in Wohnungen und Häusern verwenden, trieben das Geschäft ebenfalls kräftig an. "Das Video-Geschäft treibt bei Netzwerken weiter die Nachfrage", bestätigte Cisco-Chef John Chambers.
Der Neunmonatsumsatz legte auf 25,5 Mrd. $ nach 20,5 Mrd. im Vorjahr zu. Cisco verbuchte in den ersten drei Quartalen des laufenden Geschäftsjahres einen Gewinn von 5,4 Mrd. $ oder 86 Cent je Aktie.
Konzernchef John Chambers hob das anhaltende Wachstum hervor. Cisco habe Marktänderungen vorhergesehen und könne dadurch laufende und zukünftige Produktchancen nutzen. Cisco setzt nicht zuletzt auf die starke Auslandsexpansion und das steigende Geschäft in den Schwellenländern.
Cisco kündigte unterdessen in der Berichtszeit den Kauf der auf Internet-Web-Konferenzen ausgerichteten Firma WebEx Communications für 3,2 Mrd. $ an.
Foster Wheeler Ltd.
09.05.07 18:06 Uhr
83,98 USD
+14,81 % [+10,83]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=FWLT.NAS&lColors=0x000000&sSym=FWLT.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=FWLT.NAS&lColors=0x000000&sSym=FWLT.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=FWLT.NAS&lColors=0x000000&sSym=FWLT.NAS&hcmask=
Börse
NASDAQ
Aktuell
83,98 USD
Zeit
09.05.07 18:06
Diff. Vortag
+14,81 %
Tages-Vol.
299,66 Mio.
Gehandelte Stück
4,3 Mio.
EIExploratioinInvestor: Foster Wheeler Announces Fourth Consecutive Record-Breaking Earnings Quarter
May 09, 2007 (M2 PRESSWIRE via COMTEX) -- Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs. While working to keep you in touch with market activity, we also will keep you updated on the latest press. Today we have identified, Foster Wheeler Ltd. (NASDAQ: FWLT) due to the attention they received after this recent corporate developments.
Foster Wheeler Ltd. (NASDAQ: FWLT) today announced record net earnings of $114.8 million for the first quarter of 2007, compared with $14.6 million for the first quarter of 2006. Earnings per diluted share for the first quarter of 2007 were $1.60, compared with a net loss per diluted share of $0.08 for the first quarter of 2006. The first-quarter 2006 net loss per diluted share included the $0.29 per diluted share allocation of earnings to shares issued to warrant holders who participated in the Company's January 2006 warrant inducement offers.
"I would like to congratulate all Foster Wheeler employees worldwide for producing a fourth consecutive record-breaking earnings quarter," said Raymond J. Milchovich, chairman and chief executive officer. "Our consistent pursuit of commercial and operational excellence is clearly re-inventing the earning capability of our 116-year-old company. Both of our business groups delivered performance breakthroughs from the year-ago quarter, the most notable of which are summarized below."
First-quarter 2007 consolidated EBITDA (earnings before interest expense, income taxes, depreciation and amortization) increased by 254 percent to $162.3 million, up from $45.9 million in the first quarter of 2006.
The Company delivered another strong bookings quarter with consolidated new orders measured in Foster Wheeler scope, which excludes flow-through costs, increasing by 29 percent to $1.07 billion in the first quarter of 2007, compared with $833.9 million in the first quarter of 2006.
For the first quarter of 2007, consolidated operating revenues measured in Foster Wheeler scope increased by 65 percent to $854.5 million, from $518.0 million for the year-ago quarter.
Consolidated scope backlog increased to $2.74 billion at the end of the first quarter of 2007 from $2.53 billion at the end of the fourth quarter of 2006, and increased by 10 percent from the $2.49 billion scope backlog at the end of the year-ago quarter.
Foster Wheeler Ltd. is a global company offering, through its subsidiaries, a broad range of engineering, procurement, construction, manufacturing, project development and management, research and plant operation services. Foster Wheeler serves the refining, upstream oil and gas, LNG and gas-to-liquids, petrochemical, chemicals, power, pharmaceuticals, biotechnology and healthcare industries. The corporation is based in Hamilton, Bermuda, and its operational headquarters are in Clinton, New Jersey, USA.
During daily trading shares are up 10% to $80.65 with over 1,600,000 in volume. The Exploration Investor Research Team will continue to gauge the short and long term affects that this announcement will have on the company.
10.05.2007 17:16 Uhr
Verfügt über einen exzellenten Draht zu Russlands Präsident Wladimir Putin:
Der russische Multi-Milliardäre Oleg Deripaska.
Russen steigen bei Magna ein
Der russische Milliardär Oleg Deripaska stärkt den kanadischen Autozulieferer bei den Kaufverhandlungen mit DaimlerChrysler über die US-Sparte Chrysler Group.
Von Daniel Brössler und Michael Kuntz
Beim Autosalon in Genf Ende Februar machte bereits als Gerücht die Runde, was jetzt aus Kanada offiziell vermeldet wird: Der russische Milliardär Oleg Deripaska greift Magna-Großaktionär Frank Stronach unter die Arme. In Genf hatte Stronach noch abgewiegelt: Nichts.
Doch der aus Österreich stammende, seit Jahrzehnten in Kanada verwurzelte Unternehmer kann eine Kapitalspritze derzeit gut gebrauchen. Magna macht ein Drittel seines Umsatzes mit Chrysler, dem Tochterunternehmen des deutsch-amerikanischen Konzerns DaimlerChrysler, das für das vergangene Jahr mehr als eine Milliarde Euro Verlust auswies.
Die Probleme von Chrysler sind also in gewissem Umfang auch Probleme von Magna, heißt es in der Automobilindustrie.
Alle Optionen offen
Magna könnte sich in dieser Situation eventuellen Hilferufen von DaimlerChrysler-Chef Dieter Zetsche schlecht entziehen. Zetsche hatte Mitte Februar ein weiteres Sanierungsprogramm angekündigt und erstmals erklärt, für die Zukunft von Chrysler seien alle Optionen offen - bis hin zu einem Verkauf.
Magna-Eigner Stronach hat inzwischen ein grundsätzliches Interesse an Chrysler oder Teilen davon öffentlich bekundet. Stronach bietet angelsächsischen Medienberichten zufolge gemeinsam mit der kanadischen Investmentfirma Onex für die Chrysler Group.
Die Beteiligung des kapitalkräftigen russischen Unternehmers an der kanadischen Firma könnte die Magna-Position im Blick auf Chrysler stärken, meinen Marktbeobachter. DaimlerChrysler lehnt jede Stellungnahme zu irgendwelchen Verhandlungen über Chrysler ab.
43 Prozent der Stimmrechte
Der russische Mischkonzern Basic Element erwirbt über eine Tochterfirma für 1,54 Milliarden US-Dollar (1,1 Milliarden Euro) 43 Prozent der Stimmrechte an Magna. Dies gab das kanadische Unternehmen in Aurora (Provinz Ontario) bekannt.
Käufer ist die Basic-Element-Tochter Russian Machines. Sie kontrolliert unter anderem den zweitgrößten russischen Autohersteller GAZ Group. Magna hatte bereits 2006 mehrere Joint Ventures mit GAZ angekündigt. Magna gehört zu den führenden Autoteileherstellern der Welt und beliefert auch deutsche Konzerne.
Der neue Magna-Großaktionär Oleg Deripaska ist eine der Schlüsselfiguren in der russischen Wirtschaft und verfügt über einen exzellenten Draht zu Präsident Wladimir Putin.
Die russische Zeitung Wedomosti schätzt das Vermögen des 38-Jährigen auf 14 Milliarden Dollar, das US-Magazin Forbes taxierte es auf 13,3 Milliarden Dollar.
Aufstieg in der Aluminiumindustrie
Deripaska war in den wilden neunziger Jahren in der russischen Aluminiumindustrie aufgestiegen und schuf mit Basic Element einen Konzern mit einem Umsatz von mehr als 13 Milliarden Dollar und 290000 Beschäftigten.
Zum Reich Deripaskas gehören Aluminiumhütten ebenso wie Autohersteller, Banken und Baufirmen in vielen Ländern der früheren Sowjetunion.
Doch das ist Deripaska schon lange nicht genug. Er versteht sich als globalen Spieler mit hohem Einsatz. Dazu passt die Fusion seines Unternehmens Rusal mit dem einheimischen Konkurrenten Sual und der schweizerischen Glencore zum größten Aluminiumproduzenten der Welt.
Vielfältige Interessen
Die Vielfältigkeit der Interessen Deripaskas zeigte sich vor wenigen Tagen, als Basic Elements drei Prozent der Hochtief AG erwarb mit der Aussicht auf mehr. Ende März erwarb der Russe 30 Prozent an der österreichischen Strabag. Dabei hatte Bauunternehmer Hans Peter Haselsteiner den Konzern doch eigentlich an die Börse bringen wollen.
Deripaskas internationale Zukäufe liegen im Trend: Viele russische Unternehmen suchen nach Standbeinen im Ausland und verbinden damit die Hoffnung auf einen Modernisierungsschub im eigenen Land.
So kaufen sie Anteile im Bereich der Hochtechnologie wie etwa beim europäischen Flugzeug- und Raumfahrtkonzern EADS und interessieren sich für Telekom- und Energiefirmen.
Russland immer wichtiger als Auslandsinvestor
Als Auslandsinvestor spielt Russland nach Angaben der Londoner Economist Intelligence Unit eine immer wichtiger werdende Rolle. Mehr als 120 Milliarden US-Dollar haben die Russen schon in ausländische Unternehmungen investiert. Diese Anlagen können auch eine Investition für schlechte Zeiten in der Heimat sein. Wer im internationalen Geschäft mitmischt, macht sich unabhängiger von den Machthabern im eigenen Land.
(SZ vom 11.05.07)
HANDELSBLATT, Donnerstag, 10. Mai 2007, 18:14 Uhr
Gewinnsteigerung im Quartal
Magna gibt sich bei Chrysler bescheiden
Der kanadische Automobilzulieferer Magna ist nur an einer Minderheit des angeschlagenen Autohersteller Chrysler interessiert. Nach dem Einstieg des russischen Oligarchen Deripaska bei Magna scheint der Autozulieferer seine Präferenzen für die zukünftigen Märkte abzustecken. Gleichzeitig lässt Magna seine Muskeln spielen.
HB FRANKFURT/MAIN. „Wir sind nur an einer Minderheitsbeteiligung interessiert“, sagte der Ko-Vorstandsvorsitzende von Magna, Siegfried Wolf, der „Frankfurter Allgemeinen Zeitung“. Als Grund nannte er die Absicht des Autozulieferers, auch künftig nicht in Konkurrenz zu den Autoherstellern treten zu wollen. „Magna hat nicht vor, künftig mit anderen Autoherstellern zu konkurrieren, das wäre doch fatal!“ Deshalb habe Magna alle seine übrigen Automobilkunden über die eigenen Pläne informiert. Magna will die Chrysler-Beteiligung über eine Holding führen, klar getrennt von der eigenen Zuliefersparte.
Die Verhandlungen mit DaimlerChrysler befinden sich in einem fortgeschrittenen Stadium: „Unser Angebot liegt DaimlerChrysler vor, das ist jetzt in der Bewertungsphase.“ Zum Einstieg des russischen Oligarchen Oleg Deripaska bei Magna sagte Wolf, dass sich sein Unternehmen dank dieser Kooperation auf Anhieb den großen russischen Automarkt erschließe und zudem Zugang zu wichtigen Rohmaterialien wie Stahl und Aluminium erhalte.
MAGNA PAC.HLDGS
Weitere Kursdaten:
DAIMLERCHRYSLER AG NA O.N
Für das erste Quartal gab der Autoteile-Hersteller am Donnerstag ein Quartalsergebnis von 218 Mill. Dollar bekannt. Damit hat Magna im Vergleich zum Vorjahresquartal seinen Gewinn um 2,8 Prozent gesteigert. Der Umsatz stieg um knapp sieben Prozent auf 6,42 Mrd. Dollar. Für das Gesamtjahr erwartet das kanadische Unternehmen Erlöse von 23,5 bis 24,8 Mrd. Dollar. DaimlerChrysler prüft derzeit einen Verkauf der angeschlagenen US-Tochter. Neben Magna hat unter anderem auch der Milliardär Kirk Kerkorian Interesse signalisiert.
Zuvor hatte Magna die Investition eines russischen Magnaten von mehr als einer Milliarde Dollar angekündigt. Russian Machines, ein Teil der vom Investor Oleg Deripaska kontrollierten Kapitalgesellschaft Basic Element, werde Magna-Aktien im Gesamtwert von 1,54 Mrd. Dollar kaufen. Damit werde das Wachstum des Zulieferers in Russland und der Region gefördert, sagte Firmenchef Frank Stronach.
10.05.2007 19:55
Aktien mit neuen 52-Wochen-Hochs und -Tiefs
Nachfolgend eine Auflistung einiger Aktien, die heute neue 52-Wochen-Hochs erreicht haben. Die Liste ist nach dem bisher gehandelten Volumen sortiert.
http://img.godmode-trader.de/charts/30/2005/abc6173.gif
Nachfolgend eine Auflistung einiger Aktien, die heute neue 52-Wochen-Tiefs erreicht haben. Die Liste ist nach dem bisher gehandelten Volumen sortiert.
http://img.godmode-trader.de/charts/30/2005/abc6174.gif
U.S. Equity News: Xethanol Completes Engineering for New 35 Million Gallon Ethanol Plant and Verasun Energy Sells $450 Million 10-Year Notes
May 14, 2007 (M2 PRESSWIRE via COMTEX) -- City of Industry, CA - Ethanol industry alert provided by U.S. Equity News. Xethanol Corporation (AMEX: XNL), a renewable biofuels company, recently announced that its consulting engineering firm, The Facility Group, has completed the design and engineering work for the new 35 million gallon ethanol production facility planned to be constructed on Xethanol's Blairstown, Iowa site. Xethanol expects the new plant to incorporate state-of-the-art ethanol technology from Praj Industries and on-site cogeneration.
May 14, 2007 - An anticipated 58 percent jump in corn-based ethanol production next year will not boost food prices enough to harm consumers, the Agriculture Department's chief economist said Friday. In its latest estimate, the department said 27 percent of the 2007 corn crop, or 3.4 billion bushels, would be converted into ethanol. This year, the USDA expects 20 percent of the corn crop, or 2.2 billion bushels, going into ethanol. Shares of Archer Daniels Midland Co (NYSE:ADM), the country's largest ethanol producer, rose 26 cents to $35.75 in midday trading.
May 14, 2007 - Verasun Energy Corp. (NYSE:VSE) on Friday sold $450 million of 10-year notes in the 144a private placement market, said market sources. VeraSun Energy Corporation engages in the production and sale of ethanol and its co-products principally in the United States. Ethanol is primarily used as a blend component in the gasoline fuel market. In addition, it offers ethanol blended VE85 fuel to gasoline retailers.
May 14, 2007 - US Farms, Inc. (OTC BB: USFI) updated Analyst Report is available from IPOdesktop.com. US Farms, Inc. is a diversified commercial farming and nursery company. The company grows, markets and distributes horticultural products through a number of subsidiaries. The horticultural products are sold through supermarkets, home centers, retail merchandisers, garden centers, re-wholesalers, and landscapers throughout the United States and Canada.
About U.S. Equity News
U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com.
U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. U.S. Equity News and its affiliates charge each client cash for news distribution and may take an equity position in the companies mentioned herein, please visit the disclaimer at www.USEquityNews.com
InvestorIdeas.com Green Investor Portals -- Consumer Choices in Green Cars; Hybrids, Electric, Biofuels and Fuel Cells Do Consumers Have to Compromise Performance to Go Green?
POINT ROBERTS, WA and DELTA, BC, May 14, 2007 (MARKET WIRE via COMTEX) -- InvestorIdeas.com green investor portals report on choices and trends in green cars including Hybrids, Electric, Biofuels, and Fuel Cell cars. As green and ethical consumerism grows to become a global phenomenon, InvestorIdeas.com discusses options and choices available and underway posing the question -- Are there enough choices and incentives to create the shift? Electric Car Manufacturer ZAP (OTCBB: ZAAP) and R.L Evans, Director Clean Energy Research Centre, University of British Columbia, help to provide insight into the highways of the future.
At the recent Hydrogen & Fuel Cells 2007Conference held in Vancouver, B.C., Bill Reinert, National Manager TMS Advanced Technologies Group, Toyota Motor Company discussed that, "By 2040, based on the current growth, there will be 2-3 billion cars on the road, up from current numbers of 1 billion, creating environmental problems 4 to 5 times of what they are today." The projected numbers of population and vehicle growth provide compelling motivation for change.
Consumers looking for green and environmentally friendly automotive choices available in the market today can visit Yahoo! Autos Green Rating and search the Top 100 Cars by Green Rating, developed in consultation with Environmental Defense (http://www.environmentaldefense.org) Users can browse through available options in Hybrid - Electric cars, Ethanol cars, Diesel - Biodiesel cars, Natural Gas cars and fuel efficient cars. The rating measures the vehicle's environmental friendliness from 1 to 100 with the higher a vehicle's Green Rating, the "greener" it is and the lower its harm to both human health and the planet.
For consumers looking at electric cars, industry players ZAP (OTCBB: ZAAP) and GM with the GM Volt offer both performance and efficiency in the near future.
ZAP, who has been in the electric car market since 1994, has a full line of competitively priced electric vehicles from A to Z ranging from electric scooters, electric ATVs and electric cars and trucks. ZAP is also working with Lotus Engineering to create the ZAP-X (http://www.zapworld.com/ZAPWorld.aspx?id=4560) utilizing the award-winning APX lightweight aluminium architecture design to achieve unprecedented levels of performance and utility for electric cars. An advanced battery system will enable the car to travel a range up to 350 miles between charges, with a rapid charge technology that can recharge the batteries in as little as 10 minutes.
"Thanks to the support our shareholders, with the only series city class electric car in production, ZAP is now uniquely positioned to maximize the current demand due to rising gas prices and concerns of global warming. Priced at around $10,000, electric cars can now not only save the environment, they can save you money," commented ZAP's Chairman of the Board, Gary Starr.
GM's Chevrolet Volt, unveiled at the 2007 Detroit Auto Show, is anticipated to hit the roads by 2010. The Volt is projected to have a charge time of 6.5 hours featuring 40 miles on just the battery alone with a 640 mile range on a full tank of gas. GM is also offering a green mix of automotive choices with E85 vehicles, Hybrids and is working on Fuel Cell Cars for the future.
In a white paper presented at a joint ASME and ATI meeting in Milan last year titled "HYDROGEN ECONOMY OR ELECTRICITY ECONOMY?" R.L. Evans, Director Clean Energy Research Centre, the University of British Columbia offers his vision of the roads of the future in his Transportation Case Study.
Excerpt from Paper:
"The successful development and introduction into the marketplace of the 'Plug-in hybrid vehicle' would mark the beginnings of a significant new transportation Paradigm, eliminating the need for road vehicles to use petroleum fuels, at least for the Majority of miles traveled. If electricity were to be generated primarily from sustainable Primary energy sources, then road transportation would also become sustainable and would result in an 'Electricity Economy', rather than a 'Hydrogen Economy'.
"Much of the development work on batteries has been driven by the successful introduction in the last few years of hybrid electric vehicles (or HEV's). Hybrid vehicles have been very successfully introduced into the market, initially in compact cars, but the technology is now spreading to larger cars and sport utility vehicles where the benefit of much greater fuel economy will be particularly welcome."
Consumers can catch up on what is available in new Hybrids for 2007 by visiting the Government web site FuelEconomy.Gov -- http://www.fueleconomy.gov/feg/hybrid_news.shtml. The 2008 Ford Escape Hybrid currently being promoted offers additional features such as a 12 percent reduction in noise, vibration and harshness (NVH) levels inside the vehicle and has seating surfaces made from 100 percent post-industrial materials.
Luxury auto manufactures see the need to offer performance as well as address environmental concerns and there are several available and in the pipeline for brand conscious consumers. Mercedes-Benz's Bluetec system in a new line of diesel-engines reduces emissions but offer drivers 700+ miles on a single tank of gas. BMW has turned green with the new Hydrogen 7, but it is not currently available to the general public.
In addition to the work with ZAP and the electric cars, Lotus has entered the biofuels market with the Lotus Exige 265E running on E85 with a 264 horsepower with 0 to 60 mph in 3.9 seconds -- no compromise for going green. Biofuels, while offering a green alternative however are projected to never be able to meet the capacity of the growing global auto market.
About Our Green Investor Portals:
www.RenewableEnergyStocks.com (R), www.FuelCellCarNews.com (R), www.EnvironmentStocks.com, www.Water-Stocks.com and www.GreentechInvestor.com are global investor and industry research portals that look at the renewable energy, water and greentech sectors. The portals do not make stock recommendations, but feature industry and stock news, exclusive articles and financial columnists, audio interviews, investor conferences, Blogs, and a directory of stocks in the sector.
Featured Green Portal Sponsor:
About ZAP
ZAP has been a leader in advanced transportation technologies since 1994, delivering over 90,000 vehicles to consumers in more than 75 countries. At the forefront of fuel-efficient transportation with new technologies including energy efficient gas systems, hydrogen, electric, fuel cell, ethanol, hybrid and other innovative power systems, ZAP is developing a high-performance crossover SUV electric car concept called ZAP-X engineered by Lotus Engineering. The Company recently launched a new portable energy technology that manages power for mobile electronics, like cell phones and laptops. For more product, dealer and investor information, visit http://www.renewableenergystocks.com/CO/ZAAP/Default.asp or http://www.zapworld.com
ZAP is a featured Company on RenewableEnergyStocks.com, TechSectorStocks.com and EnvironmentStocks.com and compensates the portals as disclosed in disclaimer below.
Universal Travel Group Q1 '07 Revenue Up 811% to $6.9 M Net Income $653,610 or $0.02 per share
LOS ANGELES, Calif. and SHENZHEN, China, May 14, 2007 /PRNewswire-FirstCall via COMTEX/ -- Universal Travel Group (OTC Bulletin Board: UTVG) which operates through its wholly-owned subsidiary, Shenzhen Yu Zhi Lu Aviation Service Company Ltd. (YZL), a leading air travel agency in Southern China, announced financial results for the first quarter of fiscal year 2007.
For the first quarter, Universal Travel reported $6.9 million in revenue, up 811% from $764,504 for the comparable quarter in fiscal year 2006. The increase is attributed to a rising customer base as well as the acquisition of Speedy Dragon and the addition of air cargo transportation and hotel booking services businesses during the quarter.
Net income was $653,610, or $0.02 per share, for the first quarter '07, up from $460,329 a year ago. Net income was adversely impacted by the second half of the company's stock compensation charge reported last fiscal year. This represents Universal's last expense in connection with this plan.
The company reported gross profit of $2.2 million and a gross profit margin of 32.4% for the quarter. Income from operations was $870,308 for the quarter.
Chairman and CEO Ms. Jiangping Jiang said, "This was a strong quarter for Universal Travel Group. We are very pleased with the increase in revenue for the quarter. Assets for the quarter were $12.5 million, up from $7.5 million for the comparable quarter a year ago. The increase in assets includes approximately $3 million in goodwill associated with the Speedy Dragon acquisition. We expect our assets to continue to grow as we complete the acquisition of Shanghai Lanbao, which we announced two weeks ago.
"Looking ahead, we expect further growth for our company. With the acquisition of Speedy Dragon and Shanghai Lanbao we will have added two new operating segments for the company that will provide an additional boost in revenue for the upcoming fiscal year. Our recent appointment of Richard Cohen to our board of directors cements our ties to our U.S. shareholder base. We are very pleased to welcome Richard to our team."
About Universal Travel Group
Universal Travel Group, through its wholly-owned subsidiary, Shenzhen Yu Zhi Lu Aviation Service Company Ltd., is engaged in providing reservation, booking, and domestic and international travel and tourism services throughout China. The company's core services include booking services for air tickets, hotels, and restaurants, tour routing for customers and an air cargo division. The company's goal is to become China's leading travel services provider. For more information, visit http://www.chutg.com.
BUYINS.NET: RGNC, VOXW, SGAT, UWNK, WMLLF Have Also Been Added To Naked Short List Today
May 15, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list:
Regency Energy Partners LP (NASDAQ: RGNC),
Voxware Inc. (NASDAQ: VOXW),
ShengdaTech Inc. (OTCBB: SGAT),
uWink Inc (OTCBB: UWNK),
Wealth Minerals Ltd. (OTCBB: WMLLF)
Regency Energy Partners LP (NASDAQ: RGNC) engages in the gathering, processing, marketing, and transportation of natural gas and natural gas liquids (NGLs) north Louisiana, Texas and the mid-continent region of the United States. It operates in two segments, Gathering and Processing, and Transportation. The Gathering and Processing segment provides "wellhead-to-market" services to producers of natural gas, which include transporting raw natural gas from the wellhead through gathering systems; processing raw natural gas to separate natural gas liquids, or NGLs from the raw natural gas; and selling or delivering the pipeline-quality natural gas and NGLs to various markets and pipeline systems. The Transportation segment delivers natural gas from northwest Louisiana to markets in northeast Louisiana through its 320-mile Regency Intrastate Pipeline system. The company, formerly known as Regency Gas Services LLC, was founded in 2003 and is based in Dallas, Texas. With 46.95 million shares outstanding and 681,400 shares declared short as of April 2007, there is a failure to deliver in shares of RGNC.
Voxware Inc. (NASDAQ: VOXW) and its subsidiaries provide voice-based technology solutions that optimize the front line logistics and distribution center workforce primarily in North America and Europe. It offers VoiceLogistics Express, an application suite for enhancing distribution center workforce performance for various logistics functions, including picking and replenishment; and VoiceLogistics Pro, which includes a basic suite of tools for designing, developing, and integrating voice-enabled logistics solutions. The company?s VoiceLogistics solutions include Voxware proprietary software technologies that are installed on each wearable computer. Its VoiceLogistics solutions, enabled by its patented speech recognition VoiceXML Web browser technology, create a real-time link between mobile workers, the warehouse management system, and supervisory personnel. The VoiceLogistics solutions also includes a Voxware application software component installed on a server that communicates with a central warehouse management system and a variety of wearable computers that are worn by individual warehouse workers. The company offers its products primarily to customers in industry sectors, including food service, grocery, retail, consumer packaged goods, automotive parts, third party logistics providers, and wholesale distribution. Voxware sells its products through third parties, such as consultants; value added resellers; wireless computer manufacturers and vendors; and systems integrators. The company was founded in 1993 and is headquartered in Lawrenceville, New Jersey. With 6.29 million shares outstanding and 5,900 shares declared short as of April 2007, there is a failure to deliver in shares of VOXW.
ShengdaTech Inc. (OTCBB: SGAT) is engaged in the business of manufacturing, marketing and selling a variety of nano precipitated calcium carbonate ("NPCC") products and coal-based chemicals for use in various applications. The Company converts limestone into NPCC using its proprietary technology. The unique chemical and physical attributes make NPCC a valuable ingredient in tires, paints, polyvinyl chloride ("PVC") building materials and other products. It enhances the durability of many products by increased strength, heat resistance, and dimension stabilization. The Company is also engaged in the manufacture and sale of coal-based chemical products namely ammonium bicarbonate, liquid ammonia, melamine and methanol. The Company markets and sells its coal-based products mainly for chemical fertilizers and raw materials in the production of organic and inorganic chemical products, including formaldehyde and pesticides. With 54.10 million shares outstanding and 71,300 shares declared short as of April 2007, there is a failure to deliver in shares of SGAT.
uWink Inc. (OTCBB: UWNK) operates as an entertainment restaurant company in the United States. The company primarily operates and develops an interactive entertainment restaurant concept, called uWink. The uWink concept enables customers to order food, drinks, and games from the uWink Game Library and other digital media at the table through touch screen terminals. It also licenses SNAP!, a countertop video game terminal technology; and Bear Shop, an entertainment vending platform technology for animated point of purchase vending. The company was incorporated in 1999 and is based in Van Nuys, California. With 25.93 million shares outstanding and 12,600 shares declared short as of April 2007, there is a failure to deliver in shares of UWNK.
Wealth Minerals Ltd. (OTCBB: WMLLF) is a well financed mineral exploration company with approximately 27.0 million shares issued and listings on the TSX Venture and Frankfurt Stock Exchanges and the OTCBB. The Company's focus is the acquisition and exploration of prospective uranium properties, primarily in Argentina and Peru. In addition to ongoing work programs on its existing properties, it continues to actively evaluate new potential uranium projects in these countries. With 20.54 million shares outstanding and 21,500 shares declared short as of April 2007, there is a failure to deliver in shares of WMLLF.
Wall Street News Alert: OEGY Is on the Move! May 15, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, May 15, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Open Energy Corp. (OTCBB: OEGY),
General Electric Company (NYSE: GE),
Applied Materials, Inc. (NASDAQ: AMAT) and
Duke Energy (NYSE: DUK).
Open Energy Corp. (OTCBB: OEGY) is another new stock to put on your radar and watch as Wall Street News Alert initiates coverage of the company. This morning, the company and Suntech Power Holdings Co., one of the world's leading manufacturers of photovoltaic (PV) cells and modules, issued a press release announcing the signing of a letter of intent for broad initiatives targeting the expansion of the Building Integrated Photovoltaic (BIPV) products sales of each company.
This could be great news for the company. Suntech will provide cost effective and high quality production for Open Energy's SolarSave(R) PV Tiles. The companies will market each other's broad portfolio of BIPV products within the North American market. Suntech will also have the right to acquire up to 5% of the outstanding shares of Open Energy as part of this strategic cooperation.
David Saltman, CEO of Open Energy, stated, "This alliance with Suntech is of major strategic importance to our company. Suntech is a high volume manufacturer of quality solar photovoltaic products and in our meetings with its Chairman and CEO, Dr. Zhengrong Shi and Suntech's production and engineering staff, we were convinced that Suntech is the ideal partner to manufacture SolarSave(R) tiles in China thus enabling us to enhance our sales volumes and margins. This agreement secures our product supply at competitive pricing, and positions Open Energy as an innovative developer and aggressive marketer of solar solutions in North America. In addition, with its acquisition of MSK in Japan, Suntech now has considerable expertise in architectural PV glass, a product set that is gaining traction among developers here in the States as well as deep design support for BIPV projects. We are additionally excited to welcome Suntech as a future strategic core shareholder."
Wall Street News Alert is placing Aggressive Investors on alert to monitor the progress of Open Energy Corp! Len May, Suntech America's Vice President of Business Development spoke positively about the newly-formed alliance, "This agreement is an important step forward in demonstrating the synergies of our acquisition of MSK Corporation by combining Suntech's manufacturing strength with MSK's strength of high-end and innovative BIPV solutions. We believe that this marketing alliance with Open Energy will accelerate the momentum that we have achieved since we acquired MSK with its BIPV product offerings and development expertise which will enable us to broadly address the performance and project demands of a rapidly growing market for BIPV products here in America as well as in Asia, Europe and other parts of the world. We also intend to engage in joint development with Open Energy of innovative next generation BIPV products. We are also pleased to have warrants to acquire shares in our new partner Open Energy who we think will have a bright future particularly as we together grow our mutual BIPV initiatives."
Continue to watch this company. The transactions contemplated by the letter of intent are subject to the execution of definitive agreements, which are currently contemplated to be completed by the end of June 2007.
Prior to the latest press release, the stock closed Monday at Thirty Nine cents a share.
In case you are not familiar with the companies: Open Energy Corporation is a renewable energy company focused on the development and commercialization of a portfolio of technologies capable of delivering low-risk, cost-competitive electricity, fresh water and related commodities on a global basis. Open Energy offers building-integrated photovoltaic (PV) roofing materials for commercial, industrial, and residential markets. Marketed under the trade name SolarSave(R), the product line includes roofing membranes, roofing tiles, custom architectural PV glass, and balance of systems equipment such as inverters, combiners, and accessories. The Company also holds an exclusive, worldwide license to a solar thermal technology called SunCone(TM) CSP (Concentrating Solar Power), which is currently being developed to generate potable water and distributed power. The company's mission is to enhance life by harnessing the power of the sun.
Suntech Power Holdings Co., Ltd. is a leading solar energy company in the world as measured by both production output and capacity of solar cells and modules. Suntech provides solar solutions for a green future. Suntech designs, develops, manufactures, and markets a variety of high quality, cost effective and environmentally friendly PV cells and modules for electric power applications in the residential, commercial, industrial, and public utility sectors. Suntech's majority-owned subsidiary, MSK Corporation is one of the top-ranked companies in the building-integrated photovoltaics (BIPV) space. Suntech's customers are located in various markets worldwide, including key markets throughout Europe, Japan, China and the United States. Suntech America, Inc. is a wholly owned subsidiary of Suntech Power Holdings Co., Ltd.
General Electric Company (NYSE: GE) down 1% on27.7 million shares traded. GE, a diversified technology, is a media and financial services company focused on solving some of the world's toughest problems. With products and services ranging from aircraft engines, power generation, water processing and security technology to medical imaging, business and consumer financing, media content and advanced materials, GE serves customers in more than 100 countries and employs more than 300,000 people worldwide.
Applied Materials, Inc. (NASDAQ: AMAT) up 3.5% on 51.9 million shares traded Applied Materials, Inc. is the global leader in Nanomanufacturing Technology(TM) solutions with a broad portfolio of innovative equipment, service and software products for the fabrication of semiconductor chips, flat panels, solar photovoltaic cells, flexible electronics and energy efficient glass.
Duke Energy (NYSE: DUK) up m1.2% on 5.7 million shares traded. Duke Energy Corp., one of the largest electric power companies in the United States, supplies and delivers energy to approximately 3.9 million U.S. customers.
Market Commentary:
"We are feeling it at the pump! Gas set a new record on Monday, as the average national price of a gallon of gas hit $3.073, up almost a penny from Sunday's also record-setting price. Gasoline is now well above the previous post-Hurricane Katrina record of $3.057, set on Sept. 5, 2005," stated Sonja Rudd
Strathmore Acquires Additional Near-Surface Uranium Deposits in the Gas Hills, Wyoming: Historical Resource Exceeds 2.7 Million Pounds
KELOWNA, BRITISH COLUMBIA, May 15, 2007 (MARKET WIRE via COMTEX) -- STRATHMORE MINERALS CORP. (the "Company") (TSX VENTURE: STM) is pleased to announce that the Company has recently acquired two additional areas of known mineralization in the Gas Hills Uranium District, Wyoming; by staking lode mining claims on lands administered by the U.S. Bureau of Land Management. The Gas Hills Uranium District was one of the most prolific producing areas in the United States during the last uranium cycle, with total production exceeding 100 million pounds. The majority of this production was from conventional open-pit mining, and to a much lesser extent by underground and in-situ recovery. The Gas Hills area is located 45 miles east of Riverton Wyoming, home of the Company's U.S. exploration and development office. The two claimed properties, Andria and East Day Loma, were extensively drilled in the 1960s and 1970s and scheduled for open-pit development during the early 1980s. The Andria ore body was previously drilled by Federal American Partners (FAP) and the East Day Loma pits were delineated by Energy Fuels Inc. The uranium is hosted within roll-front deposits of the Eocene Wind River Formation sandstones, from surface to 500 feet deep. Significant infrastructure exists on and near the acquired properties, including haulage roads and electrical power lines.
According to historical documents, the Andria Ore Body contains 949,100 lbs. U3O8 and the East Day Loma property contains 1,940,945 lbs. U3O8. The new properties are in close proximity to the Company's existing Gas Hills deposits, which include the Bull Rush, Loco-Lee & George Ver claims with a historical resource estimate of 6,131,504 tonnes at an average grade of 0.069% U3O8 (8,440,490 lbs U3O8; see press release of November 9, 2006 for additional details) and the Frazier LeMac Property with a historical resource estimate of 696,327 tonnes at an average grade of 0.11% U3O8 (1,522,000 lbs U3O8; see press release of Feb 1, 2007 for additional details). The following tables summarize the historic resources for the two new properties. The resources shown for East Day Loma are for only that mineralization contained within four previously designed pits; historical drill-hole location maps (with +mineralized intercept data) show considerable mineralization surrounding the designed pits, with a potential to significantly increase the known resources there.
INGERSOLL RAND LTD A
15.05.07 16:08 Uhr
49,50 USD
+6,20 % [+2,89]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=IR.NYS&lColors=0x000000&sSym=IR.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=IR.NYS&lColors=0x000000&sSym=IR.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=IR.NYS&lColors=0x000000&sSym=IR.NYS&hcmask=
Börse
NYSE
Aktuell
49,50 USD
Zeit
15.05.07 16:08
Diff. Vortag
+6,20 %
Tages-Vol.
272,66 Mio.
Gehandelte Stück
5,6 Mio.
Ingersoll Rand Exploring Strategic Alternatives for its Bobcat and Construction-related Businesses Board Approves Expansion of Share Repurchase Authorization From $2 Billion to $4 Billion Share Repurchase Program to be Accelerated
HAMILTON, Bermuda, May 15, 2007 (BUSINESS WIRE) -- Ingersoll-Rand Company Limited (NYSE:IR) today announced that it has initiated a process to explore strategic alternatives for its Bobcat and construction-related businesses, including the Utility Equipment and Attachments businesses. The company's alternatives may include an outright sale of the businesses or a spin-off to shareholders. For full-year 2006 these businesses collectively generated approximately $2.6 billion in revenues. The company expects to conclude the process in the second half of 2007.
"Our Bobcat, Utility Equipment and Attachments businesses represent world-class operations with exceptional people, products and brands; however, these businesses no longer fit Ingersoll Rand's long-term strategy," said Herbert L. Henkel, chairman, president and chief executive officer. "The eventual outcome of our process to explore strategic alternatives for these businesses will be the strategic repositioning of Ingersoll Rand away from the capital-intense, heavy-machinery profile of the company's past and toward a true diversified industrial company with powerful growth platforms consisting of climate control, industrial and security businesses. These businesses are well positioned to deliver consistent growth throughout the business cycle."
In addition, the company's board of directors yesterday approved the expansion of its share-repurchase authorization, originally announced in December 2006, from $2 billion to $4 billion. The company plans to accelerate the repurchase program to complete $2 billion of share repurchases by the end of the 2007 third quarter, and will consider various alternatives to effect the accelerated share repurchase. Approximately $330 million in shares have been repurchased to date under the authorization.
The timing of the remaining $2 billion of the share repurchase authorization will depend on the disposition of the Bobcat, Utility Equipment and Attachments businesses, as well as other uses of proceeds in conjunction with the company's acquisition program.
"Our strong operating cash flow, the proceeds we generate from a sale or spin-off of businesses, and our strong balance sheet allows us to continue to pursue growth through strategic acquisitions," Henkel said. "At the same time, the board's approval of an expanded share repurchase program provides the flexibility to deploy prospective proceeds to enhance shareholder value."
Astea International, Inc.
15.05.07 16:23 Uhr
9,20 USD
+63,70 % [+3,58]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ATEA.NAS&lColors=0x000000&sSym=ATEA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ATEA.NAS&lColors=0x000000&sSym=ATEA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ATEA.NAS&lColors=0x000000&sSym=ATEA.NAS&hcmask=
Börse
NASDAQ
Aktuell
9,20 USD
Zeit
15.05.07 16:23
Diff. Vortag
+63,70 %
Tages-Vol.
9,55 Mio.
Gehandelte Stück
1,4 Mio
Astea International Inc. (NASDAQ: ATEA), a global provider of service management solutions, today released financial results for the first quarter of 2007.
For the first quarter ended March 31, 2007, Astea reported revenues of $7.8 million compared to revenues of $3.8 million for the same period in 2006. Net profit for the first quarter was $1.3 million or $.36 per share, compared to a net loss of $2.3 million or $.64 per share for the same period in 2006. License revenues were $1.7 million compared to $125,000 in 2006. Total service and maintenance revenue increased 65% to $6.1 million. The improvement in license revenue comes from a number of sales to existing customers; recognition of income from a sale which occurred in the second quarter of 2006, which is spread out over 18 month; sales to new customers and recognition of license revenue deferred from a European customer in December 2004. Cash on hand increased $1.1 million from December 31, 2006.
For the quarter ended March 31, 2007, Astea recognized $1.6 million of revenue which had been deferred from a transaction that occurred with a customer in the U.K. in the fourth quarter of 2004 and continued through the end of 2006. This revenue is comprised of $384,000 of license revenue and $1.2 million in services and maintenance revenue. All costs related to generating these revenues were expensed in the periods in which they incurred. The results from operations for the quarter include all of the revenues discussed, but no related costs. Therefore, gross profit on revenue this quarter appears higher than other quarters. Such operation results are not typical for the Company and are not expected to recur.
"We are pleased to see the substantial improvements in our reported revenues this quarter, yet we recognize that we are still not where we need to be regarding our financial performance. Without the recognition of the deferred revenue from the UK transaction, we would not have been profitable. Nevertheless our pipeline is healthy. However, the sales cycles on our larger opportunities are inherently more complex and it is difficult to predict their timing. We are beginning to see the positive outcomes of our cost containment strategies as well as our shifted focus to aggressive sales and marketing execution," stated Zack Bergreen, Chairman and CEO, Astea International. "Our service revenue has improved dramatically and the expertise of our services team continues to be one of our compelling differentiators in this competitive market. Organizations around the world continue to turn to Astea as the clear choice for industry leading service lifecyle management solutions to support their global service operations."
Astea will host a conference call that will be broadcast live over the Internet on May 16, 2007 at 11:00 AM EDT to discuss the Company's first quarter financial results. Investors can access the call from the Company's Web site at http://www.astea.com/about_investors.asp. For those who cannot listen to the live broadcast, a replay will be available shortly after the call.
About Astea International
Astea International (NASDAQ: ATEA) is a global provider of service management software that addresses the unique needs of companies who manage capital equipment, mission critical assets and human capital. With the acquisition of FieldCentrix, Astea complements its existing portfolio with the industry's leading mobile field service execution solutions. Astea is helping companies drive even higher levels of customer satisfaction with faster response times and proactive communication, creating a seamless, consistent and highly personalized experience at every customer relationship touch point. Since its inception in 1979, Astea has licensed applications to companies, around the world, in a wide range of sectors including information technology, telecommunications, instruments and controls, business systems, HVAC, gaming/leisure, imaging, industrial equipment, and medical devices.
During mid-morning trading shares are up 43.77% to $8.08 with over 895,000 in volume. The Exploration Investor Research Team will continue to gauge the short and long term affects that this announcement will have on the company.
STEC, Inc.15.05.07 16:32 Uhr
6,35 USD
-21,89 % [-1,78]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=STEC.NAS&lColors=0x000000&sSym=STEC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=STEC.NAS&lColors=0x000000&sSym=STEC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=STEC.NAS&lColors=0x000000&sSym=STEC.NAS&hcmask=
Börse
NASDAQ
Aktuell
6,35 USD
Zeit
15.05.07 16:32
Diff. Vortag
-21,89 %
Tages-Vol.
14,91 Mio.
Gehandelte Stück
2,4 Mio.
STEC Announces First Quarter 2007 Results
SANTA ANA, Calif., May 14, 2007 (PrimeNewswire via COMTEX) -- STEC, Inc. (Nasdaq: STEC), announced today its financial results for the quarter ended March 31, 2007.
Revenue for the first quarter of 2007 was $47.2 million, an increase of 16.8% from $40.4 million for the first quarter of 2006, and a decrease of 36.5% from $74.3 million for the fourth quarter of 2006. Gross profit margin was 30.6% for the first quarter of 2007, compared to 22.7% for the first quarter of 2006, and 33.9% for the fourth quarter of 2006. Diluted earnings per share was $0.04 for the first quarter of 2007, compared to $0.02 for the first quarter of 2006, and $0.19 for the fourth quarter of 2006. In addition, diluted earnings per share from discontinued operations was $0.09 for the first quarter of 2007, comprised of break-even operating results from the Consumer Division from January 1, 2007 to the date of the sale, and $0.09 of diluted earnings per share related to the gain on the sale of the division.
In the first quarter of 2007, the company incurred $489,000 of after-tax expenses ($0.01 per diluted share) related to start-up costs for the company's new Malaysian manufacturing facility, set-up costs related to global tax structuring and first-year Sarbanes-Oxley implementation costs. On February 9, 2007, the company divested its Consumer Division and all financial information related to the Consumer Division is now reported as discontinued operations
About STEC, Inc. (Nasdaq: STEC)
STEC, Inc., designs, develops, manufactures and markets custom memory solutions based on Flash memory and DRAM technologies
Cerberus macht Tempo bei Chrysler
von Michael Gassmann (New York) und Oliver Wihofszki (Stuttgart)
Cerberus ist für Chrysler nur eine Übergangslösung - davon sind viele Branchenkenner überzeugt, ungeachtet der gegenteiligen Versicherung von John Snow, dem Chef der privaten Beteiligungsfirma, die Chrysler am Montag von Daimler übernommen hat.
Der drittgrößte US-Autohersteller werde in wenigen Jahren Anlehnung an einen anderen Autokonzern suchen, sagte Dave Cole vom Center für Automotive Research in Michigan. "Wir werden in diesem Spiel noch andere Namen sehen. Chrysler braucht einen industriellen Partner", erklärte Cole. Branchenriesen wie General Motors oder Nissan könnten interessiert sein, wenn Chrysler wieder besser dastehe, glaubt Cole.
Cerberus hat Investitionen von 7,4 Mrd. $ in die Zukunft von Chrysler zugesagt, dazu kommt nach Informationen aus Bankenkreisen eine Kreditlinie über 12 Mrd. $ zur Entwicklung neuer Produkte. Die Summe reicht aus, um die laufende Entwicklung neuer Autotypen fertigzustellen und neue Modelle zu entwickeln. Für den langfristigen Erfolg fehlten jedoch Grundvoraussetzungen wie ein tragfähiges Markenimage und Kompetenz für kleinere Motoren, sagte der Marktforscher Heinz van Deelen.
Überkapazitäten:
Autos der Marke Dodge auf Halde. Spritschlucker finden immer weniger Käufer"Langfristig scheint es zweifelhaft, dass Chrysler eigenständig überleben kann", sagte der Analyst Jürgen Pieper vom Frankfurter Bankhaus Metzler. Chrysler kämpft im härtesten Automarkt der Welt mit zu hohen Produktionskosten und einer verfehlten Modellpalette. Problematisch ist vor allem das Massengeschäft mit seinem hohen Anteil an schweren Geländewagen, Pick-ups und Sportfahrzeugen mit hohem Energieverbrauch. Nur 25,6 Prozent der im vergangenen Jahr verkauften 2,66 Millionen Autos der Konzernmarken Chrysler, Dodge und Jeep waren herkömmliche Personenwagen.
Konzentriert auf schwere Wagen
Mit einem strategischen Verbündeten aus der Industrie, der in die Entwicklung neuer Modelle investiert oder Kostenvorteile durch gemeinsame Entwicklung bringt, könnte sich diese Position verbessern lassen. Zudem habe Chrysler nicht die globale Präsenz, um die Schwierigkeiten des US-Geschäfts auszugleichen. "Da stehen die Rivalen Ford und General Motors, etwa mit Opel in Europa, besser da", sagte Analyst Pieper. "Ich denke, dass Cerberus kein langfristiger Investor sein wird. In zwei, drei Jahren dürfte Chrysler bereits wieder verkauft oder an die Börse gebracht werden", glaubt auch er.
Kosten drücken als oberste Maxime
Cerberus dürfte die Kosten drücken und einige starke Unternehmensteile fördern. Der neue Chrysler-Eigner versucht voraussichtlich als Erstes, bei den im kommenden Monat beginnenden Verhandlungen mit der Automobilarbeitergewerkschaft UAW die Kosten für die Krankenversicherung der Mitarbeiter zu senken. Die nehmen seit Langem mit zweistelligen Steigerungsraten pro Jahr zu und machen inzwischen über 1000 $ pro Auto bei den Produktionskosten aus. Zudem sollte Chrysler die Rabattschlacht einstellen, mit der der Konzern seinen Marktanteil in den USA über 14 Prozent schraubte, empfiehlt Analyst Jon Rogers von der Citigroup: "Chryslers Rabatte von durchschnittlich 3800 $ je Auto liegen neun Prozent über dem Durchschnitt der US-Autohersteller."
Andererseits kann der Finanzinvestor auf einige starke Firmenteile bei Chrysler zurückgreifen. So gelten die Marke Jeep und das Segment Minivans als gesunde Sparten. Als Perle gilt zudem die Finanzierungstochter.Für den Stuttgarter Mutterkonzern ist die Trennung nach Meinung einiger Analysten positiv. "Ende des Chrysler-Albtraums" kommentierte etwa Georges Dieng von Ixis Securities die Abgabe der US-Tochter. Cole zeigte sich dagegen überrascht über den Zeitpunkt des Verkaufs: "Er hätte eigentlich nicht schlechter sein können." So sei noch nicht absehbar, ob der Abbau der Überkapazitäten der gesamten Industrie ausreiche. General Motors, Ford und Chrysler bauen Zehntausende von Stellen ab und schließen Dutzende Werke, um ihre Kostenbasis den schrumpfenden Marktanteilen in einem stagnierenden Markt anzupassen. Für Chrysler hängt viel davon ab, dass der US-Automarkt im konjunkturellen Abschwung nicht einbricht. Der Konzern hat bisher die Streichung von 13.000 Stellen angekündigt
15.05.2007 22:35
Applied Materials kann Erwartungen übertreffen
Santa Clara, CA (aktiencheck.de AG) - Die amerikanische Applied Materials Inc. (ISIN US0382221051 (Nachrichten)/ WKN 865177) veröffentlichte am Dienstag nach US-Börsenschluss die Zahlen für das zweite Fiskalquartal 2006/07. Der größte Chip-Ausrüster in den USA konnte dabei den Umsatz deutlich steigern und die Umsatz- und Gewinnerwartungen übertreffen.
Das Nettoergebnis belief sich demnach auf 411 Mio. Dollar bzw. 29 Cents je Aktie, nach 413 Mio. Dollar bzw. 26 Cents je Aktie im Vorjahreszeitraum. Die Analysten hatten im Vorfeld ein EPS von durchschnittlich 28 Cents erwartet.
Die Umsatzerlöse stiegen um 13 Prozent auf nun 2,53 Mrd. Dollar. Die Analysten hatten zuvor Umsätze von 2,36 Mrd. Dollar erwartet.
Für das laufende dritte Fiskalquartal 2006/07 erwarten die Analysten ein EPS von 30 Cents bei Umsätzen von 2,44 Mrd. Dollar.
Die Aktie von Applied Materials schloss heute an der NASDAQ bei 19,78 Dollar. Nachbörslich gewinnt der Titel 1,31 Prozent auf 20,04 Dollar. (15.05.2007/ac/n/a)
15.05.2007 16:59
Time Warner: AOL übernimmt Third Screen Media
New York (aktiencheck.de AG) - Die zum US-Medienkonzern Time Warner Inc. (ISIN US8873171057 (Nachrichten/Aktienkurs)/ WKN 592629) gehörende Online-Tochter AOL hat ihre Präsenz im Werbesegment durch einen Zukauf verstärkt.
Wie der Konzern am Dienstag erklärte, wurde ein Abkommen zur Übernahme der nicht börsennotierten Third Screen Media geschlossen. Bei der in Boston ansässigen Gesellschaft handelt es sich um einen der führenden Anbieter von Advertising-Plattformen im Bereich Mobilfunk und sorgt für das Management und die Übertragung von Mobiltelefonwerbung via WAP, SMS und MMS.
Nach Abschluss der Akquisition wird Third Screen Media innerhalb der Advertising.com-Sparte von AOL als eigenständige Gesellschaft integriert. Finanzielle Einzelheiten der Transaktion wurden nicht bekannt gegeben.
Die Aktie von Time Warner notiert aktuell mit einem Plus von 0,23 Prozent bei 21,40 Dollar. (15.05.2007/ac/n/a)
BUYINS.NET: HLYS, MATH, TINY, DIAAF, ETLS, TEXG Have Also Been Added To Naked Short List Today
May 16, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list:
Heelys Inc. (NASDAQ: HLYS),
MathStar Inc (NASDAQ: MATH),
Harris & Harris Group Inc. (NASDAQ: TINY),
Diamant Art Corp (OTCBB: DIAAF),
eTotalSource Inc. (OTCBB: ETLS),
Terax Energy Inc. (OTCBB: TEXG)
Heelys Inc. (NASDAQ: HLYS) engages in the design, marketing, and distribution of action sports-inspired products for 14 year-old boys and girls. It offers its products under the HEELYS brand name. The company's primary product, HEELYS-wheeled footwear is a dual-purpose footwear product that incorporates a stealth and removable wheel in the heel. The HEELYS-wheeled footwear allows the user to transition from walking and running to skating by shifting weight to the heel. Heelys also sells branded accessories, such as replacement wheels, helmets, protective gear, and apparel items. It distributes its products through independent distributors and retail stores in the United States and internationally. The company was incorporated in 2000 as Heeling, Inc. and changed its name to Heelys, Inc. in 2006. Heelys is headquartered in Carrollton, Texas. With 27.05 million shares outstanding and 3.68 million shares declared short as of April 2007, there is a failure to deliver in shares of HLYS.
MathStar Inc. (NASDAQ: MATH) a development stage fabless semiconductor company, engages in the design, development, and marketing of semiconductor integrated circuits or chips, known as field programmable object arrays (FPOAs), in the United States. FPOAs are reprogrammable integrated circuits based on its proprietary silicon object technology. The company's FPOAs consist of small, pre-designed, high-speed computing, and data storage elements or silicon objects that are arranged in a grid pattern along with internal and external memory and data input and output channels. MathStar sells its products through manufacturers' representatives in North America and Europe. The company was founded in 1997 and is headquartered in Hillsboro, Oregon. With 20.93 million shares outstanding and 98,700 shares declared short as of April 2007, there is a failure to deliver in shares of MATH.
Harris & Harris Group Inc. (NASDAQ: TINY) is a public investment firm that operates as a venture capital firm investing in tiny-technology-enabled companies. It primarily invests in tiny technology which includes nanotechnology, microsystems, and microelectromechanical systems technology. The firm traditionally invests in early stage companies. The company was incorporated in 1981 and is based in New York City. With 20.76 million shares outstanding and 3.01 million shares declared short as of April 2007, there is a failure to deliver in shares of TINY.
Diamant Art Corp. (OTCBB: DIAAF) primarily engages in the production, distribution, and marketing of replications of original paintings. It produces replications of original paintings that incorporate brushwork texture, including oil, acrylic, and other textured pigment mediums under the name Artagraph using its patented and proprietary technologies. The company manufactures reproductions of impressionist and postimpressionist paintings, as well as paintings by contemporary artists. It also contracts with art publishers, and produces and sells replications of contemporary works of art. Diamant Art supplies its catalogue products to retail store or art gallery customers in Canada and the United States. In addition, the company intends to manufacture a non-PVC (poly vinyl chloride) food packaging stretch film, under license from Diamant Plastics Corp. and under the trade name DIAMANT. Diamant Art was incorporated in 1986. It was formerly known as ART International, Inc. and changed its name to ART International Corporation in 2003. Further, the name was changed to Diamant Art Corporation in 2004. The company is headquartered in Markham, Canada. With 20 million shares outstanding and 1.15 million shares declared short as of April 2007, there is a failure to deliver in shares of DIAAF.
eTotalSource Inc. (OTCBB: ETLS) engages in the development and supply of multimedia software technology, as well as in the publication of multimedia training content. It offers the beta Presenta Pro platform, which features back-end development of multipanel time synchronized presentations and course work, as well as testing, feedback, and performance monitoring options for distance learning and computer-based training through the Internet, Intranet, or CD/DVD ROM. Presenta pro also simplifies the production and delivery of multimedia presentations. The company publishes and produces original content and postproduction services, as well as participates in the sales and distribution of the published product. eTotalSource's primary customers include corporations, governmental organizations, and agencies. The company was founded in 2000 and is headquartered in Yuba City, California. With 83.67 million shares outstanding and 200 shares declared short as of April 2007, there is a failure to deliver in shares of ETLS.
Terax Energy Inc. (OTCBB: TEXG) operates as an independent gas exploration, development, and production company in the United States. The company focuses on exploring the gas reserves located in the Barnett Shale formations of the Fort Worth Basin. Its principal properties consist of 2 blocks of oil and gas leases, 1 covering approximately 11,300 gross acres in Erath County, Texas; and 1 covering a block of approximately 16,200 gross acres in Comanche County, Texas. Terax Energy was founded in 2000 as Royal Phoenix and changed its name to Terax Energy, Inc. in 2005. The company is headquartered in Austin, Texas. With 3.07 million shares outstanding and 13,400 shares declared short as of April 2007, there is a failure to deliver in shares of TEXG.
Wall Street News Alert: Breaking News Alert -- USSU! May 16, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, May 16, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
USA Superior Energy Holdings, Inc. (OTCBB: USSU),
ConocoPhillips (NYSE: COP),
Chevron Corporation (NYSE: CVX),
Puda Coal, Inc. (OTCBB: PUDC)
USA Superior Energy Holdings, Inc. (OTCBB: USSU)
continues to issue positive news, and should warrant the attention of investors this morning. Yesterday, after the markets closed, the company, focused on the application of new technologies to increase production in oil and gas wells, issued a press release announcing that in the month of May, USA Superior is continuing maintenance on its existing oil wells in the Bateman Field area.
This is good news for the company as according to the press release, eight wells were brought on line and are now pumping. These wells had not been producing for many months. The company has a fulltime crew working in the field, cleaning, clearing, and bringing all wells and facilities up to current safety, environmental and Texas Railroad Commission regulations.
The company is beginning a series of tests on the Wendland lease in the Bateman Field to delineate and isolate a suspected water producing zone from the other oil producing zones within the Austin Chalk formation. A successful test will allow USA Superior to eliminate this suspected water zone in numerous other wells in this identical zone across the field. This is part of firm's strategy to reduce expenses by reducing the volume and cost of disposal of water produced.
The operational efforts of the company continue in cleanup and reduction issues associated with paraffin in the Bateman Field. Due to the previous ten plus years of minimal maintenance under prior owners, paraffin (a waxy buildup) had accumulated in the wells tubing, the underground well pumps and in the formation surrounding the wells. This buildup can detrimentally affect the volume of oil that can be produced and therefore revenue. The control or elimination of paraffin problems is one of the opportunities USA Superior recognized to increase income in this field.
Wall Street News Alert is placing Aggressive Investors on alert to monitor the progress of USA Superior Energy! The efforts being made are obviously a success for even with the wells off production due to power loss or maintenance, overall field production is equal or higher than previous months. According to the press release, even with weather shutdowns, and extensive maintenance operations on existing producing wells, overall the Bateman field production remains relatively constant at 1200 barrels of oil per month (average last 6 months).
Last week, we reported that the company has completed an equity financing for a total of $1.0 Million USD with an additional $1.0 Million in possible financing through the exercise of warrants.
The stock closed Monday at Eighty-One cents a share.
In case you are not familiar with the company: USA Superior Energy Holdings, Inc. is a company focusing on applying new technologies to oil and gas fields as well as other industries. The company is composed of a team of experts in their field, highly qualified with over 200 man-years of oil and gas field experience; from finding to drilling, well completion to operations and production, to problem solving, seasoned with success. Environmentally concerned and responsible, responsive to project needs and specializing in special projects, USA Superior Energy's focus has been on developing and utilizing complementary technologies: Nitrogen (N2) and cased hole horizontal drilling. USA Superior will seek to use these technologies independently or in combination to exploit business opportunities.
Nitrogen (N2) is used to force oil out of reservoirs. It can be applied to existing reservoirs and wellbores, thus minimizing the risk of finding oil and gas. Cased Hole Horizontal Drilling (CHHD) is a new emerging technology that can significantly increase the "communication" from the wellbore to the fluids in the reservoir. With the current price environment, many existing marginal wells can be rejuvenated into very profitable wells.
ConocoPhillips (NYSE: COP) even on 9.9 million shares traded. ConocoPhillips is an integrated petroleum company with interests around the world.
Chevron Corporation (NYSE: CVX) down 0.1% on 9.8 million shares traded. Chevron Corporation has had operations in the U.S. Gulf of Mexico and surrounding states for more than 60 years. Chevron is one of the world's leading energy companies.
Puda Coal, Inc. (OTCBB: PUDC) up 6% on 954,000 shares traded Puda Coal, through its affiliates and controlled entities, supplies premium grade coking coal to the steel making industry for use in making coke.
http://chart.world-of-investment.is-teledata.com/snapshot.chart?ID_NOTATION=13088697&TIME_SPAN=3m
http://www.worldofinvestment.com
BUYINS.NET: HLYS, MATH, TINY, DIAAF, ETLS, TEXG Have Also Been Added To Naked Short List Today
May 16, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list:
Heelys Inc. (NASDAQ: HLYS),
MathStar Inc (NASDAQ: MATH),
Harris & Harris Group Inc. (NASDAQ: TINY),
Diamant Art Corp (OTCBB: DIAAF),
eTotalSource Inc. (OTCBB: ETLS),
Terax Energy Inc. (OTCBB: TEXG)
Heelys Inc. (NASDAQ: HLYS) engages in the design, marketing, and distribution of action sports-inspired products for 14 year-old boys and girls. It offers its products under the HEELYS brand name. The company's primary product, HEELYS-wheeled footwear is a dual-purpose footwear product that incorporates a stealth and removable wheel in the heel. The HEELYS-wheeled footwear allows the user to transition from walking and running to skating by shifting weight to the heel. Heelys also sells branded accessories, such as replacement wheels, helmets, protective gear, and apparel items. It distributes its products through independent distributors and retail stores in the United States and internationally. The company was incorporated in 2000 as Heeling, Inc. and changed its name to Heelys, Inc. in 2006. Heelys is headquartered in Carrollton, Texas. With 27.05 million shares outstanding and 3.68 million shares declared short as of April 2007, there is a failure to deliver in shares of HLYS.
MathStar Inc. (NASDAQ: MATH) a development stage fabless semiconductor company, engages in the design, development, and marketing of semiconductor integrated circuits or chips, known as field programmable object arrays (FPOAs), in the United States. FPOAs are reprogrammable integrated circuits based on its proprietary silicon object technology. The company's FPOAs consist of small, pre-designed, high-speed computing, and data storage elements or silicon objects that are arranged in a grid pattern along with internal and external memory and data input and output channels. MathStar sells its products through manufacturers' representatives in North America and Europe. The company was founded in 1997 and is headquartered in Hillsboro, Oregon. With 20.93 million shares outstanding and 98,700 shares declared short as of April 2007, there is a failure to deliver in shares of MATH.
Harris & Harris Group Inc. (NASDAQ: TINY) is a public investment firm that operates as a venture capital firm investing in tiny-technology-enabled companies. It primarily invests in tiny technology which includes nanotechnology, microsystems, and microelectromechanical systems technology. The firm traditionally invests in early stage companies. The company was incorporated in 1981 and is based in New York City. With 20.76 million shares outstanding and 3.01 million shares declared short as of April 2007, there is a failure to deliver in shares of TINY.
Diamant Art Corp. (OTCBB: DIAAF) primarily engages in the production, distribution, and marketing of replications of original paintings. It produces replications of original paintings that incorporate brushwork texture, including oil, acrylic, and other textured pigment mediums under the name Artagraph using its patented and proprietary technologies. The company manufactures reproductions of impressionist and postimpressionist paintings, as well as paintings by contemporary artists. It also contracts with art publishers, and produces and sells replications of contemporary works of art. Diamant Art supplies its catalogue products to retail store or art gallery customers in Canada and the United States. In addition, the company intends to manufacture a non-PVC (poly vinyl chloride) food packaging stretch film, under license from Diamant Plastics Corp. and under the trade name DIAMANT. Diamant Art was incorporated in 1986. It was formerly known as ART International, Inc. and changed its name to ART International Corporation in 2003. Further, the name was changed to Diamant Art Corporation in 2004. The company is headquartered in Markham, Canada. With 20 million shares outstanding and 1.15 million shares declared short as of April 2007, there is a failure to deliver in shares of DIAAF.
eTotalSource Inc. (OTCBB: ETLS) engages in the development and supply of multimedia software technology, as well as in the publication of multimedia training content. It offers the beta Presenta Pro platform, which features back-end development of multipanel time synchronized presentations and course work, as well as testing, feedback, and performance monitoring options for distance learning and computer-based training through the Internet, Intranet, or CD/DVD ROM. Presenta pro also simplifies the production and delivery of multimedia presentations. The company publishes and produces original content and postproduction services, as well as participates in the sales and distribution of the published product. eTotalSource's primary customers include corporations, governmental organizations, and agencies. The company was founded in 2000 and is headquartered in Yuba City, California. With 83.67 million shares outstanding and 200 shares declared short as of April 2007, there is a failure to deliver in shares of ETLS.
http://http://chart.world-of-investment.is-teledata.com/snapshot.chart?ID_NOTATION=16763169&TIME_SPAN=3m
http://www.worldofinvestment.com
Terax Energy Inc. (OTCBB: TEXG) operates as an independent gas exploration, development, and production company in the United States. The company focuses on exploring the gas reserves located in the Barnett Shale formations of the Fort Worth Basin. Its principal properties consist of 2 blocks of oil and gas leases, 1 covering approximately 11,300 gross acres in Erath County, Texas; and 1 covering a block of approximately 16,200 gross acres in Comanche County, Texas. Terax Energy was founded in 2000 as Royal Phoenix and changed its name to Terax Energy, Inc. in 2005. The company is headquartered in Austin, Texas. With 3.07 million shares outstanding and 13,400 shares declared short as of April 2007, there is a failure to deliver in shares of TEXG.
PC-Hersteller Hewlett-Packard steigert Umsatz - Aktie legt zu
Do Mai 17, 2007 7:31 MESZ
New York (Reuters) - Eine starke Nachfrage nach PCs und Servern hat dem weltgrößten PC-Hersteller Hewlett-Packard im abgelaufenen Quartal glänzende Geschäfte beschert.
Zwar wies der US-Konzern am Mittwoch nach US-Börsenschluss für das zweite Quartal einen Rückgang beim Reingewinn um sechs Prozent auf 1,78 Milliarden Dollar aus. Der Vorjahreswert war aber durch einen Sonderposten aufgebläht. Wird dieser herausgerechnet, ergibt sich ein Zuwachs von 27 Prozent. Der Umsatz kletterte um 13 Prozent auf 25,5 Milliarden Dollar. Die HP-Aktien stiegen nachbörslich um 1,3 Prozent.
HP hatte erst vor kurzem seine Umsatz-Erwartungen für das zweite Geschäftsquartal um eine Milliarde auf bis zu 25,55 Milliarden Dollar angehoben. Zur Begründung war auf das starke PC- und Servergeschäft verwiesen worden.
HP hat im harten Wettbewerb am PC-Markt inzwischen den Rivalen Dell von der Spitze verdrängt. Dell kämpft seit Monaten mit Kostenproblemen und musste zu Jahresbeginn einen Gewinneinbruch verkraften.
Friday's Analysts' Upgrades and Downgrades
By TSC Staff
5/18/2007 10:52 AM EDT
CHANGE IN RATINGS
CACI International (CAI - Cramer's Take - Stockpickr) upgraded at UBS to Buy rating from Neutral. Price target lifts to $56 from $53, and 2008 EPS estimates rise to $2.89 from $2.77.
Intel (INTC - Cramer's Take - Stockpickr) was upgraded from Neutral to Buy at Merrill Lynch. $28 price target. Company is handling AMD, and is coming up toward an exciting product cycle.
ITT Corp. (ITT - Cramer's Take - Stockpickr) initiated at Morgan Stanley with an equal weight rating and $68 price target.
Juniper Networks (JNPR - Cramer's Take - Stockpickr) downgraded at Citigroup from Buy to Hold. Stock is up 30% since January, reaching the $24 price target. Share repurchase program may even become dilutive at current levels.
Nova Chemicals (NCX - Cramer's Take - Stockpickr) downgraded at UBS to Neutral rating from Buy. However, 2007 EPS estimates rise to $4.00 from $3.80 from price target lifts to $38 from $36.
Priceline.com (PCLN - Cramer's Take - Stockpickr) upgraded at Citigroup from Hold to Buy. Stock has dropped 10% since its earnings report, but the company's strategy should continue to be successful over the long term. $69 price target.
Riverbed Tech (RVBD - Cramer's Take - Stockpickr) upgraded from Hold to Buy at Citigroup. $52 price target. Company had a strong quarter, and the product cycle remains favorable heading into the second half of the year.
Tenet Healthcare (THC - Cramer's Take - Stockpickr) was downgraded from Peer Perform to Underperform at Bear Stearns. Company has struggled in California, and margins could remain weak over the coming quarters. Estimates also cut. Fair value lies around $5.50 a share.
Verizon (VZ - Cramer's Take - Stockpickr - Rating) was upgraded from Sell to Buy at Citigroup. $48 price target. Wireline fundamentals should bottom out this year, and the outlook for wireless remains strong.
STOCK COMMENTS / EPS CHANGES
Advance Auto Parts (AAP - Cramer's Take - Stockpickr - Rating) target raised at Goldman to $45 from $43 after company posted inline earnings and margins for its first quarter. See potential for a new CEO to come in harness potential in AAP's assets. Maintained Buy rating.
HB Fuller (FUL - Cramer's Take - Stockpickr - Rating) added to Focus List at JP Morgan. $32.50 price target. Company trades at a discount to its peers and has a healthy free cash flow yield.
Kohl's (KSS - Cramer's Take - Stockpickr - Rating) numbers raised at Jefferies. Price target jumps to $103 from $85, and 2008 EPS estimates rise to $4.58 from $4.50. Reiterates Buy rating.
Marvell Technology (MRVL - Cramer's Take - Stockpickr - Rating) numbers lowered at Jefferies. Price target lowered $21 from $22, and 2008 EPS estimates drop to $0.70 from $0.74. Reiterates Buy rating.
Luna Innovations Incorporated
21.05.07 15:48 Uhr
4,54 USD
+51,33 % [+1,54]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=LUNA.NAS&lColors=0x000000&sSym=LUNA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=LUNA.NAS&lColors=0x000000&sSym=LUNA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=LUNA.NAS&lColors=0x000000&sSym=LUNA.NAS&hcmask=
Börse
NASDAQ
Aktuell
4,54 USD
Zeit
21.05.07 15:48
Diff. Vortag
+51,33 %
Tages-Vol.
2,75 Mio.
Gehandelte Stück
637.013
Luna Innovations Blood Circuit Monitor Receives FDA Clearance EDAC(TM) QUANTIFIER Counts and Measures Gaseous Emboli in Real-Time
ROANOKE, Va., May 21, 2007 (BUSINESS WIRE) -- Luna Innovations (NASDAQ: LUNA) announced today that it has received a market clearance letter in response to its 510(k) application to the U.S. Food and Drug Administration for the EDAC(TM) (Emboli Detection and Classification) QUANTIFIER. This cardiopulmonary bubble detector is an innovative medical device that uses quantitative ultrasound technology to non-invasively detect gaseous emboli in an extracorporeal bypass circuit line. Luna will market and sell the EDAC QUANTIFIER for clinical use in the United States.
Emboli can be air bubbles or solid matter, variable in their size and consistency, and can enter the extracorporeal blood circuit during invasive medical procedures such as cardiopulmonary bypass surgery. Many researchers and clinicians agree that one of the most significant risks associated with emboli is brain damage caused by gaseous microemboli which are introduced into the cerebral blood flow during such procedures.
"The dramatic new emboli data and the graphic display of the EDAC QUANTIFIER will open clinicians' eyes to a world of flowing microscopic gaseous emboli that we have not been able to visualize previously," said Jeffery B. Riley MHPE, CCT, Program Director and Assistant Professor-Clinical Allied Medicine, The Ohio State University, who has been using Luna's EDAC QUANTIFIER in a research setting since October 2006. "Adopting the EDAC QUANTIFIER gives us the opportunity to reduce one of the major side-effects of cardiopulmonary bypass, neurocognitive problems which can be caused by embolism, and improve the care of our cardiac surgical patients. Additionally, the hardware and user-interface for the EDAC QUANTIFIER are advance-of-the-art, accurate, and easy to use during the procedure."
Luna's EDAC QUANTIFIER simultaneously monitors up to three bypass circuit locations, provides count rates up to at least 1000 per second and detects emboli as small as 10 microns in diameter. In addition, the blood circuit monitor also provides real-time feedback and archived data on critical information such as emboli counts and volume estimates. This new device offers a user-friendly interface and requires minimal training for use.
"The EDAC market clearance exemplifies the Luna Innovations business model in the ever demanding high technology arena of cardiovascular bypass surgery," said Kent Murphy, Chairman and CEO of Luna Innovations. "The EDAC product emerged through innovative engineering originally funded from research with the Navy and we will continue to advance and expand our core ultrasound technology."
Luna's EDAC QUANTIFIER comes configured in a standalone system with a three-channel, ultrasonic pulser-receiver unit, a touch-panel computer and ultrasound transducers. It is available immediately with an estimated six to eight week delivery time. Additional information can be found at www.lunamedicalproducts.com or by contacting support@lunamedicalproducts.com About Luna Innovations:
Luna Innovations Incorporated develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. Our products are used to measure, monitor, protect and improve critical processes in the markets we serve. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia. Additional information can be found at www.lunainnovations.com.
Cytyc Corporation
21.05.07 15:53 Uhr
43,03 USD
+22,77 % [+7,98]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CYTC.NAS&lColors=0x000000&sSym=CYTC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CYTC.NAS&lColors=0x000000&sSym=CYTC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CYTC.NAS&lColors=0x000000&sSym=CYTC.NAS&hcmask=
Börse
NASDAQ
Aktuell
43,03 USD
Zeit
21.05.07 15:53
Diff. Vortag
+22,77 %
Tages-Vol.
241,54 Mio.
Gehandelte Stück
7,3 Mio.
Hologic Agrees To Acquire Device Maker Cytyc For $6.2 Billion In Cash, Stock
May 21, 2007 (financialwire.net via COMTEX) -- May 21, 2007 (FinancialWire) Hologic Inc. (NASDAQ: HOLX), a maker of diagnostic and medical imaging systems, has agreed to acquire medical device maker Cytyc Corp. (NASDAQ: CYTC) for $.62 billion in cash and stock.
The deal will create a $10 billion company that will focus exclusively on advanced technology in women's health.
The deal was unanimously approved by the companies' boards of directors and is expected to be completed in the third quarter of 2007.
The combination is expected to drive cross-selling across units of the new company, generating more than $75 million in extra revenues within the first three years. Efficiencies in marketing, purchasing, logistics and shared administrative services are expected to generate $25 million to $30 million in annual cost savings.
Under the terms of the deal, Cytyc shareholders will receive 0.52 shares of Hologic common stock and $16.50 in cash for each share of Cytyc common stock they own.
The combined company will be called Hologic, and Cytyc will become its wholly owned subsidiary.
The deal is subject to approval by regulators and both companies' shareholders.
Antigenics Inc.
21.05.07 17:30 Uhr
3,50 USD
+37,80 % [+0,96]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
Börse
NASDAQ
Aktuell
3,50 USD
Zeit
21.05.07 17:30
Diff. Vortag
+37,80 %
Tages-Vol.
10,28 Mio.
Gehandelte Stück
3,2 Mio.
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer Overall Survival Improvement Also Observed in Intermediate-Risk Kidney Cancer Patients Who Received Oncophage A
ANAHEIM, Calif., May 21, 2007 (BUSINESS WIRE) -- Antigenics Inc. (NASDAQ: AGEN) today announced additional follow-up data on the company's Phase 3 investigational therapeutic cancer vaccine Oncophage(R) (vitespen). The end-of-study results, which reflect an additional 17 months' data collection, showed that in a substantial subset of patients (n = 362) at intermediate risk for disease recurrence, Oncophage demonstrated a clinically significant improvement in recurrence-free survival (RFS) of approximately 45 percent (P less than 0.01; hazard ratio (HR) = 0.55). In addition, updated analysis in this group of patients revealed a new potential benefit associated with Oncophage treatment: for intermediate-risk patients there was a trend towards improved overall survival, the study's secondary endpoint. Furthermore, the positive overall survival trend observed to date correlates with the RFS improvement demonstrated in previous analyses. This is the largest, randomized Phase 3 kidney cancer trial ever completed in the adjuvant treatment setting.
Christopher G. Wood, MD, associate professor of urology at M. D. Anderson Cancer Center in Houston, presented the Phase 3 end-of-study results at the annual meeting of the American Urological Association (AUA; abstract #633).
"These results continue to underscore the significant potential benefit of Oncophage in a well-defined, clinically and biologically relevant subset of patients who are the most appropriate candidates for cancer vaccines," said Dr. Wood. "In addition, there are currently no approved therapies for these patients, which represent a growing and significant population due to increased use of early detection techniques."
"We are particularly encouraged to see that the clinically significant trend observed from our earlier analysis has been strengthened by the updated data from an additional 17-month follow-up of patients," said Garo H. Armen, PhD, chairman and CEO of Antigenics. "Although there are challenges associated with interpretation of subset analyses, the improvement demonstrated in this group of patients supports the opinion of key experts that patients with better prognostic factors are the most appropriate population to benefit from therapeutic cancer vaccines. Combined with decades of preclinical and clinical cancer vaccine data, we believe our results provide a higher level of reliability than that generally associated with outcomes from typical subset analyses."
Study Findings
Results from the investigator-reported data, which represented all data collected through the end of study (March 31, 2007), showed that:
-- Patients receiving Oncophage in the intermediate-risk population (stages I/II high-grade, III T1/2/3a low-grade) who were without disease at baseline (n = 362) demonstrated a clinically significant improvement in recurrence-free survival of approximately 45 percent (P less than 0.01; HR = 0.55). This patient population is defined by the Eastern Cooperative Oncology Group (ECOG) as at intermediate risk for disease recurrence*. Although the median survival has not yet been reached, results from the 25th percentile indicate that recurrence-free survival was extended by approximately 1.8 years in the Oncophage arm.
-- Analysis of overall survival showed improvement associated with Oncophage in the intermediate-risk population. As of data cut-off on January 2, 2006, one additional patient had died in the Oncophage arm versus 13 patients in the observation arm. This now brings the total reported deaths to 15 patients (8.2 percent) in the Oncophage arm compared with 25 deaths (14.0 percent) in the observation arm. The overall survival data are still immature due to the small number of deaths that have occurred to date; patients will continue to be monitored for survival through a global patient registry.
-- Among all eligible patients (intermediate- and high-risk patients without baseline disease; n = 604), Oncophage was associated with an 11.4 percent improvement in recurrence-free survival, which was not statistically significant (HR = 0.89).
-- There was also a promising trend for overall survival associated with Oncophage in the eligible patient population (n = 604). As of data cut-off on January 2, 2006, 24 additional deaths have been reported, with six in the Oncophage arm and 18 in the observation arm, bringing the total to 37 (12.3 percent) and 40 (13.2 percent) deaths, respectively.
-- Adverse events reported during the trial were generally mild and expected. The more frequently reported adverse events were mainly constitutional in nature or related to the actual injection.
The company is working with study investigators to publish the final findings in a peer-reviewed medical journal.
Antigenics To Continue To Follow Patients for Recurrence-Free Survival and Overall Survival Through a Global Patient Registry
A global patient registry is being launched to continue collecting data on all patients from the trial for recurrence-free survival and overall survival. The registry, which is expected to provide additional data on the effectiveness of Oncophage, will follow patients for an additional three years from closure of the initial trial, providing more than five years' worth of data collection from the last patient enrolled.
Global Registrational Strategy
Antigenics intends to seek a meeting with US Food and Drug Administration to discuss the results of the updated analyses utilizing data through March 2007 to determine whether there is an opportunity to file a biologics license application (BLA) on the basis of these results along with appropriate commitments to conduct further clinical investigations to support the efficacy of Oncophage in renal cell carcinoma. Antigenics also plans to explore the need for further clinical studies to support approval of Oncophage in ex-US markets.
http://chart.world-of-investment.is-teledata.com/snapshot.chart?ID_NOTATION=253846&TIME_SPAN=1d
http://www.worldofinvestment.com/wkn/934396/FRA/
die Frankfurter interessieren sich net dafür, normaler weise geiern die immer nach den usa
Antigenics Inc.
21.05.07 17:30 Uhr
3,50 USD
+37,80 % [+0,96]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AGEN.NAS&lColors=0x000000&sSym=AGEN.NAS&hcmask=
Börse
NASDAQ
Aktuell
3,50 USD
Zeit
21.05.07 17:30
Diff. Vortag
+37,80 %
Tages-Vol.
10,28 Mio.
Gehandelte Stück
3,2 Mio.
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer Overall Survival Improvement Also Observed in Intermediate-Risk Kidney Cancer Patients Who Received Oncophage A
ANAHEIM, Calif., May 21, 2007 (BUSINESS WIRE) -- Antigenics Inc. (NASDAQ: AGEN) today announced additional follow-up data on the company's Phase 3 investigational therapeutic cancer vaccine Oncophage(R) (vitespen). The end-of-study results, which reflect an additional 17 months' data collection, showed that in a substantial subset of patients (n = 362) at intermediate risk for disease recurrence, Oncophage demonstrated a clinically significant improvement in recurrence-free survival (RFS) of approximately 45 percent (P less than 0.01; hazard ratio (HR) = 0.55). In addition, updated analysis in this group of patients revealed a new potential benefit associated with Oncophage treatment: for intermediate-risk patients there was a trend towards improved overall survival, the study's secondary endpoint. Furthermore, the positive overall survival trend observed to date correlates with the RFS improvement demonstrated in previous analyses. This is the largest, randomized Phase 3 kidney cancer trial ever completed in the adjuvant treatment setting.
Christopher G. Wood, MD, associate professor of urology at M. D. Anderson Cancer Center in Houston, presented the Phase 3 end-of-study results at the annual meeting of the American Urological Association (AUA; abstract #633).
"These results continue to underscore the significant potential benefit of Oncophage in a well-defined, clinically and biologically relevant subset of patients who are the most appropriate candidates for cancer vaccines," said Dr. Wood. "In addition, there are currently no approved therapies for these patients, which represent a growing and significant population due to increased use of early detection techniques."
"We are particularly encouraged to see that the clinically significant trend observed from our earlier analysis has been strengthened by the updated data from an additional 17-month follow-up of patients," said Garo H. Armen, PhD, chairman and CEO of Antigenics. "Although there are challenges associated with interpretation of subset analyses, the improvement demonstrated in this group of patients supports the opinion of key experts that patients with better prognostic factors are the most appropriate population to benefit from therapeutic cancer vaccines. Combined with decades of preclinical and clinical cancer vaccine data, we believe our results provide a higher level of reliability than that generally associated with outcomes from typical subset analyses."
Study Findings
Results from the investigator-reported data, which represented all data collected through the end of study (March 31, 2007), showed that:
-- Patients receiving Oncophage in the intermediate-risk population (stages I/II high-grade, III T1/2/3a low-grade) who were without disease at baseline (n = 362) demonstrated a clinically significant improvement in recurrence-free survival of approximately 45 percent (P less than 0.01; HR = 0.55). This patient population is defined by the Eastern Cooperative Oncology Group (ECOG) as at intermediate risk for disease recurrence*. Although the median survival has not yet been reached, results from the 25th percentile indicate that recurrence-free survival was extended by approximately 1.8 years in the Oncophage arm.
-- Analysis of overall survival showed improvement associated with Oncophage in the intermediate-risk population. As of data cut-off on January 2, 2006, one additional patient had died in the Oncophage arm versus 13 patients in the observation arm. This now brings the total reported deaths to 15 patients (8.2 percent) in the Oncophage arm compared with 25 deaths (14.0 percent) in the observation arm. The overall survival data are still immature due to the small number of deaths that have occurred to date; patients will continue to be monitored for survival through a global patient registry.
-- Among all eligible patients (intermediate- and high-risk patients without baseline disease; n = 604), Oncophage was associated with an 11.4 percent improvement in recurrence-free survival, which was not statistically significant (HR = 0.89).
-- There was also a promising trend for overall survival associated with Oncophage in the eligible patient population (n = 604). As of data cut-off on January 2, 2006, 24 additional deaths have been reported, with six in the Oncophage arm and 18 in the observation arm, bringing the total to 37 (12.3 percent) and 40 (13.2 percent) deaths, respectively.
-- Adverse events reported during the trial were generally mild and expected. The more frequently reported adverse events were mainly constitutional in nature or related to the actual injection.
The company is working with study investigators to publish the final findings in a peer-reviewed medical journal.
Antigenics To Continue To Follow Patients for Recurrence-Free Survival and Overall Survival Through a Global Patient Registry
A global patient registry is being launched to continue collecting data on all patients from the trial for recurrence-free survival and overall survival. The registry, which is expected to provide additional data on the effectiveness of Oncophage, will follow patients for an additional three years from closure of the initial trial, providing more than five years' worth of data collection from the last patient enrolled.
Global Registrational Strategy
Antigenics intends to seek a meeting with US Food and Drug Administration to discuss the results of the updated analyses utilizing data through March 2007 to determine whether there is an opportunity to file a biologics license application (BLA) on the basis of these results along with appropriate commitments to conduct further clinical investigations to support the efficacy of Oncophage in renal cell carcinoma. Antigenics also plans to explore the need for further clinical studies to support approval of Oncophage in ex-US markets.
Cypress Bioscience, Inc.
23.05.07 15:47 Uhr
17,63 USD
+108,64 % [+9,18]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CYPB.NAS&lColors=0x000000&sSym=CYPB.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CYPB.NAS&lColors=0x000000&sSym=CYPB.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CYPB.NAS&lColors=0x000000&sSym=CYPB.NAS&hcmask=
Börse
NASDAQ
Aktuell
17,60 USD
Zeit
23.05.07 15:48
Diff. Vortag
+108,28 %
Tages-Vol.
85,55 Mio.
Gehandelte Stück
8,4 Mio.
CYPB surges and FRX gains after reporting late Tuesday positive data from a phase III study for Milnacipran in fibromyalgia syndrome
Vion Pharmaceuticals Inc.
23.05.07 16:10 Uhr
1,02 USD
-49,50 % [-1,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=VION.NAS&lColors=0x000000&sSym=VION.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=VION.NAS&lColors=0x000000&sSym=VION.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=VION.NAS&lColors=0x000000&sSym=VION.NAS&hcmask=
Börse
NASDAQ
Aktuell
1,02 USD
Zeit
23.05.07 16:10
Diff. Vortag
-49,50 %
Tages-Vol.
5,25 Mio.
Gehandelte Stück
7,3 Mio.
Vion Announces Suspension of Phase III Trial in Relapsed AML Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly Patients with De Novo Poor-Risk AML Continues to Accrue Patients Company to Hold Conference Call at 10:30 A.M. Eastern Time Today
NEW HAVEN, Conn., May 23, 2007 /PRNewswire-FirstCall via COMTEX/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) announced today that it would suspend enrollment and further patient treatment in its Phase III clinical study of Cloretazine(R) (VNP40101M) for patients with relapsed adult myelogenous leukemia (AML) pending a detailed review of all of the data from the trial. This decision was based on the recommendation of the trial's independent Data Safety Monitoring Board (DSMB) after a planned interim analysis.
The Phase III trial is a double-blind placebo-controlled randomized evaluation of an experimental treatment consisting of Ara-C plus Cloretazine(R) (VNP40101M) versus a control arm regimen of Ara-C and placebo. The trial is designed to accrue patients in first relapse AML whose first complete remission (CR) was more than three months but less than twenty-four months in duration. Patients are stratified according to: (i) age, greater than or less than 60 years and (ii) length of the first CR, more than or less than 12 months in duration. The primary endpoint for the trial is the objective response rate, defined as CR plus CRp (a complete remission with incomplete recovery of platelet count). Secondary endpoints include time to progression, duration of response, overall survival and toxicity.
The DSMB's review of clinical data from the first 210 treated patients resulted in a recommendation that enrollment and further treatment of patients on study be suspended. The DSMB's recommendation was based on their evaluation that any advantage in complete remission could be compromised by the observed on-study mortality to date.
The study will remain blinded while a complete medical review is conducted.
Alan Kessman, Chief Executive Officer, stated, "There will be a thorough analysis of all the data to date from this trial, and we will base any decision on the continuation, possible modification or termination of the study on the available data." He concluded, "We will provide an update on the status of the analysis as soon more information is available."
The Company is also evaluating Cloretazine(R) (VNP40101M) as a single agent in a pivotal Phase II trial in elderly patients with de novo poor-risk AML. This trial is being conducted in over twenty sites in the U.S. and Europe. Completion of accrual to this trial is expected to occur in June or July 2007.
ANALOG DEVICES
23.05.07 16:10 Uhr
36,94 USD
-8,61 % [-3,48]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ADI.NYS&lColors=0x000000&sSym=ADI.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ADI.NYS&lColors=0x000000&sSym=ADI.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ADI.NYS&lColors=0x000000&sSym=ADI.NYS&hcmask=
Börse
NYSE
Aktuell
36,94 USD
Zeit
23.05.07 16:10
Diff. Vortag
-8,61 %
Tages-Vol.
163,28 Mio.
Gehandelte Stück
5,1 Mio.
Analog Devices Stretching to Fresh Extended-Hours Lows in Pre-Market
Boston, May 23, 2007 (MidnightTrader via COMTEX) -- It's not taking long for ADI to stretch to a new extended-hours low of 37.16 in today's pre-market, outpacing the Tuesday night after-hours bottom of 37.71. Thus far this morning the stock has seen a range of 37.98 to 37.16, with the bulk of the downside trade matching south of 37.30.
Northfield Laboratories Inc.
23.05.07 17:12 Uhr
2,24 USD
-47,29 % [-2,01]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NFLD.NAS&lColors=0x000000&sSym=NFLD.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NFLD.NAS&lColors=0x000000&sSym=NFLD.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=NFLD.NAS&lColors=0x000000&sSym=NFLD.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,24 USD
Zeit
23.05.07 17:12
Diff. Vortag
-47,29 %
Tages-Vol.
4,09 Mio.
Gehandelte Stück
2,3 Mio.
Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study Conference Call Scheduled for 8:30 am Today
EVANSTON, Ill., May 23, 2007 (BUSINESS WIRE) -- Northfield Laboratories, Inc. (NASDAQ: NFLD) reported today results of its pivotal Phase III trauma trial with PolyHeme(R), its human hemoglobin-based oxygen-carrying red blood cell substitute. The trial was designed to seek an indication for use in the treatment of life-threatening red blood cell loss when transfusion is required and red blood cells are not available, not for use interchangeably with blood. This indication addresses a critical, unmet medical need.
The primary efficacy endpoint of the study was a dual superiority-noninferiority assessment of mortality at 30 days after injury. The margin to assess noninferiority, using the upper limit of the confidence interval, was set at 7% more than control. In the primary Modified Intent to Treat population, the upper limit was 7.65%. In the As Treated population, the upper limit was 7.06%. In the Per Protocol population, the upper limit was 6.29%.
Day 30 mortality was also a primary safety endpoint. Further analysis of the mortality data indicates that the difference in mortality at 30 days between patients who received PolyHeme beginning at the scene and continuing for up to 12 hours following injury, and control patients who received the standard of care, including early blood, was not statistically significant.
"The results of this study are best understood in the context of bleeding patients who do not have early access to blood transfusion," said Steven A. Gould, M.D., Chairman and Chief Executive Officer. "47 million Americans live more than an hour away from a trauma center where blood is available. Mortality rates in that scenario would be considerably higher than those observed in the control patients in the urban setting of this trial, where transit times were relatively short. We believe that when our data are extrapolated to patients who need an oxygen carrier and have delayed access to blood, PolyHeme can play an important role in saving lives."
STRIDE RITE CP
23.05.07 17:28 Uhr
20,23 USD
+30,94 % [+4,78]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SRR.NYS&lColors=0x000000&sSym=SRR.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SRR.NYS&lColors=0x000000&sSym=SRR.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SRR.NYS&lColors=0x000000&sSym=SRR.NYS&hcmask=
Börse
NYSE
Aktuell
20,23 USD
Zeit
23.05.07 17:28
Diff. Vortag
+30,94 %
Tages-Vol.
34,83 Mio.
Gehandelte Stück
1,8 Mio.
Payless ShoeSource Inc to acquire Stride Rite for USD800m
May 23, 2007 (M2 EQUITYBITES via COMTEX) -- Payless ShoeSource Inc (NYSE:PSS), a family footwear retailer, reported on 22 May that it has signed an agreement to acquire the US children's shoes company The Stride Rite Corporation (NYSE:SRR).
Stride Rite currently owns or licenses brand names as Stride Rite Keds, Sperry Top-Sider, Tommy Hilfiger Footwear, Saucony and Robeez.
The acquisition will cost Payless ShoeSource USD800m, plus the assumption of Stride Rite debt, and the deal will be financed through existing cash resources and committed new financings.
The all-cash offer by Payless of USD20.50 per share is a 32% premium over Stride Rite's average stock price over the past 90 days.
MEDTRONIC INC. Registered Shares DL -,10
23.05.07 17:16 Uhr
39,78 EUR
+4,88 % [+1,85]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MDT.FSE&lColors=0x000000&sSym=MDT.FSE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MDT.FSE&lColors=0x000000&sSym=MDT.FSE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MDT.FSE&lColors=0x000000&sSym=MDT.FSE&hcmask=
Börse
Frankfurt
Aktuell
39,78 EUR
Zeit
23.05.07 17:16
Diff. Vortag
+4,88 %
Tages-Vol.
697.282,96
Gehandelte Stück
17.674
Medtronic's Bryan(R) Cervical Disc System to Be Reviewed by FDA Panel
MEMPHIS, Tenn., May 23, 2007 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) recently announced the Bryan(R) Cervical Disc System will be reviewed by the U.S. Food and Drug Administration's (FDA) Orthopedic and Rehabilitation Devices advisory panel on July 17, 2007.
William Hawkins, president and chief operating officer, made the announcement during Medtronic's fourth quarter earnings conference call on Tuesday, May 22. If the panel votes to recommend approval, the FDA will consider this vote when deciding on full approval. The Bryan Cervical Disc System is the second disc arthroplasty system for the cervical spine to be reviewed by an FDA panel. The first, Medtronic's Prestige(R) Cervical Disc, is currently under evaluation by the FDA with expected approval later this summer.
The Bryan Cervical Disc is designed to alleviate pain and preserve motion and flexibility while replacing a diseased disc that is removed from a patient's cervical spine. Traditionally, the most common form of surgery for treating cervical degenerative disc disease (DDD) is cervical spine fusion. More than 200,000 cervical procedures are performed each year to relieve compression on the spinal cord or nerve roots and to implant a metal plate to rigidly fuse the vertebrae together.
The Bryan Cervical Disc underwent a multi-center prospective, randomized, controlled, equivalency clinical trial to assess the safety and effectiveness based on comparisons between data collected from 463 skeletally mature patients with single level symptomatic cervical DDD at one level between C3-C7. The investigational group of 242 patients was implanted with the Bryan Cervical Disc, while the control group of 221 patients received a single level anterior interbody fusion procedure with allograft and plate stabilization.
In the clinical trial, cervical DDD was defined as a combination of the following: disc herniation with radiculopathy, spondylotic radiculopathy, disc herniation with myelopathy, or spondylotic myelopathy.
About the Spinal Business at Medtronic
The Spinal and Biologics business of Medtronic, based in Memphis, Tenn., is the global leader in today's spine market and committed to advancing the treatment of spinal conditions. Medtronic's spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art products and technologies for neurological, orthopedic, oral maxillofacial and spinal conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about the company and its spinal treatments can be found at www.medtronicspinal.com and its patient-education Web sites, www.back.com, www.iscoliosis.com, www.maturespine.com and www.necksurgery.com.
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
HP Lands $5.6 Billion NASA Contract
The seven-year agreement includes desktops, workstations, blade PCs, servers, and printers.
By Michael Singer
InformationWeek
Mai 23, 2007 03:45 PM
It's all systems go at Hewlett-Packard(HP) as the PC and printer maker on Wednesday announced a new seven-year contract with NASA, to the tune of $5.6 billion.
The pact allows NASA's procurement department to select from HP desktops, workstations, blade PCs with Linux and Unix capabilities, servers, and printers, among other offerings.
The agreement is an indefinite delivery indefinite quantity (IDIQ) contract, meaning that the space agency has an open date on the purchases as well as the exact amount spent on individual products. The entire federal government and its authorized prime contractors also have the option to purchase HP technology through the contract, also known as a "Solutions for Enterprise-Wide Procurement (SEWP) IV Class 5."
The partnership agreement ends when the money runs out, but the government's procurement office has the option to renew or expand the contract if it sees fit. For example, the U.S. Department of Veterans Affairs said it is also making NASA's relationship with HP its mandatory contract for acquiring technology.
The deal is a boon for taxpayers as well since the contract specifies that HP's products must be guaranteed at or below U.S. General Services Administration schedule prices. That means the government is paying the lowest surcharge (0.6%) -- capped at $18,000 for orders more than $3 million, HP said in its announcement.
To date, HP said it has delivered more than $620 million worth of products and services to federal government agencies between 1992 and 2007 through previous NASA contracts.
But the company's relationship with the government IT contracts has not been without its controversies. The U.S. Department of Justice said in April 2007 that it will investigate claims suggesting HP and others made kickbacks to other companies involved in technology contracts with government agencies.
Wednesday's Tech Winners & Losers
By Mark Martinez
TheStreet.com Staff Reporter
5/23/2007 4:35 PM EDT
Updated from 11:49 a.m. EDT
Tech stocks moved slightly higher Wednesday as investors digested earnings news from tech companies.
Analog Devices (ADI - Cramer's Take - Stockpickr - Rating) slid 10% after the chipmaker posted second-quarter results above expectations, but issued third-quarter guidance that did not please investors. The company earned $125.4 million, or 37 cents a share, on revenue of $669.1 million. Analysts expected earnings of 35 cents a share on revenue of $659 million.
Looking ahead, Analog Devices sees third-quarter earnings of 33 cents to 37 cents a share on revenue of $655 million to $685 million. Analysts project earnings of 40 cents a share on revenue of $683.5 million. Shares closed down $4.03 to $36.39.
Elsewhere, Omnicell (OMCL - Cramer's Take - Stockpickr - Rating) rose 5.3% after the patient safety technology company priced a public offering of 3.9 million shares at $21.50 apiece. Omnicell, which will receive all of the proceeds, granted underwriters a 30-day option to buy an additional 585,000 shares to cover over-allotments. Merrill Lynch led the underwriting syndicate. Shares were trading up $1.17 to $23.20.
Meanwhile, Priceline.com (PCLN - Cramer's Take - Stockpickr - Rating) rose 0.7% after the online travel company said that full-year earnings could come in slightly above its previous guidance. The company lifted its bookings guidance to $4.25 billion, up from an earlier view of $4.2 billion. The company said that if bookings come in at the high end of guidance, earnings would likely be at or above its earnings guidance range, which is $2.90 to $3.10 a share. Analysts project earnings of $3.06 a share. Shares closed up 43 cents to $61.50.
Shanda Interactive Entertainment (SNDA - Cramer's Take - Stockpickr - Rating) rose 1.6% after the online gaming company posted better-than-expected first-quarter earnings. The company posted adjusted earnings of $26.4 million, or 36 cents per American depositary share, on revenue of $68.8 million. Analysts expected earnings of 29 cents a share on revenue of $65.3 million. Shares closed up 45 cents to $29.09.
As for the broader technology sector, the Nasdaq 100 was down about 12 points to 1904.41.
La Jolla Pharmaceutical Company
24.05.07 16:10 Uhr
6,5399 USD
+19,56 % [+1,0699]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=LJPC.NAS&lColors=0x000000&sSym=LJPC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=LJPC.NAS&lColors=0x000000&sSym=LJPC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=LJPC.NAS&lColors=0x000000&sSym=LJPC.NAS&hcmask=
Börse
NASDAQ
Aktuell
6,5399 USD
Zeit
24.05.07 16:10
Diff. Vortag
+19,56 %
Tages-Vol.
15,27 Mio.
Gehandelte Stück
3,7 Mio.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) today May 24th announced that it presented three papers related to Riquent (abetimus sodium), its drug candidate for systemic lupus erythematosus ("lupus" or "SLE") at the 8th International Congress on SLE. The first presentation reviewed recently announced safety and interim antibody data from the current Phase 3 study which highlighted the definitive and significant dose response observed between the 100 mg, 300 mg and 900 mg doses of Riquent compared with placebo (p=0.0001). The second presentation reviewed the safety and drug levels of Riquent at doses up to 2400 mg in healthy volunteers and the third, cardiovascular safety in healthy volunteers.
"These three presentations provide important, additional data that continue to indicate that Riquent is well tolerated even at much higher doses," said Deirdre Y. Gillespie, M.D., President and Chief Executive Officer of La Jolla Pharmaceutical Company. "Unlike other medications currently used to treat lupus that can severely suppress the immune system and can result in serious infections, Riquent is highly specific and designed not to suppress the healthy functions of the immune system. We believe that Riquent has the potential to be highly efficacious and well-tolerated -- it is designed to specifically target and reduce antibodies to double-stranded DNA (anti-dsDNA) that are believed to cause lupus renal disease."
Interim Antibody Data
Michael Tansey, M.D., Ph.D., the Company's Chief Medical Officer, presented on Thursday, May 24, 2007, a detailed review of the recently announced interim antibody reduction data from the current international Phase 3 clinical trial of Riquent in a talk entitled: "Effect of Three Doses of Abetimus and Placebo on ds-DNA Antibodies in Patients with SLE and a History of Renal Flare -- An Interim Analysis."
In the talk, Dr. Tansey highlighted data supporting the dose response observed between the 100 mg, 300 mg and 900 mg doses of Riquent compared with placebo (p=0.0001). The reductions in median antibody levels between the Riquent treatment groups and the placebo treatment group at week 8 were 100 mg: 30%; 300 mg: 40%; 900 mg: 58% (p=0.0032, p<0.0001, p<0.0001, respectively). To date, the adverse event profile for all patients in the study, including those treated with the 300 mg and 900 mg doses, does not appear to differ from that seen in previous studies, where only 100 mg of Riquent was the treatment dose.
Riquent Drug Levels and Safety at Higher Doses
In addition to Dr. Tansey's talk, the Company presented two posters detailing data from previously completed clinical safety studies of Riquent. The first poster, "Safety and Pharmacokinetic Assessment of Abetimus Sodium in Healthy Volunteers," evaluated the safety, tolerability and pharmacokinetics of Riquent at doses up to 2400 mg in healthy male and female volunteers. Riquent was well tolerated at all doses. As seen with many DNA-containing drugs, Riquent treatment was associated with a dose-dependent increase in activated partial thromboplastin time (aPTT), but not prothrombin time (PT), which was not considered clinically significant.
Electrocardiographic Safety
The second poster presentation, "Electrocardiographic Safety Assessment of Abetimus Sodium in Healthy Volunteers," summarized cardiovascular safety assessments including the potential to increase QT wave prolongation following Riquent treatment at doses of 100 mg and 300 mg. Studies to evaluate the potential of a new drug to increase QT wave prolongation are standard safety assessments of most drugs in development. The data demonstrated no effect of abetimus on changes in QT wave prolongation from baseline. In this study, Riquent was well tolerated and the incidence of adverse events was similar in the placebo, 100 mg and 300 mg groups. In addition, patients exhibited no serious adverse events, and no subject discontinued the study.
About Riquent
Riquent is being developed to specifically treat lupus renal disease by preventing or delaying renal flares, a leading cause of sickness and death in lupus patients. Riquent has been well tolerated in all 13 clinical trials, with no serious Riquent-related side effects identified to date. Riquent's only known biological activity is the reduction of circulating levels of anti-dsDNA antibodies. Increases in these antibodies are associated with an increased risk of renal flare. Although clinical benefit has not yet been proven, Riquent treatment has significantly reduced these antibody levels in all clinical trials where they were measured.
About Lupus
Lupus is a chronic, potentially life-threatening autoimmune disease. About 90% of lupus patients are female, and many are diagnosed with the disease during their childbearing years. Approximately 50% of lupus patients have renal disease, which can lead to irreversible renal damage, renal failure and the need for dialysis, and is a leading cause of death in lupus patients. Latinos, African Americans and Asians face an increased risk of serious renal disease associated with lupus. The current standard of care for lupus renal disease often involves treatment with high doses of corticosteroids and immunosuppressive drugs that can cause severe side effects including diabetes, hypertension and sterility, and may leave patients vulnerable to opportunistic infections. To date, no lupus specific drug has been approved in the U.S.
About La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company is dedicated to improving and preserving human life by developing innovative pharmaceutical products. The Company's leading product in development is Riquent . The Company has also developed small molecules to treat various other autoimmune and inflammatory conditions. The Company's common stock is traded on The NASDAQ Global Market under the symbol LJPC. More information about the Company is available on its Web site: http://www.ljpc.com.
During morning trading shares are up 26.87% to $6.94 with over 2,165,000 in volume. The Exploration Investor Research Team will continue to gauge the short and long term affects that this announcement will have on the company.
Network Appliance, Inc.
24.05.07 16:18 Uhr
33,92 USD
-10,88 % [-4,14]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NTAP.NAS&lColors=0x000000&sSym=NTAP.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NTAP.NAS&lColors=0x000000&sSym=NTAP.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=NTAP.NAS&lColors=0x000000&sSym=NTAP.NAS&hcmask=
Börse
NASDAQ
Aktuell
33,92 USD
Zeit
24.05.07 16:18
Diff. Vortag
-10,88 %
Tages-Vol.
506,53 Mio.
Gehandelte Stück
19 Mio
Network Appliance Edging Off Pre-Bell Highs, Holding Pre-Market Support Mostly Above 31
Boston, May 24, 2007 (MidnightTrader via COMTEX) -- NTAP is edging back from a pre-market high of 31.85, trading in a still negative range surrounding 31.60. The stock has seen support above 31 for the bulk of this morning's trade.
Network Appliance Sees Revenue Downturn
May 24, 2007 (financialwire.net via COMTEX) -- May 24, 2007 (FinancialWire) Share of Network Appliance Inc (NASDAQ: NTAP) dove as much as 20% after the company predicted an unexpected revenue downturn.
The company, which makes data network storage gear, said that a slowdown in US technology spending had caused a 7% revenue decline from the fourth quarter of 2006. Net Appliances also scrapped its 2007 revenue growth estimates of 30% and said that it would update on a quarterly basis instead.
According to CEO Dan Warmenhoven the company was not confident that the US economy was back in a normal spending pattern yet.
Shares of Network Appliances dropped $7.40 to $31.66 in extended trading.
PacificNet Inc.
24.05.07 16:38 Uhr
5,63 USD
+43,14 % [+1,6968]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&&lSyms=PACT.NAS&lColors=0x000000&sSym=PACT.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=10d&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PACT.NAS&lColors=0x000000&sSym=PACT.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PACT.NAS&lColors=0x000000&sSym=PACT.NAS&hcmask=
Börse
NASDAQ
Aktuell
5,63 USD
Zeit
24.05.07 16:38
Diff. Vortag
+43,14 %
Tages-Vol.
5,51 Mio.
Gehandelte Stück
1,1 Mio
Small Cap News: Morning Alert for Pacificnet Inc
May 24, 2007 (M2 PRESSWIRE via COMTEX) -- Morning Alert for Pacificnet Inc (NASDAQ: PACT)
PacificNet, Inc., through its subsidiaries, provides outsourcing, telecom value-added, and telecom and gaming services in the People's Republic of China, Hong Kong, Macau, and Taiwan. It operates in three segments: Outsourcing Services, Telecom Value-Added Services, and Products. The Outsourcing Services provides business process outsourcing services, such as call centers, and CRM and telemarketing services; and information technology outsourcing, including software programming and development services. The Telecom Value-Added Services segment offers content, platform, and service providing telecom services comprising interactive voice response systems, call center management systems, and voice over Internet protocol; and mobile phone value-added services, such as short messaging services and multimedia messaging services. The Products segment provides telecom and gaming products distribution services, multimedia interactive self-service kiosk distribution, and online mobile phone distribution; and engages in the design, manufacture, and marketing of gaming machines, including Asian multi-player electronic gaming machines, as well as offers gaming related maintenance solutions to hotel, casino, and slot hall operators. It serves telecom operators, banks, insurance, travel, marketing, government, services companies, and telecom consumers. The company was founded in 1987 and is headquartered in Beijing, the People's Republic of China.
Shares were up 20% after reporting unaudited results for the first quarter.
ORBCOMM Inc.
25.05.07 16:40 Uhr
13,086 USD
+12,62 % [+1,466]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ORBC.NAS&lColors=0x000000&sSym=ORBC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ORBC.NAS&lColors=0x000000&sSym=ORBC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ORBC.NAS&lColors=0x000000&sSym=ORBC.NAS&hcmask=
Börse
NASDAQ
Aktuell
13,086 USD
Zeit
25.05.07 16:40
Diff. Vortag
+12,62 %
Tages-Vol.
14,52 Mio.
Gehandelte Stück
1,3 Mio.
ORBCOMM Announces Agreement with Major Wireless Carrier New Service Will Allow ORBCOMM To Offer Wireless Data Plans That Combine Satellite and Cellular Wireless Services Stellar Satellite Communications, MobiApps and Quake Global Set To Offer Dual-Mo
FORT LEE, N.J., May 16, 2007 (BUSINESS WIRE) -- ORBCOMM (Nasdaq: ORBC), announced today that it would begin offering terrestrial wireless services to complement its existing satellite-based wireless services. The addition of terrestrial wireless technologies will enable the company to expand its global M2M services and its leadership in this space. The company has entered into a formal agreement with one of the four largest wireless carriers in the United States. ORBCOMM will resell the carrier's wireless airtime services for M2M applications, allowing ORBCOMM to offer the industry's first blended airtime plans from a global M2M satellite carrier that incorporate both cellular and satellite data plans for one low price. The combined rate plans will be marketed by ORBCOMM to address a diverse range of applications that require ubiquitous coverage and high-data rate capability.
ORBCOMM's CEO, Jerome Eisenberg said, "The combination of ORBCOMM's satellite capabilities with this carrier's robust terrestrial capabilities creates a very compelling combination of coverage, performance and price." He continued, "This will create a first in our industry: satellite coverage and cellular capability from a single provider. Furthermore, ORBCOMM will bring this dual-mode service to market at prices that most people associate with single-mode services."
Devices that will take advantage of both networks are already available from several vendors, including Stellar Satellite Communications and MobiApps, with others in development. These "dual mode" devices will allow users to access both networks, selecting the appropriate network depending on the user's data messaging requirements.
About ORBCOMM
ORBCOMM is a global satellite data communications company that provides reliable, cost-effective data communications services to customers around the world through its unique low-earth orbit (LEO) satellite network and global ground infrastructure. A diverse customer base, including industry leaders General Electric, Caterpillar Inc., Volvo Group, XATA, Hitachi and Komatsu, uses ORBCOMM services to track, monitor and control mobile and fixed assets, including trucks, containers, marine vessels, locomotives, heavy machinery, pipelines, oil wells, utility meters and storage tanks anywhere in the world. For more information call 1-800-ORBCOMM or visit its website at www.orbcomm.com.
ARCHSTONE-SMITH TR
25.05.07 16:46 Uhr
55,23 USD
+8,02 % [+4,10]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ASN.NYS&lColors=0x000000&sSym=ASN.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ASN.NYS&lColors=0x000000&sSym=ASN.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ASN.NYS&lColors=0x000000&sSym=ASN.NYS&hcmask=
Börse
NYSE
Aktuell
55,23 USD
Zeit
25.05.07 16:46
Diff. Vortag
+8,02 %
Tages-Vol.
347,91 Mio.
Gehandelte Stück
6,5 Mio
ANALYSIS: Camden Property Trust Upgraded
May 16, 2007 (M2 PRESSWIRE via COMTEX) -- Stifel Nicolaus upgraded real estate investment trusts, Archstone-Smith Trust, BRE Properties Inc. Camden Property Trust and AvalonBay Communities Inc., to "buy" from "hold".
The brokerage said Tuesday May 15, 2007 it expects these companies, which have large development pipelines, to outperform over the next few years, due to value creation and external growth drivers.
Stifel set a price target of $145 on AvalonBay Communities, $62 on Archstone-Smith, $72 on BRE Properties and $84 on Camden Property, it said in its research note.
Sterling Financial Corporation
25.05.07 17:01 Uhr
10,44 USD
-35,40 % [-5,72]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SLFI.NAS&lColors=0x000000&sSym=SLFI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SLFI.NAS&lColors=0x000000&sSym=SLFI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SLFI.NAS&lColors=0x000000&sSym=SLFI.NAS&hcmask=
Börse
NASDAQ
Aktuell
10,44 USD
Zeit
25.05.07 17:01
Diff. Vortag
-35,40 %
Tages-Vol.
13,23 Mio.
Gehandelte Stück
1,3 Mio.
Sterling Financial of Lancaster, PA Announces Initial Investigation Findings; Significant, Sophisticated Loan Scheme Uncovered
LANCASTER, Pa., May 24, 2007 /PRNewswire-FirstCall via COMTEX/ -- Sterling Financial Corporation of Lancaster, PA (Nasdaq: SLFI) announced today, based on information from a still ongoing investigation, that previously reported irregularities in certain financing contracts in one of Sterling's financial services affiliates, Equipment Finance LLC (EFI), are a direct result of collusion by a group of EFI employees. Sterling is committing all necessary resources to complete the investigation in a thorough, timely and professional manner and to take all necessary corrective steps.
Sterling's investigation to date has revealed evidence of a sophisticated loan scheme, orchestrated deliberately by certain EFI officers and employees over an extended period of time, to conceal credit delinquencies, falsify financing contracts and related documents, and subvert Sterling's established internal controls and reporting systems. The scheme was able to avoid detection until recently due to the depth and breadth of the collusion. In other words, employees at different seniority levels and functional areas were apparently involved.
These deceptive activities were limited to EFI and no customer accounts in Sterling's banks or other affiliates were involved.
The Board of Directors, upon the recommendation of management through the Disclosure Committee, and with the concurrence of the Audit Committee, concluded on May 23 that Sterling will be required to record, under U.S. generally accepted accounting principles, a material impairment of certain assets of EFI. These assets include EFI financing contracts, interest associated with those contracts, and potentially goodwill attributable to EFI. While Sterling has not determined the annual periods in which the impairment occurred, Sterling currently expects to record a cumulative after-tax charge to the December 31, 2006 financial statements of approximately $145 million to $165 million, based upon the results of the investigation's preliminary findings. However, at this point in the investigation, Sterling has not determined the final financial impact, including any potential recoveries, such as insurance and collateral.
Sterling is working closely with its regulators and all appropriate federal authorities on the ongoing investigation.
"Our investigation has now revealed evidence that Sterling and its shareholders were subjected to a significant, sophisticated loan scheme, specifically designed to deceive and avoid detection," said J. Roger Moyer, Jr., president and chief executive officer of Sterling Financial Corporation. "Our priority now is to address the problem and continue serving our customers. Decisive actions have been taken to reinforce oversight and centralize operational management at EFI."
As a result of our investigation, Sterling implemented immediate changes in EFI's management structure. Five EFI employees have now been terminated, including the Chief Operating Officer and Executive Vice President, and Sterling installed an acting Chief Operating Officer. Further, a special collections team has been deployed to maximize recoveries from the impaired contracts.
Sterling moved to centralize management and control of financial, credit and information systems previously managed by EFI. In addition, the Promontory Financial Group, an international financial and regulatory consulting firm with world class expertise in bank control mechanisms, headed by former Comptroller of the Currency Eugene Ludwig, has been engaged to evaluate controls across all of Sterling and make recommendations.
AVAYA INC
29.05.07 16:15 Uhr
15,599 USD
+14,11 % [+1,929]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AV.NYS&lColors=0x000000&sSym=AV.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AV.NYS&lColors=0x000000&sSym=AV.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AV.NYS&lColors=0x000000&sSym=AV.NYS&hcmask=
Börse
NYSE
Aktuell
15,599 USD
Zeit
29.05.07 16:15
Diff. Vortag
+14,11 %
Tages-Vol.
148,07 Mio.
Gehandelte Stück
14 Mio
Der Netzwerker Avaya verbessert sich im frühen Handel um 4 Prozent, nachdem sich um den Konzern Übernahmegerüchte ranken. Das Wall Street Journal und die New York Times berichten, dass sowohl private Investoren interessiert sind als auch Nortel Networks, der direkte Konkurrent von Lucent, der Avaya einst ausgegliedert hat.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=EYE.NYS&lColors=0x000000&sSym=EYE.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=EYE.NYS&lColors=0x000000&sSym=EYE.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=EYE.NYS&lColors=0x000000&sSym=EYE.NYS&hcmask=
About Advanced Medical Optics (AMO)
AMO develops advanced, life-improving vision technologies for people of all ages. Products in the cataract/implant line include intraocular lenses (IOLs), phacoemulsification systems, viscoelastics, and related products used in ocular surgery. AMO owns or has the rights to such product brands as ReZoom(R), Tecnis(R), Clariflex(R), Sensar(R), and Verisyse(R) IOLs, Sovereign(R) , Sovereign(R) Compact and WhiteStar Signature(TM) phacoemulsification systems with WhiteStar(R) technology, Healon(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the laser vision correction line include wavefront diagnostic devices, femtosecond lasers and associated patient interface devices, and excimer laser vision correction systems and treatment cards. AMO brands in the laser vision correction business include Star S4 IR(R), WaveScan Wavefront(R), CustomVue(R), IntraLase(R) FS, IntraLase Method(TM) and IntraLasik(R). Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE Moisture PLUS(R), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(TM) and blink(TM) branded products. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Website at www.amo-inc.com
Sexy Rock'n'Roll Spekulation
2007-05-30 08:31:00
Wie man mit der Liebe zur Musik zwischendurch an der Börse spekulieren kann
http://www.be24.at/media/BElogs/Entries/image/6182/scalex/80
Fast jeder weiss, dass Apple iTunes dem Apple (AAPL) Unternehmen durch den iPod neues Leben verleiht hat. Aber in der Musikbranche gibt es auch einige nicht so bekannte Aussenseiter, die Milliarden umsetzen und unter Umständen irgendwann einmal aus ihrem Dornröschenschlaft erweckt werden.
Interessant ist, dass wir eine Art Vision für Guitar Center, Inc.(GTRC) vorige Woche hatten, und sogleich einen Bericht darüber vorebereitet haben, doch dann schlussendlich nicht veröffentlichten da wir am Wochenende drei andere Berichte publizierten. Wie es sich eben öfters so ergibt, ist die Aktie plötzlich ohne irgendwelche News am 29. Mai 2007 Intraday um mehr als 12% nach oben geschnellt, Üblicherweise hat die Aktie wenig Handelsvolumen, und insgesamt ist es ein eher ödes Papier und belebt sich nur hin und wieder, sodass man eigentlich nichts darüber berichten will, da eine Investition in dieses Papier zu einer ewigen Warterei werden könnte.
Wenn man etwas tiefer gräbt und den Markt kennt, dann findet man heraus, dass Guitar Center, Inc. mit seinen etlichen Nebenfirmen und einem Jahresgesamtumsatz von mehr als US$ 2 Mrd. eines der grössten Musikinstrumentehandelskonzerne der Welt ist. Das Unternehmen hat nach und nach einen Konkurrenten nach dem anderen aufgekauft, und meist um sehr wenig Geld, da anscheinend der Musikinstrumentehandel viele Firmen in den letzten paar Jahren in die Pleite getrieben hat. Zudem ist das Business sehr fragmentiert, sodass wahrscheinlich nur 1 - 2 der grössten Unternehmen der Branche, nämlich vor allem Guitar Center, Inc. (GTRC) überleben wird und sich so praktisch eine Monopolstellung angeeignet hat.
Obwohl das Unternehmen mehr als US$ 2 Mrd. Jahresumsatz verbucht, bleiben unterm Strich nur ein paar Millionen übrig, d.h. die Brutto Margins von fast 30% reduzieren sich Netto gewaltig. Das könnte sich allerdings in den kommenden Jahren bzw. vielleicht schon im jetzigen Jahr 2007 und dann auch 2008 gewaltig ändern, was vor allem auf die Art Monopolstellung des Unternehmens zurückzuführen ist. Da das Unternehmen durch ein ausgeweitetes Netz von Affiliate Websites Millionen von Kunden betreut, könnten auch die Private Equity Firmen an diesem dominierenden Unternehmen der Branche demnächst Interesse zeigen, ... derzeit eine reine Spekulation (!!!), ... doch es wäre eine Möglichkeit da Private Equity Firmen sich immer die Top Firmen einer Branche aussuchen. Zudem ist Guitar Center (GTRC) im Umsatz-/Market Cap Verhältnis sehr günstig, und Guitar Center hat neben etlichen Websites und dem Kataloggeschäft auch eine grosse Anzahl riesiger Musikgeschäfte kreuz und quer in den USA. Das P/E ist natürlich extrem hoch und uninteressant, doch wenn ein Management Team mit Streamlining und Effizienzschwerpunkten eingesetzt wird, könnte das Unternehmen ziemlich rasch zu einer Cash Cow werden. Und wie bekannt, sind Private Equity Firmen auf die Kunst des Streamlining spezialisiert. Zudem sind die unterliegenden Immobilienwerte der Stores sicherlich auch sehr interessant, da Eddy Lambert (SHLD) z.B. die Kaufhausketten Sears und K-Mart grundsätzlich nur wegen derer Immobilienbesitze in den letzten paar Jahren erworben hatte.
An dieser Stelle sei auch zu erwähnen mit leicht unterschweliger Werbeabsicht, dass Cascada Corporation mit seinen Websites wie z.B. scherf.com und ShopGuitars.com, etc. ebenfalls ein Affiliate einer Tochter der GTRC ist, und es ist eines unserer besten Cash Geschäfte, das seit Jahren laufend jährlich expandierte. Mit einem Angebot von über 150.000 Musikinstrumenten und Accessories sind wir mit scherf.com vor allem auf den Musikinstrumenteexport von den USA aus spezialisiert. Allein bei Gitarren offerieren wir mehr als 100 Marken und insgesamt viele tausende Gitarren die versandbereit auf Lager verfügbar sind.Mehr scherf.com Information über Musikinstrumente gibt es unter:
AKTIENSPEKULATION BEI GUITAR CENTER (GTRC):
Wie erwähnt ist Guitar Center (GTRC) ein möglicher Takeover/Buyout Kanditat, da das Unternehmen durch den Kauf fast aller seiner grossen Konkurrenten nun eine Art Monopolstellung in den USA innehält, sowie vom Market Cap relativ günstig ist. Sollte sich eine Private Equity Firma für GTRC interessieren, z.B. durch ein Taking Private oder dgl., dann könnte der Aktienkurs von derzeit knapp über US$ 52,- auf ca. US$ 70,- bis US$ 75,- je Aktie gehen, ... vielleicht auch höher. Sollte sich jedoch nichts in dieser Sache ergeben, dann kann man nur hoffen, dass das Unternehmen beginnt kräftige Nettogewinne zu schreiben, was durchaus möglich ist, und dann dauert die Sache wesentlich länger.
Wie vorhin erwähnt ist die Aktie von ca. US$ 47,- Intraday am Dienstag, 29. Mai bei einem Handelsvolumen von ca. 2,2 Mio. Aktien auf über US$ 53,- gesprungen, was ausserordentlich ist, insbesondere da es keine News gab, und es gab eine gute Tradingmöglichkeit in diesem Papier. Man muss wissen, dass diese Aktie generell eher als eine lahme Ente zu betrachten ist und wenn die Action wieder aus dem Papier ist, sich oft nicht viel darin abspielt und das Handelsvolumen auf ein Minimum versickert. Man kann sich allerdings oft mit kostengünstigen Put Optionen absichern, sodass zumindest ein gewisses Hedging möglich ist. Needless to say, die Call Optionen haben sich natürlich am 29. Mai kräftig vervielfacht.
http://www.be24.at/media/BElogs/Medias/photo/2648/scalex/600
Das Geschäft mit Gitarren blüht! Hier ist die limitierte FENDER Masterbuilt Crash Stratocaster Electric Guitar
30.05.2007 15:11
Wall Street Vorbörse: Top-News auf einen Blick
New York (BoerseGo.de) - Apple steigt vorbörslich um 0,5% nachdem Morgan Stanley das Kursziel von 110 auf 150 Dollar angehoben hat
Borders Group weist einen Verlust von 51 cents je Aktie aus gg. einem erwarteten Verlust von 38 cents je Aktie
CDW wird von Madison Dearborn Partners für 87,75 Dollar in bar übernommen
Coldwater Creek gewinnt nach Übertreffen der Gewinnprognosen vorbörslich 10%
IntercontinentalExchange und CBOE bestätigten ein Abkommen das der CBOE im Rahmen eines geplanten Zusammenschlusses zwischen ICE und Chicago Board of Trade die Ausübung von Rechten gewährt.
Microsoft hat einen mit „Surface“ bezeichneten neuen Berührungsbildschirm eingeführt
Smithfield Foods verlieren nach einer Gewinnwarnung vorbörslich um 5%
William Sonoma verdient 16 cents je Aktie gg. erwarteten 13 cents je Aktie
Pulte Homes will die Belegschaft um 16% reduzieren
Biogen Idec kündigt einen Rückkauf von Aktien von 3 Milliarden Dollar an
Wall Street News Alert: Investment Watch: HMSO! May 30, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, May 30, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Hemis Corporation (OTCBB: HMSO),
Compania de Minas Buenaventura (NYSE: BVN),
Hecla Mining Company (NYSE: HL) and
Harmony Gold Mining Co. Ltd (NYSE: HMY).
There is more exciting news out of Hemis Corporation (OTCBB: HMSO) for investors. The company, an international resource company with several advanced stage exploration properties in Mexico and a project in Cook Inlet, Alaska, has issued a press release announcing that it has entered into an agreement to acquire Aspen Exploration Corporation's Anchor Point gold project in the Cook Inlet area of Alaska, which includes all of Aspen's interests in maps, aeromagnetic surveys and geological information developed by Aspen in the Cook Inlet as well as rights to Offshore Prospecting Permit (OPP) applications.
This could be great news! Under the terms of the agreement, Aspen was paid $50,000 at signing and will be paid this amount on each anniversary of the agreement in order to maintain Hemis' interest in the project. Aspen is entitled to a 5% production royalty, which may be taken in kind or in cash as Aspen prefers.
Aspen geologists, led by R. V. Bailey, Chairman of Aspen's board, carried out exploration for gold in Alaska in the 1980s. Activities at Anchor Point included flying an aeromagnetic survey, beach sampling and the filing of OPPs with the State of Alaska. Uncertainties in the permitting process and a declining price of gold resulted in Aspen putting the project on hold.
Wall Street News Alert first initiated coverage of the company on March 29th, when it announced that it has signed an Earn-In agreement with Goldcorp Inc. through its Mexican subsidiary Glamis Exploration S.A. de C.V ("Goldcorp") and Corex Gold Corp. Goldcorp is the world's second largest gold company.
Wall Street News Alert is continuing to place Aggressive Investors on alert to monitor the progress of Hemis Corp! Dr. Douglas Oliver, Chief Geologist for Hemis, explains the rationale for exploration at Anchor Point: 'Gold has been known from the beaches around Cook Inlet for over a century. The gold is often associated with the mineral magnetite, which can be identified by geophysical surveys. Our review of the existing aeromag data suggests that the potential exists for off-shore gold deposits in the Anchor Point area.'
Dr. Oliver acknowledges that working in Cook Inlet, which has some of Earth's highest tides, will present some logistical challenges. However, he states that it also has some advantages: 'In Alaska you are always fighting the lack of infrastructure. However, Cook Inlet is located close to the main population center and the offshore nature of this project eliminates the need to build roads. The accessibility of this project was a key factor in our decision to pursue this.'
The stock closed Tuesday at Ninety-Five cents a share.
In case you are not familiar with the company: Hemis Corporation is a precious metals exploration company trading on the OTCBB under the symbol HMSO and listed on the Frankfurt stock exchange under the symbol XZA. The company is comprised of both a resource division and a resource investment unit. Hemis' high profile team is focused on evaluating gold projects with strong potential. The resource investment unit is actively reviewing other natural resource companies for joint ventures and investment.
Hemis is incorporated in Nevada, USA with its head office in Zurich, Switzerland and North American corporate communications representatives in Canada and the United States. Led by an experienced team of exploration geologists and financial professionals, this company has extensive international capital markets experience and proven track records.
Compania de Minas Buenaventura (NYSE: BVN) down 0.8% on 435,000 shares traded. Buenaventura currently operates three mines in Peru and also has controlling interests in four mining companies as well as a minority interest in several other mining companies in Peru. The Company owns 43.65% in Minera Yanacocha S.R.L. (a partnership with Newmont Mining Corporation) and is one of the most important precious metal producers in the world.
Hecla Mining Company (NYSE: HL) down 0.3% on 2 million shares traded. Hecla Mining Company, headquartered in Coeur d'Alene, Idaho, mines, processes and explores for silver and gold in the United States, Venezuela and Mexico. A 116-year-old company, Hecla has long been well known in the mining world and financial markets as a quality silver and gold producer.
Harmony Gold Mining Co. Ltd (NYSE: HMY) down 1% on 1 million shares traded. Harmony Gold Mining Company Limited engages in the exploration, processing, smelting, refining, and beneficiation of gold in South Africa, Australia, and Papua New Guinea.
Market Commentary:
"Crude futures fell sharply after the holiday weekend. Oil was off by $1.77 or $63.43, as news of Nigerian oil workers calling off a strike and, 'surprise surprise,' as Gomer Pyle would say, three refineries in the Gulf Coast are coming back online," stated Sonja Rudd
BUYINS.NET: PACT, MOBL, TYRIA, RGDE, STNL Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days
May 30, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold list for 13 consecutive trading days:
PacificNet Inc. (NASDAQ: PACT),
MobilePro Corp (OTCBB: MOBL),
Trey Resources Inc (OTCBB: TYRIA),
Renegade Energy Corp. (OTC: RGDE),
Solution Technology International, Inc. (OTC: STNL).
Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer's total shares outstanding. Regulation SHO mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.
PacificNet Inc. (NASDAQ: PACT) through its subsidiaries, provides outsourcing, telecom value-added, and telecom and gaming services in the People's Republic of China, Hong Kong, Macau, and Taiwan. It operates in three segments: Outsourcing Services, Telecom Value-Added Services, and Products. The Outsourcing Services provides business process outsourcing services, such as call centers, and CRM and telemarketing services; and information technology outsourcing, including software programming and development services. The Telecom Value-Added Services segment offers content, platform, and service providing telecom services comprising interactive voice response systems, call center management systems, and voice over Internet protocol; and mobile phone value-added services, such as short messaging services and multimedia messaging services. The Products segment provides telecom and gaming products distribution services, multimedia interactive self-service kiosk distribution, and online mobile phone distribution; and engages in the design, manufacture, and marketing of gaming machines, including Asian multi-player electronic gaming machines, as well as offers gaming related maintenance solutions to hotel, casino, and slot hall operators. It serves telecom operators, banks, insurance, travel, marketing, government, services companies, and telecom consumers. The company was founded in 1987 and is headquartered in Beijing, the People's Republic of China. With 11.67 million shares outstanding and 973,700 shares declared short as of April 2007, the failure to deliver in shares of PACT has not been resolved and a buy-in is imminent.
MobilePro Corp (OTCBB: MOBL) together with its subsidiaries, operates as a broadband wireless, telecommunications, and integrated data communication services company in the United States. The company offers a suite of voice and data communications services, including local exchange, long distance, enhanced data, Internet, cellular, and wireless broadband services. It operates in three segments: Voice Services, Internet Services, and Wireless Networks. The Voice Services segment offers various telecommunications services, including local, long-distance, 1-800-CloseCall anytime/anywhere calling, digital wireless, voice over Internet protocol (VoIP), and dial-up and digital subscriber line Internet services. It also offers payphone services, including coin calls; noncoin calls, such as calling card, credit card, collect, and third-party billed calls; and dial-around calls. The Internet services segment provides broadband, dial-up, Web hosting and Web design services, co-location, VoIP, and other related Internet services to business and residential customers. The Wireless Networks segment deploys, owns, and manages a broadband wireless access network, which enables a range of free and fee-based services, and provides access to data, voice, and video. It also provides municipal services to the city's police, fire, emergency, and administrative personnel. Mobilepro markets and sells its communications services to residential and business customers through 11 offices in 8 states. As of March 31, 2006, the company served approximately 155,000 billed accounts representing approximately 270,000 equivalent subscriber lines, including 140,000 local and long-distance telephone lines, 62,000 dial-up lines, 6,000 broadband lines, 6,000 cellular lines, and 18,000 wireless broadband customers; and owned and operated approximately 34,800 payphones located in 44 states and the District of Columbia. Mobilepro was incorporated in 2000 and is based in Bethesda, Maryland. With 641.56 million shares outstanding and 128,000 shares declared short as of April 2007, the failure to deliver in shares of MOBL has not been resolved and a buy-in is imminent.
Trey Resources Inc. (OTCBB: TYRIA) operates as a business consultant, value-added reseller, and developer of financial accounting software to small and medium-sized businesses in the United States. The company also publishes its own proprietary electronic data interchange software, MAPADOC, which is used to automate existing processes. It resells accounting software to perform and support various functions related to accounting, including financial reporting, accounts payable and accounts receivable, and inventory management primarily focused on manufacturing and distribution industries; and warehouse management system software to control the movement and storage of materials within an operation, and process the associated transactions. The company also provides network maintenance and service upgrades, such as server implementation, support and assistance, operation and maintenance of large central systems, technical design of network infrastructure, technical troubleshooting for large scale problems, and network and server security, as well as backup, archiving, and storage of data from servers. In addition, Trey Resources offers value-added services, including programming, training, technical support, and other consulting and professional services. Further, it provides software customization, data migration, business consulting, and implementation assistance for complex design environments. The company was incorporated in 2002 as iVoice Acquisition 1, Inc. and changed its name to Trey Industries, Inc. in April 2003. Further, the company changed its name to Trey Resources, Inc. in September 2003. Trey Resources is headquartered in Livingston, New Jersey. With 223.35 million shares outstanding and 4,000 shares declared short as of April 2007, the failure to deliver in shares of TYRIA has not been resolved and a buy-in is imminent.
Renegade Energy Corp. (OTC: RGDE) is an oil and gas Company engaged in the exploration, development, acquisition, and production of high quality, producing oil and gas properties. As previously stated, Renegade Energy is committed to providing a current, detailed summary of the Company's core asset components. This information will be publicly disseminated over the coming weeks to provide the investment community with valuable insight needed to monitor the progress, development, production, and sale of crude oil and natural gas. With 99,000 shares outstanding and an undisclosed short position, the failure to deliver in shares of RGDE has not been resolved and a buy-in is possible.
Solution Technology International, Inc. (OTC: STNL) a software product company, engages in the design, development, marketing, and support of Web-based software solution used by insurance and reinsurance companies to facilitate and support critical back-office business processes. It offers SurSITE software that automates the reinsurance technical accounting workflow from the primary insurance policy to business that is reinsured, as well as supports a user's multiple divisions and branches. The company is also designing support for facultative reinsurance used to insure very large risks for multinational corporations, airlines and aerospace, cargo, energy, engineering, manufacturers, and ocean hull markets. In addition, it offers consulting services with complete requirements studies, data migration, data integration tools, system integration, and other related professional services. The company serves large insurance groups, captive insurance companies, reinsurance companies, insurance and reinsurance consortia, and run-off and commutation markets. It offers its software solution and services in North America, the Pacific Rim, China, Japan, and Africa. The company was founded in 1993 and is based in McHenry, Maryland. With 54.67 million shares outstanding and an undisclosed short position, the failure to deliver in shares of STNL has not been resolved and a buy-in is possible.
BUYINS.NET: WEESF, ADNW, FGBF, TWRAQ Have Also Been Removed From Naked Short List Today
May 30, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list:
Wavefront Energy and Environmental Services Inc. (OTC: WEESF),
Auto Data Network Inc. (OTC: ADNW),
1st Global Financial Corp. (OTC: FGBF),
Tower Automotive Inc. (OTC: TWRAQ).
Wavefront Energy and Environmental Services Inc. (OTC: WEESF) is a technology-based company with a focused, strategic plan to leverage the value of our intellectual property in order to maximize oil production recovery operations, as well as provide additional solutions for environmental applications. With 38.87 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of WEESF.
Auto Data Network Inc. (OTC: ADNW) is a group of established companies that provide software products and services to the automotive industry. The company's main customer base is the auto dealership marketplace. This marketplace consists of approximately 78,000 dealers in North America and 92,000 dealers in Europe. The company estimates that this represents a $15 billion market for software and services specifically for auto dealerships. With 30.69 million shares outstanding and 231,200 shares declared short as of April 2007, there is no longer a failure to deliver in shares of ADNW.
1st Global Financial Corp. (OTC: FGBF) offers a range of financial services to the business and consumer sectors in the United States. It offers stored-value debit cards that primarily include MasterCard branded debit cards, private label cards, and ATM cards for various organizations, churches, school groups, and fraternal organizations. The company also offers alternative financing for small to mid-size businesses to buy inventory, and additional or replacement equipment, as well as for advertising, payroll, remodeling, emergencies, and various working capital requirements. 1st Global Financial Corporation markets its products and services through its own sales and marketing subsidiary and by independent agents. The company was formerly known as McKinley Media, Inc. and changed its name to Global Debit Cash Card, Inc. in 2003. Subsequently, it changed its name to 1st Global Financial Corporation in 2006. The company is based in Las Vegas, Nevada. With 292.36 million shares outstanding and 1,100 shares declared short as of April 2007, there is no longer a failure to deliver in shares of FGBF.
Tower Automotive Inc. (OTC: TWRAQ) together with its subsidiaries, engages in the design, development, and production of vehicle structural components and assemblies used by the automotive original equipment manufacturers (OEM). Its products include body structures and assemblies, lower vehicle frames and structures, chassis modules and systems, and suspension components. The company's body structures and assemblies include large metal stampings, such as body pillars, roof rails, side sills, parcel shelves, and intrusion beams, as well as exposed sheet metal components, such as body sides, pick-up box sides, door panels, and fenders. It offers lower vehicle frames and structures comprising pickup truck and SUV full frames, automotive engine and rear suspension cradles, and floor pan components and cross members. The company's chassis modules and systems include axle assemblies consisting of stamped metal trailing axles, assembled brake shoes, hoses, and tie rods; and front and rear structural suspension modules/systems consisting of control arms, suspension links, value-added assemblies, and powertrain modules. Its suspension components include stamped, formed, and welded products, such as control arms, suspension links, track bars, spring and shock towers, and trailing axles. In addition, the company manufactures various other products, including heat shields and other precision stampings for OEM customers. It markets its products to OEMs directly by the sales and engineering teams primarily in the United States, Canada, Mexico, Germany, Belgium, Italy, Slovakia, Poland, France, Spain, Brazil, India, South Korea, Japan, and China. The company was founded in 1993 and is based in Novi, Michigan. Tower Automotive filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Court in February 2005. Tower Automotive operates its business as a debtors-in-possession. With 58.55 million shares outstanding and 37,300 shares declared short as of April 2007, there is no longer a failure to deliver in shares of TWRAQ.
30.05.2007 15:55
Aktien mit Eröffnungs-Gaps
Nachfolgend eine Auflistung einiger Aktien, die heute mit einem Gap Up eröffnet haben.
http://img.godmode-trader.de/charts/46/2005/gapup319.gif
Nachfolgend eine Auflistung einiger Aktien, die heute mit einem Gap Down eröffnet haben.
http://img.godmode-trader.de/charts/46/2005/gapdown319.gif
Novacea, Inc.
30.05.07 20:29 Uhr
13,32 USD
+65,26 % [+5,26]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NOVC.NAS&lColors=0x000000&sSym=NOVC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NOVC.NAS&lColors=0x000000&sSym=NOVC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=NOVC.NAS&lColors=0x000000&sSym=NOVC.NAS&hcmask=
Börse
NASDAQ
Aktuell
13,32 USD
Zeit
30.05.07 20:29
Diff. Vortag
+65,26 %
Tages-Vol.
224,18 Mio.
Gehandelte Stück
15 Mio.
EIExplorationInvestor: Novacea and Schering-Plough Enter Exclusive Worldwide Development and Commercialization Agreement for Asentar
May 30, 2007 (M2 PRESSWIRE via COMTEX) -- Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs. While working to keep you in touch with market activity, we also will keep you updated on the latest press. Today we have identified, Novacea, Inc. (NASDAQ: NOVC) due to the attention they received after this recent corporate developments.
Novacea, Inc. (NASDAQ: NOVC) and Schering-Plough Corporation (NYSE:SGP) today May 30th announced that they have entered into an exclusive worldwide license agreement for the development and commercialization of Asentar(TM) (DN-101). Novacea is currently conducting a large international Phase 3 trial (ASCENT-2) evaluating Asentar in 900 patients with androgen-independent prostate cancer (AIPC). Asentar is a novel, proprietary, high-dose oral formulation of calcitriol, a potent hormone that exerts its effects through the vitamin D receptor (VDR).
Under the terms of the agreement, Novacea will receive an upfront payment of $60 million, including $35 million as reimbursement for past research and development expenses, a license fee of $25 million, as well as a commitment by Schering-Plough to purchase $12 million of Novacea common stock at a predetermined price within ten days of the closing. Additionally, the agreement provides Novacea with potential pre-commercial milestone payments of up to $380 million, and tiered royalties on worldwide sales of Asentar. Closing of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act (HSR) and is anticipated to occur following HSR clearance.
Schering-Plough will be responsible for all forward development costs in exploring indications for earlier stages of prostate cancer, such as androgen-dependent prostate cancer (ADPC) and adjuvant therapy and will lead all global commercialization efforts for Asentar. Novacea will provide medical support to Schering-Plough's commercial operations for Asentar in the United States, including deployment of their Medical Science Liaisons, which will be funded by Schering-Plough.
"A corporate partnership has been a significant corporate goal for 2007, and we are proud to be co-developing Asentar with a highly-respected pharmaceutical company such as Schering-Plough. The partnership leverages Novacea's existing capabilities with Schering-Plough's experienced development, regulatory and commercial teams and will provide Novacea with an opportunity to support the commercialization of Asentar in the United States. Additionally, this agreement provides us with substantial funding for the continued development of our operations," said John P. Walker, Novacea's chairman and interim chief executive officer.
"This agreement with Novacea allows us the potential opportunity to extend our oncology pipeline into a tumor with significant unmet need," said Thomas P. Koestler, Ph.D. executive vice president and president of Schering-Plough Research Institute. "Asentar represents an innovative research development and reinforces our continual commitment to patients."
About Asentar
Asentar is currently being developed as an oral treatment in combination with Taxotere (docetaxel) for the treatment of AIPC. Prostate cancer is the second leading cause of cancer death in men with approximately 232,000 new cases and 30,000 deaths in the U.S. in 2005. AIPC is an advanced disease state of prostate cancer. Based on results of Novacea's completed Phase 2 clinical trial, known as ASCENT, the use of weekly Asentar in combination with weekly Taxotere may provide AIPC patients with an innovative cancer therapy that may prolong survival with the potential in reducing some of the toxicities and complications normally associated with chemotherapy. Novacea is now evaluating the benefits of Asentar in a 900-patient Phase 3 trial, known as ASCENT-2, which uses overall survival as the primary endpoint and compares weekly Asentar plus Taxotere to the current standard of care in the treatment of AIPC.
About Schering-Plough
Schering-Plough Corporation is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 33,500 people around the world. The company's Web site is www.scheringplough.com.
About Novacea
Novacea, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing novel cancer therapies. Novacea has two product candidates in clinical trials, including Asentar(TM), which currently is in a Phase 3 clinical trial for androgen-independent prostate cancer, or AIPC. Novacea's second product candidate, AQ4N, is a hypoxia-activated prodrug that is currently in a Phase 1b/2a clinical trial in glioblastoma multiforme. More information on any of Novacea's trials can be found at www.ClinicalTrials.gov.
During morning trading shares are up 98% to $15.93 with over 2,181,000 in volume. The Exploration Investor Research Team will continue to gauge the short and long term affects that this announcement will have on the company.
Coldwater Creek, Inc.
30.05.07 20:36 Uhr
24,45 USD
+16,99 % [+3,55]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CWTR.NAS&lColors=0x000000&sSym=CWTR.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CWTR.NAS&lColors=0x000000&sSym=CWTR.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CWTR.NAS&lColors=0x000000&sSym=CWTR.NAS&hcmask=
Börse
NASDAQ
Aktuell
24,45 USD
Zeit
30.05.07 20:36
Diff. Vortag
+16,99 %
Tages-Vol.
300,28 Mio.
Gehandelte Stück
13 Mio.
Coldwater Creek reports 4% rise in quarterly income
May 30, 2007 (The Idaho Statesman - McClatchy-Tribune Information Services via COMTEX) -- Coldwater Creek Inc. said its net income rose 4 percent to $12 million, or 13 cents a share, for the three-month period ended May 5.
This compares with net income of $11.6 million, or $0.12 per share, for the same period in 2006, the Sandpoint-based company said Tuesday.
Net sales increased 30.7 percent to $281.3 million, from $215.3 million in the fiscal 2006 first quarter.
Comparable store sales increased 7.3 percent for the three-month period, compared with a 9.6 percent increase in the prior-year period.
"The net sales and earnings performance for the first quarter was a result of solid response to our spring merchandise in combination with effective cost-control measures," said Dennis Pence, chairman and chief executive officer for Coldwater Creek.
Pence said the company added new stores and gained additional market share despite challenges affecting the women's specialty apparel sector.
Sales in stores, from direct sales and over the Internet rose, while catalog sales declined.
Solarfun Power Holdings Co., Ltd.
30.05.07 20:43 Uhr
10,024 USD
-19,29 % [-2,396]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SOLF.NAS&lColors=0x000000&sSym=SOLF.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SOLF.NAS&lColors=0x000000&sSym=SOLF.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SOLF.NAS&lColors=0x000000&sSym=SOLF.NAS&hcmask=
Börse
NASDAQ
Aktuell
10,024 USD
Zeit
30.05.07 20:43
Diff. Vortag
-19,29 %
Tages-Vol.
29,00 Mio.
Gehandelte Stück
3,1 Mio.
Solarfun Reports First Quarter 2007 Results
SHANGHAI, China, May 30, 2007 (BUSINESS WIRE) -- Solarfun Power Holdings Co., Ltd. (NASDAQ: SOLF), an established manufacturer of both photovoltaic (PV) cells and modules in China, today reported its financial results for the quarter ended March 31, 2007.
First Quarter 2007:
-- Net revenue for the first quarter of 2007 were RMB190.7 million (US$24.7 million), compared to RMB102.5 million (US$13.3 million) for the first quarter of 2006, and RMB244.7 million (US$31.7 million) in the fourth quarter of 2006.
-- Gross profit for the first quarter of 2007 was RMB32.8 million (US$4.2 million).
-- Net loss attributable to ordinary shareholders for the first quarter of 2007 was RMB2.5 million (US$0.3 million), while there was net income attributable to ordinary shareholders of RMB33.1 million (US$4.3 million) for the first quarter of 2006, and net income attributable to ordinary shareholders of RMB29.5 million (US$3.8 million) for the fourth quarter of 2006.
-- A loss of RMB0.053 per basic ADS (US$0.007 per basic ADS) in the first quarter of 2007.
-- Net PV module shipments totaled 6.5MW, up from 2.9MW in the first quarter of 2006 and down from 7.8MW in the fourth quarter of 2006
Mr. Yonghua Lu, Chairman and CEO of Solarfun, commented, "As we forewarned in our last earnings release, the first quarter turned out to be a challenging one for our company, but we are fully confident in our ongoing strategy. Market conditions in Europe were increasingly competitive in the first few months of the year. In addition to typical seasonal weakness in the first quarter, as a result of delayed solar subsidy legislation in Spain and Italy, we saw an inventory build-up among some of our end customers in those two countries, which resulted in unexecuted sales orders from those customers. At the same time, we worked to diversify our customer base in other markets. By recognizing the challenge early on, we started to expand and strengthen our international team. For example, we recently hired two senior-level executives who we believe to be the right personnel to help us improved our international sales, marketing and purchasing activities. Both have significant international sales experience, one in the PV industry and the other in the semiconductor industry, and their primary objective will be to build our presence in the European and U.S. markets.
We have also been able to make other improvements in our business operations, such as enhancing our productivity, improving our component sourcing and upgrading our credit risk management.
Our capacity expansion plans remain on track and we believe we are favorably positioned in terms of silicon supply for the remainder of the year. Additionally, in the past month, all of our current module products were approved by the California Energy Commission to be eligible for the state's solar rebate program. With this, and new incentives set to be unveiled in Spain, we believe we are well positioned for the strong growth that we foresee in the market towards the end of the year."
First Quarter 2007 Financial Results
Solarfun's total net revenue for the first quarter of 2007 increased 86.1% to RMB190.7 million (US$24.7 million) from RMB102.5 million in the first quarter of 2006, and decreased 22.0% from RMB244.7 million in the fourth quarter of 2006. The sequential decline was primarily due to a decrease in shipments and a decline in average selling price ("ASP") from the fourth quarter of last year. Total net PV module shipments and ASP were 6.5MW and US$3.77 per watt in the first quarter of 2007 compared to 7.8MW and US$3.96 per watt in the fourth quarter of 2006 and 2.9MW and US$3.98 per watt in the first quarter of 2006. During the first quarter, Solarfun derived almost all of its total net revenue from the sale of PV modules.
Gross profit for the first quarter of 2007 was RMB32.8 million (US$4.2 million), representing a decrease of 8.4% from RMB35.8 million from the first quarter of 2006 and a decrease of 50.0% from RMB65.6 million in the fourth quarter of 2006. The gross margin decreased to 17.2% from 34.9% in the first quarter of 2006 and 26.8% in the fourth quarter of 2006. The sequential decrease was largely attributable to the decrease in ASP and also the higher costs of non-silicon module materials in the first quarter of 2007.
Income from operations for the first quarter of 2007 was RMB4.3 million (US$0.6 million), or 2.2% of total net revenue, which compares with RMB35.3 million, or 14.4% of total net revenue in the fourth quarter of 2006, and RMB32.3 million, or 31.5% of total net revenue in the first quarter of 2006. The year-over-year increase was primarily due to higher operating costs to support the growth of the business. The sequential decrease in operating margin was mainly due to the decrease in gross profit and relatively constant total operating costs.
Share-based compensation expenses for the first quarter of 2007 totaled RMB 8.4 million (US$1.1 million), compared to RMB2.9 million in the fourth quarter of 2006. There were no share-based compensation expenses in the first quarter of 2006.
Net loss attributable to ordinary shareholders for the first quarter of 2007 was RMB2.5 million (US$0.3 million), representing a decrease of 107.6% from net income attributable to ordinary shareholders of RMB33.1 million in the first quarter of 2006 and a decrease of 107.7% from net income attributable to ordinary shareholders of RMB29.5 million in the fourth quarter of 2006. Basic loss per ADS for the first quarter of 2007 was RMB0.053, or US$0.007 per ADS.
Business Outlook for 2007
Based on current operating and other conditions, Solarfun revises its previous annual estimates for the full 2007 fiscal year. The new guidance is as follows:
-- Net revenue of US$250 million to US$270 million, representing year-over-year growth of 209% to 234%.
-- PV product shipments of 70 to 80 MW, representing year-over-year growth of 210% to 254%.
-- Annualized total PV cell production capacity of 240MW by the end of 2007 (unchanged from prior guidance).
30.05.2007 22:11
Investor rät Bancroft-Familie zum Verkauf
New York (BoerseGo.de) - Der Vorstandschef des Vermögensmanagementunternehmens, T. Rowe Price, Brian Rogers, hat der Bancroft- Familie geraten, das Kaufangebot der News Corp für den Verlag Dow Jones&Co. anzunehmen. T. Rowe Price ist nach der Bancroft- Familie, die ungefähr zwei Drittel der umlaufenden Aktien besitzt, einer der größten Anteilseigner von Dow Jones. Rogers sagte zur Begründung seines öffentlichen Ratschlags, er könne sich nicht vorstellen, dass es aus seiner momentanen Sicht möglich ist, dass die Familie selbst durch Umstrukturierungen des Unternehmens einen Anteilspreis von 60 Dollar erreicht.
Murdoch hatte diesen Preis sowie einen zusätzlichen Aufsichtsratssitz für die Bancroft-Familie bei News Corp geboten, falls die Übernahme akzeptiert werde.
Dow Jones&Co. steigen heute um 2,2 Prozent auf 52,99 Dollar nach, News Corp gewinnen 0,8 Prozent auf 23,92 Dollar hinzu.
Wall Street News Alert: UCPI Is Thursday's Stock to Watch! May 31, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, May 31, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Unicorp Inc. (OTCBB: UCPI),
Halliburton (NYSE: HAL),
Williams (NYSE: WMB) and Index Oil and Gas, Inc. (OTCBB: IXOG)
Unicorp Inc. (OTCBB: UCPI) is apparently about to release great news for its investors! Wednesday after the markets closed, the company (engaged in the acquisition, development, exploration and production of crude oil and natural gas) issued a press release announcing that it expects to complete the acquisition of a producing field located in South Louisiana with current production of 40-45 barrels of oil per day and potential gross production of 200 barrels of oil per day.
This should be news to investor's ears. According to the press release, this field has a total of fifteen wells of which two are currently producing oil, two are saltwater injection wells and eleven are work-over opportunities. Unicorp will have a 100% working interest in this field.
UCPI has been in the news quite a bit lately. On May 23rd, the company announced that its East Texas prospect located in Henderson County, Texas has been successfully logged which has indicated multiple productive zones for testing. The electric log has identified up to four formations that could be productive. This prospect has the potential for seven additional wells and potential gross reserves of 1,000,000 barrels of oil and 4 Bcf of gas. Unicorp has an approximate 21% before payout working interest and approximate 16% after payout working interest in this prospect.
On May 21st, the company announced that it has entered into a stock purchase agreement with Cornell Capital Partners, LP providing a loan to the company of up to $7,000,000.
On May 16th, UCPI announced really big news! It's South Creole Prospect located in Cameron Parish, Louisiana is now online and currently producing at a rate of approximately 2.8 Mmcf per day of gross gas production and 58 barrels of condensate. This was very big news! According to the press release, at this rate, this well will double Unicorp's existing monthly revenue to over $250,000 and brings the company to profitability, excluding non-cash charges.
Last month, the company announced that it has elected to participate in the Catfish Prospect with potential gross reserves of 2,500,000 barrels of oil.
Market Advisors, Inc. issued a price target of $1.05 for Unicorp shares. The report cited the recent 280% increase in 2006 revenues and the company's exploration and acquisition strategy as a main factor for their report.
Wall Street News Alert has continuously updated investors as to UCPI's prospects, and is continuing to alert investors to monitor the progress of the company. Unlike most "prospecting companies," Unicorp actually has oil-producing wells. The Walley Estate #1 has been producing an average of approximately 85 barrels of oil per day and has produced hundreds of thousands of dollars in gross oil revenue since first production in November 2006. Unicorp has a 60% working interest and a 47.55% net revenue interest in this prospect. The company has been doing its best to tell investors about the company's bright future. Near the end of last year, the company announced that it expected to triple its gross profit in fiscal 2007! This was huge news! Keep watching this company. It could be only a matter of time before the company strikes it big!
Before the news hit the wires, Unicorp's stock closed Wednesday at Thirty Six cents a share.
In case you are not familiar with the company: Unicorp, Inc. is primarily engaged in the acquisition, development, exploration and production of crude oil and natural gas. Its focus is on aggressively acquiring working interests in crude oil and natural gas properties with the intent of exploration and development or by enhancing production through the use of modern development techniques such as horizontal drilling, satellite technology and 3-D seismic. The company's goal is to achieve a high return on its investment by limiting its up-front acquisition costs, by quickly developing its acquisitions and by practicing a sound and smart approach to oil and gas exploration and development.
Halliburton (NYSE: HAL) up 1.1% on 19.9 million shares traded. Halliburton is one of the world's largest providers of products and services to the energy industry. With more than 45,000 employees in nearly 70 countries, the company serves the upstream oil and gas industry throughout the life cycle of the reservoir -- from locating hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completion, and optimizing production through the life of the field.
Williams (NYSE: WMB) up 3.1% on 6.7 million shares traded. Williams, through its subsidiaries, primarily finds, produces, gathers, processes and transports natural gas. Williams' operations are concentrated in the Pacific Northwest, Rocky Mountains, Gulf Coast, Southern California and Eastern Seaboard.
Index Oil and Gas, Inc. (OTCBB: IXOG) up 2.6% on 577,000 shares traded Index is a gas biased oil and gas exploration and production company, with activities in Kansas, Texas, Louisiana, Mississippi and Alabama.
Market Commentary:
"Early news of the 6.5% drop in the Shanghai Composite because of a large tax hike did not hurt the U.S. indexes, although many overseas Bourses did not take the news as well as the NYSE," stated Sonja Rudd
31.05.2007 15:11
Wall Street Vorbörse: Top-News auf einen Blick
New York (BoerseGo.de) - A.G. Edwards erhält von Wachovia ein Angebot zum Aufkauf für 89,50 Dollar in bar und Aktien
Big Lots verdient 26 cents je Aktie gg. erwarteten 20 cents je Aktie
Brocade zahlt im Rahmen einer Einigung mit der SEC eine Strafe von 7 Millionen Dollar
Ciena verdient 26 cents je Aktie gg. erwarteten 25 cents je Aktie; der Erlösausblick für 2007 sieht ein Wachstum von 36% vor, was über der früheren Prognose eines Zuwachses von 27-30% liegt
Cleveland Cliffs ist Kandidat für eine Übernahme durch Jim Gramer und Mad Money
Conn verdient 54 cents je Aktie gg. erwarteten 48 cents je Aktie
Costco Wholesale verdient 56 cents je Aktie gg. erwarteten 56 cents je Aktie
Jackson Hewitt verdient 2,04 Dollar je Aktie gg. erwarteten 1,93 Dollar je Aktie
Layne Christensen verdient 52 cents je Aktie gg. erwarteten 37 cents je Aktie
Medarex meldet eine Entwicklungspartnerschaft mit Mitsubishi Pharma
Motorola kündigt im Rahmen eines auf 11 Jahre angelegten Restrukturierungsplans die Entlassung von 4.000 Mitarbeitern an
Novell gewinnt nach Übertreffen der Gewinnerwartungen vorbörslich rund 3%
Bei WellPoint hat der CFO den Rücktritt erklärt
Wyeth erhält von der FDA eine Zulassung für mTOR zur Behandlung von fortgeschrittenen Nierenkrebs
US-Airlines wollen aus der Krise fliegen
Es ist ein historischer Tag für die amerikanische Airline-Branche: Zum ersten Mal seit fünf Jahren befindet sich keine der großen Fluggesellschaften im Gläubigerschutz. Mit Northwest Airlines fliegt am Donnerstag der letzte große Carrier aus der Restrukturierung – aber keineswegs in eine sorglose Zukunft.
Douglas Steenland´s Lächeln wirkte etwas gezwungen, als er am Donnerstagmorgen die Eröffnungsglocke an der New York Stock Exchange läutete. Dabei hätte der CEO von Northwest Airlines eigentlich Grund zur Freude gehabt. Fast zwei Jahre nachdem die Aktie an der Nasdaq aus dem Handel genommen wurde, gibt es ein neues Papier unter dem Tickerkürzel NWA. Man hat 20 Monate lang umgebaut, den Schuldenberg um 4,2 Milliarden Dollar abgebaut und 2,4 Milliarden Dollar an jährlichen Kosten gesenkt. Sowohl die Flugzeuge als auch die Aktie könnten nun steil in den Himmel steigen.
Werden sie aber wohl nicht. Anleger sehen den Neustart von NWA mit der gleichen Skepsis, mit der die ganze Branche betrachtet wird. Die allgemeinen Probleme der großen Fluggesellschaften sind lange bekannt, vor allem die Konkurrenz der Billig-Flieger und die hohen Preise für Flugbenzin, die gemeinsam die Margen erschüttern.
Bei Northwest kommt ein weiteres Problem hinzu: Die Mitarbeiter sind schwer frustriert. In zähen Verhandlungen haben die größtenteils gewerkschaftlich organisierten Angestellten Lohneingeständnisse von 1,4 Milliarden Dollar gegeben. Wenige Tage vor dem Börsenstart haben sie erfahren, dass dem Top-Management für das laufende Jahr dicke Prämien in die Verträge geschrieben wurden. Bis zu 20 Millionen Dollar kann allein CEO Steenland an Aktien und Optionen einstreichen, während Piloten, Flugbegleiter und Bodenpersonal ihre privaten Haushaltspläne zusammenstreichen müssen.
Vor allem in einer Service-orientierten Branche wie dem Flugsektor ist es gefährlich, frustrierte und unmotivierte Mitarbeiter zu haben. Überträgt sich deren miese Stimmung auf die Kunden, ziehen die schnell zur Konkurrenz weiter. Umso unverständlicher ist, dass das Management von Northwest Airlines aus den Fehlern der Vergangenheit – auch denen der Konkurrenten – nichts gelernt hat. Vor vier Jahren wurde CEO Don Carty bei American Airlines mit Schimpf und Schande davon gejagt, nachdem Tarifverhandlungen mit den Gewerkschaften gescheitert waren. Diese hatten bereits auf 1 Milliarde Dollar an Löhnen und Gehältern verzichtet und dann erfahren, dass das Management an eigenen Boni über 41 Millionen Dollar festhalten wollte.
Zurück zu Northwest: Der Fehlstart disqualifiziert das Unternehmen nicht zwingend von einem erfolgreichen Neubeginn. Branchen-Analysten sehen das Unternehmen in einer guten Marktposition, vor allem wegen dessen Dominanz an den Verteiler-Flughäfen in Detroit und Minneapolis. Diese mache es dem Unternehmen möglich, für schnellere Anbindungen höhere Ticketpreise zu verlangen als die Konkurrenz.
Andere setzen auf Konsolidierung, die etwas Konkurrenzdruck aus dem Markt nehmen könnte. Eine Übernahme von Northwest durch Delta Air Lines wird von Branchen-Insidern nicht ausgeschlossen. Zuletzt schlossen sich vor zwei Jahren US Airways und American West zusammen, was seinerzeit American West vor der Pleite bewahrte.
Bevor allerdings entsprechende Verhandlungen geführt werden, dürften die Chefs sämtlicher Fluggesellschaften zumindest einmal den Sommer abwarten. Man steht vor der ersten Reise-Saison, an der die gesamte Branche außerhalb des Gläubigerschutzes gegeneinander antritt und kann nun die Fronten klären.
Lars Halter -
YouTube makes a deal with EMI
SAN FRANCISCO2007-05-31 16:04:09 GMT (Reuters) (Reuters) — Google's YouTube has agreed to a deal with major music label EMI Group Plc to give users of the video-sharing site broad access to music videos by EMI artists.
The companies said Thursday that YouTube users would be allowed not only to watch and play authorized videos and recordings from EMI artists including Coldplay, Norah Jones and David Bowie, but also to incorporate elements of the videos in YouTube users' own "user generated content."
"With this deal, all four of the world's major music companies are now official YouTube partners," Chad Hurley, chief executive and co-founder of YouTube, said in a statement.
Following news of the deal, Google's shares rose 1.5% to $506, the first time they have broken $500 in five months. EMI shares were little changed, down 0.09% at 275 pence.
The deal follows copyright lawsuits filed by media companies that accuse YouTube of allowing its users to pirate their programs on the popular video sharing site.
FIND MORE STORIES IN: Reuters | IPTC | Youtube | Viacom | Warner Music Group | EMI | Universal Music Group | GOOG | Warner EMI Music, Inc. | BMG Entertainment
Though YouTube has had talks with media companies, they have not all been convinced by its claims that the site will be able to efficiently identify and remove illegally uploaded video clips by its users. In March, Viacom filed a $1 billion copyright suit against Google.
London-based EMI, the No. 3 music company, is the last of the four major record companies to sign a deal with YouTube. The statement from the two companies said EMI will use the YouTube content management system to help the music company track its content and pay its artists. No financial terms were disclosed.
Last year, Warner Music Group, Universal Music Group and Sony BMG Entertainment each signed a content deal with YouTube. As part of the agreements each music company took a small stake in YouTube, prior to it being bought by Google, according to sources familiar with the talks.
(Additional reporting by Yinka Adegoke in New York)
Copyright 2007 Reuters
BUYINS.NET: PHMD, DFNS, GTRE, SOSI, USEI Have Also Been Added To Naked Short List Today
Jun 01, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list:
PhotoMedex Inc. (NASDAQ: PHMD),
Defense Industries International Inc (OTCBB: DFNS),
Gran Tierra Energy Inc (OTCBB: GTRE),
Somerset International Group Inc. (OTCBB: SOSI),
US Energy Initiatives Corp (OTCBB: USEI).
PhotoMedex Inc. (NASDAQ: PHMD) engages in the development, manufacture, and marketing of medical laser products and services in the United States and internationally. It provides contract medical procedures to hospitals, surgi-centers, and doctors' offices, offering a range of products and services in various specialty areas, including dermatology, urology, gynecology, orthopedics, and other surgical specialties. The company designs and manufactures XTRAC laser system to phototherapeutically treat psoriasis, vitiligo, atopic dermatitis, and leukoderma. PhotoMedex also markets products for skin health, including medical specialties of dermatology, plastic, and cosmetic surgery under GraftCyte System and the Complex Cu3 brand names; Neova Therapy line of anti-aging products; Ti-Silc and Z-Silc sun protection products; Tricomin line of hair care products; and chronic wound care products under the Iamin brand name. In addition, it develops, manufactures, and markets surgical products, including proprietary laser probes and laser scalpels made of synthetic sapphire or fused silica; disposable gas or fluid cartridge systems; reusable laser aspiration hand pieces for intra-nasal/endoscopic sinus and oropharyngeal procedures requiring smoke and/or fluid evacuation; cutting instruments used for sinus surgery; ClearESS, an irrigation and suction system to remove blood and debris for visualization during endoscopic sinus surgery; and proprietary laser units for contact and non-contact surgery. Further, it offers surgical services. PhotoMedex sells its products and disposables directly to dermatologists, plastic and cosmetic surgeons, and spas and salons, as well as through licenses with strategic partners. The company was founded in 1987 and is headquartered in Montgomeryville, Pennsylvania. With 62.54 million shares outstanding and 1.21 million shares declared short as of May 2007, there is a failure to deliver in shares of PHMD.
Defense Industries International Inc (OTCBB: DFNS) is a leading manufacturer and global provider of personal military and civilian protective equipment and supplies. Defense Industries' main products include body armor, bomb disposal suits and bullet-resistant vests and jackets; ballistic wall covers, ceramic armor plates and lightweight armor UHMW-PE plates; personal military equipment, battle pouch units and combat harness units; dry storage units, liquid logistics, tents and vehicle covers; winter suits, sleeping bags and backpacks. The Company's manufacturing facilities meet American EQNET and international ISO 9001 standards. The Company has three principal subsidiaries, Export Erez Ltd., Achidatex Nazareth Elite ltd. and Owen Mills in the USA. With 28.79 million shares outstanding and 29,100 shares declared short as of May 2007, there is a failure to deliver in shares of DFNS.
Gran Tierra Energy Inc. (OTCBB: GTRE) is an international oil and gas exploration and production company, headquartered in Calgary, Canada, incorporated and traded in the United States and operating in South America. Gran Tierra holds interests in producing and prospective properties in Argentina, Colombia and Peru. To date, Gran Tierra has pursued a strategy that focuses on establishing a portfolio of producing properties, development and exploration opportunities, through selective acquisitions, to provide a base for future growth. With 78.79 million shares outstanding and 423,400 shares declared short as of May 2007, there is a failure to deliver in shares of GTRE.
Somerset International Group Inc. (OTCBB: SOSI) through its wholly-owned subsidiary, Secure System, Inc., engages in the design, manufacture, installation, and maintenance of personal security systems in the United States. Its products include personal alarm systems, wireless transmitters and receivers, and personal alarm locators. Somerset International Group serves colleges and universities, medical and mental health facilities, office campuses, and residential and correctional facilities. The company, formerly known as ORS Automation, Inc., was incorporated in 1968. Somerset International Group is based in Bedminster, New Jersey. With 7.04 million shares outstanding and 100 shares declared short as of May 2007, there is a failure to deliver in shares of SOSI.
US Energy Initiatives Corp. (OTCBB: USEI) engages in the manufacture and marketing of retrofit systems in the United States and internationally. These systems are used for the conversion of gasoline and diesel engines, and stationary or vehicular to non-petroleum based fuels, such as compressed natural gas and liquefied natural gas. It offers dual-fuel conversion system designed to convert medium and heavy-duty mobile diesel engines to operate in a natural gas/diesel dual-fuel mode. In addition, US Energy Initiatives engages in electronics engineering and manufacturing of printed circuit board assembly products for original equipment manufacturers in communications, instrumentation and controls, consumer, automotive, and military industries. The company, formerly known as Hybrid Fuel Systems, Inc., was founded in 1996. It changed its name to US Energy Initiatives Corporation in 2006. The company is headquartered in Tampa, Florida. With 212.07 million shares outstanding and 5,800 shares declared short as of May 2007, there is a failure to deliver in shares of USEI.
CKX, Inc.
01.06.07 16:05 Uhr
14,70 USD
+38,29 % [+4,07
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CKXE.NAS&lColors=0x000000&sSym=CKXE.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CKXE.NAS&lColors=0x000000&sSym=CKXE.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CKXE.NAS&lColors=0x000000&sSym=CKXE.NAS&hcmask=
Börse
NASDAQ
Aktuell
14,70 USD
Zeit
01.06.07 16:05
Diff. Vortag
+38,29 %
Tages-Vol.
20,46 Mio.
Gehandelte Stück
1,4 Mio
Robert F.X. Sillerman and Simon Fuller to Take CKX Private and Spin off Shares in Location-Based Entertainment Company to Stockholders CKX Stockholders to Receive $13.75 Per Share in Cash, and Continued Participation in Elvis Presley- and Muhammad Al
NEW YORK, June 1, 2007 /PRNewswire-FirstCall via COMTEX/ -- CKX, Inc. (Nasdaq: CKXE), announced today that it entered into a series of transactions that will result in the sale of the Company at a price of $13.75 per share in cash and the distribution to CKX stockholders of shares in FX Luxury Realty, LLC, an affiliate of Robert F.X. Sillerman that has significant real estate interests in Las Vegas and has entered into licenses to use certain intellectual property rights of CKX associated with Elvis Presley and Muhammad Ali in the development of real estate and attraction based projects.
The sale transaction and distribution of shares in FX Luxury Realty are intended to allow CKX stockholders to receive a cash return on their CKX investment while continuing to share directly in the exploitation of CKX's Elvis Presley and Muhammad Ali assets through FX Luxury Realty's real estate projects, which are expected to include Elvis Presley- and Muhammad Ali-themed attractions as well as FX Luxury Realty's other real estate ventures.
As a result of the merger transaction and the FX Luxury Realty stock distribution, CKX stockholders will receive the $13.75 cash merger consideration and a share of stock in FX Luxury Realty for each share of CKX common stock that they hold.
The sale of CKX will be accomplished through a merger with 19X, Inc., a private company owned and controlled by Mr. Sillerman, Chairman and Chief Executive Officer of CKX, and Simon R. Fuller, a director of CKX and the Chief Executive Officer of 19 Entertainment Limited, a wholly-owned subsidiary of CKX. 19X has informed CKX that it expects to finance the acquisition of CKX through a combination of equity and debt financing, with Mr. Sillerman and Mr. Fuller, as well as other members of senior management, providing a substantial portion of the equity commitment.
The merger agreement contains a 45-day "go-shop" provision pursuant to which CKX, acting through a special committee of independent directors and its financial advisor, will solicit competing proposals. During the "go shop" period no termination fee would be payable to 19X. The merger agreement does not contain a financing contingency. Mr. Sillerman, Mr. Fuller and members of senior management have agreed to vote their shares in favor of certain competing offers that the special committee deems more favorable, from a financial point of view.
Commenting on the series of transactions, Mr. Sillerman said, "After two successful years of developing and exploiting the assets we have acquired, during which time we have seen tremendous year over year growth, we have come to realize that there is a substantial opportunity to capitalize on the Elvis Presley and Muhammad Ali assets in real estate and location-based attractions. However, the pursuit of these opportunities would require a significant investment of capital, which could hinder our ability to grow the core area of our business and which is not consistent with the business plan that we have always described to our stockholders. As a result, we thought it best to provide our stockholders a capital realization opportunity as well as the opportunity to participate in a new public company that will develop real estate and location-based projects that exploit CKX's iconic intellectual property content. We believe that the transactions that we announced today accomplish that goal."
Mr. Fuller added, "I am extremely proud of what we have accomplished and am looking forward so much to continuing to work with Bob building the amazing assets that we have in Idol, Elvis Presley, Muhammad Ali and the Beckhams. I believe this transaction provides the best way to maximize the value we have created."
Also on June 1, 2007, CKX acquired 50 percent of FX Luxury Realty LLC for cash consideration of $100 million. The distribution by CKX to its stockholders of half of CKX's interests in FX Luxury Realty is a condition to the closing of the merger transaction.
FX Luxury Realty is co-owned by Flag Luxury Properties LLC, a real estate development company and an affiliate of Mr. Sillerman. FX Luxury Realty indirectly owns 50 percent of approximately 18 contiguous acres of land on Las Vegas Boulevard in Las Vegas, Nevada and has entered into a binding agreement to acquire the other 50 percent of this property for $180 million. FX Luxury Realty intends to pursue a retail, hotel, casino, commercial and residential development project on the Las Vegas property. Additionally, FX Luxury Realty is part of a control group that owns approximately 13 percent of Riviera Holdings Corporation (Amex: RIV), a company that owns and operates the Riviera Hotel & Casino in Las Vegas, and has recently made an offer to the board of directors of Riviera Holdings Corp of $34 per share for the remaining outstanding shares of Riviera Holdings Corp common stock.
Simultaneous with making the investment in FX Luxury Realty, CKX, though its subsidiaries Elvis Presley Enterprises, Inc. and Muhammad Ali Enterprises LLC, entered into license agreements with FX Luxury Realty granting FX Luxury Realty the right to use certain intellectual property rights associated with Elvis Presley and Muhammad Ali in the development of real estate and attraction-based projects, including Elvis Presley-themed hotels, casinos and lounges and Muhammad Ali-themed hotels and retreat centers.
All of these transactions were approved by a unanimous vote of the independent members of CKX's board of directors who serve on a special committee of the board of directors. Houlihan, Lokey, Howard & Zukin acted as financial advisor to the special committee and has issued an opinion to the CKX board of directors stating that the merger consideration is fair to unaffiliated CKX stockholders from a financial point of view and that the investment in FX Luxury Realty is fair to unaffiliated CKX stockholders from a financial point of view.
19X was advised by Credit Suisse on this transaction.
For more detailed information on the transactions see our Current Report on Form 8-K, which was filed today and may be obtained at the Company's website at http://www.ckx.com as well as at the SEC's web site at http://www.sec.gov.
About CKX, Inc.
CKX, Inc. is engaged in the ownership, development and commercial utilization of entertainment content. To date, the Company has focused on acquiring globally recognized entertainment content and related assets, including the rights to the name, image and likeness of Elvis Presley, the operations of Graceland, the rights to the name, image and likeness of Muhammad Ali and proprietary rights to the IDOLS television brand, including the American Idol series in the United States and local adaptations of the IDOLS television show format which, collectively, air in over 100 countries around the world. CKX plans to continue to make strategic acquisitions of, or partner or align with, companies or individuals that control various forms of established entertainment content, which may include intellectual property rights in music, film, television programming, written works and characters, rights to names, images and likenesses, video games, corporate brands and other related assets. For more information about CKX, Inc., visit its corporate website at http://www.ckx.com.
Was wird aus dem Wall Street Journal?
Als der amerikanische Medienzar Rupert Murdoch vor einem Monat 5 Milliarden Dollar für den Verlag Dow Jones bot, der unter anderem das einflussreiche Wall Street Journal druckt, schoss zwar dessen Aktie in die Höhe. Doch außer ein paar Spekulanten glaubte kaum jemand an einen möglichen Deal – zu unterschiedlich sind die beiden Parteien.
Und doch könnten sie bald Partner werden. Nach sechs Wochen Bedenkzeit – Dow Jones erhielt das Angebot der News Corp. zwei Wochen vor der öffentlichen Bekanntgabe – zeigt sich die Familie Bancroft als Mehrheitsaktionär gesprächsbereit. Man will sich mit Murdoch treffen und möglicherweise auch mit anderen Bietern, die es bislang aber nicht gibt. Und auch nicht geben dürfte, denn der Preis den Rupert Murdoch vorgelegt hat, ist nicht leicht zu schlagen.
5 Milliarden Dollar für das Unternehmen bedeuten 60 Dollar pro Aktie, deren Kurs vor Bekanntgabe des Angebots bei 36 Dollar gelegen hatte. Andere Großinvestoren – darunter der Nachrichtendienst Bloomberg und Warren Buffett als Großaktionär der Washington Post – hatten schnell erklärt, auf einen Bieterwettstreit keine Lust zu haben.
Sie hätten auch nichts davon, denn Murdoch kann sich den hohen Preis leisten, weil er ungewöhnlich hohe Synergien sieht. Es ist ein offenes Geheimnis, dass er die Erfahrung und Anerkennung des Wirtschaftsverlages gerne mit der Popularität seiner Senderfamilie Fox zusammenbringen und einen Finanzsender gründen würde. Der wäre direkter Konkurrent von CNBC, dem aktuellen Marktführer aus der Familie von General Electric.
Was geschäftlich durchaus Sinn machen würde, jagt Journalisten und zahlreichen Wall-Street-Experten kalte Schauer über den Rücken. So einflussreich Rupert Murdoch ist, so einseitig ist er: Als linientreuer Freund der Bush-Regierung hat er in den letzten Jahren seine Produkte – Fox ebenso wie die New York Post im Printbereich – auf Kurs gehalten. Bei News Corp. werden Bush & Co. über den grünen Klee gelobt, Kritiker im In- und Ausland in die Ecke gestellt – oder in die „Achse der Feiglinge“, in der sich Deutschland und Frankreich fanden, als sie Bushs Irakkrieg nicht unterstützen wollten.
Während nun Bush an der Wall Street beliebter sein dürfte als im nationalen Durchschnitt, ist Anlegern und Analysten eine offene und ausgewogene Berichterstattung doch noch wichtiger. Nur auf eine solche lässt sich schließlich zuverlässig investieren. Entsprechend laut ist der Schrei gegen eine eventuelle Übernahme von Dow Jones.
Noch lauter wehren sich hingegen Stimmen im eigenen Haus gegen den Murdoch-Angriff. Die Redakteure fürchten nicht nur um den guten Ruf und die Marke des Wall Street Journal, sondern auch um ihren Arbeitsplatz. Für den gewieften Geschäftsmann Murdoch sei das Unternehmen bei einem so hohen Kaufpreis nur profitabel, wenn schnell Kosten gesenkt werden können – am ehesten in der Redaktion. Das wiederum kann auch die Bancroft-Familie nicht wollen, die den Verlag immerhin seit 105 Jahren hält.
Allerdings geht es an der Wall Street eben nicht nur um Integrität, sondern auch um´s Geld. Und wenngleich einige Mitglieder der Bancroft-Familie tapfer erklären, ein Deal mit Murdoch bringe dem Unternehmen nichts, dürfte Brian Rogers, der Chef des Brokerhauses T. Rowe Price, etwas näher an der Wahrheit sein. Er meint, dass Dow Jones den Aktienkurs alleine nie bei 60 Dollar halten könnte und auch kaum Wachstumspotenzial habe. Und Rogers will Wachstum sehen, seine Firma hält 4,5 Millionen Dow-Jones-Aktien.
Lars Halter
NEWSWATCH
U.S. stocks rally; S&P 500, Dow take new closing highs
By MarketWatch
Last Update: 9:00 AM ET Jun 2, 2007
MARKETWATCH FRONT PAGE
NEW YORK (MarketWatch) -- U.S. stocks rallied Friday, pushing the S&P 500 to its third record close in a row and the Dow Jones industrials to new high water marks, after reports showed that more jobs than expected were created in May and inflation fell into the Federal Reserve's comfort zone.
Dell on the rise, but is turnaround already priced in?
SAN FRANCISCO (MarketWatch) -- The good news for Dell Inc. investors is that if they bought their shares on Jan. 31 -- the day founder Michael Dell reclaimed the company's CEO spot -- they have watched their investment rise by more than 14%.
FundWatch: New signs of growth point managers to Western European markets
SAN FRANCISCO (MarketWatch) -- While consumption still lags in much of Western Europe, new economic data are giving mutual-fund managers in the U.S. reason for optimism. See full story.
Capitol Report: U.S. economy catching a second wind
WASHINGTON (MarketWatch) -- The headwinds that have been slowing the U.S. economy over the past year are beginning to shift, dispelling fears of a recession or protracted slump.
Wal-Mart to scale back supercenter openings
CHICAGO (MarketWatch) -- Wal-Mart Stores Inc. is scaling back its plans to open supercenters this year by roughly 25% in a move aimed at wringing more productivity out of its stores, reducing overlap of neighboring stores and boosting its share price.
MARKETWATCH COMMENTARY
David Weidner's Writing on the Wall: CORRECT: Want to beat the market? Take the inside path
NEW YORK (MarketWatch) -- Forget software, algorithms and friends in high places -- a banker within earshot of the mergers and acquisitions department at your local Wall Street bank is the key to beating the market.
MARKETWATCH PERSONAL FINANCE
Weekend Edition: Five little-known tips for getting better gas mileage
WASHINGTON (MarketWatch) -- On a recent drive to work, Philip Reed was able to boost his car's gas mileage by almost 25%.
DAVID WEIDNER'S WRITING ON THE WALL
The insider's path to beating the market
Commentary: Insider cases show how easy it really is
By David Weidner, MarketWatch
Last Update: 3:29 PM ET May 31, 2007
A previous version of this story misspelled Qwest Communications International Inc.
NEW YORK (MarketWatch) -- Forget software, algorithms and friends in high places -- a banker within earshot of the mergers and acquisitions department at your local Wall Street bank is the key to beating the market.
The latest insider cases show just how easy and commonplace insider dealing is. They also suggest that it's very easy to fly under the radar of regulators, who find the cases generally irrelevant.
On Tuesday, federal prosecutors charged Ajaz Rahim for insider trading that included a mammoth $5.14 million gain in TXU Corp. (TXU : TXU Corp
Last: 67.54+0.09+0.13%
4:00pm 06/01/2007
Rahim, 44, was an investment banker for Faysal Bank, one of Pakistan's biggest financial firms.
In another illustration of how brazen the bad guys in insider dealing are these days, Rahim is alleged to have been the recipient of insider dope on deals involving Northwestern Corp. (NWEC : northwestern corp com new
News , chart , profile , more
Last: 32.97+0.01+0.03%
4:00pm 06/01/2007
NWEC32.97, +0.01, +0.0%) , John H. Harland Co., Jacuzzi Brands Inc., Veritas DGC Inc. and others.
'When Naseem set up Rahim to run the account, he wrote in an e-mail, "Let the fun begin." '
His source was none other than Hafiz Muhammad Zubair Naseem, who worked in the energy investment banking group at Credit Suisse (CS : Last: 76.60+0.67+0.88%,
4:01pm 06/01/2007
CS76.60, +0.67, +0.9%) , prosecutors say. Naseem was indicted May 3 on 26 counts of securities fraud. Regulators seem to think that for Rahim the tips were as free flowing drinks in Lindsay Lohan's car.
Between April 2006 and February of this year, Rahim and Naseem appear to have been doing just fine with their insider scheme. There was nothing complicated in the process.
Naseem, from his desk at Credit Suisse, would simply make a call to Rahim, who would then make a trade in Naseem's account. When Naseem set up Rahim to run the account, he wrote in an e-mail, "Let the fun begin."
He bought 2,000 shares of Northwestern on April 6, 2006. He bought another 2,000 a day later and 16,000 shares on April 24. Every call -- and there were two or three a day within 24 hours of the trades -- was recorded on the log at Credit Suisse, prosecutors say.
Then Rahim bought 1,000 shares in Veritas last June and 3,500 more shares in four trades in July. He bought 2,000 shares in Energy Partners Ltd. in July and 2,000 shares in Tramell Crow Co. in October, according to court documents.
There were 26 purchases in 10 months. In April, Rahim made $69,640 from the Northwestern stock. By August, both Rahim and Naseem had made $131,290 in Veritas stock. Jacuzzi shares brought them $59,526, according to the indictment. They were rolling now -- and using house money to boot.
And so it went, undetected, for nearly a year until they apparently got even greedier.
TXU
It was the TXU trades, however, that were too big to ignore. In February, after talking to Naseem, Rahim bought 6,700 call options for $1.1 million. He bought 15,000 shares of TXU for $878,890. After the announcement that a Kohlberg Kravis Roberts & Co. group would buy the energy company for $45 billion, Rahim unloaded the stock Feb. 26 and pocketed $5.14 million.
Well, fool me 25 times, shame on you. The Securities and Exchange Commission filed charges March 2 and court documents don't say what tipped investigators off. It's fair to say most insider cases are aided by the vast and powerful array of computer tools the commission uses to monitor trading.
After you flip one (of the conspirators), a former Assistant U.S. Attorney told me, it's easy from there.
So, why did it take 10 months? Former officials said that regulators squeeze insiders every once in while to send a message to the market and when the media crow about enforcement. The reality, one former agent told me, was that many investigators believe unusual but small trades aren't worth the effort.
In addition, there's also a belief that meaningful insider cases -- cheating at the top levels by the likes of Ivan Boesky, Michael Milken and Qwest's Joseph Nacchio -- are the noteworthy exceptions. Small-time offenders can be prosecuted civilly, if at all.
So there you have it. Make a buddy on Wall Street. Keep your trades modest and let the fun begin.
Big Coincidence
Rahim and Naseem might be temporarily sidelined, but someone else out there is getting the feeling with EMC Corp. (EMC : EMC Corporation Last: 16.83-0.06-0.36% 4:03pm 06/01/2007
EMC16.83, -0.06, -0.4%) , the Hopkinton, Mass.-based computer networking and storage company that is this week's Big Coincidence. OptionMonster's Jon Najarian alerted us last week about unusual option volume in EMC on Thursday.
"Normal full session volume is 27 million shares, and we traded that much in the first 45 minutes of trading today," Najarian said.
Indeed, at the end of the session there were 83,249 call option contracts in EMC, compared to just 10,817 puts. In the cash equity market, EMC volume ticked up slightly that day toward the end of the session, and the shares finished up 1.4% to $16.05. Najarian points out that contracts were executed at $16.64 and higher.
That looked like a risky bet until...EMC's chief competitor Network Appliance Inc. (NTAP : Network Appliance Inc
Last: 30.74-1.42-4.42% 4:00pm 06/01/2007
NTAP30.74, -1.42, -4.4%) announced, after the market closed that day, a lower-than-expected sales forecast for the coming quarter. Surprise, surprise: EMC shares hit $16.85, up 5% before settling down to a 2% gain. The stock was the most active issue on the New York Stock Exchange that day.
Maybe Network Appliance investors made an educated bet that the forecast would come in on the wrong side and bid up options in EMC, or EMC investors bet big on the opposite.
Either way, it does not compute.
David Weidner covers Wall Street for MarketWatch.
GRAHAM CP
05.06.07 19:59 Uhr
23,00 USD
+26,51 % [+4,82]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GHM.ASE&lColors=0x000000&sSym=GHM.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GHM.ASE&lColors=0x000000&sSym=GHM.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GHM.ASE&lColors=0x000000&sSym=GHM.ASE&hcmask=
Börse
AMEX
Aktuell
23,00 USD
Zeit
05.06.07 19:59
Diff. Vortag
+26,51 %
Tages-Vol.
10,00 Mio.
Gehandelte Stück
462.500
Graham Corporation Achieves Fourth Quarter Record Earnings and 2007 Year-End Backlog -- Year-end sales of $65.8 million; fourth quarter sales of $20.8 million -- Gross margin of 29.2% in fourth quarter -- Record backlog of $54.2 million and orders of
BATAVIA, N.Y., Jun 05, 2007 (BUSINESS WIRE) -- Graham Corporation (AMEX: GHM) today reported record earnings for its fourth quarter and year ended March 31, 2007, including recognition of a $1.4 million tax credit. Sales for the fourth quarter were $20.8 million, a 31% increase from sales of $15.9 million in the fourth quarter of the prior fiscal year. This increase was driven by continued strong demand for Graham's vacuum systems and surface condensers for refineries and petrochemical processing plants. For the full fiscal year, sales were $65.8 million compared with $55.2 million in fiscal year 2006.
Net income for the fourth quarter was $3.4 million, or $0.86 per diluted share, compared with $1.0 million, or $0.25 per diluted share, in the same period the prior year. Net income for the year ended March 31, 2007, was $5.8 million, or $1.46 per diluted share, up from $3.6 million, or $0.96 per diluted share, for fiscal year 2006. Included in net income for the fourth quarter was the recognition of an out-of-period research and development tax credit of $1.4 million, or $0.35 per diluted share. Excluding such tax credit, net income was $2.0 million for the fourth quarter of fiscal year 2007, up 110% compared with the prior year's fourth quarter net income. Excluding the aforementioned tax credit, net income for the full fiscal year would have been $4.4 million, or $1.11 per diluted share for the full year. Going forward, the tax credit is expected to be in the range of $150 to $250 thousand per year, provided the credit is extended by Congress beyond fiscal 2007.
Record revenue growth in the fourth quarter of fiscal year 2007 was the result of sales of approximately 36% for oil refining projects, 37% for petrochemical and chemical projects and the remaining 27% for other industrial and commercial applications. With the strength of these industries and the strong recognition for Graham's quality engineered vacuum systems and surface condensers, Graham has focused on capturing high quality opportunities by successfully addressing customers' needs. Domestic projects accounted for 56% of total sales in the fourth quarter of fiscal 2007, while projects in the Middle East contributed 20% of sales and Asian projects contributed 19%.
Gross margin for the fourth quarter of fiscal year 2007 was 29.2%, an increase from 27.6% during the same period the prior year, and a 580 basis point sequential increase from 23.4% in the third quarter of fiscal year 2007. Higher contract prices helped to offset the volatility of material costs, a major component of the cost of goods sold. For the year ended March 31, 2007, gross margin was 25.6% compared with 28.9% for the year ended March 31, 2006
Outlook
Orders for the fourth quarter of fiscal year 2007 were $27.3 million, a 46% increase from orders of $18.6 million in the fourth quarter the prior fiscal year. For the year, orders were $86.5 million, a 31% increase from $66.2 million in fiscal year 2006.
At March 31, 2007, backlog was at an all-time high of $54.2 million compared with $33.1 million at March 31, 2006. Backlog at March 31, 2007 consists of approximately 43% for refinery projects, 35% for the petrochemical and chemical industry and 22% for other industrial or commercial applications. Revenue is recognized on a percentage of completion basis, and approximately 85% of the orders currently in backlog are expected to contribute to revenue during the coming fiscal year.
ABOUT GRAHAM CORPORATION
With world-renowned engineering expertise in vacuum and heat transfer technology, Graham Corporation is a global designer, manufacturer and supplier of ejectors, pumps, condensers, vacuum systems and heat exchangers. Over the past 70 years, Graham has built a reputation for top quality, reliable products and high-standards of customer service. Sold either as components or complete system solutions, the principal markets for Graham's equipment are the petrochemical, oil refining and electric power generation industries, including cogeneration and geothermal plants. Graham equipment can be found in diverse applications, such as metal refining, pulp and paper processing, ship-building, water heating, refrigeration, desalination, food processing, pharmaceutical, heating, ventilating and air conditioning.
Graham Corporation's reach spans the globe. Its equipment is installed in facilities from North and South America to Europe, Asia, Africa and the Middle East. More information regarding Graham can be found at its website
Dendreon Corporation
05.06.07 20:10 Uhr
8,66 USD
+5,61 % [+0,46]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=DNDN.NAS&lColors=0x000000&sSym=DNDN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=DNDN.NAS&lColors=0x000000&sSym=DNDN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DNDN.NAS&lColors=0x000000&sSym=DNDN.NAS&hcmask=
Börse
NASDAQ
Aktuell
8,66 USD
Zeit
05.06.07 20:10
Diff. Vortag
+5,61 %
Tages-Vol.
123,34 Mio.
Gehandelte Stück
15 Mio
Headline Maker: Dendreon Corporation Announces Intention to Offer $75 Million Convertible Senior Subordinated Notes
Jun 05, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NASDAQ market has brought this company to the attention of our research team. Dendreon Corporation (Nasdaq: DNDN), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
June 4 - Dendreon Corporation (Nasdaq: DNDN) announced the Company intends to offer, subject to market conditions and other factors, $75 million aggregate principal amount of convertible senior subordinated notes due 2014. This offering will be made through a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
The interest rate, terms of conversion, offering price, registration rights and other terms of the notes will be determined by negotiations between the Company and the initial purchaser of the notes. The Company expects to grant the initial purchaser of the notes a 30-day overallotment option to purchase up to an additional $25 million aggregate principal amount of the notes.
The Company intends to use the net proceeds of this offering to finance its activities relating to the potential commercialization of Provenge (sipuleucel-T), expand its manufacturing facilities for the commercial production of PROVENGE, fund ongoing and new clinical trials for PROVENGE and its other product candidates, support research and preclinical development activities for its other potential product candidates, and for general corporate purposes, including working capital.
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics that harness the immune system to fight cancer.
During pre-market trading shares are up 3% to $8.50 with over 100,000 in volume. The Market Gainer Research Team will continue to gauge the short and long term affects that this announcement will have on the company
INOVIO BIOMED CORP
05.06.07 21:40 Uhr
2,29 USD
-33,24 % [-1,14]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=INO.ASE&lColors=0x000000&sSym=INO.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=INO.ASE&lColors=0x000000&sSym=INO.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=INO.ASE&lColors=0x000000&sSym=INO.ASE&hcmask=
Börse
AMEX
Aktuell
2,29 USD
Zeit
05.06.07 21:40
Diff. Vortag
-33,24 %
Tages-Vol.
2,82 Mio.
Gehandelte Stück
1,2 Mio
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
SAN DIEGO, Jun 05, 2007 (BUSINESS WIRE) -- Inovio Biomedical Corporation (AMEX: INO) announced today that it will stop further patient enrollment in its two Phase III pivotal studies for squamous cell head & neck cancer using its Selective Electrochemical Tumor Ablation (SECTA) investigational therapy based on a recommendation by the trial's independent data monitoring committee (DMC). In making its recommendation, the DMC expressed concern about efficacy and serious adverse events, including higher mortality rates on the SECTA arm of the study than on the surgery arm. In the DMC's opinion, based on the totality of the issues, the SECTA arm has an unfavorable benefit-to-risk profile, relative to the surgery arm. The DMC also suggested enrollment difficulties represent a possible challenge to meeting the goals of the trial.
Dr. Paul Goldfarb, Consulting Medical Director overseeing the Phase III studies, said, "Based on the evidence of prior SECTA studies, we are surprised by the information and recommendation received from the DMC, the only body that has had access to the unblinded data. This new information was unexpected given the potential benefits of this technology. In respecting the DMC's concerns, we have accepted their recommendation to stop enrollment without further analysis. We will determine our next steps based on a thorough evaluation of the unblinded data."
The DMC reviewed clinical data from 212 treated patients out of the targeted 400 patients defined in the clinical trial protocol. Inovio is notifying clinical investigators involved in the Phase III studies to terminate enrollment and is informing the Food & Drug Administration, other regulatory authorities, and all clinical investigators participating in other ongoing cancer trials using the SECTA therapy. Inovio will follow the treated patients for up to two years to further evaluate safety and efficacy, as per the protocol.
Dr. Avtar Dhillon, President and CEO, said, "We are reviewing the DMC's observations and believe it is prudent to act on their recommendation. We believe the SECTA therapy has notable merits that, from a medical and shareholder perspective, justify ongoing development of SECTA toward commercialization and we are continuing forward with the development of this therapy. Furthermore, this outcome has no bearing on our DNA delivery technology for DNA-based immunotherapeutics and we will continue to advance our trial and partnering activities in this field as well."
Inovio's SECTA therapy is a therapy using bleomycin sulfate delivered intratumorally using Inovio's MedPulser(R) electroporation system. The two Phase III clinical studies are designed to evaluate the use of SECTA as a treatment for resectable recurrent and second primary squamous cell carcinomas of the head and neck (SCCHN). The studies have been accruing patients with recurrent SCCs in the anterior and posterior areas of the oral cavity in North America and Europe. The primary endpoint is to demonstrate that patients treated with bleomycin and electroporation have superior preservation of function (e.g. eating, swallowing, and talking) compared to surgery. Secondary endpoints include comparing quality of life, safety, and pharmacoeconomics, in addition to showing local tumor control and survival that are equivalent to surgery.
06. Juni 2007 webnews Yigg folkd Mister Wong Linkarena Del.icio.us Schrift:
RINGEN UM "WALL STREET JOURNAL"
Milliardär macht Murdoch Konkurrenz
Der amerikanische Investor Ron Burkle, der sein Geld mit Supermärkten verdiente, träumt schon länger vom Einstieg ins Zeitungsgeschäft. Jetzt erwägt er ein Gebot für den "Wall Street Journal"-Verlag Dow Jones - und gerät damit Rupert Murdoch in die Quere.
ANZEIGE
Hamburg - Burkle arbeite mit Vertretern der Druckerei-Gewerkschaft Independent Association of Publishers's Employees (IAPE) zusammen, um Alternativen zu Murdochs Fünf-Milliarden-Dollar-Gebot für Dow Jones zu suchen, teilte die Gewerkschaft mit. Sie hatte sich gezielt nach anderen Investoren umgesehen und unter anderem auch Warren Buffett angesprochen.
Die Gewerkschafter widersetzen sich Murdochs Ambitionen, weil sie befürchten, der Chef von News Corp. könne die redaktionelle Unabhängigkeit des "Wall Street Journals" beeinträchtigen. Die IAPE vertritt rund ein Viertel der Beschäftigten bei Dow Jones.
Burkle hat sein Vermögen mit Investitionen in Supermarkt-Ketten erworben. Er hatte sich jüngst zusammen mit einem Co-Investor vergeblich um die Zeitungsgruppe Tribune beworben. Ebenso erfolglos hatte er sich um den Verlag Knight Ridder, den "Philadelphia Inquirer" und die "Philadelphia Daily News" bemüht.
Murdoch war bei seinem Versuch, Dow Jones zu übernehmen, bisher auf Gegenwehr bei den Eignern gestoßen. Vertreter der Bancroft-Familie, die einen Verkauf lange abgelehnt hatten, haben sich am Montag aber mit dem Unternehmer getroffen. Hinterher teilten beide Seiten mit, die Gespräche seien konstruktiv verlaufen, sie nannten aber keine Details.
itz
Panera Bread Company
06.06.07 15:59 Uhr
50,99 USD
-12,57 % [-7,33]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=PNRA.NAS&lColors=0x000000&sSym=PNRA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=PNRA.NAS&lColors=0x000000&sSym=PNRA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PNRA.NAS&lColors=0x000000&sSym=PNRA.NAS&hcmask=
Börse
NASDAQ
Aktuell
50,99 USD
Zeit
06.06.07 15:59
Diff. Vortag
-12,57 %
Tages-Vol.
147,77 Mio.
Gehandelte Stück
3,5 Mio
SmarTrend(R) News Watch: Panera Bread Lowers Guidance
Jun 06, 2007 (SmarTrend(R) News Watch via COMTEX) -- On Wednesday, Panera Bread Co. lowered its earnings and same-store sales forecast for the second quarter, estimating earnings to be in the range of $0.38 to $0.40 per share. The company's previous guidance had been in the range of $0.47 to $0.51 per share. Panera Bread reported earnings of $0.44 per share in the second quarter of 2006. Same-store sales are expected to increase 1.5% to 2.5%, short of the previously forecasted growth of 3.5% to 4.5%.
US-Behörde blockiert Öko-Merger
In einer historischen Flut von Mergern und Übernahmen, die seit Monaten an der Wall Street gemeldet werden, will die US-Regierung aus Wettbewerbsgründen nun einen verhindern. Doch der war nicht in der Öl- oder Energiebranche geplant, nicht bei den Banken oder Airlines, nein: es geht um zwei Öko-Ketten mit organischen Lebensmitteln.
Dass aus hunderten von Übernahmen ausgerechnet die von Whole Foods Markets auf Protest bei der Regulierungsbehörde FTC stößt, ist wirklich ironisch. Das Unternehmen, das sich auf organische Lebensmittel spezialisiert, wollte für 565 Millionen Dollar den kleineren Konkurrenten Wild Oats Markets kaufen. Die FTC droht nun mit Klage und reagiere damit, so heißt es aus Washington, auf ein Horrorszenario, nach dem Whole Foods die Preise erhöhen und den Service zurückfahren könnte.
Das ist insofern völliger Unsinn, als es ausgerechnet der hervorragende Service war, der die Whole-Foods-Läden so erfolgreich gemacht hat. Von 2002 bis 2006 hat sich die Aktie im Wert vervierfacht, erst im letzten Jahr brach der Kurs ein.
Zudem hätte Whole Foods auch nach einer Übernahme von Wild Oats keine Markt beherrschende Stellung. Sicher, im Segment der Öko-Läden gibt es nicht allzu viele Anbieter. US-weit hält nur noch Trader´s Joe mit, ein US-Ableger des deutschen Aldi-Konzerns. Aber immer mehr normale Supermarktketten haben in den vergangenen Jahren ihr Angebot im Natur- und im organischen Bereich deutlich ausgebaut. Darunter sind Safeway und Supervalue ebenso wie die Retail-Größen Wal-Mart und Costco, die immer mehr Lebensmittel anbieten und „grüne“ Ecken eingerichtet haben.
Auch das Argument, den Verbraucher vor höheren Preisen schützen zu wollen, zieht ausgerechnet im Öko-Sektor nicht. Wer bei Whole Foods einkauft, zahlt ohnehin freiwillig mehr für jeden Salatkopf und jede Schachtel Eier. Dafür ist die Ware organisch, und das rechtfertigt einen Aufschlag.
Für zahlreiche Analysten an der Wall Street ist der Deal nun noch lange nicht vom Tisch. Bei Goldman Sachs geht man davon aus, dass eine Übernahme nun sechs bis neun Monate länger dauern dürfte. Das könnte aber teuer werden, da die Geschäfte bei Wild Oats nicht allzu gut laufen und eine verzögerte Übernahme höhere Investitionen mit sich bringen könnte.
Ähnlich sieht man das bei anderen Brokerhäusern. Morgan Stanley stuft Whole Foods auf „neutral“ zurück, und bei der UBS fährt man das Kursziel um mehr als 10 Prozent auf 50 Dollar zurück.
Lars Halter
HANDELSBLATT, Donnerstag, 7. Juni 2007, 21:37 Uhr
Bieterwettkampf möglich
Investor Tierney bekundet Interesse an Dow Jones
Um den von Medienzar Rupert Murdoch umworbenen Dow-Jones-Konzern zeichnet sich ein Bieterwettkampf ab. Der Chef der Philadelphia Media Holdings, Brian Tierney, bekundete am Donnerstag sein Interesse an dem Medienunternehmen, der unter anderem das renommierte „Wall Street Journal“ herausgibt. Ein weiteres angebot wird erwartet.
HB NEW YORK. Tierney deutete an, sein Konzern würde gemeinsam mit Partnern mindestens die fünf Mrd. Dollar zahlen, die Murdochs NewsCorp bietet. „Wir glauben nicht, dass Murdoch zuviel bezahlt“, erklärte Tierney. Tierney hatte im vergangenen Jahr eine Investorengruppe angeführt, welche die Tageszeitungen „Philadelphia Inquirer“ und „The Philadelphia Daily News“ gekauft hatten.
Gewerkschaftsangaben vom Dienstag zufolge erwägt auch der US-Milliardär Ron Burkle eine Gegenofferte zum Murdoch-Gebot. Eine Gewerkschaft, die etwa 2000 Dow-Jones-Beschäftigte vertritt, widersetzt sich einer Übernahme durch Murdoch und favorisiert andere Bieter wie Burkle oder den Milliardär Warren Buffet.
Am Montag hatte sich Murdoch erstmals mit Mitgliedern der Bancroft-Familie getroffen, die Dow Jones kontrollieren. Nach den etwa fünfstündigen Beratungen in New York sagte Murdoch zu Journalisten: „Wir hatten ein sehr langes und konstruktives Treffen.“ Das Gespräch dürfte sich vor allem um die Bedenken der Bancrofts gedreht haben, dass nach einer Übernahme durch Murdochs Medienkonzern News Corp. die Redaktion des „Wall Street Journal“ ihre journalistische Unabhängigkeit verlieren könnte.
Oracle Corporation
07.06.07 22:00 Uhr
18,7301 USD
-3,20 % [-0,6199]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ORCL.NAS&lColors=0x000000&sSym=ORCL.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ORCL.NAS&lColors=0x000000&sSym=ORCL.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ORCL.NAS&lColors=0x000000&sSym=ORCL.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ORCL.NAS&lColors=0x000000&sSym=ORCL.NAS&hcmask=
Börse
NASDAQ
Aktuell
18,7301 USD
Zeit
07.06.07 22:00
Diff. Vortag
-3,20 %
Tages-Vol.
698,61 Mio.
Gehandelte Stück
40 Mio
Headline Maker: Oracle Announces the Availability of Oracle Database Lite 10g Release 3
Jun 07, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NASDAQ market has brought this company to the attention of our research team. Oracle (NASDAQ: ORCL), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
June 6 - Oracle today announced the general availability of Oracle Database Lite 10g Release 3, a comprehensive solution that enables customers and partners to rapidly develop and deploy applications for mobile and embedded environments. With enhanced synchronization and increased support for a broader range of platforms, Oracle Database Lite 10g Release 3 brings unmatched mobile data management capabilities to the enterprise.
Oracle Database Lite 10g is a highly-scalable, mobile solution that enables applications to run even when disconnected from the network, while periodically synchronizing to an Oracle Database server. Comprised of a Mobile Server and a mobile relational database, Oracle Database Lite 10g Release 3 helps users reliably and securely exchange data with a corporate database; enables application, device and user provisioning and provides centralized management tools. Additionally, the latest release includes automatic synchronization that enables data to be synchronized bidirectionally without user intervention, so mobile users can work seamlessly-- whether or not they are connected to the network.
"The new enhancements in Oracle Database Lite 10g reflect Oracle's dedication to offering mobile users an identical experience to their connected colleagues, when it comes to continuous data availability," said Rex Wang, vice president Embedded Product Marketing, Oracle. "Providing access to offline applications is key to helping organizations improve productivity, automate data capture and track distributed assets, which ultimately improves operational efficiency and customer satisfaction."
INFINERA CORP
07.06.07 22:00 Uhr
19,705 USD
+0,00 % [+0,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=INFN.NAS&lColors=0x000000&sSym=INFN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=INFN.NAS&lColors=0x000000&sSym=INFN.NAS&hcmask=
Börse
NASDAQ
Aktuell
19,705 USD
Zeit
07.06.07 22:00
Diff. Vortag
+0,00 %
Tages-Vol.
207,79 Mio.
Gehandelte Stück
12 Mio
Telekenex Selects Infinera for Metro Network VoIP Pioneer Targets Fast-Growing Small & Mid-Sized Business Sector
SUNNYVALE, CA, May 22, 2007 (MARKET WIRE via COMTEX) -- Telekenex has selected an Infinera Digital Optical Network for its fast-growing metro network in the San Francisco Bay Area.
Based in San Francisco, Telekenex is a pioneer in business-grade voice over IP solutions. Telekenex's network connects central offices and data centers across California and nationwide, enabling them to offer a wide range of voice and converged voice, video and data services to small and medium-sized businesses. After completing a private fundraising last month, Telekenex is expanding its network and its service offerings to meet growing demand.
"Small and medium-sized businesses have the same communications challenges as large enterprises. We help SMBs leverage our converged network with fully managed IP solutions that improve productivity and save money," said Telekenex CEO Brandon Chaney. "This is an underserved market and we are seeing tremendous growth right now."
Operational Simplicity of Digital Optical Networking
Telekenex selected Infinera because of the operational simplicity of Infinera's Digital architecture and the quick and easy scalability of the Infinera solution. Telekenex Chief Operating Officer Anthony Zabit said that when attempting to plan for network growth with traditional optical systems, it was very hard to reliably forecast the costs of adding wavelengths or circuits because complex optical parameters, such as optical amplification, could require unforeseen modifications and change-outs.
"The Infinera operating model is simpler, more cost-effective and more consistent," Mr. Zabit commented. "Telekenex chose the simpler and more scalable solution, which positions us to grow our network as demand grows."
"We are very pleased to welcome an innovative, fast-growing company like Telekenex as a customer," said Infinera CEO Jagdeep Singh. Mr. Singh added that the selection of the Infinera DTN by both metro and long-haul carriers shows the versatility of the Infinera Digital Optical Networking architecture, and the expected cost-effectiveness of Infinera's large-scale photonic integrated circuits, which are at the heart of every Infinera DTN System.
The Infinera DTN is architected to combine high-capacity transport, fully reconfigurable switching and GMPLS service intelligence in one platform.
About Infinera
Infinera provides Digital Optical Networking systems (the DTN System) to telecommunications carriers, cable operators and other service providers worldwide. Infinera's large-scale photonic integrated circuit (PIC) incorporates 100 Gigabits per second of transmit and receive capacity and the functionality of more than 60 discrete optical components into a pair of indium phosphide chips. Infinera's DTN system and PIC technology are designed to provide optical networks that provide operating simplicity, enhanced revenue generation, faster time-to-service and capital cost savings. For more information, please visit www.infinera.com.
About Telekenex
Telekenex is a business-grade IP service provider with a robust private international network and innovative managed solutions, including Hosted VoIP, MPLS + Internet, Managed Ethernet and Data Center. For more information about Telekenex, visit: www.telekenex.com or email press@telekenex.com This press release contains certain forward-looking statements based on current expectations, forecasts and assumptions that involve risks and uncertainties. These statements are based on information available to Infinera as of the date hereof; and actual results could differ materially from those stated or implied, due to risks and uncertainties.
DYNCORP INTL INC.
07.06.07 22:01 Uhr
20,70 USD
+22,85 % [+3,85]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=DCP.NYS&lColors=0x000000&sSym=DCP.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=DCP.NYS&lColors=0x000000&sSym=DCP.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DCP.NYS&lColors=0x000000&sSym=DCP.NYS&hcmask=
Börse
NYSE
Aktuell
20,70 USD
Zeit
07.06.07 22:01
Diff. Vortag
+22,85 %
Tages-Vol.
44,06 Mio.
Gehandelte Stück
2,2 Mio.
About DynCorp International
DynCorp International Inc., through its operating company DynCorp International LLC, is a provider of specialized mission-critical technical services, mostly to civilian and military government agencies. It operates major programs in law enforcement training and support, security services, base operations, aviation services and operations, and logistics support worldwide. Headquartered in Falls Church, Va., DynCorp International LLC has approximately 14,600 employees worldwide. For more information, visit www.dyn-intl.com.
During morning trading shares are up 17.03% to $19.72 with over 1,000,000 in volume. The Exploration Investor Research Team will continue to gauge the short and long term affects that this announcement will have on the company.
Fiscal 2007 Fourth Quarter Results
Revenue for the 2007 fourth quarter ended March 30, 2007 was $552.3 million, up 0.6% from revenue for the fiscal 2006 fourth quarter. Revenue from the Government Services ("GS") segment for the fourth quarter decreased 2.9% over the comparable period in 2006. The lower GS revenue was attributable to reduced construction activity on the U.S. Department of State Civilian Police program. Revenue from the Maintenance and Technical Support Services ("MTSS") segment increased 7.9% over the 2006 fourth quarter. The higher MTSS revenue was attributable to the C-21 program and an increased level of effort at Columbus AFB.
Operating income for the fiscal 2007 fourth quarter increased 13.2% to $42.9 million from the fiscal 2006 fourth quarter. Operating margin for the fiscal 2007 fourth quarter was 7.8%, compared to operating margin of 6.9% in the fiscal 2006 fourth quarter. Operating margin increased by 0.9% of revenue primarily due to strong contract performance and the effect of claims on two aviation contracts.
Net income for the fiscal 2007 fourth quarter was $18.9 million, or $0.33 per share, compared to net income of $5.8 million, or $0.18 per share, for the comparable period in fiscal 2006. The increase in 2007 fourth quarter net income was due to improved operating margins and lower interest expense resulting from redemption of the Company's preferred stock and reductions of outstanding debt during the first quarter of fiscal 2007.
Adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") for the 2007 fourth quarter increased to $56.7 million, or 10.3% of revenue, from $55.6 million, or 10.1% of revenue, for the comparable period in fiscal 2006. Earnings per share for the 2007 fourth quarter improved 83.3% to $0.33 per share from the comparable period in fiscal 2006.
SmarTrend(R) UPTREND Alert: National Semiconductor Corporation (NYSE:NSM)
Jun 07, 2007 (Comtex SmarTrend(R) Spotlight via COMTEX) -- Shares of National Semiconductor Corporation are up sharply on the day following their after-hours report of financial results for Q4 fiscal year 2007 yesterday. The Santa Clara-based semiconductor maker announced that sales for the quarter ended May 27, 2007 reached $455.9 million, an improvement of 5.8% from the previous quarter, but down 20.4% lower than the year-ago period. Net income was reported at $90.1 million, or $0.28 per share.
NATL SEMICONDUCTOR
08.06.07 19:50 Uhr
29,48 USD
+14,31 % [+3,69]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NSM.NYS&lColors=0x000000&sSym=NSM.NYS&hcmask=#
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NSM.NYS&lColors=0x000000&sSym=NSM.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=NSM.NYS&lColors=0x000000&sSym=NSM.NYS&hcmask=
Börse
NYSE
Aktuell
29,48 USD
Zeit
08.06.07 19:50
Diff. Vortag
+14,31 %
Tages-Vol.
623,50 Mio.
Gehandelte Stück
22 Mio.
ENDEAVOR INTL CORP
08.06.07 21:19 Uhr
1,675 USD
-18,69 % [-0,385]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=END.ASE&lColors=0x000000&sSym=END.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=END.ASE&lColors=0x000000&sSym=END.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=END.ASE&lColors=0x000000&sSym=END.ASE&hcmask=
Börse
AMEX
Aktuell
1,675 USD
Zeit
08.06.07 21:19
Diff. Vortag
-18,69 %
Tages-Vol.
22,58 Mio.
Gehandelte Stück
13 Mio
Endeavour International Corporation is an international oil and gas exploration and production company focused on the acquisition, exploration and development of energy reserves in the North Sea
LIMELIGHT NETWORK INC
08.06.07 21:33 Uhr
22,40 USD
+0,00 % [+0,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=LLNW.NAS&lColors=0x000000&sSym=LLNW.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=LLNW.NAS&lColors=0x000000&sSym=LLNW.NAS&hcmask=
Börse
NASDAQ
Aktuell
22,40 USD
Zeit
08.06.07 21:33
Diff. Vortag
+0,00 %
Tages-Vol.
261,66 Mio.
Gehandelte Stück
12 Mio
Limelight Networks, Inc. Announces Pricing of Initial Public Offering of Common Stock
TEMPE, Ariz., Jun 07, 2007 (BUSINESS WIRE) -- Limelight Networks, Inc. announced that its initial public offering of 16,000,000 shares of common stock has been priced at $15.00 per share. Shares of Limelight Networks' common stock will begin trading on June 8, 2007 on the Nasdaq Global Market under the symbol LLNW.
Of the shares being offered, 12,500,000 are being offered by Limelight Networks, and 3,500,000 are being offered by selling stockholders. Limelight Networks will not receive any of the proceeds from the sale of the shares being sold by the selling stockholders. Net proceeds to the company are expected to be approximately $170 million.
The company has granted to the underwriters an option to purchase up to an additional 2,400,000 shares from Limelight Networks at the initial public offering price. Goldman, Sachs & Co. acted as the sole book-running manager for the offering, Morgan Stanley acted as joint lead manager and qualified independent underwriter, and Jefferies & Company, Piper Jaffray, and Friedman, Billings, Ramsey & Co., Inc. acted as co-managers.
INFINERA CORP
08.06.07 21:39 Uhr
25,99 USD
+31,90 % [+6,285]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=INFN.NAS&lColors=0x000000&sSym=INFN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=INFN.NAS&lColors=0x000000&sSym=INFN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=INFN.NAS&lColors=0x000000&sSym=INFN.NAS&hcmask=
Börse
NASDAQ
Aktuell
25,99 USD
Zeit
08.06.07 21:39
Diff. Vortag
+31,90 %
Tages-Vol.
89,13 Mio.
Gehandelte Stück
3,9 Mio.
bellwetherreport.com: Trade Alert for INFINERA CORPORATION
Jun 08, 2007 (M2 PRESSWIRE via COMTEX) -- Trade Alert for INFINERA CORPORATION (NASDAQ: INFN)
Infinera provides Digital Optical Networking systems (the DTN System) to telecommunications carriers, cable operators and other service providers worldwide. Infinera's large-scale photonic integrated circuit (PIC) incorporates 100 Gigabits per second of transmit and receive capacity and the functionality of more than 60 discrete optical components into a pair of indium phosphide chips. Infinera's DTN system and PIC technology are designed to provide optical networks that provide operating simplicity, enhanced revenue generation, faster time-to-service and capital cost savings. For more information, please visit www.infinera.com.
Shares were up 10% a day after raising $182 million in an initial public offering.
National Semiconductor neues Kursziel
08.06.2007
Credit Suisse
Rating-Update:
Zürich (aktiencheck.de AG) - Die Analysten der Credit Suisse stufen die Aktie von National Semiconductor (ISIN US6376401039 / WKN 857469) unverändert mit "neutral" ein. Das Kursziel werde von 26 auf 29 USD angehoben. (08.06.2007/ac/a/u)
SmarTrend(R) UPTREND Alert: National Semiconductor Corporation (NYSE:NSM)
Jun 07, 2007 (Comtex SmarTrend(R) Spotlight via COMTEX) -- Shares of National Semiconductor Corporation are up sharply on the day following their after-hours report of financial results for Q4 fiscal year 2007 yesterday. The Santa Clara-based semiconductor maker announced that sales for the quarter ended May 27, 2007 reached $455.9 million, an improvement of 5.8% from the previous quarter, but down 20.4% lower than the year-ago period. Net income was reported at $90.1 million, or $0.28 per share.
NATL SEMICONDUCTOR
08.06.07 19:50 Uhr
29,48 USD
+14,31 % [+3,69]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NSM.NYS&lColors=0x000000&sSym=NSM.NYS&hcmask=#
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NSM.NYS&lColors=0x000000&sSym=NSM.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=NSM.NYS&lColors=0x000000&sSym=NSM.NYS&hcmask=
Börse
NYSE
Aktuell
29,48 USD
Zeit
08.06.07 19:50
Diff. Vortag
+14,31 %
Tages-Vol.
623,50 Mio.
Gehandelte Stück
22 Mio.
Wall Street News Alert: CRFU Is on the Move! June 11, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, Jun 11, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Capital Resource Funding Corp. (OTCBB: CRFU),
Sun Microsystems (NASDAQ: SUNW),
National Semiconductor Corporation (NYSE: NSM),
Exxon Mobil Corp. (NYSE: XOM).
It could be a huge trading day for Capital Resource Funding Corp. (OTCBB: CRFU), soon to be known as China Sun Group High-Tech Co., this Monday morning! Wall Street News Alert is initiating coverage of the company as it has issued two tremendous press releases. Friday after the markets closed, the company, one of China's largest producers of anode materials for use in lithium ion batteries, issued two press releases; the first announcing that it has signed a purchasing contract with a Japanese company that is projected to generate $12.6 million in revenues over 12-months. The second release announced that the company is forecasting fourth quarter revenues of $3.2 million and a turnaround to profitability.
Together, this is huge news for the company and could spark a real interest in the company's shares Monday morning! The contract is with the Japanese company Honjo Chemical Co. to supply them with a fixed amount of 20 tons of cobaltosic oxide every month, for 12-months, beginning July 2007. According to the press release, Capital Resource projects the order will deliver monthly sales of approximately $1,050,000 per month, resulting in total revenues of approximately $12.6 million in 12-months. Revenues are calculated based on London MB's price as of the quarter ended March 31, 2007, the exchange rate of one US dollar to RMB, and the proportion of cobalt in the Company's product. All three of these factors may fluctuate during the course of the contract, which could have a material effect on the Company's total sales projection.
Wall Street News Alert is placing Aggressive Investors on alert to monitor the progress of Capital Resource Funding Corp! According to the company's press release, for the fourth quarter ended May 31, 2007, the Company forecasts net revenues of $3,200,000, an increase of 20%, compared to $2,661,696 in net revenues reported in the third quarter ended February 28, 2007. Forecasted gross profit in the fourth quarter of 2007 is $1,100,000, or 34% of forecasted net revenues, representing an increase of 42% compared to gross profit of $772,766 reported in the third quarter of 2007. Forecasted net income for the fourth quarter of 2007 is $500,000, compared to a net loss of ($208,459) reported in the third quarter of 2007.
Continue to watch this company. Chairman and CEO of Capital Resource Funding Corp. Wang Bin said, "We are pleased we have established a solid revenue base in the fourth quarter of 2007, which we expect will show an increase over the third fiscal quarter ended February 28, 2007 and a turnaround to profitability."
Bin continued, "We have successfully completed our integration with DLX, the second largest cobalt production facility in China. We look forward to capitalizing on their manufacturing strengths, while expanding our operations during the remainder of 2007. We plan to establish an electro-chemistry testing center to increase the quality of our current product line of anode materials used in lithium ion batteries. Our future plans also include establishing a processing factory on our property located at the Dalian High-Tech Park Ganjingzi Zone in China."
HANDELSBLATT, Dienstag, 12. Juni 2007, 06:31 Uhr
Bulle & Bär
Der grüne Riese
Von Frank Wiebe
Bisher hatte Jeff Immelt wenig Glück mit der Börse. Seit er 2001 die Leitung von General Electric (GE) übernahm, ging es zunächst einmal bergab mit dem Aktienkurs – und danach seitwärts, während die meisten anderen Aktien schon wieder deutlich anzogen. Doch eine von vielen belächelte Strategie könnte ihm jetzt nützlich sein.
DÜSSELDORF. Immelt hat im wesentlichen die Strategie seines Vorgängers Jack Welch fortgesetzt: permanent den riesigen Konzern umbauen, unrentable Teile abstoßen, chancenreiche hinzukaufen. Immelt hat viel bewegt, zum Beispiel das Rückvesicherungsgeschäft und die Plastiksparte verkauft. Und die Zahlen sind ganz gut. Trotzdem hört er viel Kritik und bekommt hin und wieder den guten Ratschlag, den ganzen Konzern aufzuspalten. Besonders unsinnig ist dabei die gelegentlich geäußerte Idee, sich von der lukrativen Finanzsparte zu trennen. Dabei profitiert gerade dieser Bereich besonders davon, Teil des mächtigsten Industriekonzerns der Welt zu sein: Das verschafft ihm ein hervorragendes Rating und damit eine bessere Gewinnmarge, als er allein erreichen könnte. Immelt hatte zunächst einmal unter der fast schon religiösen Verehrung zu leiden, die die Aktionäre seinem Vorgänger Jack Welch entgegenbrachten. Der hatte in 20 Jahren als GE-Chef den Gewinn vervielfacht. Während Konglomerate normalerweise mit einem Malus bewertet werden – also niedriger als ihren Einzelunternehmen entsprechen würde –, gab es für Welch einen Bonus. Normalerweise mögen Analysten Konglomerate nicht, weil sie sie nicht verstehen – bei Welch haben viele einfach darauf vertraut, dass er es schon richtig macht. Dieser Bonus verschwand zunächst einmal mit Welchs Abgang – ein wichtiger Grund für die schlechte Kursentwicklung, der sich aber mittlerweile überholt haben dürfte. Doch wenn eine Aktie einmal schlecht läuft, dann bleibt das blasse Image oft sehr lange an ihr kleben. Was könnte sie zu neuem Leben erwecken? Möglicherweise der eine entscheidende Schritt, mit dem Immelt sich deutlich von seinem Vorgänger abgesetzt hat. Im Jahr 2004 definierte er GE neu als „grünen“ Konzern. Zunächst wurde er belächelt. Seine Aktion wirkte bei einem Hersteller von Kraftwerken und Flugzeugturbinen ungefähr so, als würde Michael Schumacher für ein Drei-Liter-Auto werben. Inzwischen zeigt sich, dass Immelt Trendsetter war: Immer mehr Konzerne definieren sich über ihr Umweltengagement. Hinzu kommt: Ein gigantischer Maschinenbau- und Kraftwerkskonzern kann ganz praktisch sehr viel mehr für Energieeffizienz tun als alle in Heiligendamm versammelten Politiker. Und weil „grün“ inzwischen Trendfarbe ist, lässt sich damit auch Geld verdienen. Es besteht also die Chance, dass sich das Bild wandelt und Immelt bald nicht mehr als Nachfolger von Welch sondern als Pionier der „grünen“ Welle gilt. Mit diesem Image kann er wieder höhere Aktienbewertungen erreichen.
Horizon Offshore, Inc.
12.06.07 17:17 Uhr
18,92 USD
+11,62 % [+1,97]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=HOFF.NAS&lColors=0x000000&sSym=HOFF.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=HOFF.NAS&lColors=0x000000&sSym=HOFF.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=HOFF.NAS&lColors=0x000000&sSym=HOFF.NAS&hcmask=
Börse
NASDAQ
Aktuell
18,92 USD
Zeit
12.06.07 17:17
Diff. Vortag
+11,62 %
Tages-Vol.
69,15 Mio.
Gehandelte Stück
3,8 Mio.
Horizon Offshore Agrees to be Acquired by Cal Dive International
HOUSTON, Jun 12, 2007 (PrimeNewswire via COMTEX) -- Horizon Offshore, Inc. (Nasdaq: HOFF) announced yesterday that it has entered into a definitive merger agreement with Cal Dive International, Inc. (NYSE:DVR). Under the terms of the agreement, Horizon stockholders will receive in the merger, aggregate total consideration equal to 0.625 shares of Cal Dive common stock and $9.25 in cash for each share of Horizon common stock outstanding, or an estimated total of 20.4 million Cal Dive shares and $302.5 million in cash. Based on Cal Dive's closing stock price on Monday, June 11, 2007, this equates to a transaction value of approximately $19.25 per Horizon share, which represents premiums of approximately 14% to Horizon's closing price on Monday, June 11, 2007, and approximately 18% to Horizon's 30-day average trading price. The transaction is valued at approximately $650 million, including approximately $22 million of Horizon's net debt as of March 31, 2007.
The merger agreement includes a "go shop" provision that allows Horizon until July 27, 2007, to actively solicit alternative acquisition proposals from third parties. After that date, Horizon is not permitted to solicit alternative acquisition proposals and may only respond to certain unsolicited proposals prior to Horizon's stockholders' approval of the transaction. If Horizon's board of directors accepts a superior proposal, it will terminate the merger agreement and would be obligated to pay to Cal Dive a break-up fee of approximately $9.4 million. In accordance with the merger agreement, Horizon, with the assistance of its advisors, intends to actively solicit superior proposals during this period. Horizon advises that there can be no assurance that the solicitation of superior proposals will result in an alternative transaction. Horizon does not intend to disclose developments with respect to the solicitation process unless and until its board of directors has made a decision.
About Horizon Offshore
Horizon Offshore, Inc., headquartered in Houston, Texas, provides marine construction services for the offshore oil and gas and energy industries. The Company's fleet of nine vessels is used to perform a wide range of marine construction services, including installation and repair of marine pipelines to transport oil and gas and other subsea production systems, and the installation and abandonment of production platforms, in the Gulf of Mexico, Latin America, Southeast Asia/Mediterranean, and West Africa.
The Horizon Offshore logo is available at http://media.primezone.com/prs/single/?pkgid=760
Medivation, Inc.
12.06.07 21:48 Uhr
17,41 USD
-12,07 % [-2,39]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MDVN.NAS&lColors=0x000000&sSym=MDVN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MDVN.NAS&lColors=0x000000&sSym=MDVN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MDVN.NAS&lColors=0x000000&sSym=MDVN.NAS&hcmask=
Börse
NASDAQ
Aktuell
17,41 USD
Zeit
12.06.07 21:48
Diff. Vortag
-12,07 %
Tages-Vol.
45,85 Mio.
Gehandelte Stück
2,6 Mio.
Medivation Experimental Alzheimer's Drug Dimebon Shows Promise In Trials
Jun 12, 2007 (financialwire.net via COMTEX) -- June 12, 2007 (FinancialWire) Medivation Inc. (NASDAQ: MDVN) has said that a small trial of its experimental Alzheimer's drug, Dimebon, prevented key symptoms of the disease from worsening over the period of a year.
The drug works in a different way from cholinesterase inhibitors such as Pfizer Inc.'s (NYSE: PFE) Aricept, which do not attack amyloid protein or plaque.
A mid-stage study of 183 patients with mild to moderate Alzheimer's who took Dimebon, experienced a significant benefit compared with those taking a placebo as measured by overall cognitive functioning, activities of daily living and behavioral problems.
Medivation said the most frequently reported adverse events among patients receiving the drug were dry mouth and sweating. However, roughly 32 percent of patients dropped out of the trial, similar to the 37 percent dropout rate among patients taking the placebo.
One group of patients received oral doses of Dimebon three times a day, while another group took placebo, for six months. The company plans to seek approval for the medicine as an Alzheimer's treatment in 2010.
Shares Medivation were up $3.59, or 22.2 percent, to $19.77, after earlier on Monday rising to $21.85, past its 52-week high of $20.50.
Yahoo-Chef unter Feuer
Eric Jackson hat einen Traum. Oder zumindest einen Plan, den er „Plan B“ nennt und der besser sein soll als was auch immer zur Zeit dem Management von Yahoo zugrunde liegt. Bei der Aktionärsversammlung am Dienstag tritt Jackson für eine Restrukturierung bei dem lahmenden Internetriesen ein, für die Entmachtung von CEO Terry Semel – und, wer weiß, ein wenig vielleicht für einen Sitz im Vorstand. Doch das wäre dann wieder mehr Traum als Plan.
Denn in das „Board“ der Onlinefirma wird man Jackson wohl kaum berufen. Auch sonst dürften nicht viele Außenstehende als Vertreter der Aktionäre offiziell zu Amt und Würden kommen. Das ist schlicht und einfach nicht üblich, auch wenn es in Einzelfällen schon geklappt hat.
Als Teilerfolg würde Jackson aber schon feiern, wenn am Dienstag der Abschied von Terry Semel vorbereitet wird. Der steht seit 2001 an der Unternehmensspitze und ist dort nicht besonders erfolgreich. Die Konkurrenz rast Yahoo davon. In allen direkten Vergleichen sind die anderen besser, vor allem Google. So hat Yahoo im Suchmaschinenbereich einen Marktanteil von 22 Prozent, Google kommt auf 55 Prozent. Yahoos Wachstum im vergangenen Jahr betrug 28 Prozent, deutlich weniger als die 42 Prozent bei Google.
Die wichtigste Statistik für Anleger ist jedoch der Aktienkurs. Da hat Yahoo auf Sicht von zwölf Monaten 10 Prozent verloren, während Google auf ein Plus von 30 Prozent blickt.
Dass CEO Terry Semel für eine derart schwache Performance mehr als 100 Millionen Dollar samt Optionen kassiert, stößt auf Protest bei den Anteilseignern. Viele – darunter Eric Jackson – haben sich bei Youtube und in Blogs bereits vor der Versammlung am Dienstag abgeschprochen und Eingaben vorbereitet. Andere vertrauen einfach auf die Macht, die mit ihrem Ruf kommt, darunter vor allem die großen Beraterfirmen, die Semels Gehalt ebenso kritisieren wie die Aktiviten unter den Anlegern.
Nun soll Semel gehen. Manche möchten ihn durch Finanzchefin Susan Decker ersetzen, andere hoffen aus frischen Wind von außen. Der ist bitter nötig, zumal in den letzten Monaten unter Semels unglücklichem Zepter 17 Top-Manager das Weite gesucht haben und Yahoo unter einem dramatischen „Brain-Drain“ leidet.
Die die geblieben sind, kämpfen täglich gegen ein Betriebsklima, in dem kaum Fortschritt möglich scheint. In einem Memo, das vor einem halben Jahr an die Presse kam, kritisiert ein VP, Yahoo habe sich zu breit verteilt und habe in keinem Bereich mehr eine tiefgreifende Kompetenz oder Marktposition. Prozesse seien außerdem zu bürokratisch geworden, man brauche dringend eine Reform.
Die scheint nicht voranzukommen, solange Terry Semel die Zügel in der Hand hält. Aktionäre schauen am Dienstag auf die Yahoo-Konferenz und hoffen auf Signale aus dem Management, die über den internen Reformwillen Aufschluss geben. In den nächsten Tagen wird sich zeigen, ob Anleger nur auf wirklich radikale Schritte reagieren, oder ob sie sich – zumindest für einige Zeit – auch mit weniger drastischen Maßnahman abfinden können, die den Shareholder Value erhöhen würden. Unter den weniger umstrittenen Vorlagen am Dienstag sind eine Beschleunigung eines ohnehin bereits angekündigten Aktienrückkaufs und die Zahlung einer Dividende.
Lars Halter -
American Commercial Lines Inc
12.06.07 22:00 Uhr
26,27 USD
-9,10 % [-2,63]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ACLI.NAS&lColors=0x000000&sSym=ACLI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ACLI.NAS&lColors=0x000000&sSym=ACLI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ACLI.NAS&lColors=0x000000&sSym=ACLI.NAS&hcmask=
Börse
NASDAQ
Aktuell
26,27 USD
Zeit
12.06.07 22:00
Diff. Vortag
-9,10 %
Tages-Vol.
281,31 Mio.
Gehandelte Stück
11 Mio.
American Commercial Lines Lowers Earnings Expectations, OKs $200 Million Stock Repurchase
Jun 12, 2007 (financialwire.net via COMTEX) -- June 12, 2007 (FinancialWire) American Commercial Lines Inc. (NASDAQ: ACLI) is lowering its earnings guidance for the year ending December 31, 2007 to $1.45 to $1.65 in earnings per share for 2007 versus the current street consensus of $1.84. The company's previous guidance for 2007 was $1.75 to $1.95.
The lowered guidance is driven primarily by the further weakness in the spot grain markets over first quarter levels and lower than planned productivity levels in the manufacturing segment during the second quarter.
Mark R. Holden, president and chief executive officer, stated "While our revised guidance still represents a very strong year for the company, it also reaffirms our organic growth strategy of shifting more of our commodity mix away from volatile and seasonal spot grain commodities toward more ratable, predictable commodities, including liquids and coal."
He said the company now expects manufacturing results to approximate $30 to $40 million of EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) compared to its previous expectations of $45 to $55 million of EBITDA.
Additionally, the company announced that its board of directors has approved a stock repurchase program of up to $200 million, and that it will conduct a conference call to review and discuss its second quarter financial results on July 26, 2007, at 10: 00 a.m. eastern daylight time. ACL is scheduled to release its financial results for the quarter on Wednesday, July 25, 2007 after the close of the financial markets.
The telephone numbers to access the ACL Conference Call are: Domestic 561-2731; International 614-3528; and the Participant Passcode is 10184837. The call may also be accessed live on the company's internet web site at www.aclines.com. For those unable to participate in the live call or webcast, the ACL Conference Call will be archived at www.aclines.com within three hours of the conclusion of the live call and will remain available through September 24, 2007.
QWEST COMM INTL INC
12.06.07 22:00 Uhr
9,39 USD
+0,32 % [+0,03]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=Q.NYS&lColors=0x000000&sSym=Q.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=Q.NYS&lColors=0x000000&sSym=Q.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=Q.NYS&lColors=0x000000&sSym=Q.NYS&hcmask=
Die erste Aufregung hat sich gelegt! Noch gibt es kein richtiges Überverkauft-Signal!
Börse
NYSE
Aktuell
9,39 USD
Zeit
12.06.07 22:00
Diff. Vortag
+0,32 %
Tages-Vol.
451,29 Mio.
Gehandelte Stück
59 Mio.
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=Q.NYS&lColors=0x000000&sSym=Q.NYS&hcmask=
12.06.2007 13:07
Qwest Communications International Inc.: sell (Citigroup)
New York (aktiencheck.de AG) - Die Analysten der Citigroup stufen die Aktie von Qwest Communications (ISIN US7491211097 (Nachrichten)/ WKN 907671) unverändert mit "sell" ein und bestätigen das Kursziel von 6,50 USD.
Chairman und CEO Dirk Notebaert habe mitgeteilt, nach dem Finden eines Nachfolgers zurücktreten zu wollen. Nach Ansicht der Analysten sei Notebaert einer der Architekten der operativen und finanziellen Restrukturierung in den letzten Jahren gewesen.
Das Board of Directors habe nun mit der formalen Suche nach einem Nachfolger begonnen. Allerdings sei kein Zeitplan für die Benennung gesetzt worden.
Die Analysten würden weiterhin glauben, dass die Planung des Unternehmens zum Free Cash Flow unter dem Risiko von Druck aus dem Großhandelssegment stehe. Auf Sicht von zwölf Monaten könnte BellSouth seinen Traffic auf das Netzwerk von AT&T verschieben. Zudem dürfte der Druck auf das Privatkundensegment zunehmen, da Kabel-VoIP in dem Einflussbereich von Qwest verstärkt vertrieben werde.
Vor diesem Hintergrund bleiben die Analysten der Citigroup bei ihrer Empfehlung die Aktie von Qwest Communications zu verkaufen. (Analyse vom 12.06.07) (12.06.2007/ac/a/a) Analyse-Datum: 12.06.2007
vom 13.06.2007
Apple schiebt ein Trojanisches Pferd auf den Windows-Schreibtisch
von Christoph Dernbach
San Francisco. Microsoft gegen Apple - Windows gegen Macintosh: Kaum ein Wettstreit in der Computergeschichte wurde so emotional ausgetragen wie der Konkurrenzkampf zwischen den Firmengründern Bill Gates und Steve Jobs. Dabei ist Microsoft seit den achtziger Jahren ein wichtiger Software-Lieferant für die Apple-Plattform - und Apple gehört mit seiner Musiksoftware iTunes zu den größten Software-Herstellern für Windows-PCs. Nach dem Erfolg von iTunes in der PC-Gemeinde will Apple nun ein weiteres Trojanisches Pferd auf den Windows-Desktop schieben: Der Browser Safari (Browser sind spezielle Computerprogramme zum Betrachten von Internetseiten) soll wie iTunes die PC-Anhänger davon überzeugen, wie elegant und leistungsfähig Programme von Apple sind - und ihnen langfristig einen kompletten Wechsel nahelegen. „Wir haben große Träume“, sagte Jobs auf dem Entwicklerforum seines Unternehmens (WWDC) in San Francisco: „Wir denken, dass Windows-Anwender ziemlich beeindruckt sein werden, wenn sie sehen, wie schnell und intuitiv das Surfen mit Safari sein kann.“ Google-Chef Eric Schmidt, der bei Apple im Aufsichtsrat sitzt, nahm dies unter den rund 5000 Zuhörern im Moscone-Center mit einem breiten
--------------------------------------------------------------------------------
Steve Jobs: „Wir
haben große Träume“
--------------------------------------------------------------------------------
Grinsen auf. Der Browser-Vorstoß von Apple passt gut zur Strategie des Suchmaschinengiganten, Online-Programme wie Google Docs als Alternative zu den Produkten von Microsoft zu positionieren. In der Windows-Welt ist bislang der Internet Explorer von Microsoft der mit Abstand führende Browser. Der Webbrowser Safari soll Programmierern auch die Möglichkeit geben, webbasierte Anwendungen für das neue Apple-Handy iPhone zu schreiben. „Einige Entwickler werden enttäuscht sein, dass sie nicht direkt Anwendungen schreiben können, die auf dem iPhone laufen“, sagte
--------------------------------------------------------------------------------
iPhone-Start in Europa steht noch nicht fest
--------------------------------------------------------------------------------
Gene Munster, Analyst von Piper Jaffray & Co. Apple wolle mit diesem Umweg aber vor allem die Sicherheit des iPhone gewährleisten, sagte Jobs. Nach Einschätzung von Mike McGuire, Analyst bei Gartner, stellt diese Entscheidung zumindest sicher, dass das neue Handy nicht mit einer Vielzahl von Programmen überladen wird, die am Ende die eigentliche Funktion, nämlich das Telefonieren, stören könnte. Apple wird das iPhone am 29. Juni in den USA zusammen mit dem Telekomriesen AT&T auf den Markt bringen. Ein Starttermin für Europa steht noch nicht exakt fest. Im Januar hatte Steve Jobs angekündigt, das iPhone im vierten Quartal 2007 auch in Europa einzuführen. Jobs präsentierte auf der Konferenz auch die nahezu fertig gestellte Version des neuen Apple-Betriebssystems „Mac OS X Leopard“, das im Oktober auf den Markt kommen soll. Dann soll auch die endgültige Version von Safari - sowohl für PC als auch für Mac - veröffentlicht werden. Als Betaversion steht Safari bereits zum Download zur Verfügung. Enttäuscht wurden WWDC-Besucher, die auf weitere Produktankündigungen von Apple spekuliert hatten. Doch der Zauberer Steve Jobs hatte weder ein neues Ultraleicht-Notebook noch einen neuen iMac im Zylinder. Die Börse in New York reagierte prompt darauf und schickte den Kurs der Apple-Aktie um 4,30 Dollar auf 120,19 Dollar nach unten. Die Gerüchte im Vorfeld der Entwicklerkonferenz hatten die Woche zuvor das Papier auf ein neues Allzeithoch von 127,61 Dollar getrieben. dpa
Ford prüft Verkauf von Jaguar und Land Rover
LONDON -
Der US-Autokonzern Ford schließt einen Verkauf seiner britischen Luxusmarken Jaguar und Land Rover nicht aus. Das Unternehmen prüfe "aktiv" die bestmögliche Lösung für die beiden Töchter, sagte Sprecher John Gardiner. Die britische Regierung sorgt sich bereits um Arbeitsplätze. Man habe Ford deswegen kontaktiert, sagte ein Sprecher von Premierminister Tony Blair.
AFP
erschienen am 13. Juni 2007
Penn National Gaming, Inc.
15.06.07 20:16 Uhr
62,53 USD
+22,27 % [+11,39]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=PENN.NAS&lColors=0x000000&sSym=PENN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=PENN.NAS&lColors=0x000000&sSym=PENN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PENN.NAS&lColors=0x000000&sSym=PENN.NAS&hcmask=
Börse
NASDAQ
Aktuell
62,53 USD
Zeit
15.06.07 20:16
Diff. Vortag
+22,27 %
Tages-Vol.
488,36 Mio.
Gehandelte Stück
7,9 Mio
SmarTrend(R) News Watch: Penn National agrees to buyout
Jun 15, 2007 (SmarTrend(R) News Watch via COMTEX) -- Penn National Gaming announced today that it has entered into a definitive agreement to be acquired by two investment companies, Fortress Investment Group LL and Centerbridge Partners LP. The racetrack and casino company said the all-cash transaction is valued at approximately $8.9 billion. The agreement would call for Penn National shareholders to receive $67.00 in cash for each outstanding share.
Sirius Satellite Radio Inc.
15.06.07 20:57 Uhr
2,90 USD
+5,45 % [+0,15]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,90 USD
Zeit
15.06.07 20:57
Diff. Vortag
+5,45 %
Tages-Vol.
107,25 Mio.
Gehandelte Stück
39 Mio.
bellwetherreport.com: Current Research on Sirius Satellite Radio Inc
Jun 15, 2007 (M2 PRESSWIRE via COMTEX) -- Current Research on Sirius Satellite Radio Inc (NASDAQ: SIRI)
Sirius Satellite Radio, Inc. provides satellite radio services in the United States. It offers commercial-free music channels that provide a selection of music genres, such as rock, pop, hip-hop, country, dance, jazz, Latin, and classical; and channels of sports, news, talk, entertainment, traffic, weather, and data content. As of December 31, 2006, the company offered a programming lineup of 69 channels of commercial-free music; 54 channels of sports, news, talk, and entertainment; and 11 channels of traffic and weather, as well as informational data services. It also had 6,024,555 subscribers. In addition, the company sells radios and accessories for use in cars, trucks, homes, offices, boats, or other locations primarily through automakers, consumer electronics retailers, and mobile audio dealers, as well as through its Web site. Further, it provides SIRIUS Internet Radio, an Internet service offering a CD-quality, Internet-only version of its service. The company was founded as Satellite CD Radio, Inc. in 1990 and changed its name to CD Radio, Inc. in 1992. Further, the company changed its name to Sirius Satellite Radio, Inc. in 1999. Sirius Satellite Radio is headquartered in New York, New York.
Shares were up 0.72% after releasing a study regarding the merger of SIRIUS Satellite Radio and XM Satellite Radio.
BUILD A BEAR WORKSHP
15.06.07 21:42 Uhr
22,77 USD
-23,10 % [-6,84]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=BBW.NYS&lColors=0x000000&sSym=BBW.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=BBW.NYS&lColors=0x000000&sSym=BBW.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=BBW.NYS&lColors=0x000000&sSym=BBW.NYS&hcmask=
Börse
NYSE
Aktuell
22,77 USD
Zeit
15.06.07 21:42
Diff. Vortag
-23,10 %
Tages-Vol.
129,88 Mio.
Gehandelte Stück
5,6 Mio
bellwetherreport.com: Afternoon Alert for Build-A-Bear Workshop Inc.
Jun 15, 2007 (M2 PRESSWIRE via COMTEX) -- The Build-A-Bear Workshop covers the "bear" necessities and much more. Located mainly in malls, the stores allow kids to design their own teddy bears and other stuffed animals complete with clothing (formalwear to western wear), shoes (including Skechers), and a barrage of accessories (eyewear, cell phones, sporting goods, and the like). Customers can also build bears online. Other offerings include the in-store Build-A-Party, online features such as e-cards, and bear fashions that match outfits sold at Limited Too clothing stores. The company, founded by CEO Maxine Clark in 1997, operates 275-plus stores in the Canada, the UK, and the US, as well as franchised stores in other countries. Clark owns about 17% of the company.
Shares were down 20% Slashes Outlook.
16. Juni 2007
VERLAGSÜBERNAHME
Pearson sucht Partner für Dow Jones-Gebot
Der Herausgeber der "Financial Times" plant offenbar, den Medienkonzern Dow Jones aufzukaufen. Das berichtet das "Wall Street Journal" - größter Konkurrent der "Financial Times" und selbst unter dem Dach von Dow Jones.
New York- Dem Bericht zufolge sucht die britische Verlagsgruppe Pearson nach Partnern, um gemeinsam für den Medienkonzern Dow Jones zu bieten.
Pearson soll unter anderem mit den US-Konzernen Hearst und General Electric über ein Kaufangebot gesprochen haben. Hearst verlegt selber Zeitungen, GE gehört der Fernsehkanal CNBC.
Die Mitarbeiter des Dow-Jones-Konzerns suchen schon länger nach Alternativen zu einer Übernahme durch den Medienmogul Rupert Murdoch. Sie befürchten, dass sich Murdoch nach einer Übernahme in redaktionelle Belange des Medienunternehmens einmischen könnte.
esp/Reuters
Market Pulse Announces its AM Stock Picks for Monday, June 18, 2007: ORCL, SGCP, ADBE, DELL
ATLANTA, Jun 18, 2007 (PrimeNewswire via COMTEX) -- Market Pulse is pleased to announce the following stock picks. Bernard Schmitt of Market Pulse states, "These particular stocks should be closely watched due to existing fundamental and technical factors affecting each company." Bernard possesses many years of experience in the financial industry evaluating and picking stocks. He rates them as follows:
Oracle Corp. (Nasdaq: ORCL): Market Outperform
Sierra Gold Corporation (Pink Sheets:SGCP): Attractive
Adobe Systems Inc. (Nasdaq: ADBE): Market Underperform
Dell Inc. (Nasdaq: DELL): Attractive
Stocks to Watch for Monday, June 18, 2007: SGCP - Sierra Gold Corporation Receives Positive Gold Assay Results From Hard Rock Formation! NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.
ATLANTA, GA, Jun 18, 2007 (MARKET WIRE via COMTEX) -- Market Pulse is pleased to introduce our featured stock, Sierra Gold Corporation (PINKSHEETS: SGCP), to the investment community! Sierra Gold is new to Market Pulse and is poised to become a significant player in the mining industry! SGCP has had several excellent news announcements out lately and one again after Friday's bell announcing it receives positive gold assay results from hard rock formation! This could be great news for investors! Other notable stocks that should be closely watched due to existing fundamental and technical factors affecting each company include:
Nvidia Corp. (NASDAQ: NVDA) : Market Outperform
Earth Biofuels Inc. (OTCBB: EBOF) : Attractive
Yahoo! Inc. (NASDAQ: YHOO) : Bearish
18.06.2007 15:16
Juniper Networks Achieves TL 9000 Recertification
Juniper Networks, (Nachrichten/Aktienkurs) Inc. (NASDAQ: JNPR), the leader in high-performance networking, today announced that it has again been awarded the prestigious TL 9000 certification for its core and edge routing products by the Quality of Excellence for Suppliers of Telecommunications (QuEST) Forum. In 2004, Juniper was the first and only IP routing vendor to achieve certification in the TL 9000 R3.0,1.2.9 router category, and this re-certification is a testament to the company's continued commitment to excellence in meeting the quality requirements of its customers.
“As one of the founding members of the QuEST Forum, Verizon considers TL 9000 important as an internal Quality Management System for our own business units, as well as our supply chain requirement for our suppliers,“ stated Patrick Pelan of Verizon's S&PO program management. “TL 9000 defines the telecommunications quality system requirements for the design, development, production, delivery, installation and maintenance of products and services.“
Through TL 9000, The QuEST Forum developed and maintains a single common set of worldwide telecom quality management system requirements that build on existing industry standards and practices. By selecting TL 9000 certified suppliers, companies are assured that they have a quality management system (QMS) that has been systematically audited by an independent TL 9000 registrar. Furthermore, the advanced measurements system facilitates analysis against industry benchmarks, providing the basis for objective product or supplier evaluations to make fully informed supply decisions.
“Juniper Networks is an organization where the intent of TL9000 permeates the company, from executive management through all operational departments, with these requirements supporting their day-to-day operations,“ said John Trubiano, lead auditor, TÜV SÜD America, a leading international service group. “The integration of TL9000 into their processes and the commitment demonstrated by the organization has been a direct contributor to the success and growth of Juniper over the last three years. Juniper Networks was first organization to obtain TL 9000 certification for product category 1.2.9 for their core and edge router products and their strong working relationship with TÜV SÜD America has been key to successfully achieving their 3 year recommendation for continued certification.“
“Our TL 9000 certification reaffirms our commitment to product and process quality, which is ultimately reflected in customers' satisfaction and loyalty to Juniper,“ said Brad Kashani, senior vice president of worldwide services. “The company has grown significantly since first achieving TL9000 certification; however, we remain focused on the quality and execution of Juniper's high-performance network products and services.“
About Juniper Networks
Juniper Networks, Inc. is the leader in high-performance networking. Juniper offers a high-performance network infrastructure that creates a responsive and trusted environment for accelerating the deployment of services and applications from a single network which fuels high performance businesses. Additional information can be found at www.juniper.net.
Ahead of the Bell: Endo
Monday June 18, 9:12 am ET
Analyst Raises Price Target on Endo Pharmaceuticals, Pointing to Lidoderm and Opana Sales
NEW YORK (AP) -- A Jefferies & Co. analyst raised his price target on shares of Endo Pharmaceuticals Holdings Inc. on Monday, citing strong sales of two pain relief drugs.
David Windley maintained a "Buy" rating on the stock, and said he expects the share price to rise to $41 over the next year. The analyst said sales of Lidoderm, a patch that relieves post-shingles pain, were better than he expected in April and May. He now forecasts $696 million in Lidoderm sales for the year, up from $686 million.
Marketing efforts have improved sales of pain drug Opana, he added, and there is still room for growth as physicians become more familiar with Opana and Medicare reimbursement rates increase.
The stock could rise this summer, he added, if the Food and Drug Administration approves Frova as a treatment for short-term menstrual migraines in August. The drug was approved to treat acute migraines in 2001.
Windley raised his 2007 profit estimate for Endo to $1.72 per share from $1.69, and increased his 2008 estimate to $2.21 per share from $2.14. His target price implies growth of 18.7 percent. He had expected the stock to dip slightly, to $34.
Analysts polled by Thomson Financial expect earnings of $1.71 per share this year, and $2.13 per share in 2008.
Endo shares were not trading premarket, and closed at $34.53 Friday.
Chart of the Day: Bunge
By Scott Maragioglio
Special to TheStreet.com
6/18/2007 8:51 AM EDT
Click here for more stories by Scott Maragioglio
What would you say if I told you that food supplies are at their lowest levels in 35 years, while the number of acres being planted for food grains is at its lowest level over the same period? It sounds to us like a great supply/demand relationship for higher agriculture prices.
E*TRADE FINANCIAL
Zecco.com
Bank of America
CyberTrader
Scottrade
Fisher Investments
Well, interestingly enough, this scenario is currently in place. The demand for ethanol has farmers planting fewer acres for food and more acres for ethanol. The government has latched onto the ethanol theme and is using it to show that they're trying to do something to reduce our dependency on foreign oil.
The demand for basic food products is growing, as well, and driving agriculture commodities higher. The worldwide economic boom means people have more money and are demanding more protein in their diet. This means demand for meat products is also rising worldwide.
It takes grain to feed cattle, hogs and chickens and we all know those feed grains are grown by the farmers. Demand for agricultural product seems to be growing from all sides.
The increase in demand means that more acreage will have to be planted in the future and the need for machinery, seed, fertilizer and related agricultural products should increase accordingly.
The companies that supply products to this industry stand to benefit from this supply/demand scenario. The agriculture-related stocks continue to show impressive strength, and stocks in the group are moving higher with some conviction.
The bullish agricultural theme is getting some legs here and the sector overlays several other strong groups in this market, such as machinery, chemicals, biotech, food and consumer staples, which can only help.
The worldwide bull market for commodities isn't hurting the case for agriculture stocks either. This is a sector that has all the stars aligned for a continued bull move to the upside in the coming months.
Two names in the group that stand out are Bunge (BG - Cramer's Take - Stockpickr - Rating), which is a major manufacturer of fertilizer in South America, and Agco (AG - Cramer's Take - Stockpickr - Rating), which is a manufacturer of farm machinery.
Bunge
http://images.thestreet.com/tsc/common/images/storyimages/061507_BG.gif
Bunge has worked its way back to the primary uptrend line over the last few months and retested support. Since then, BG has broken the downtrend channel and is challenging the highs. The stock should breakout here and reassert the primary uptrend.
Agco
http://images.thestreet.com/tsc/common/images/storyimages/061507_AG_t.gif
Agco has been a strong stock that has moved up steadily over the past year. AG has rallied in an orderly "stair step" fashion, and the stock looks ready to break out of the recent consolidation to make new highs. These are bullish charts that suggest the bulls are firmly in control of these stocks.
China Medical Technologies, Inc. - ADS
18.06.07 18:04 Uhr
31,16 USD
+14,35 % [+3,91]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CMED.NAS&lColors=0x000000&sSym=CMED.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CMED.NAS&lColors=0x000000&sSym=CMED.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CMED.NAS&lColors=0x000000&sSym=CMED.NAS&hcmask=
Börse
NASDAQ
Aktuell
31,16 USD
Zeit
18.06.07 18:04
Diff. Vortag
+14,35 %
Tages-Vol.
113,21 Mio.
Gehandelte Stück
3,9 Mio.
Headline Maker: China Medical Technologies Announces Unaudited Fourth Quarter and Full Year Financial Results
Jun 18, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NASDAQ market has brought this company to the attention of our research team. China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), is responding to the attention of investors Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
June 18 - China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy system, today announced its unaudited financial results for the fourth quarter ("4Q FY2006") and full year of the fiscal year ended March 31, 2007 ("FY2006").
FY2006 Highlights Net revenues increased by 47.1% year-over-year to RMB547.0 million (US$70.8 million) exceeding the high end of our targeted range of RMB533 million.
Net income increased by 45.6% year-over-year to RMB289.7 million (US$37.5 million) exceeding the high end of our targeted range of RMB271 million. Non-GAAP adjusted net income, as defined below, increased by 48.8% year-over-year to RMB309.9 million (US$40.1 million).
Diluted earnings per ADS* were RMB10.74 (US$1.39). Non-GAAP adjusted diluted earnings per ADS*, as defined below, were RMB11.44 (US$1.48).
Cash dividend of US$0.40 per ADS* was declared.
4Q FY2006 Highlights Net revenues increased by 46.0% year-over-year to RMB163.1 million (US$21.1 million).
Net income increased by 21.3% year-over-year to RMB83.7 million (US$10.8 million). Non-GAAP adjusted net income, as defined below, increased by 37.2% year-over-year to RMB91.8 million (US$11.9 million).
Diluted earnings per ADS* were RMB3.11 (US$0.40). Non-GAAP adjusted diluted earnings per ADS*, as defined below, were RMB3.37 (US$0.44).
Encysive Pharmaceuticals Inc
18.06.07 18:09 Uhr
2,26 USD
-44,88 % [-1,84]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ENCY.NAS&lColors=0x000000&sSym=ENCY.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ENCY.NAS&lColors=0x000000&sSym=ENCY.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ENCY.NAS&lColors=0x000000&sSym=ENCY.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,26 USD
Zeit
18.06.07 18:09
Diff. Vortag
-44,88 %
Tages-Vol.
41,02 Mio.
Gehandelte Stück
21 Mio.
FDA Declines To Approve Encysive's Thelin
Jun 18, 2007 (financialwire.net via COMTEX) -- June 18, 2007 (FinancialWire) Encysive Pharmaceuticals Inc. (NASDAQ: ENCY) said that the Food and Drug Administration has again declined to approve its drug Thelin as a treatment for a life-threatening lung disease, sending shares down six percent.
The company's announcement came hours after Gilead Sciences Inc. (NASDAQ: GILD) said it won FDA approval for Thelin rival Letairis.
As a result of the FDA's decision, the company has said that it may have to make significant infrastructure and staff cuts in the United States and is also reviewing its strategic alternatives.
The Food and Drug Administration, in a third approvable letter, said Thelin did not demonstrate the effectiveness required for approval as a treatment for pulmonary arterial hypertension, or PAH.
There is no cure for PAH, in which blood vessels in the lungs face high blood pressure. Narrowing of the vessels makes it harder for blood to pass through, causing the heart to pump harder and leading to possible heart failure. Thelin, a type of drug known as an endothelin receptor antagonist, aims to prevent the vessels from constricting.
Thelin won Canadian approval in May and is already approved in Europe.
Encysive shares sank 11 percent to close at $4.10 and fell $3.85 in after-hours trading.
Sicherheit in Plastiktüten
Die Koffer sind gepackt, Tickets und Pass liegen bereit. Morgen geht´s los, meine einwöchige Reise nach Deutschland ist halb geschäftlich und halb privat… und führt mich wieder einmal durch endlose Schlangen am Flughafen, wo Sicherheit über alles geht – und auch manchen Unternehmen nutzt.
Dass seit gut fünf Jahren Gepäckstücke nicht nur geröntgt, sondern auch auf alle möglichen und unmöglichen Inhaltsstoffe getestet werden, hat einigen börsennotierten Konzernen massive Umsatzzuwächse beschert und manche Aktie klettern lassen. Allen voran stehen Konzerne wie L-3 Communications oder InVision, der Sicherheits-Spezialist, der unlängst von General Electric übernommen wurde.
Solche auf Sicherheitstechnologie spezialierte Unternehmen sind – ebenso wie Öl-Konzerne und Rüstungs-Anbieter – durchaus gewohnt, dass neue Gesetze Wachstum bringen. Entsprechend viel Geld investiert man in Lobbyisten, die in Washington dafür sorgen, dass neue Vorschriften geschliffen werden, bis sie optimal zu Unternehmens-Strategie und Produktpalette passen.
Doch gibt es auch Konzerne, die völlig überraschend von neuen Sicherheitsvorkehrungen profitieren, darunter zum Beispiel die Konsumriesen Clorox und Procter & Gamble, oder der privat gehaltene Konkurrent S.C. Johnson.
Alle drei profitieren seit gut einem Jahr von einer massiv gestiegenen Nachfrage nach kleinen Plastikbeuteln. Seit eine Gruppe von Terroristen in Großbritannien aufgeflogen ist, die angeblich versucht haben soll, eine Peroxid-Verbindung in ein Sportgetränk zu rühren und dadurch einen leicht entflammbaren Sprengsatz zu bauen und an Bord von bis zu zehn Flugzeugen zu bringen, dürfen Passagiere bekanntlich keine Flüssigkeiten mehr an Bord bringen – außer… und jetzt wird es interessant für die Unternehmen:
Flüssigkeiten dürfen mit an Bord gebracht werden, wenn sie in Behältnissen von unter 100 Millilitern sind. (Das allein hat die Umfrage nach Deo und Zahnpasta in Reiseportionen erhöht.) Und wenn sich die Kleinpackungen zusätzlich in einem „verschließbaren Plastikbeutel von nicht mehr als 20 mal 20 Zentimeter Größe“ befinden.
Solche Beutel stellt beispielsweise Clorox her, in diesem Fall in der Glad-Reihe. Die reicht von Mülltüten bis hin zu Einfrierbeuteln. Die kleinsten – eben 20 auf 20 Zentimeter – waren bislang nicht allzu gefragt. Verbraucher bevorzugen die größere Variante. Doch seit die neuen Vorschriften für Flugsicherheit gelten, sind die Umsätze bei kleinen Tüten um 7 Prozent gestiegen, was sich auch auf den Aktienkurs auswirkte.
„Für uns ist es ungewohnt, dass neue gesetzliche Vorschriften neues Geschäft bringen“, meint David Kellis, der Glad-Chef bei Clorox. Auch bei Pactiv hatte man damit keine Erfahrung, bis Flughäfen massenhaft Beutel aus der Hefty-Reihe kauften, um Fluggästen den Inhalt der Hygienebeutel vor der Sicherheitsschleuse zu ermöglichen.
Dieses Umräumen werde ich mir sparen, meine Utensilien stecken im Klarsichtbeutel. Allerdings im Produkt einer Billigmarke, die doch gut genug ist um Deo und Zahnpaste zu transportieren und das Hühnefilet für den nächsten Grillabend frisch zu halten.
Lars Halter
Yahoo’s problematischer Neustart
Ob es einem CEO persönlich weh tut, wenn Anleger den Abschied mit einem Kursplus von 5 Prozent feiern? Man erfährt das nie, wenn Konzerne ihre Chefs feuern, denn die haben verständlicherweise kein Interesse daran, öffentlich zu jammern. Lieber gibt man sich stark und freut sich über das Erreichte – und wenn es nur ein dickes Konto ist.
Von dem ehemaligen Yahoo-Chef Terry Semel ist ebenso wenig wie von seinen Schicksalsgenossen zu erwarten, dass er sich je zu seinen Gefühlen im Zusammenhang mit seinem Rausschmiss äußern wird. Aber grämen wird es ihn schon, dass Anleger seinen Abschied aus der Zentrale ganz offensichtlich kaum erwarten konnten.
Vielleicht tut es ihm allerdings gut zu sehen, dass die Aktie im Handel an der Nasdaq ihren Freudensprung nicht lange durchhielt. Analysten gaben schnell zu bedenken, dass Semel nicht das einzige Problem bei dem Internet-Portal war – und dass sein Nachfolger Jerry Yang auch kein leichtes Spiel haben dürfte.
Im Gegenteil: Mit Jerry Yang kommt ja kein frischer Wind ins Yahoo-Hauptquartier. Der Mitgründer der Firma hat die letzten Jahre als aktives Vorstandsmitglied an der Seite von Terry Semel den Weg der Suchmaschine mitgestaltet. Wenn er auch für falsche Entscheidungen oder mangelnden Innovationsgeist nicht hauptverantwortlich war, war er so doch immer Teil des Problems.
Doch das ist nicht einmal die Hauptsorge der Analysten, die über die Personalie aus Silicon Valley ganz und gar nicht begeistert sind. Vielmehr geben sie zu bedenken, dass Yang zwar ein herausragender „geek“ ist – also ein Hightech-Genie. Aber Management-Erfahrung hat der Mann keine, der jetzt ein 11 000 Mitarbeiter starkes Unternehmen führen soll.
In erster Linie wird Jerry Yang Anlegern in den nächsten Wochen erklären müssen, wie er Yahoo nach dem Tiefflug der letzten Jahre wieder in Schwung bringen will, und wie er sich dem Konkurrenten Google annähern kann. Da besteht Nachholbedarf, wie jüngste Prognosen belegen. Ausgerechnet mit der Meldung über den Führungswechsel warnt Yahoo, dass die Ergebnisse im zu Ende gehenden Vierteljahr am unteren Ende der Prognosen einlaufen dürften – und das auch noch aus den ungünstigsten Gründen: Man hat im Anzeigengeschäft weitere Marktanteile verloren, womit Yang ein noch schwächeres Fundament übernimmt als befürchtet.
Andererseit könnte Yang zumindest eines ändern, was zuletzt bei Yahoo schief gelaufen war. Unter Terry Semel haben sich zuletzt viele frühere Führungskräfte verabschiedet, denen im Konzern zu viel Energie in das Anzeigengeschäft zu fließen schien. Man habe sich nicht mehr ausreichend auf die technische Verbesserung des Produkts konzentriert, so ein regelmäßiger Vorwurf frustrierter Mitarbeiter. Auf diese technischen Erneuerungen hatte hingegen Google alle Energie verwendet – mit beeindruckenden Resultaten: Die weltweit führende Suchmaschine fügt ihrem Portal fast wöchentlich neue, teils revolutionäre Applikationen an, die Fans – und Kunden – bei der Stange halten. Vielleicht fällt Yang in diesem Bereich mehr ein als seinem Management-bezogenen Vorgänger.
Insofern hat Yahoo durchaus eine Chance, gestärkt aus dem Führungswechsel hervorzugehen. Ein Kinderspiel wird es aber nicht, weshalb sich die Aktie auch nach einem ersten Freudensprung auch wieder beruhigte.
Lars Halter
Wal-Mart verliert erneut Diskrimierungsprozess
1,5 Millionen Euro für Wal-Mart-Mitarbeiterin
[Bildunterschrift: Weltgrößter Einzelhändler verliert erneut Diskriminierungsprozess]
Der amerikanische Kaufhauskonzern Wal-Mart muss einer ehemaligen Mitarbeiterin wegen Diskriminierung zwei Millionen Dollar (1,46 Millionen Euro) zahlen. Die Geschworenen im Obergericht Berkshire in Pittsfield/Massachusetts entschieden, dass Wal-Mart die Apothekerin Cynthia Haddad nur aus dem Grund entlassen habe, weil sie die gleiche Bezahlung wie ihre männlichen Kollegen verlangt habe.
Wal-Mart hat nach Angaben von Konzernsprecher John Simley noch nicht über eine Berufung entschieden. Wal-Mart-Anwälte hatten in dem Prozess erklärt, Haddad sei wegen verschiedener Verfehlungen, darunter Sicherheitsvergehen, entlassen worden. Die Anwälte Haddads hatten gekontert, die männlichen Kollegen hätten wesentlich schwerere Verstöße begangen, die ungeahndet geblieben seien.
20.06.2007 18:11
Murdoch interssiert sich für Yahoo
Sunnyvale (BoerseGo.de) - Rupert Murdoch ist offenbar an Yahoo (Nachrichten) interessiert und hätte gern ein Viertel an der Online-Suchmaschine. Der mächtige Medienunternehmer spekuliere dabei auf ein Tauschgeschäft, so die Londoner Times. Murdoch wolle die Web-Community Myspace gegen einen Anteil von 25 Prozent an dem Internetkonzern eintauschen, Es sei aber unklar, ob die Gespräche nach dem Ausscheiden des bisherigen Yahoo-Chefs Terry Semel weitergehen. Die "Times" gehört zu Murdochs Medienkonzern News Corp. (Nachrichten) und dürfte gut informiert sein.Yahoo ist an der Börse derzeit rund 37 Milliarden Dollar wert. Mit einem Viertel würde Murdoch also auf gut 12 Milliarden Dollar kommen. Murdoch hatte Myspace 2005 für 580 Millionen Dollar gekauft und damit eine Goldgräberstimmung in der Internet-Wirtschaft ausgelöst. Bei Myspace können Nutzer ihre eigenen Websites anlegen und miteinander kommunizieren. Die Community hat inzwischen fast 185 Millionen angemeldete Mitglieder in aller Welt. Murdochs Investition war damals als zu teuer kritisiert worden.
Die Aktie von Yahoo steigt heute an der Technologiebörse Nasdaq in New York um 1,3 Prozent auf 27,99 Dollar.
HANDELSBLATT, Donnerstag, 21. Juni 2007, 19:30 Uhr
Medienbranche
Pearson und GE wollen nicht für Dow Jones bieten
Der britische Medienkonzern Pearson und der US-Mischkonzern General Electric (GE) haben ihre Gespräche über ein mögliches Gebot für den US-Medienkonzern Dow Jones abgebrochen.
HB LONDON/NEW YORK. Das teilten beide Unternehmen am Donnerstag in London und New York mit. Bei den Gesprächen sei es um einen möglichen Zusammenschluss von Dow Jones mit der von Pearson herausgegebenen „Financial Times“ und mit dem Fernsehsender CNBC von GE gegangen. Dies werde nicht weiter geprüft. Ein Zusammenschluss der „Financial Times“ mit CNBC ohne Dow Jones werde dagegen weiter geprüft, teilte Pearson mit.
An Dow Jones, Herausgeber des „Wall Street Journal“, ist auch Medienmogul Rupert Murdoch interessiert. Murdoch hatte über seine News Corp. ein Angebot von fünf Milliarden Dollar oder 60 Dollar je Aktie für Dow Jones gemacht.
21.06.2007 20:55
NVIDIA - Ein großer Bulle zeigt sich
Nvidia (Nachrichten) - Kürzel: NVDA - ISIN: US67066G1040
Börse: Nasdaq in USD / Kursstand: 42,52 $
Kursverlauf vom 19.10.2006 bis 21.06.2007 (log. Kerzenchartdarstellung / 1 Kerze = 1 Tag)
Rückblick: Die NVIDIA Aktie drehte Anfang April an der Kreuzunterstützung aus 50% Retracement und Aufwärtstrend seit August 2002 bei 28,07 $ wieder nach oben und vollzog eine Aufwärtsbewegung bis 35,52 $. Ein Ausbruch über diese Marke scheiterte zunächst und die Aktie kippte nach unten weg. Letztendlich kann aber festgestellt werden, dass die Aktie sich innerhalb des Aufwärtstrends seit April diesen Jahres stets stabilisieren konnte. Als Konsequenz daraus stieg die Aktie schließlich über 35,52 $ an und generierte ein weiteres Kaufsignal. Mit dem aktuellen Kursanstieg über den charttechnischen Widerstand bei 38,96 $ wird ein weiterer bullischer Aspekt geliefert.
Charttechnischer Ausblick: Die Aktie besitzt jetzt durchaus weiteres Aufwärtspotenzial bis zum nächstliegenden Etappenziel bei 51,00 $. Grundsätzlich sollte die Aktie aber nicht unter 38,96 $ rutschen, um das bestehende Aufwärtspotenzial nicht zu gefährden. .
https://ssl.godmode-trader.de/charts/30/2005/abc6581.gif
25.06.2007
drucken verschicken
YAHOO
Yang räumt auf
Der Internetkonzern legt seine amerikanischen Anzeigenbereiche zusammen, um an Google verlorenen Boden wettzumachen. Ob das die richtige Entscheidung war, bewerten Analysten kritisch. Immerhin verliert Yahoo seine Verkaufsmanagerin Wenda Harris Millard, die das Online-Werbegeschäft vorantrieb.
San Francisco - Der US-Internetkonzern Yahoo reagiert mit einem Umbau seiner Werbesparten auf den zunehmenden Konkurrenzdruck des Erzrivalen Google .
© AP
Großansicht
Hier wird getüftelt: Yahoo versucht sich am Umbau des Werbegeschäfts
Eine Woche nach dem Abtritt von Konzernchef Terry Semel kündigte Yahoo an, die beiden Hauptaktivitäten im US-Werbegeschäft zu bündeln. Die Zusammenlegung von Internet-Banner-Werbung und dem Suchmaschinen-Anzeigengeschäft spiegele die veränderte Nachfrage wider, erläuterte Yahoo-Präsidentin Susan Decker in der Nacht zu Montag in einem Telefoninterview.
Yahoo bastelt bereits seit sechs Monaten an seinem schwächelnden Werbegeschäft. Im Zuge dessen gab es zudem zahlreiche Veränderungen im Management. Infolge des jüngsten Umbaus verliert Yahoo nun auch die langjährige Verkaufsmanagerin Wenda Harris Millard. Sie wechselt zum Medienunternehmen Martha Stewart Living Omnimedia und soll dort die Internetgeschäfte auf Vordermann bringen.
Mehr zum Thema
· Yahoo: CEO Semel kapituliert (19.06.2007)
· Yahoo: Denkzettel für das Management (13.06.2007)
· Yahoo: Führungschaos in Sunnyvale (01.06.2007)
David Karnstedt, der bisher nur den Suchanzeigenverkauf führte, wurde zum Leiter des neuen Bereichs ernannt, wie die Yahoo mitteilte.
Im lukrativen Online-Anzeigenmarkt ist Yahoo zuletzt insbesondere am Heimatmarkt gegenüber dem Hauptrivalen Google massiv zurückgefallen. Auch Internet-Kontaktseiten wie MySpace von Murdochs News Corp. machten Yahoo zunehmend zu schaffen. Vor einer Woche warnte der Konzern bereits, die schleppende Entwicklung im Online-Anzeigengeschäft werde zu einem schwächeren Ergebnis im zweiten Quartal führen.
Um den Negativtrend umzukehren, übernahm vor einer Woche Yahoo-Mitgründer Jerry Yang wieder das Ruder bei dem Konzern. Er löste Semel ab, der indes Mitglied des Führungsgremiums bleibt.
Analysten schließen nicht aus, dass sich der Verlust von Millard negativ auf Yahoo auswirken wird. Die Managerin habe entscheidenden Anteil gehabt, Wachstum im Online-Werbegeschäft voranzutreiben, sagte Brian Pitz, Analyst bei Bank of America .
Mit Onlinewerbung erzielt Yahoo mehr als 80 Prozent der Umsätze.
manager-magazin.de mit Material von reuters und dpa
U.S. Xpress Enterprises, Inc.
25.06.07 15:52 Uhr
19,20 USD
+35,21 % [+5,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=XPRSA.NAS&lColors=0x000000&sSym=XPRSA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=XPRSA.NAS&lColors=0x000000&sSym=XPRSA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=XPRSA.NAS&lColors=0x000000&sSym=XPRSA.NAS&hcmask=
Börse
NASDAQ
Aktuell
19,20 USD
Zeit
25.06.07 15:52
Diff. Vortag
+35,21 %
Tages-Vol.
6,10 Mio.
Gehandelte Stück
343.692
Hauler plans to go private
Jun 23, 2007 (Chattanooga Times/Free Press - McClatchy-Tribune Information Services via COMTEX) -- U.S. Xpress Enterprises Cochairmen Pat Quinn and Max Fuller announced Friday they intend to take the publicly held trucking company private.
Mr. Quinn and Mr. Fuller unveiled a plan to initiate a $20 per share tender offer in a management-led buyout of the Chattanooga-based company they founded in 1985.
They have formed a buyout firm, Mountain Lake Acquisition Co., to start the tender offer "as soon as is practicable," officials said in a statement.
The offer price by the two company officials, who took the business public in 1994, is about a 41 percent premium to the stock's closing price of $14.20 cents a share Friday.
The deal would be valued at more than $300 million, according to estimates, although the two men already own 42 percent of the company's outstanding Class A and Class B common shares.
Neither Mr. Quinn nor Mr. Fuller could be reached immediately for comment.
FREEDOM ACQUISITION
25.06.07 16:03 Uhr
11,90 USD
+13,88 % [+1,45]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=FRH.ASE&lColors=0x000000&sSym=FRH.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=FRH.ASE&lColors=0x000000&sSym=FRH.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=FRH.ASE&lColors=0x000000&sSym=FRH.ASE&hcmask=
Börse
AMEX
Aktuell
11,90 USD
Zeit
25.06.07 16:03
Diff. Vortag
+13,88 %
Tages-Vol.
21,95 Mio.
Gehandelte Stück
4,1 Mio.
GLG Partners to Access Public Markets Through Reverse Acquisition Transaction is a Key Strategic Step in Building GLG's Global Business
LONDON, June 25, 2007 /PRNewswire via COMTEX/ -- GLG Partners ("GLG"), a leading alternative asset manager with gross assets under management of over $20 billion, today announces that it plans to access the public markets through a reverse acquisition transaction with Freedom Acquisition Holdings, Inc. ("Freedom") (Amex: FRH) This transaction values GLG at approximately $3.4 billion based on Freedom's closing price on June 22, 2007, and has been unanimously approved by the board of Freedom.
Under the terms of the agreement, the owners of GLG will receive from Freedom $1 billion in cash and 230 million shares of Freedom common stock on a fully diluted basis. The transaction is subject to Freedom shareholder approval, regulatory approval and other customary closing conditions. Assuming these conditions are met, GLG anticipates completing the transaction early in the fourth quarter of this year.
The combined company will be named GLG Partners, Inc. Shares of the combined company are expected to trade on the New York Stock Exchange under the ticker symbol "GLG" upon consummation of the transaction. GLG will also explore the merits of a dual listing in Europe. Based on the closing price of Freedom's shares on Friday, June 22, 2007, Freedom's shareholders will own approximately 28 percent and current GLG equity holders will own approximately 72 percent of the combined company's shares on a fully diluted basis. Upon completion of the transaction, GLG's equity holders have committed to reinvest approximately 50% of their after tax cash proceeds into GLG's funds at full fees.
GLG is the largest independent alternative investment manager in Europe and the eleventh largest alternative asset manager in the world. GLG has built a highly scalable investment platform, infrastructure and support system, which represents a combination of world-class investment talent, cutting-edge technology and rigorous controls and risk management. GLG manages over 40 funds, as well as managed accounts for high net worth individuals and institutions, using both alternative and long only strategies and products. These strategies and products have generated substantial absolute returns since inception, during periods of both supportive and difficult market conditions.
"This strategic transaction is an important step in building GLG's global business, affording us the opportunity to increase brand awareness and expand in major targeted markets, including the US, Middle East and Asia," said Noam Gottesman, Founder, Managing Director and Co-CEO of GLG. "Accessing the public markets through Freedom allows GLG to take full advantage of our highly scalable infrastructure as well as our recent growth and track record of success to expand our client relationships and distribution capabilities. In addition it will provide us with a publicly traded equity currency with which to compete for, retain and incentivize the most talented and sought after professionals in our industry and pursue our growth strategies."
"GLG is one of the world's most successful multi-strategy asset managers with an experienced team of highly-regarded investment professionals and a long history of strong and sustained investment performance," said Martin E. Franklin, Chairman of Freedom.
"GLG's highly scalable asset management platform represents an excellent investment opportunity for our shareholders. We look forward to working with the management team of GLG as they continue to grow the company's business and expand into the US and other dynamic global markets," added Nicolas Berggruen, President and CEO of Freedom.
Syntroleum Corporation
25.06.07 16:17 Uhr
3,37 USD
+22,10 % [+0,61]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SYNM.NAS&lColors=0x000000&sSym=SYNM.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SYNM.NAS&lColors=0x000000&sSym=SYNM.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SYNM.NAS&lColors=0x000000&sSym=SYNM.NAS&hcmask=
Börse
NASDAQ
Aktuell
3,37 USD
Zeit
25.06.07 16:17
Diff. Vortag
+22,10 %
Tages-Vol.
5,72 Mio.
Gehandelte Stück
2,3 Mio
Today, June 25th we have identified, Syntroleum Corporation (Nasdaq: SYNM),) due to the attention they received after this recent corporate developments.
(+)SYNM jumps on a renewable fuels venture with TSN
GEN DYNAMICS CP
25.06.07 16:39 Uhr
78,69 USD
+0,86 % [+0,67]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GD.NYS&lColors=0x000000&sSym=GD.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GD.NYS&lColors=0x000000&sSym=GD.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GD.NYS&lColors=0x000000&sSym=GD.NYS&hcmask=
Börse
NYSE
Aktuell
78,69 USD
Zeit
25.06.07 16:39
Diff. Vortag
+0,86 %
Tages-Vol.
21,88 Mio.
Gehandelte Stück
282.300
25.06.2007 16:47
General Dynamics erhält Auftrag für $ 22 Mio.
Falls Church (BoerseGo.de) - Der US- Rüstungs- und Industriegüterhersteller General Dynamics (Nachrichten) hat am Montag einen Auftrag für Rüstungsgüter von der US-Armee im Wert von 22 Millionen Dollar erhalten. In dem zweigeteilten Auftrag geht es jeweils um Zuliefer- und Ersatzteile für den Abrams- Kampfpanzer (12 Millionen Dollar) sowie für das Stryker- Landkampffahrzeug (10 Millionen Dollar). Die Lieferung der Nachrüstungen erfolgt bis in den Zeitraum zwischen Dezember 2008 und Dezember 2010. Beliefert werden hauptsächlich im Irak und Afghanistan eingesetzte Module.
General Dynamics legen um 0,8 Prozent auf 78,63 Dollar zu.
Healthy Profits at Walgreen
By Melissa Davis
Senior Writer
6/25/2007 10:32 AM EDT
Click here for more stories by Melissa Davis
TD AMERITRADE
Charles Schwab
Scottrade
CyberTrader
Fidelity Investments
Fisher Investments
Walgreen (WAG - Cramer's Take - Stockpickr - Rating) looks quite healthy after beating Wall Street estimates for the third quarter in a row.
The giant drugstore chain on Monday posted third-quarter profits of $561 million, up almost 20% from a year ago, with soaring sales of high-margin generic drugs boosting the company's results.
Excluding favorable gains, the company's earnings per share of 54 cents topped analysts' average expectation by a penny.
Total revenue for the quarter ended May 31 rose 13% to $13.7 billion, but it fell a bit shy of Wall Street's estimate of $13.79 billion due to rising sales of cheap -- but extremely lucrative -- generic drugs.
Prescription sales, which account for two-thirds of Walgreen's business, jumped 14% in the latest quarter.
Total same-store sales, representing sales at drugstores open more than a year, rose 7.8% in the quarter, while front-end same-store sales rose 5.6%. The company posted market-share gains in 56 of its top 60 "front-end" product categories to boot.
Nevertheless, Walgreen's stock recently was down 41 cents to $44.56 a share.
Based on recent company updates highlighting the boom in generic sales, Wall Street was already looking for strong results from the drugstore chain. Earlier this month, in fact, several analysts raised their earnings estimates for the company in anticipation of yet another upside surprise. Some of them urged investors to buy the company's stock, which they view as unusually cheap, ahead of this week's report as well.
"While this is the lowest level of pharmacy comp-store dollar growth in over a year, Walgreen reported figures are being depressed by the increased penetration of generics," William Blair analyst Mark Miller stressed in early June. Meanwhile, "Walgreen's relative price-to-earnings premium [vs. the S&P 500] on 2007 earnings has not been this low since 1996. [Thus] we reiterate our outperform rating on Walgreen and recommend investors build positions at current valuation levels."
A member of Miller's family has taken a long position in the company's stock already.
SunTrust Robinson Humphrey analyst David Magee views Walgreen's stock as a bargain investment, too. Indeed, Magee feels that now is an ideal time to buy the shares.
"Walgreen is a good hedge against higher inflation ... and interest rates [because] Walgreen has no debt," Magee explained last week. "And with 65% of the business coming from the highly resilient pharmacy, it is also a good hedge against any slowing in the economy."
Magee has a buy recommendation and a $55 price target on Walgreen's shares.
Bear Stearns analyst Robert Summers feels more cautious. He, too, predicted that Walgreen would beat Wall Street targets yet again -- in fact, he questioned why those targets were so low -- but he warned of a looming slowdown ahead.
"We are reluctant to afford the current earnings cycle a premium multiple, as growth appears to be peaking," Summers wrote on Thursday. "We question how Walgreen will replace margin gains from generics when [the] rate of substitution begins sharp deceleration by [fiscal] 2009. In our opinion, the compressing multiple ... reflects some caution regarding earnings trajectory beyond [fiscal] 2008."
Summers has a market-weight recommendation on Walgreen's stock in the meantime. His firm has non-investment banking ties to the company.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=WAG.NYS&lColors=0x000000&sSym=WAG.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=WAG.NYS&lColors=0x000000&sSym=WAG.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=WAG.NYS&lColors=0x000000&sSym=WAG.NYS&hcmask=
25.06.2007 21:59
General Mills beschließt Dividendenerhöhung
Minneapolis (aktiencheck.de AG) - Der amerikanische Lebensmittelkonzern General Mills Inc. (ISIN US3703341046 (Nachrichten)/ WKN 853862) hat am Montag eine Dividendenerhöhung beschlossen.
Demnach soll die quartalsweise Ausschüttung um 8,3 Prozent auf 39 Cents je Aktie gesteigert werden. Im Vorquartal hatte General Mills 36 Cents je Aktie ausgeschüttet. Die nächste Auszahlung soll zum 1. August mit Ex-Tag 10. Juli erfolgen.
Im dritten Fiskalquartal 2006/07 hatte der weltweit zweitgrößte Hersteller von Frühstückscerealien seinen Gewinn gesteigert, was mit geringeren Produktionskosten und höheren Umsätzen als Folge verstärkter Marketing-Ausgaben zusammenhängt.
Die Zahlen zum Schlussquartal 2006/07 werden am Donnerstag veröffentlicht. Die Analysten erwarten ein EPS von 62 Cents bei Umsätzen von 2,99 Mrd. Dollar.
Die Aktie von General Mills notiert derzeit an der NYSE bei 58,82 Dollar (+0,62 Prozent). (25.06.2007/ac/n/a)
Ventana Medical Systems, Inc.
26.06.07 19:54 Uhr
76,70 USD
+48,24 % [+24,96]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=VMSI.NAS&lColors=0x000000&sSym=VMSI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=VMSI.NAS&lColors=0x000000&sSym=VMSI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=VMSI.NAS&lColors=0x000000&sSym=VMSI.NAS&hcmask=
Börse
NASDAQ
Aktuell
76,70 USD
Zeit
26.06.07 19:54
Diff. Vortag
+48,24 %
Tages-Vol.
383,64 Mio.
Gehandelte Stück
5,5 Mio
Ventana Medical takeover sought
Jun 26, 2007 (The Arizona Daily Star - McClatchy-Tribune Information Services via COMTEX) -- Swiss drug giant Roche Holding AG, the world's biggest maker of diagnostic tests, has made a unsolicited offer to buy Oro Valley-based Ventana Medical Systems Inc. for about $3 billion, or $75 a share, in cash.
Roche would retain Ventana's management team and employees, as well as its Oro Valley headquarters, the Basel, Switzerland-based company said in a statement Monday.
Ventana Chief Financial Officer Lawrence Mehren said Ventana's board "will consider the offer in due course." He declined to comment further.
Founded by University of Arizona pathologist Dr. Thomas Grogan in 1985, Ventana is a leading maker of automated laboratory instruments for tissue analysis.
The company, headquartered at 1910 E. Innovation Park Drive, ranks 90th on the Star 200 list of Southern Arizona's major employers, with 580 full-time-equivalent workers at the end of 2006. Ventana employs about 765 people companywide and had 2006 revenues of $238 million.
Roche's hostile buyout bid points up the rising prominence of Tucson's biosciences industry, said Larry Hecker, a Tucson attorney specializing in corporate and securities law who has long been active in local economic-development work.
"It's definitely a testament to the strength of the (biotech) industry cluster in this community, and I would hope they would keep it here," said Hecker, who chaired a committee that helped draft an economic-development "blueprint" for Tucson Regional Economic Opportunities Inc.
"On the downside, Ventana is one of very few (locally) headquartered public companies, and you always hate to lose that -- you don't want to become a branch of a larger company," said Hecker, who said he doesn't own any Ventana shares.
Roche said its offer represents a 44 percent premium to Ventana's close of $51.95 on Friday and a 55 percent premium to its three-month average share price of $48.30.
Roche said it had "made multiple efforts" to negotiate a buyout, but Ventana so far has declined to enter buyout discussions, leading to the tender offer. Roche said it "remains willing to discuss a negotiated transaction agreed to by both parties, as this continues to be Roche's preferred option."
In an unsolicited, or hostile, takeover bid, the prospective buyer makes an offer directly to shareholders.
Roche said the acquisition of Ventana would allow the company to broaden its diagnostic products, and would complement its diagnostic systems and cancer therapies.
The company said it would operate Ventana as a dedicated business within the Roche Diagnostics Division and would retain Ventana's headquarters in Tucson.
Ventana shares closed Monday down 21 cents, at $51.74 at the close of regular trading on the Nasdaq Stock Market.
Hoku Scientific, Inc.
26.06.07 19:59 Uhr
12,08 USD
+12,48 % [+1,3401]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=HOKU.NAS&lColors=0x000000&sSym=HOKU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=HOKU.NAS&lColors=0x000000&sSym=HOKU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=HOKU.NAS&lColors=0x000000&sSym=HOKU.NAS&hcmask=
Börse
NASDAQ
Aktuell
12,08 USD
Zeit
26.06.07 19:59
Diff. Vortag
+12,48 %
Tages-Vol.
199,65 Mio.
Gehandelte Stück
18 Mio
Hoku Among Pre-Market Volume Leaders, Adding to Big June Gains
Boston, Jun 26, 2007 (MidnightTrader via COMTEX) -- HOKU is up more than 10% late in today's pre-market session, adding to a more than 100% rise recorded since mid-June. We're not seeing a corporate-specific news peg on today's move, but volume remains lively at this hour.
HUNTSMAN CORPORATION
26.06.07 20:16 Uhr
24,29 USD
+28,52 % [+5,39]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=HUN.NYS&lColors=0x000000&sSym=HUN.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=HUN.NYS&lColors=0x000000&sSym=HUN.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=HUN.NYS&lColors=0x000000&sSym=HUN.NYS&hcmask=
Börse
NYSE
Aktuell
24,29 USD
Zeit
26.06.07 20:16
Diff. Vortag
+28,52 %
Tages-Vol.
383,22 Mio.
Gehandelte Stück
20 Mio.
Top Of Our Radar: Basell to Acquire Huntsman
Jun 26, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NYSE market has brought this company to the attention of our research team. Huntsman Corporation (NYSE: HUN), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
June 26 - Basell, the global leader in polyolefins' technology, production and marketing, and Huntsman Corporation (NYSE: HUN), one of the world's largest manufacturers and marketers of differentiated chemicals and pigments, announced today that they have signed a definitive agreement pursuant to which Basell will acquire Huntsman in a transaction valued at approximately $9.6 billion, including the assumption of debt.
Under the terms of the agreement, Basell will acquire all of the outstanding common stock of Huntsman for $25.25 per share in cash.
The transaction was unanimously approved by the Boards of Directors of both Basell and Huntsman. Huntsman's Board of Directors approved the transaction agreement at the recommendation of a Transaction Committee comprised of Huntsman independent directors.
The transaction is subject to customary closing conditions, including regulatory approval in the U.S. and in Europe, as well as the approval of Huntsman shareholders. Entities controlled by MatlinPaterson and the Huntsman family, who collectively own 57% of Huntsman's common stock, have agreed to approve the transaction. Closing is expected in the fourth quarter of 2007.
The combined company will have an extensive geographic footprint, with operations on all continents of the world, and will be well positioned in fast-growing markets such as China, India, Eastern Europe and Latin America. In 2006, Basell and Huntsman had combined revenues of more than $26 billion and employed approximately 20,900 people.
Volker Trautz, CEO of Basell, said: "Basell's industry-leading polyolefins businesses and Huntsman's businesses will benefit from the expertise both companies have demonstrated in technology, innovation and customer service. Together we will be able to achieve even more."
Commenting on the announcement, Len Blavatnik, Chairman and founder of U.S.-based Access Industries, owner of Basell, said: "This transaction enhances our position as a global industrial group with long-term strategic assets in the chemicals industry."
Mr. Blavatnik added: "Basell's management team has done an excellent job in growing and enhancing the company over the last two years, putting it in a position to make this acquisition. We look forward to further growth and profitability in this industry."
Jon M. Huntsman, founder and Chairman of Huntsman Corporation, said: "This transaction opens a new chapter in the proud history of Huntsman and for the thousands of people who work in our facilities around the world. I am confident Basell is the right owner for the company going forward. The proceeds of this transaction will allow our family to focus more effectively on the elimination of human suffering and on finding cures for cancer."
Peter R. Huntsman, President and CEO of Huntsman, said: "This transaction represents outstanding value for Huntsman's shareholders. The merger of Basell and Huntsman creates one of the largest chemical companies in the world. I am confident that this combination will allow us to even more effectively pursue our underlying business strategies and continue to provide rewarding opportunities for our associates."
About Basell
Basell is the global leader in polyolefins technology, production and marketing. It is the largest producer of polypropylene and advanced polyolefin products; a leading supplier of polyethylene and catalysts, and the industry leader in licensing polypropylene and polyethylene processes, including providing technical services for its proprietary technologies. Basell, together with its joint ventures, has manufacturing facilities in 19 countries and sells products in more than 120 countries. Basell is privately owned by Access Industries. (www.basell.com)
About Access Industries
Access Industries is a privately held, U.S.-based industrial group with long-term holdings worldwide. Access was founded in 1986 by Chairman, Len Blavatnik, an American industrialist. Access' industrial focus spans three sectors: natural resources and chemicals; telecommunications and media; and real estate. (www.accessindustries.com)
About Huntsman
Huntsman is a global manufacturer and marketer of differentiated chemicals and pigments. Its operating companies manufacture products for a variety of global industries, including chemicals, plastics, automotive, aviation, textiles, footwear, paints and coatings, construction, technology, agriculture, health care, detergents, personal care, furniture, appliances and packaging. Originally known for pioneering innovations in packaging and, later for rapid and integrated growth in petrochemicals, Huntsman today has operations in 24 countries. The company had 2006 revenues from all operations of over $13 billion. (www.huntsman.com)
During afternoon trading shares are up 28% to $24.31 with over 15 million in volume. The Market Gainer Research Team will continue to gauge the short and long term affects that this announcement will have on the company
26.06.2007 20:19
Intraday "Pacemaker" Screening
Bestandteil des Intradayscreenings ist die Auswertung der Tendenzen und Trends der hochkapitalisierten Aktien im S&P 500 Index und Nasdaq 100. Diese Large Cap Aktien haben aufgrund ihrer hohen Gewichtung in den Indizes maßgeblichen Einfluß auf die Indexbewegungen. Sie gelten als "Pace Maker" (Schrittmacher).
Aktuelle Kursliste der Top 30 Large Cap Aktien im S&P 500 Index.
http://img.godmode-trader.de/charts/30/2005/abc6629.gif
Aktuelle Kursliste der Top 30 Large Cap Aktien im Nasdaq 100.
http://img.godmode-trader.de/charts/30/2005/abc6630.gif
W HOLDING CO INC
26.06.07 20:31 Uhr
3,24 USD
-35,33 % [-1,77]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=WHI.NYS&lColors=0x000000&sSym=WHI.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=WHI.NYS&lColors=0x000000&sSym=WHI.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=WHI.NYS&lColors=0x000000&sSym=WHI.NYS&hcmask=
Börse
NYSE
Aktuell
3,24 USD
Zeit
26.06.07 20:31
Diff. Vortag
-35,33 %
Tages-Vol.
25,37 Mio.
Gehandelte Stück
7,5 Mio.
About the Company
Westernbank Puerto Rico, a wholly owned subsidiary of W Holding Company, Inc., is the second-largest commercial bank in Puerto Rico, based on total assets, operating throughout 57 full-fledged branches, including 33 in the southwestern region of Puerto Rico, 8 in the northeastern region, 14 in the San Juan Metropolitan area of Puerto Rico and 2 in the eastern region of Puerto Rico, and a fully functional banking site on the Internet. W Holding Company, Inc. also owns Westernbank Insurance Corp., a general insurance agent placing property, casualty, life and disability insurance, whose results of operations and financial condition are reported on a consolidated basis.
iShares Silver Trust
26.06.07 20:38 Uhr
121,86 USD
-4,98 % [-6,39]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SLV.ASE&lColors=0x000000&sSym=SLV.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=SLV.ASE&lColors=0x000000&sSym=SLV.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SLV.ASE&lColors=0x000000&sSym=SLV.ASE&hcmask=
Aktuell
121,86
Zeit
26.06.07 20:38
Diff. Vortag
-4,98%
Tages-Vol.
182,61 Mio.
Geh. Stück
1,5 Mio
Kapitalgesellschaft (KAG)KAG
iShares Public Limited Company
Anschrift
Mayor Street Lower
Dublin .., IE
Internet
--
Depotbank
--
Mitglied im BVI
Nein
Schuhverkäufe lassen Nike-Gewinn in die Höhe schießen
Der Sportartikelhersteller Nike hat seinen Gewinn gesteigert und von einer regen Nachfrage nach seinen Sportschuhen profitiert. Für das vierte Quartal gab das Unternehmen gestern nach Börsenschluss einen Nettogewinn von 438 Millionen Dollar (325 Mio. Euro) nach 333 Millionen Dollar im Vorjahreszeitraum bekannt.
Der Gewinn je Aktie ohne Sonderposten betrug 90 Cent, während von Reuters befragte Analysten 86 Cent erwartet hatten. Der Umsatz lag um neun Prozent höher bei 4,38 Milliarden Dollar. Nike-Aktien stiegen im nachbörslichen Handel um 2,4 Prozent auf 55,10 Dollar.
28.06.2007 15:11
Wall Street Vorbörse: Top-News auf einen Blick
New York (BoerseGo.de) - Apples iPhone kommt morgen auf den Markt
Atmel verdient 6 cents je Aktie gg. erwarteten 5 cents je Aktie
Bed Bath&Beyond verdient 38 cents je Aktie gg. erwarteten 37 cents je Aktie
California Micro senkt die Prognosen
America`s Car-Mart verdient 12 cents je Aktie gg. erwarteten 10 cents je Aktie
Digital River verlieren vorbörslich wegen einer Gewinnwarnung über 10%
Ford kündigt eine Initiative für Null-Finanzierungen über 3 Jahre an
General Mills verdient 62 cents je Aktie gg. erwarteten 63 cents je Aktie
Gerber Scientific verdient 24 cents je Aktie gg. erwarteten 23 cents je Aktie
KB Homes weist einen Verlust von 1,93 Dollar je Aktie aus gg. einem erwarteten Gewinn von 7 cents je Aktie
Novellus stellt bei den Prognosen zu Gewinn, Erlös und Auftragseingängen nur ein Erreichen des unteren Zielbereichs in Aussicht
Paychex verdient 36 cents je Aktie gg. erwarteten 36 cents je Aktie
Rite-Aid verdient 4 cents je Aktie gg. einem erwarteten Verlust von 1 cent je Aktie
Red Hat verdient 16 cents je Aktie und erzielt einen Erlös von 118,9 Millionen Dollar gg. erwarteten 15 cents je Aktie und einem erwarteten Erlös von 117,15 Millionen Dollar
Vodafone befindet sich mit Apple in Gesprächen über eine exklusive Vermarktung des iPhone in Europa
Am Tage eins vor iPhone…
Einmal werden wir noch wach – heißa, dann kommt das iPhone. Die schicke Handy-Email-Internet-Kalender-Taschenrechner-mp3-und-sonst-noch-was-Kombination von Apple wird ab Freitagabend 18 Uhr in die Läden kommen. Dem ersten Ansturm der Hightech-Camper nach dürfte das Gerät auch bald ausverkauft sein.
Das ist eigentlich erstaunlich, kostet das iPhone doch zwischen 500 und 600 Dollar und sollte damit eigentlich nur für einen kleinen Teil der Bevölkerung interessant sein. Dass das Gerät dennoch Fans anzieht wie sonst nur der neueste Harry-Potter-Schinken im 30-Dollar-Format, hat allerdings einen Grund: Das iPhone ist nicht nur das soundsovielste Gadget, sondern in all seinen Funktionen revolutionär und damit – wirklich!!! – unwiderstehlich.
Das schlägt sich seit Monaten in einem Hype nieder, wie es ihn bislang um kein Produkt gegeben hat. Bereits 11 Millionen Zeitungs- und Magazin-Artikel sind über das iPhone geschrieben worden, die Suchmaschine Google verzeichnet zu dem Begriff mehr als 82 Millionen Treffer – diese Zeilen erweitern die schnell wachsende Liste. In den Hightech-Blogs wird das Gerät als „Jesus Phone“ verehrt.
Selbst die erfahrensten Gadget-Kritiker kriegen sich wenige Tage vor der Auslieferung des Wunderhandys kaum noch ein. Walt Mossberg, seit mehr als einem Jahrzehnt als Hightech-Experte des Wall Street Journal die Koryphäe schlechthin, nennt das iPhone „das schönste Handheld-Gerät aller Zeiten“ und überschlägt sich auch in der Beschreibung von einzelnen Features in Superlativen.
Er lobt beispielsweise den „besten Internet-Browser, den ich je auf einem Handy gesehen habe“, während sein Tech-Kollege David Pogue von der New York Times vor allem die Bedienfreundlichkeit nutzt. Die Software sei „schnell, wunderschön und unglaublich einfach zu bedienen“, wird da geschwärmt. Das kann auch nachvollziehen, wer ein 20-minütiges Werbefilmchen auf der Apple-Webseite anschaut. Wenn der Hersteller „den besten iPod aller Zeiten“ herausstellt und Funktionen wie Börsen- und Wetterdaten lobt, mag auch der kritischste Beobachter nicht widersprechen.
Sicher, einige Details sind immer gewöhnungsbedürftig. Weil das iPhone keine Tastatur hat, sondern Telefonnummern, Emails und sonstige Details über einen Touchscreen eingegeben werden, wollte Kritiker Mossberg das Teil „nach drei Tagen aus dem Fenster werfen“. Nach fünf Tagen aber sei er soweit an die Tastatur gewöhnt gewesen, dass er schneller getippt hätte als auf jedem anderen Handheld.
Eine Schwachstelle sehen Mossberg und nahezu alle seine Kollegen dennoch: Der Exklusivvertrag, den Apple mit AT&T als Mobilfunk-Partner geschlossen hat, dürfte manchen User vergrätzen. Der Dow-notierte Branchenriese AT&T mag zwar das größte Netz in den USA haben, dessen Qualität variiert aber von Ort zu Ort. Wer in einer Gegend lebt, in der AT&T nur einen schwachen Empfang bietet, der kann mit dem schönsten und vielseitigsten iPhone nichts anfangen – denn es taugt nicht zum Telefonieren.
Zudem arbeitet das iPhone auf AT&T mit dem Datennetz Edge, das zu den langsamsten der Mobilfunkbranche gehört. Die Webseite der New York Times, mit der Apple in iPhone-Filmchen wirbt, habe in persönlichen Tests 55 Sekunden lang geladen, schimpft der Kritiker Pogue, Amazon.com habe 100 Sekunden gebraucht und Yahoo unglaubliche zwei Minuten.
Ein Providerwechsel ist dennoch nicht möglich, denn das iPhone kann nicht geöffnet werden. Weder die Sim-Karte noch die Batterie können ausgewechselt werden, ohne das Gerät an den Hersteller zu schicken.
Doch von solchen praktischen Einwänden dürfte sich kaum ein Gadget-Fan abhalten lassen, am Freitag die Apple- und AT&T-Läden zu stürmen. Wer in der Produktpräsentation gesehen hat, wie sich Kontaktadressen und Schallplatten per Fingerzeig durchblättern lassen, wie Fotos intuitiv vergrößert und verkleinert werden, wie problemlos Konferenzschaltungen geführt werden können, der wird nicht widerstehen können. Zumal es ja durchaus die Hoffnung gibt, dass AT&T die Gewinne aus dem massiven Kundenansturm nutzen wird, um das eigene Netz zu verstärken.
Lars Halter
28.06.2007 17:11
Google: Skeptischer Brokerkommentar belastet Aktienkurs
Mountain View, California (BoerseGo.de) - Die Aktien von Google (Nachrichten/Aktienkurs) leiden derzeit noch unter einem skeptischen Brokerkommentar, der den Kurs bereits gestern ins Rutschen brachte.
Analyst Jordan Rohan von RBC Capital hatte sich gestern vorsichtig zu Google geäußert. Jordan hält zwar an seinem Urteil Outperform fest, traut der Aktie aber kurzfristig nur wenig Spielraum zu.
Kurzfristig sieht der Analyst einige Belastungsfaktoren:
Das europäische Suchgeschäft leide in diesem Quartal unter der üblichen saisonalen Sommerschwäche
Die im vergangenen Jahr zugekaufte Tochte YouTube bewege sich in einer Übergangsphase mit hohen Kosten für neue Partnerschaften
Der Rivale Microsoft könnte im Juni Google Marktanteile im Suchmaschinengeschäft abgenommen haben
Für das laufende Quartal stellt Rohan einen Gewinn von 3.44 Dollar je Aktie in Aussicht. Der Konsens geht von 3.58 Dollar aus.
Google bröckelt momentan 0,17% auf 525.39 Dollar.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Google ist schön angestiegen, aber wenn ich Google mit anderen Werten vergleiche, sieht es nicht mehr so krass aus! Da kommen ganz sicher einige M-Dax-Werte ganz locker mit :)!
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
z.B. DIE!!
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&ind0=VOLUME&¤cy=&lSyms=SZG.ETR&lColors=0x000000&sSym=SZG.ETR&hcmask=
CryoCor, Inc.
28.06.07 17:38 Uhr
4,68 USD
+84,25 % [+2,14]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CRYO.NAS&lColors=0x000000&sSym=CRYO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CRYO.NAS&lColors=0x000000&sSym=CRYO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CRYO.NAS&lColors=0x000000&sSym=CRYO.NAS&hcmask=
Börse
NASDAQ
Aktuell
4,68 USD
Zeit
28.06.07 17:38
Diff. Vortag
+84,25 %
Tages-Vol.
9,62 Mio.
Gehandelte Stück
2,1 Mio.
Headline Maker: Approval of CryoCor's PMA Recommended by FDA Advisory Panel
Jun 28, 2007 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NASDAQ market has brought this company to the attention of our research team. CryoCor, Inc. (Nasdaq: CRYO), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.
June 27 - CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced that the Advisory Panel of the United States Food and Drug Administration, or FDA, recommended that CryoCor's application for pre-market approval, or PMA, for the treatment of atrial flutter be approved by the FDA. The meeting of the Advisory Panel was held on June 27, 2007 and a decision from the FDA on CryoCor's PMA is expected in August 2007. The FDA usually follows the recommendation of its Advisory Panels; however, it is not required to do so.
Dr. Helen Barold, M.D. said, "We are pleased with the decision by the Advisory Panel to recommend our PMA for approval and look forward to the FDA's decision in August. We also look forward to working with the FDA to finalize the proper labeling for our medical device and begin our commercialization efforts in the United States."
About CryoCor
CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System, or the Cryoablation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, or AF, and atrial flutter, or AFL, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor is conducting a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of AF, and has submitted a PMA for the treatment of AFL. For more information please visit the Company's website at http://www.cryocor.com During morning trading shares are up 88% to $4.78 with over 200,000 in volume. The Market Gainer Research Team will continue to gauge the short and long term affects that this announcement will have on the company
PROS Holdings, Inc. Announces Pricing of Initial Public Offering
HOUSTON, Jun 27, 2007 (BUSINESS WIRE) -- PROS Holdings, Inc. (NYSE: PRO) today announced the pricing of its initial public offering of 6,825,000 shares of common stock at $11.00 per share, including 1,706,250 million shares being offered by certain selling stockholders of PROS. PROS' common stock will be listed on the New York Stock Exchange under the symbol "PRO."
The shares are being sold through underwriters led by JPMorgan Securities Inc. and Deutsche Bank Securities Inc., as joint book-running managers, and Jefferies & Company, Inc. and Thomas Weisel Partners LLC, as co-managers. The selling stockholders of PROS have granted the underwriters a 30-day option to purchase up to an additional 1,023,750 additional shares to cover over-allotments, if any.
http://chart.bigcharts.com/custom/frt-com/big.chart?symbol=PRO&sid=2766753&time=2dy&freq=5mi&compidx=aaaaa%7E0&ma=0&maval=50&uf=197632&lf=1&lf2=0&lf3=0&ctype=64&style=1968&size=1&pwidth=578&symb=PRO&type=64&mocktick=1&country=US&rand=2544
ABBCD ABINGTON BANCORP, INC. COMMON
9.85 6.45 (-39.50%) 1,174,900 Vol.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ABBCD.NAS&lColors=0x000000&sSym=ABBCD.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ABBCD.NAS&lColors=0x000000&sSym=ABBCD.NAS&hcmask=
Digital River, Inc.
28.06.07 17:57 Uhr
45,46 USD
-10,28 % [-5,21]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=DRIV.NAS&lColors=0x000000&sSym=DRIV.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=DRIV.NAS&lColors=0x000000&sSym=DRIV.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DRIV.NAS&lColors=0x000000&sSym=DRIV.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DRIV.NAS&lColors=0x000000&sSym=DRIV.NAS&hcmask=
Börse
NASDAQ
Aktuell
45,46 USD
Zeit
28.06.07 17:57
Diff. Vortag
-10,28 %
Tages-Vol.
306,30 Mio.
Gehandelte Stück
7,5 Mio
Digital River Cuts Outlook
Jun 28, 2007 (financialwire.net via COMTEX) -- June 28, 2007 (FinancialWire) Digital River (NASDAQ: DRIV) has slashed its second quarter and full year financial forecasts due to slower than expected business from key clients.
The company manages online business commerce and said that it now estimates second quarter revenue to be around $78 million, down from earlier estimates of $85 million. Digital River's chief executive cited delays related to the transition of Symantec's (NASDAQ: SYMC) global subscription business and drops from Micrososft (NASDAQ: MSFT) as responsible for the revision Shares of Digital River fell 13% on the news to close at $43.90 in after hours trading.
The company also said that it has authorized an expanded share buyback program of up to $200 million of its common stock.
MERIDIAN GOLD INC.
28.06.07 17:57 Uhr
27,88 USD
+14,26 % [+3,48]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MDG.NYS&lColors=0x000000&sSym=MDG.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MDG.NYS&lColors=0x000000&sSym=MDG.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MDG.NYS&lColors=0x000000&sSym=MDG.NYS&hcmask=
Börse
NYSE
Aktuell
27,88 USD
Zeit
28.06.07 17:57
Diff. Vortag
+14,26 %
Tages-Vol.
117,26 Mio.
Gehandelte Stück
4,2 Mio.
DJ Meridian Gold To Review Yamana Gold Plan >MDG
Jun 28, 2007 (Dow Jones Commodities News via Comtex) -- DOW JONES NEWSWIRES
Meridian Gold Inc. (MDG) said its board will review the announcement by Yamana Gold Inc. (AUY) that it plans to make an offer to acquire Meridian.
The Reno, Nev., mining company said no formal offer has been made by Yamana, and Meridian won't comment further on the situation until it completes its review.
Yamana on Wednesday said it has entered an agreement to combine with Northern Orion Resources Inc. (NTO), in a deal that is contingent upon Yamana's purchase of two-thirds of Meridian's shares.
Meridian's New York Stock Exchange-listed shares were recently up $4.60, or 19%, at $29.
BUILD A BEAR WORKSHP
28.06.07 18:49 Uhr
25,77 USD
+14,48 % [+3,26]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=BBW.NYS&lColors=0x000000&sSym=BBW.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=BBW.NYS&lColors=0x000000&sSym=BBW.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=BBW.NYS&lColors=0x000000&sSym=BBW.NYS&hcmask=
Börse
NYSE
Aktuell
25,77 USD
Zeit
28.06.07 18:49
Diff. Vortag
+14,48 %
Tages-Vol.
50,51 Mio.
Gehandelte Stück
2,1 Mio.
Breaking News: Build-A-Bear Workshop, Inc. Announces It is Evaluating Strategic Alternatives for Enhancing Long-Term Shareholder Value
Jun 28, 2007 (M2 PRESSWIRE via COMTEX) -- Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs. While working to keep you in touch with market activity, we also will keep you updated on the latest press. Today, June 28 2007, we have identified, Build-A-Bear Workshop, Inc. (NYSE: BBW) due to the attention they received after this recent corporate developments.
Build-A-Bear Workshop, Inc. (NYSE: BBW), an interactive, entertainment retailer of customized stuffed animals, announced today that the company has retained Lehman Brothers to assist it and the board of directors in an analysis and consideration of a broad range of potential strategic alternatives to enhance long-term shareholder value.
"We believe that through our highly profitable business model and unique retail-entertainment concept we will continue to grow total revenues, increase net income, and generate excess cash flow", said Maxine Clark, chairman and chief executive bear. "Our future success and the drivers of our future growth will continue to be to implement our strategy of expanding our North American store base to at least 350 stores, building our European store base to approximately 120 stores, growing our international franchising operations to approximately 300 stores, developing and growing our existing portfolio of new concepts and brand extensions, and investing in our interactive website. That said, we also believe that we have an obligation to shareholders to consider a broad range of potential strategic alternatives that could further enhance shareholder value. During this evaluation process, we will continue to remain focused on business as usual for all operations of our company and on executing our plans."
There is no assurance that this process will result in any changes to the company's current business plans or lead to any specific action or transaction. However, while the process is underway, the company does not expect to disclose further developments regarding the process until the Board's review of strategic alternatives has been completed. Also, during the process, the company will not provide any new earnings guidance, nor will the company update or comment further upon the earnings guidance previously provided.
Build-A-Bear Workshop plans to release financial results for the second quarter on Thursday, July 26, 2007, before the opening of trading on the New York Stock Exchange.
LSI CORPORATION
28.06.07 20:00 Uhr
7,77 USD
-10,07 % [-0,87]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=LSI.NYS&lColors=0x000000&sSym=LSI.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=LSI.NYS&lColors=0x000000&sSym=LSI.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=LSI.NYS&lColors=0x000000&sSym=LSI.NYS&hcmask=
Börse
NYSE
Aktuell
7,77 USD
Zeit
28.06.07 20:00
Diff. Vortag
-10,07 %
Tages-Vol.
342,89 Mio.
Gehandelte Stück
44 Mio.
LSI Corporation: Magnum Semiconductor Agrees To Acquire LSI Consumer Products Business
Jun 28, 2007 (M2 PRESSWIRE via COMTEX) -- LSI Corporation (NYSE: LSI) and Magnum Semiconductor, Inc. announced today that they have entered into a definitive agreement under which Magnum will acquire the LSI consumer products business in a transaction to be funded by private equity investment.
The combination of each company's consumer products portfolio is expected to allow Magnum to strengthen its position as a leading provider of chips, software and platforms for consumer entertainment systems. The sale of the consumer products business will enable LSI to focus its investments on its businesses in the storage, networking and mobility market segments. The transaction is expected to close in the third quarter and is not subject to regulatory approval. Financial terms are not being disclosed.
Jack Guedj, president and CEO of Magnum Semiconductor, said, "By taking this step we bring in people, talent and products that will accelerate our revenue ramp and our R&D efforts. Magnum now becomes one of the leaders in audio/video chips and software for the consumer electronics market. We also gain access to the market for professional broadcast solutions that deliver content to consumers." With this transaction, Magnum Semiconductor strengthens the company's existing DVD, digital TV and digital entertainment centre solutions while also adding MPEG-2 and H.264 high-definition media processing and low-power 3D graphics products to its portfolio. "Combining Magnum Semiconductor and the LSI consumer products business enhances and expands the products and services we offer to consumer electronics manufacturers worldwide," Guedj said.
Abhi Talwalkar, LSI president and CEO, said, "After exploring a full range of strategic options, we have determined that the best opportunity for the long term success of our consumer products business is an external one. The combination of both companies' strong product portfolios, together with strong backing from top-tier private equity firms and a solid technical and management team will position Magnum to achieve scale and success in the consumer electronics market."
The definitive agreement is the result of an ongoing strategic review within LSI of its business portfolio following its merger with Agere Systems on April 2, 2007.
Under the terms of the agreement, Magnum will purchase the LSI DoMiNo , Domino[X] and Zevio architectures, products and related IP of the LSI consumer products business. Additionally, Magnum will offer employment to a significant number of LSI employees associated with the business. The two companies will also work together to seamlessly transition the business to continue to offer customers the highest quality products, services and support.
28.06.2007 21:07
DELL - Hut ab!
Dell - Kürzel: DELL - ISIN: US24702R1014
Börse: Nasdaq in USD / Kursstand: 28,54 $
Kursverlauf vom 25.10.2006 bis 28.06.2007 (log. Kerzenchartdarstellung / 1 Kerze = 1 Tag)
Kurz-Kommentierung: Die DELL Aktie (Nachrichten/Aktienkurs) erreichte nach einer Aufwärtsbewegung im Juni 2007 das Novemberhoch bei 27,89 $ und prallte leicht nach unten hin ab. Letztendlich etablierte sich die Aktie aber oberhalb der charttechnischen Horizontalunterstützung bei 26,71 $. Ausgehend davon kann die Aktie wieder zu einer synamischen Aufwärtsbewegung ansetzen und erreicht in Kürze den 28,80er Widerstand. Die Aktie befindet sich in einer intakten Trendbewegung, sodass ein Kursausbruch über 28,80 $ wahrscheinlich erscheint. Ein mittelfristiges Kursziel läßt sich bei 35,00 $ ausmachen. Wichtig ist in diesem Zusammenhang, dass die Aktie nicht unter 26,71 $ abrutscht.
http://img.godmode-trader.de/charts/30/2005/abc6656.gif
02.07.2007 20:07
Aktien mit neuen 52-Wochen-Hochs und -Tiefs
Nachfolgend eine Auflistung einiger Aktien, die heute neue 52-Wochen-Hochs erreicht haben. Die Liste ist nach dem bisher gehandelten Volumen sortiert.
http://img.godmode-trader.de/charts/30/2005/abc6684.gif
Nachfolgend eine Auflistung einiger Aktien, die heute neue 52-Wochen-Tiefs erreicht haben. Die Liste ist nach dem bisher gehandelten Volumen sortiert.
http://img.godmode-trader.de/charts/30/2005/abc6685.gif
02.07.2007 19:31
EXXON - Ziemlich genau "ausgelotet"
Exxon (Nachrichten/Aktienkurs) -Kürzel: XOM - ISIN: US30231G1022
Börse: NYSE in USD / Kursstand: 84,81 $
Kursverlauf vom 13.10.2006 bis 02.07.2007 (log. Kerzenchartdarstellung / 1 Kerze = 1 Tag)
Rückblick: Die EXXON Aktie markierte nach einer langfristigen Aufwärtsbewegung im Dezember 2006 ein neues AllTimeHigh bei 79,00 $ und startete eine Abwärtskorrektur in einem bullischen Keil. Nach dem Ausbruch aus dem Keil lief sie steil auf ein neues AllTimeHigh bei 86,58 $. Wir hatten die daran anschließende Konsolidierungsphase begutachtet und sind zu dem Ergebnis gekommen, dass die Aktie erneut den 81,76er Bereich bullisch "abklopfen" sollte. Zur Demonstration haben wir den Chart aus dem Vorgängercheck als unteren Chart mit eingebunden.
Charttechnischer Ausblick: Die Aktie konnte somit unseren erwarteten Fahrplan abarbeiten und liegt auch im heutigen Handel deutlich im positiven Bereich. Ein Einstieg auf jetzigem Niveau wäre von einem schlechten Chance/Risiko Verhältnis begleitet. Ein weiteres charttechnisches Kaufsignal entsteht, wenn es zu einem Kursausbruch über das letzte Bewegungshoch bei 86,58 $ kommt. Erst dann kann aus charttechnischer Sicht prozyklisch gekauft werden.
http://img.godmode-trader.de/charts/30/2005/abc6682.gif
02.07.2007 19:55
3M COMPANY - Bullenversammlung, so oder so!
3M COMPANY Kürzel: MMM - ISIN: US88579Y1010
Börse: Nasdaq in USD / Kursstand: 87,48 $
Kursverlauf vom 12.11.2006 bis 02.07.2007 (log. Kerzenchartdarstellung / 1 Kerze = 1 Woche)
Rückblick: Die Aktie von 3M COMPANY (Nachrichten/Aktienkurs) befindet sich seit 1988 in einem übergeordneten langfristigen Aufwärtstrend, der unverändert intakt ist. Am 06.07.04 wurde ein neues, markantes Hoch bei 90,29 $ ausgebildet. In Kürze dürfte dieses Etappenziel erneut erreicht werden. Das Kursgeschehen seit dem Rallyehoch bei 89,03 $ reflektiert formationstechnisch ein symmetrisches Dreieck. Dieses wird in der Regel in Richtung des übergeordneten Trends, in diesem Fall ein Aufwärtstrend, aufgelöst.
Charttechnischer Ausblick: Mit der charttechnischen Formation dürfte die Aktie sich weiteres Aufwärtspotenzial verschaffen. Ein Tagesschlusskurs über 88,00 $ kann bereits als weitere Bestätigung herangezogen werden. Grundsätzlich bleibt die bullische Dreiecksformation intakt, solange die Aktie nicht unter 86,00 $ abrutscht. In diesem Fall wäre alternativ ein Kursrutsch bis leicht unter 84,00 $ zu erwarten, bevor es zu neuen Jahreshöchstsständen übergeht.
http://img.godmode-trader.de/charts/30/2005/abc6683.gif
04.07.2007 18:44
Pfizer weist Vorwurf von rechtswidrigen Pharmatests zurück
KANO (AP)--Der US-Pharmakonzern Pfizer (Nachrichten/Aktienkurs) hat Vorwürfe von rechtswidrigen Medikamententests an Kindern in Nigeria abermals zurückgewiesen. Vor einem Gericht in Kano im Norden des westafrikanischen Landes beantragte das Unternehmen am Mittwoch, eine Zivilklage auf Entschädigung von umgerechnet 1,46 Mrd EUR nicht zuzulassen. Die Anwälte begründeten dies mit Verfahrensfehlern. Der Richterspruch wird für den 30. Juli erwartet.
Unabhängig läuft gegen Pfizer bereits ein weiteres Verfahren, in dem die nigerianische Regierung Entschädigungsleistungen in Höhe von 5,14 Mrd EUR fordert. Zudem sollen sich mehrere Manager des Pharmakonzerns strafrechtlich wegen der Experimente aus dem Jahre 1996 verantworten. In letzterem Fall ist für den 9. Juli eine weitere Anhörung vorgesehen. Der Konzern hat die Vorwürfe stets zurückgewiesen. Eine in New York eingereichte Klage gegen Pfizer wurde dort im Jahre 2001 verworfen.
In den Prozessen geht es um die experimentelle medizinische Behandlung von Kindern während einer Meningitis-Epidemie in Kano 1996. Dabei erhielten 100 Kinder das Testmedikament "Trovan". 100 weitere bekamen ein bereits zugelassenes Antibiotikum - allerdings nicht in der vorgeschriebenen Menge, wie die Anwälte der betroffenen Familien argumentieren. Bis zu elf an der Studie beteiligte Kinder starben, zahlreiche weitere erlitten Hirnschäden und Lähmungen. Pfizer sieht darin jedoch keinen Zusammenhang mit den Medikamententests.
Die nigerianische Regierung macht Pfizer auch dafür verantwortlich, dass die Bevölkerung das Vertrauen in die einheimischen Gesundheitssysteme verloren hat. So hätten muslimische Geistliche auf den Meningitis-Fall verwiesen, um ein Impfprogramm gegen Polio zu verhindern.
Webseite: http://www.pfizer.com
DJG/nas
GENERAL MOTORS : Risiko einer Korrektur unter den ...
http://www.fimatex.de/includes/news/attachement_news.phtml?id=980793
GENERAL MOTORS : Risiko einer Korrektur unter den Widerstandslinien.
ZUSAMMENFASSUNG
Der MACD ist positiv und liegt über seiner Signallinie. Diese Konstellation unterstreicht die gute Ausrichtung des Papiers.Dennoch befindet sich der RSI in der Überkaufzone - kurzfristig ist mit einer technischen Korrektur zu rechnen.Außerdem ist die Stochastik sehr hoch, was ebenfalls auf ein hohes Risiko im Falle einer abrupten Umkehr hindeutet.Die gehandelten Volumen liegen unter dem Durchschnitt der Volumen der letzten 10 Tage.
BEWEGUNGEN UND AKTIENSTÄNDE
Das Papier erlebt eine Hausse. Es liegt über seinem beweglichen Durchschnitt über 50 Tage. Der Stand des beweglichen Durchschnitts über 20 Tage (höher als der bewegliche Durchschnitt über 50 Tage) stimmt optimistisch hinsichtlich der mittelfristigen Aussichten. Die ersten Kaufniveaus sind die Unterstützungslinien bei 34,59 USD, und dann bei 31,88 USD - nur die Widerstandslinien bei 42,71 USD, dann bei 45,42 USD, könnten die Kurse dämpfen.
Letzter Kurs : 37.98
Einschätzung : Neutral
Tendenz : kurzfristiges Ausbruchspotential
Unterstützung : 34.59 / 31.88
Widerstand : 42.71 / 45.42
Dividenden
Clevere Spiele
Von Sam Stovall
http://www.faz.net/m/%7B30B0016B-9987-4915-9651-D9F368944897%7DPicture.jpg
05. Juli 2007
Während Angst und Gier Aktienkurse kurzfristig in die Höhe treiben, erweisen sich Gewinne und Dividenden als langfristige Triebfedern. Die Anleger betrachten das Gewinnwachstum als ihren indirekten Ertragsvorteil, da höhere Gewinne üblicherweise die Aktienkurse steigen lassen.
Leider muss man die Aktien verkaufen, um die Gewinne auf dem Papier in echte Gewinne zu verwandeln. Dividenden dagegen erhält man, ohne seine Aktien abstoßen zu müssen, was sie für den ertragsorientierten Anleger attraktiver macht. Darüber hinaus können Dividenden den Anlegern auch ein wenig emotionale Unterstützung bieten, da sie Kursrückgänge bis zum Wert der Dividendenrendite kompensieren.
Abschwächung der Expansion
http://www.faz.net/m/%7BB275A9F1-48CF-4647-9DE0-BB586D689CBA%7DPicture.jpg
Üblicherweise greifen Anleger in einer frühen Phase des Börsenzyklus' nach Aktien mit niedrigen Dividenden, da hinter diesen im Allgemeinen kleinere, volatilere Emissionen stehen, deren Gewinnwachstum (und damit auch der Aktienkurs) schneller zulegen dürfte, wenn sich eine beginnende wirtschaftliche Expansion abzeichnet. Wird jedoch eine Verlangsamung des Wirtschaftswachstums erwartet, so werden üblicherweise die ertragsstärkeren Papiere bevorzugt, da die Anleger in einer Zeit, in der man mit einem weniger sicheren Gewinnwachstum rechnen muss, „fürs Warten bezahlt werden“.
Unserer Ansicht nach ziehen sich Wirtschaftsaufschwung und Bullenmarkt derzeit etwas in die Länge. Der Wirtschaftsaufschwung in den Vereinigten Staaten begann im November 2001, also vor mehr als 66 Monaten. Typische Expansionen seit 1945 hielten im Durchschnitt 60 Monate an. Der aktuelle Bullenmarkt begann Anfang Oktober 2002 und dauert nun schon beinahe 57 Monate an - drei Monate länger als der Durchschnitt seit dem Zweiten Weltkrieg. Letztendlich erwarten Aktienanalysten, dass sich das Wachstum der Unternehmensgewinne im S&P 500 abschwächen und 2007 nur um 7,3 Prozent steigen wird. Im Jahr 2006 hatte es noch um 14,7 Prozent zugelegt.
Dividendenkönige in Indizes
http://www.faz.net/m/%7BFF5F7376-4898-472C-9D62-C2934EE52B19%7DPicture.jpg
Ein an börsengehandelten Fonds (ETF) interessierter Anleger wäre gut beraten, sich den Large-Cap-Emissionen, Wertorientierungen und defensiven Sektoren zuzuwenden. Wie aus der Infografik ersichtlich wird, liefert der Large-Cap-Bereich des S&P 500 mit 1,8 Prozent die höchsten Renditen unter den drei Bezugswerten des amerikanischen Aktienmarkts. In allen drei Größenkategorien bieten die Wertkomponenten eine Rendite, die sich 55 bis 81 Prozent oberhalb ihres jeweiligen Bezugswerts befindet.
Für diejenigen Anleger, die Einzelaktien bevorzugen, gibt es zwei Möglichkeiten, am Aktienmarkt nach ertragsstarken Kandidaten zu suchen. Erstens sollte man nach jenen Teilbereiche des S&P 500 Ausschau halten, denen die S&P-Analysten positive grundlegende Aussichten bescheinigen und die 4- und 5-Sterne-Aktien beinhalten (siehe Infografik).
http://www.faz.net/m/%7B8A0437DA-9FF8-4534-90DF-1F043D8B54FE%7DPicture.jpg
http://www.faz.net/m/%7B97CCD040-BB58-40DF-9A2A-94223D34D2A3%7DPicture.jpg
http://www.faz.net/m/%7B41BBB323-0FAF-4B3F-A40C-7C3AE252CD61%7DPicture.jpg
http://www.faz.net/m/%7B094F3C11-C954-4B15-AA84-1074DB689D80%7DPicture.jpg
http://www.faz.net/m/%7B9A670ECB-A5BE-4DF5-8968-E3FA4213A214%7DPicture.jpg
http://www.faz.net/m/%7B1938BE54-3EE7-4715-B415-02AE27D5B819%7DPicture.jpg
http://www.faz.net/m/%7B3EF5B00B-6EBE-40AD-8369-7FA479843AB1%7DPicture.jpg
http://www.faz.net/m/%7B9FE59D9A-BE85-4B70-B3C8-0CFA543A4450%7DPicture.jpg
http://www.faz.net/m/%7B8F2C4006-509B-4AD2-8A31-DCA032C86450%7DPicture.jpg
http://www.faz.net/m/%7B6E84590D-4093-408C-B423-64CE91A8463A%7DPicture.jpg
http://www.faz.net/m/%7B3F3A65A6-B89E-4CDF-8D53-5790D73E19B3%7DPicture.jpg
http://www.faz.net/m/%7B4DE38614-99C7-44F3-90E0-FBF1CED8785F%7DPicture.jpg
http://www.faz.net/m/%7BD131E813-CF4F-4DAA-B716-845F00368727%7DPicture.jpg
http://www.faz.net/m/%7B59C7D96D-9A50-45E5-90EC-CD31C408F1B2%7DPicture.jpg
http://www.faz.net/m/%7B9ECD3C55-3B79-48D8-BE89-933527B4501E%7DPicture.jpg
http://www.faz.net/m/%7BAD8ED04B-E52D-4B10-B855-46B7F8BE4A15%7DPicture.jpg
http://www.faz.net/m/%7B47360906-7155-44BA-94C2-6BC13B6A273E%7DPicture.jpg
Da haben wir es also. Es stehen eine Menge Anlagetechniken zur Verfügung. Eine davon konzentriert sich auf hohe Renditen. Lassen Sie sich jedoch nicht vom Schein trügen. Wenn die Rendite ab und an zu gut erscheint, um wahr zu sein, dann ist sie das wahrscheinlich auch. Andere Unternehmen bieten zwar hohe Renditen, weisen aber eine geringe Zahl an S&P-Sternen auf (vgl. Infografik).
Sam Stovall ist Chefstratege von S&P.
Text: Business Week Online
Bildmaterial: FAZ.NET
Applied Micro Circuits Corporation
06.07.07 21:09 Uhr
2,81 USD
+15,16 % [+0,37]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AMCC.NAS&lColors=0x000000&sSym=AMCC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AMCC.NAS&lColors=0x000000&sSym=AMCC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AMCC.NAS&lColors=0x000000&sSym=AMCC.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,81 USD
Zeit
06.07.07 21:11
Diff. Vortag
+15,16 %
Tages-Vol.
35,65 Mio.
Gehandelte Stück
13 Mio.
Preliminary first quarter results declared by AMCC
Jul 06, 2007 (M2 EQUITYBITES via COMTEX) -- Applied Micro Circuits Corporation (AMCC) (Nasdaq: AMCC) on 5 July announced preliminary revenue results for the first quarter of fiscal 2008 ended 30 June 2007. AMCC expects to report net revenues of approximately USD50m in the first quarter, an approximate 29% decline as compared with revenues in the prior quarter. The company had provided guidance for first quarter revenues to be approximately USD59.6m. This decline in revenues was reportedly a result of a decline in revenues in all business lines except storage, which grew as anticipated. Sales to distributors were down nearly 28% sequentially.
NEWMONT MIN CP (HLDG
06.07.07 21:13 Uhr
41,98 USD
+6,06 % [+2,40]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NEM.NYS&lColors=0x000000&sSym=NEM.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NEM.NYS&lColors=0x000000&sSym=NEM.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=NMC.TOR&lColors=0x000000&sSym=NMC.TOR&hcmask=
Börse
NYSE
Aktuell
41,98 USD
Zeit
06.07.07 21:13
Diff. Vortag
+6,06 %
Tages-Vol.
608,34 Mio.
Gehandelte Stück
15 Mio
DJ PRECIOUS METALS HIGHLIGHTS: Top Stories Of The Day
Jul 06, 2007 (Dow Jones Commodities News via Comtex) -- TOP STORIES:
Newmont To Eliminate Gold Hedges, Discontinue Merchant BankingNewmont Mining Corp. (NEM) said late Thursday it is eliminating its entire 1.85
million-ounce gold hedge position and plans to discontinue its merchant banking
segment.
Parametric Technology Corporation
06.07.07 21:26 Uhr
17,175 USD
-20,38 % [-4,395
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=PMTC.NAS&lColors=0x000000&sSym=PMTC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=PMTC.NAS&lColors=0x000000&sSym=PMTC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PMTC.NAS&lColors=0x000000&sSym=PMTC.NAS&hcmask=
Börse
NASDAQ
Aktuell
17,175 USD
Zeit
06.07.07 21:26
Diff. Vortag
-20,38 %
Tages-Vol.
271,93 Mio.
Gehandelte Stück
18 Mio
PTC Positioning for Pre-Market Open Deep in the Red, Near Late After-Hours Levels
Boston, Jul 06, 2007 (MidnightTrader via COMTEX) -- Stock is recording an early ask of 17.19 after tumbling 21% to 16.95 late in Thursday's after-hours session. Volume interest remains light at this hour.
MidnightTrader's After-Hours Trading Range Analysis: PMTC
Boston, Jul 05, 2007 (MidnightTrader via COMTEX) -- PTC (PMTC): Stock was released from an after-hours trading halt and dove through the 17.86 mark to 16.98. It attempted to hold support surrounding 17, but sellers funneled in some decent downside pressure that took it from 17 to a mid-session low of 16.66. Buyers grew more confident off this low, but their efforts hit a fairly strong ceiling at 16.99 to 16.90. After-hours indications would suggest PMTC records a pre-market open Friday just below 17. We would initially look for any strength back near 17.50 to 17.40 for potential short entry points tomorrow as this level recorded firm downside pressure. More risk tolerant shorts may want to bring the entry closer to 17, perhaps 17.20 to 17.10, levels that got some brief downside interest earlier in tonight's session and where some of tomorrow's early buy activity may get some touches if tonight's ceiling near 17 breaks.
Baidu.com, Inc. - ADS
06.07.07 21:31 Uhr
196,72 USD
+6,34 % [+11,73]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=BIDU.NAS&lColors=0x000000&sSym=BIDU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=BIDU.NAS&lColors=0x000000&sSym=BIDU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=BIDU.NAS&lColors=0x000000&sSym=BIDU.NAS&hcmask=
Börse
NASDAQ
Aktuell
196,72 USD
Zeit
06.07.07 21:31
Diff. Vortag
+6,34 %
Tages-Vol.
1,25 Mrd.
Gehandelte Stück
6,6 Mio.
CHINA'S BAIDU TEAMS UP WITH ROCK RECORDS FOR ONLINE MUSIC
BEIJING, Jul 06, 2007 (AsiaPulse via COMTEX) -- Baidu.com, one of China's largest internet search engine, has got approval from a leading Chinese language record company to provide free music for online users, signaling a new approach from record companies looking to cooperate with websites rather than confront them.
Internet advertising will be displayed while users listen to the music, while Rock Records Co. Ltd. and Baidu (NASDAQ: BIDU) will share revenues generated by the advertisements, according to an agreement between the two sides.
"This partnership reflects growing industry recognition of the advertising-supported free music streaming model," said Baidu chairman and CEO Robin Li.
Sam Duann, founder of Rock Records Co. Ltd., said "By leveraging Baidu's leading position in the Chinese language search market and its premier digital music platform, this partnership will bring value to music lovers, record companies and advertisers alike."
However, Baidu was sued last year by seven record companies including EMI, Sony BMG, Warner Music and Universal Music for allegedly engaging in illegal downloading and playing 137 pieces of music owned by the record companies online without their permission.
Beijing's First Intermediate Court ruled that Baidu's service, which provides web links to the music, does not constitute an infringement as all the music is downloaded from web servers of third parties.
The agreement between Rock Records and Baidu.com came six months after a similar agreement between EMI and Baidu
Genzyme Corporation - Genzyme Corporation Common Stock
06.07.07 21:36 Uhr
61,17 USD
-5,70 % [-3,70]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GENZ.NAS&lColors=0x000000&sSym=GENZ.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GENZ.NAS&lColors=0x000000&sSym=GENZ.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GENZ.NAS&lColors=0x000000&sSym=GENZ.NAS&hcmask=
Börse
NASDAQ
Aktuell
61,17 USD
Zeit
06.07.07 21:36
Diff. Vortag
-5,70 %
Tages-Vol.
812,44 Mio.
Gehandelte Stück
14 Mio.
Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
CAMBRIDGE, Mass., July 6, 2007 /PRNewswire-FirstCall via COMTEX/ -- Genzyme Corp. (Nasdaq: GENZ) announced top-line data today from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic, polymer therapy for patients with Clostridium difficile associated diarrhea (CDAD). The second Phase 3 study of tolevamer liquid is fully enrolled and results are expected later this year.
In this first Phase 3 study known as the Polymer Alternative for CDAD Treatment (PACT) study, tolevamer liquid did not meet its primary endpoint of non-inferiority to the standard prescribed oral dose of the antibiotic vancomycin, as measured by the percent of patients with resolution of CDAD. This result contrasts with the findings from Genzyme's earlier Phase 2 study of a solid oral dosage formulation of tolevamer that met its primary endpoint of non-inferiority compared to vancomycin.
Consistent with recent published studies, high rates of CDAD recurrences were observed in patients treated with either vancomycin or metronidazole. High CDAD recurrence rates were not observed in patients treated with tolevamer liquid. Tolevamer liquid was generally well tolerated with no unanticipated safety concerns. Data from this first Phase 3 study is expected to be presented at a future medical conference.
"These are disappointing results that alter our expectations about the potential for commercializing tolevamer in the near future," stated Henri A. Termeer, chairman and chief executive officer of Genzyme Corp. "The results of our second Phase 3 study will be available later this year and will help us determine what contribution tolevamer might be able to make in addressing this serious unmet medical need."
C. difficile has become one of the most significant infection control concerns in healthcare today. Physicians worldwide are confronting a worsening epidemic, with an alarming rise in the incidence of disease, higher numbers of patients with complications and more frequent failures of standard antibiotic therapy.
Tolevamer is designed to bind and neutralize the toxins released by C. difficile that damage the intestine. A non-antibiotic approach has the potential to treat CDAD and reduce the number of disease recurrences, resulting in improved quality of life for the patient and significant savings to the healthcare system.
About the PACT Study
The PACT study, which involved more than 1,100 patients at approximately 300 sites in North America, Europe, and Australia, is the largest of its kind ever to be conducted for CDAD. In this trial, tolevamer was compared to metronidazole and vancomycin. Aside from testing tolevamer's efficacy, this was also the first large, rigorously designed, multi-center clinical study that will compare the efficacy of the current standards of care.
About Clostridium difficile
C. difficile proliferates in the setting of altered normal colonic bacterial flora, most commonly due to the administration of broad-spectrum antibiotics. Once established in the colon, C. difficile produces toxins that disrupt the intestinal lining, causing cell death and inflammation that result in diarrhea and colitis.
Earlier studies have shown that even after successful treatment with the current standard of care, approximately 20 percent of patients experience a recurrence of CDAD potentially requiring repeat hospitalization. In addition, a subset of patients with CDAD develop multiple recurrences of the disease, with symptoms that may persist for years.
About Genzyme One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. Genzyme has been selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.
With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.
06.07.2007 20:23
Micron: Scharf anziehende DRAM-Preise beflügeln Aktienkurs
Boise, Idaho (BoerseGo.de) - Der Speicherchiphersteller Micron Technology Inc. (Nachrichten/Aktienkurs) ist heute sehr gefragt. Der Technologie-Titel profitiert davon, dass die Preise für die sogenannten flüchtigen Speicher (DRAM) derzeit scharf anziehen. Der auf diesen Markt spezialisierte Dienst DrameXchange.com beobachtet, dass die Juli-Kontrakt-Preise für DRAMs um 15% über dem Niveau vom Juni liegen.
„Das ist eine positive Überraschung für die Wall Street“, kommentiert Analyst Jay Choi von der Citigroup, der bislang von einem Wachstum von 10% ausgegangen war.
Mikcron klettert momentan 4,77% auf 13.41 Dollar.
Die Börse ist Microsoft gegenüber großzügig
Ganze 2 Cent - noch nicht einmal ein zehntel Prozent - hat Microsofts Aktie letzten Freitag abgegeben. Hätten die Anleger nicht heftiger reagieren müssen? Weitere Themen in diesem Kapital: UBS und Hedge-Fonds-Kredite.
Immerhin hat Microsoft zugegeben, dass es im prestigeträchtigen Spielkonsolenmarkt über die vergangenen Jahre größtenteils Schrott verkauft hat und man für die Behebung dieser Mangelware rund 1,1 Mrd. $ zurückgestellt hat.
http://www.ftd.de/asset/Image/2007/07/08/MICROSOFT_kap.gif
Microsoft kommt schon länger nicht mehr mit
Auch die Analysten zeigten sich fast unbeeindruckt, was mehrere Gründe haben kann. Entweder weil die Rückstellung pro Aktie mit nur 7 Cent zu Buche schlägt. Oder weil technische Mängel bei der Xbox nichts Neues sind. Oder aber, weil die Nachricht nicht in das rosige Microsoft-Bild der Banken passt. 26 Kauf-, 8 Halte- und eine Verkaufsempfehlung vereint der Wert auf sich. Das sah zwar Mitte 2006 schon mal etwas schwächer aus, aber von 2003 bis 2005 gab es fast ausschließlich Kaufempfehlungen. Dabei hinkt die Aktie seit 2002 dem S&P 500 um 40 Prozent hinterher.
Sei's drum. In jüngster Zeit konnte Microsoft wieder Boden gutmachen, vor allem weil das hochmargige Stammgeschäft gut läuft. Und das neue Betriebssystem Vista fängt gerade erst an, an Fahrt zu gewinnen. Das Spielegeschäft trug in den ersten sechs Monaten zwar 17 Prozent zum Umsatz bei, aber keinen Gewinn, sondern Verlust. Allerdings soll sich das im nächsten Jahr ändern, womit diese Sparte einiges zur Gewinndynamik beitragen soll. Ob die Kunden aber ähnlich schnell über die Sachmängel hinwegsehen wie die Broker, wird sich zeigen. Zudem könnte Sony mit einem Preisnachlass (derzeit 20 Prozent Prämie zur Xbox) die Verkäufe weiter verlangsamen.
UBS
Ein Wechsel der Führungsspitze kann positiv gedeutet werden - wenn etwa die Firma einen Schlussstrich unter eine Fehlentwicklung zieht. Aber ein überraschender Wechsel kann ein gegenteiliges Signal aussenden - die Angst, dass bisher dem Markt noch unbekanntes Ungemach in der Firma schlummert.
Dies könnte bei UBS passieren, da der Abgang von Peter Wuffli sowohl unerwartet als auch extrem dürftig begründet daher kam. Die vorgeschobene Personaldiskussion um den Aufsichtsratsvorsitz klingt eher wie ein Nebenkriegsschauplatz. Was also hat Wuffli falsch gemacht? Zugegeben, es war ein hartes Jahr für UBS. Die Abwicklung der verlustierenden Dillon Read CM zeigte, dass es keine gute Idee war, einen konzerninternen Hedge-Fonds aufzubauen, nur um einige Toptalente zu halten. Auch die hohen Investitionen in den Ausbau des Rentengeschäfts haben sich bisher nicht ausgezahlt. Doch das sind keine Katastrophen.
Insgesamt hat Wuffli gute Arbeit geleistet. Um das Wealth-Management - das mittlerweile fast die Hälfte der Gewinne ausmacht - wird UBS von allen Rivalen beneidet. Die Aktie hat in den vergangenen fünf Jahre den Sektor geschlagen, zu dem sie immer noch mit einem Bewertungsaufschlag gehandelt wird.
Doch in jüngster Zeit wurde UBS von den Anlegern gemieden, wohl weil sie den Mix von Wealth-Management und Investmentbanking unter einem Dach nicht mehr goutierten - einige forderten schon die Aufspaltung der Bank. Der Aufsichtsrat hat zu Recht sein Festhalten an dieser Aufstellung bekräftigt. Der neue Vorstand wird nun dafür sorgen müssen, dass die Investmentbanksparte ihr volles Potenzial ausschöpft und dass die Firmenstruktur von den Anlegern akzeptiert wird. Ob man dazu einen Führungswechsel brauchte, ist fraglich.
Hedge-Fonds-Kredite
)
Die Aufmerksamkeit der Wall Street ist garantiert, wenn ein Hedge-Fonds in Not gerät. So führten erst die Implosionen der zwei Fonds von Bear Stearns jüngst dazu, dass der Qualität der zugrundeliegenden Anlageinstrumente wieder mehr Aufmerksamkeit geschenkt wird. Vor allem Fonds mit Fokus auf Ramsch-Hypotheken sind derzeit nervös.
Und wenn die Aktiva eines Fonds ins Wanken geraten, fragt sich als Nächstes, wie es denn dann mit der Passivseite aussieht. Ganz düster wird es, wenn illiquide Anlagen mit kurzfristigem Fremdkapital finanziert werden. Aber der Markt hat zum Glück seit dem Long-Term-Capital-Management-Desaster einige Lektionen gelernt. Der Einsatz wird nicht mehr mit Tagesgeld gehebelt. Stattdessen lassen sich die Fonds mittlerweile Kündigungsfristen und Zinskonditionen längerfristig garantieren, sodass sie nicht mehr durch plötzliche Konditionsänderung auf dem falschen Fuß erwischt werden können.
Eine Bank, die ihre Hausaufgaben gemacht hat - die Anlageklassen des Fonds analysiert und sich besichern hat lassen -, sollte ohnehin keine Kredite kündigen müssen. Sollte die Anlage an Wert verlieren, kann sie schließlich immer noch Nachschussforderungen geltend machen. Doch der Fonds kann sich durch die Kündigungsfrist wichtige Zeit kaufen. Hedge-Fonds-Kunden wären also gut beraten, die Bankkonditionen des Fonds zu kennen.
Alnylam Pharmaceuticals, Inc.
09.07.07 16:12 Uhr
23,04 USD
+51,58 % [+7,84]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ALNY.NAS&lColors=0x000000&sSym=ALNY.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ALNY.NAS&lColors=0x000000&sSym=ALNY.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ALNY.NAS&lColors=0x000000&sSym=ALNY.NAS&hcmask=
Börse
NASDAQ
Aktuell
23,04 USD
Zeit
09.07.07 16:12
Diff. Vortag
+51,58 %
Tages-Vol.
59,37 Mio.
Gehandelte Stück
3,4 Mio.
Roche and Alnylam Form Major Alliance on RNAi Therapeutics - Roche Accesses Nobel Prize Winning Technology for Drug Discovery and Development - - Alnylam's Site in Germany to become Roche's Center of Excellence for RNAi Therapeutics - - Alnylam to Re
BASEL, Switzerland & CAMBRIDGE, Mass., Jul 09, 2007 (BUSINESS WIRE) -- Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics. The alliance will initially cover four therapeutic areas: oncology, respiratory diseases, metabolic diseases and certain liver diseases. Alnylam and Roche also will collaborate on RNAi drug discovery for one or more disease targets in these therapeutic areas. In addition, Roche will acquire Alnylam's European research site located in Kulmbach, Germany (Bavaria), subject to regulatory approval. This site will become Roche's Center of Excellence for RNAi therapeutics discovery.
RNAi is a potential foundation for a whole new class of human therapeutic products. RNAi is a natural mechanism that the body uses to inhibit expression of certain genes. Harnessing the activity of RNAi creates a direct opportunity to develop specific and potent drugs against diseases that are difficult to treat.
"Alnylam has made significant advances in RNAi therapeutics, one of the most promising approaches to tomorrow's healthcare technology. Working together with Alnylam provides us with new capabilities to target complex diseases within our focus areas," said Lee E. Babiss, Head of Roche Global Pharma Research. "Our mission is to find novel solutions for patients who suffer from difficult to treat diseases and we will be fully committed to this goal, together with our new colleagues located at the acquired site in Kulmbach."
"We are pleased to form this new alliance with Roche, which is widely recognized for its commitment to innovation in biotechnology. We look forward to working together to advance our transformative technology into a whole new class of drugs," said John Maraganore, Ph.D., President and Chief Executive Officer of Alnylam. "Such significant support from Roche will also strengthen Alnylam's efforts to build a leading innovation-based biopharmaceutical company. Indeed, together with our demonstrated commitment to scientific excellence, advancement of our pipeline and unparalleled intellectual property estate, we believe that this new alliance greatly extends our leadership position in the discovery and development of RNAi therapeutics."
Alnylam-Roche Collaboration
Alnylam has granted to Roche a non-exclusive license providing Roche access to broad Alnylam intellectual property (IP) and know-how, including fundamental, chemistry and delivery IP. Indications will initially include oncology, respiratory disease, metabolic disease and certain liver diseases. Alnylam maintains the right to non-exclusively license its IP to additional partners in potential future agreements. In addition, Alnylam and Roche will collaborate on one or more disease targets to be identified in the future in exchange for milestone and royalty payments.
The transaction includes Roche's acquisition of Alnylam's European research site in Kulmbach, Germany (Bavaria), with about 40 employees. The team in Kulmbach will remain dedicated to RNAi therapeutics discovery as a new Center of Excellence for RNAi therapeutics within Roche's global research organization.
The alliance could be valued at over $1 billion (US dollars) in consideration of upfront payments, potential product milestone payments for multiple products and field expansion payments, excluding potential royalties on future sales of commercial products. Under the terms of the agreement, Roche will pay Alnylam $331 million (US dollars) in upfront cash payments and equity investment, including 1.975 million shares of Alnylam common stock the Roche Venture Fund agreed to purchase at $21.50 (US dollars) per share, representing just less than five percent of Alnylam's outstanding common stock. Roche will also pay Alnylam milestones on products as they advance in development and commercialization as well as royalties on future sales of commercial products. Further, Roche may pay Alnylam field expansion payments to increase the number of therapeutic areas.
The close of the agreements, including Roche's purchase of Alnylam shares and purchase of Alnylam's site in Germany, is subject to certain regulatory approvals and is expected to occur within approximately 30 days.
About RNAi
RNAi (RNA interference) is a revolution in biology, representing a breakthrough in understanding how genes are turned on and off in cells, and a completely new approach to drug discovery and development. Its discovery has been heralded as "a major scientific breakthrough that happens once every decade or so," and represents one of the most promising and rapidly advancing frontiers in biology and drug discovery today which was awarded the Nobel Prize in October 2006. RNAi is a natural process of gene silencing that occurs in organisms ranging from plants to mammals. By harnessing the natural biological process of RNAi occurring in our cells, the creation of a major new class of medicines, known as RNAi therapeutics, is on the horizon. RNAi therapeutics target the cause of diseases by potently silencing specific messenger RNAs (mRNAs), thereby preventing disease-causing proteins from being made. RNAi therapeutics have the potential to treat disease and help patients in a fundamentally new way.
About Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is leading the translation of RNAi as a new class of innovative medicines with peer-reviewed research efforts published in the world's top scientific journals including Nature, Nature Medicine, and Cell. The company is leveraging these capabilities to build a broad pipeline of RNAi therapeutics; its most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company is developing RNAi therapeutics for the treatment of influenza, hypercholesterolemia, and liver cancers, amongst other diseases. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, Biogen Idec, and Roche. The company, founded in 2002, maintains global headquarters in Cambridge, Massachusetts. For more information, visit www.alnylam.com.
About the Roche Venture Fund
The Roche Venture Fund makes investments in early stage biotech and diagnostics companies to support innovative technologies and medicines. Based in Basel, Switzerland, the Roche Venture Fund manages a portfolio of over 25 companies in 10 countries.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As one of the world's biggest biotech companies and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is one of the world leaders in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the Pharmaceuticals Division totaled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 people worldwide and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com.
Amazon.com, Inc.
09.07.07 18:30 Uhr
71,20 USD
+3,23 % [+2,23]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
Börse
NASDAQ
Aktuell
71,20 USD
Zeit
09.07.07 18:30
Diff. Vortag
+3,23 %
Tages-Vol.
497,33 Mio.
Gehandelte Stück
7,1 Mio.
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=AMZN.NAS&lColors=0x000000&sSym=AMZN.NAS&hcmask=
First Solar, Inc.
09.07.07 19:16 Uhr
115,89 USD
+20,36 % [+19,60]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=FSLR.NAS&lColors=0x000000&sSym=FSLR.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=FSLR.NAS&lColors=0x000000&sSym=FSLR.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=FSLR.NAS&lColors=0x000000&sSym=FSLR.NAS&hcmask=
Börse
NASDAQ
Aktuell
115,89 USD
Zeit
09.07.07 19:16
Diff. Vortag
+20,36 %
Tages-Vol.
606,26 Mio.
Gehandelte Stück
5,8 Mio.
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=FSLR.NAS&lColors=0x000000&sSym=FSLR.NAS&hcmask=
ExplorationInvestor: First Solar Announces 5 Agreements totaling $1.28 Billion
Jul 09, 2007 (M2 PRESSWIRE via COMTEX) -- Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs. While working to keep you in touch with market activity, we also will keep you updated on the latest press. Today, July 9th we have identified, First Solar, Inc. (Nasdaq: FSLR) due to the attention they received after this recent corporate developments.
First Solar, Inc. (Nasdaq: FSLR) announced today that it has entered into five agreements for the manufacture and sale of solar modules totaling 685 Megawatts. These new agreements are expected to allow for sales of approximately $1.28 billion at an assumed exchange rate of $1.30/EUR1.00, over the period of 2007 to 2012. Included in the new agreements are long term agreements with EDF Energies Nouvelles (EDF EN), a renewable energy producer specializing in wind, hydro, biomass, and solar power plants; and Sechilienne-Sidec, a renewable energy producer specializing in thermal, wind, and solar power plants. As part of the new contract volumes announced today, First Solar and the Juwi Group have also agreed to increase volumes under an existing long term supply agreement. These customers are targeting development of solar projects with First Solar modules in Spain, Italy, France, Greece and Portugal. Also included in the new agreements is a long term agreement with RIO Energie GmbH & Co. KG, a joint venture of the Stadtwerke Mainz AG utility company and the Juwi Group with a focus on the development of solar power plants in the utility service region of the Stadtwerke Mainz AG and its subsidiaries through 2012. These new long term agreements are structured on terms similar to First Solar's existing long term supply contracts.
''These contracts signal a major expansion into the solar market by leading energy firms with significant resources and capabilities and will accelerate the continuing evolution of the solar industry,'' said Mike Ahearn, First Solar's chief executive officer. ''We now have an expanded group of highly capable market partners developing large ground and roof mounted projects throughout Europe under long term agreements. We believe these relationships validate First Solar's leadership in serving utility scale project developers and operators of solar power plants, diversify our revenues across Europe, and provide revenue visibility to support production capacity expansion.''
Also included in the new sales contracts announced by First Solar is a multi-year agreement with SunEdison, LLC, a leading provider of solar generated electricity to commercial, municipal, and utility customers in North America. SunEdison will deploy First Solar modules in Ontario, Canada, which has adopted a feed-in tariff for solar energy. ''We are pleased to form a relationship with SunEdison and look forward to working with them to implement solar projects in Ontario,'' stated Mike Ahearn.
First Solar also announced that its board of directors has approved the construction of an additional manufacturing plant in Malaysia with an annual production nameplate rating of 120 Megawatts, representing an investment of approximately $150 million. The additional production capacity of the new plant is scheduled to come on line in the first half of 2009.
During morning trading shares are up 14.5% to $110.40 with over 3,000,000 in volume. The Exploration Investor Research Team will continue to gauge the short and long term affects that this announcement will have on the company
Rosetta Resources Inc.
09.07.07 19:22 Uhr
19,5401 USD
-10,82 % [-2,3699]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ROSE.NAS&lColors=0x000000&sSym=ROSE.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ROSE.NAS&lColors=0x000000&sSym=ROSE.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ROSE.NAS&lColors=0x000000&sSym=ROSE.NAS&hcmask=
Börse
NASDAQ
Aktuell
19,5401 USD
Zeit
09.07.07 19:22
Diff. Vortag
-10,82 %
Tages-Vol.
39,01 Mio.
Gehandelte Stück
2 Mio
Rosetta Resources Inc. Appoints Charles Chambers Acting President and CEO
HOUSTON, Jul 9, 2007 (PrimeNewswire via COMTEX) -- The Board of Directors of Rosetta Resources ("Rosetta") (Nasdaq: ROSE), an independent oil-and-gas company, today announced that Bill Berilgen is leaving the company. He has resigned as Chairman, President and CEO effective immediately.
Rosetta Executive Vice President Charles Chambers will serve as acting President and CEO. Chambers and Chief Financial Officer Michael J. Rosinski will constitute the executive team to manage the company's activities during this interim period. With a combined 67 years of leadership experience in the oil and gas industry, Chambers and Rosinski are seasoned energy executives that have helped build the company since its inception.
"Rosetta possesses a top-tier asset base, talented employees and a strong balance sheet and will continue to thrive during this transition period," said Chambers, acting President and CEO. "We wish Bill well and thank him for his contributions."
Henry Houston, currently chair of Rosetta's audit committee, has been named Chairman of the Board. He will lead the Board in its search to identify a permanent CEO. Houston has held several leadership positions in the energy industry including CFO of C & K Petroleum and CEO of KP Exploration, a subsidiary of Kidder Peabody.
About Rosetta:
Rosetta Resources Inc. is an independent oil and gas company engaged in acquisition, exploration, development and production of oil and gas properties in North America. Our operations are concentrated in the Sacramento Basin of California, South Texas, the Gulf of Mexico and the Rocky Mountains. Rosetta is a Delaware corporation based in Houston, Texas.
TRINA SOLAR LTD ADR
09.07.07 19:24 Uhr
64,9399 USD
+11,81 % [+6,8599]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=TSL.NYS&lColors=0x000000&sSym=TSL.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=TSL.NYS&lColors=0x000000&sSym=TSL.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=TSL.NYS&lColors=0x000000&sSym=TSL.NYS&hcmask=
Börse
NYSE
Aktuell
64,9399 USD
Zeit
09.07.07 19:24
Diff. Vortag
+11,81 %
Tages-Vol.
86,11 Mio.
Gehandelte Stück
1,4 Mio
Trina Solar Announces Several Solar PV Module Contract Wins in Europe
CHANGZHOU, China, July 9, 2007 /Xinhua-PRNewswire-FirstCall via COMTEX/ -- Trina Solar Limited (NYSE: TSL) ("Trina Solar" or the "Company"), an integrated manufacturer of solar power products based in Changzhou, China, announced today several contract wins to supply solar photovoltaic (PV) modules with an aggregate output of up to 99MW to key accounts in Europe over the next two to three years. Initial shipments have been made on each of the contracts.
"Our recent contract wins demonstrate our success in targeting large and medium-sized companies, including PV system integrators, distributors and wholesalers," remarked Mr. Arturo Herrero, Trina Solar's Director of Sales & Marketing. "These contract wins are also an important step for Trina Solar to continue gaining brand recognition in some of the most strategic solar PV markets in Europe and positions Trina Solar well to further expand its presence in these important markets."
During the first half of 2007, Trina Solar made significant progress towards consolidating its position in Germany and penetrating the solar PV markets in Spain and Italy. The Company's contract wins during the period include:
-- 6MW contract with Enerpoint in Italy to supply solar modules over the
next three years
-- 22MW to 33MW contract with Tecnospot in Italy to supply solar modules
over the next three years
-- 20MW contract with Enereco in Italy to supply solar modules over the
next three years
-- 40MW contract with IBC Solar in Germany to provide IBC with solar
modules over the next two years, extendable to a higher volume
"We are extremely pleased with our progress in the European market in general
and with our very strong presence in the fastest growing solar PV module markets
in Spain and Italy," said Mr. Jifan Gao, Trina Solar's Chairman and CEO. "Our
outlook remains positive, and as we enter the seasonally stronger quarters of
the year and continue to expand our geographic footprint into new markets, we
anticipate significant growth in revenues as we establish Trina Solar as one of
the top global solar products companies."About Trina Solar LimitedTrina Solar Limited (NYSE: TSL), through its wholly-owned subsidiary Changzhou
Trina Solar Energy Co., Ltd., is an integrated solar PV manufacturer based in
China. The company began research and development efforts in solar products in
1999 and in 2002 it started the system integration business. The company moved
into the assembly of solar modules in 2004 as well as the manufacturing of
monocrystalline ingots, wafers and cells in 2005, 2006, and 2007, respectively.
The company's solar modules provide reliable and environmentally-friendly
electric power for residential, commercial, industrial and other applications
worldwide. The company sells its products to customers around the globe,
including a number of European countries, such as Germany, Spain and Italy,
where government incentives have accelerated the adoption of solar power
KBR INC
09.07.07 19:32 Uhr
30,93 USD
+12,07 % [+3,33]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=KBR.NYS&lColors=0x000000&sSym=KBR.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=KBR.NYS&lColors=0x000000&sSym=KBR.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=KBR.NYS&lColors=0x000000&sSym=KBR.NYS&hcmask=
Börse
NYSE
Aktuell
30,93 USD
Zeit
09.07.07 19:32
Diff. Vortag
+12,07 %
Tages-Vol.
87,75 Mio.
Gehandelte Stück
2,9 Mio.
KBR Awarded EPC Contract for Sonatrach Skikda LNG Project
HOUSTON, Jul 09, 2007 (BUSINESS WIRE) -- KBR (NYSE: KBR) today announced it has been awarded the engineering, procurement and construction (EPC) contract for the Sonatrach Skikda LNG project, to be constructed at Skikda, Algeria. The contract has an approximate value of USD 2.8 billion.
In addition to performing the EPC work for the 4.5 million metric tons per annum LNG train along with associated LPG and condensate recovery, KBR will execute the pre-commissioning and commissioning portion of the contract. Work is expected to begin in July and will be executed in Houston prior to moving to the Skikda Site.
The award demonstrates KBR's ability to execute major, grass-roots LNG projects and its commitment to Sonatrach and the country of Algeria. "KBR is dedicated to continuing its long-term relationship with Sonatrach in Algeria to achieve their goals for increased LNG production," said John Rose, executive vice president, KBR. "Through a flexible and innovative contracting approach, Sonatrach has been able to move forward with this project in a market where many projects are delayed."
Sonatrach Downstream executive vice president Dr. Abdelhafid Feghouli stated, "The new LNG train at Skikda will enable Sonatrach to increase and recapture its LNG production. This project award also demonstrates our commitment to the LNG business and to the Skikda community."
KBR, alone or with its joint venture partners, has designed and constructed more than half of the world's operating LNG production capacity and has designed more than half of the LNG receiving terminals in operation outside of Japan.
KBR is a global engineering, construction and services company supporting the energy, petrochemicals, government services and civil infrastructure sectors. The company offers a wide range of services through its Energy and Chemicals, Government and Infrastructure, and Ventures business segments. For more information, visit www.kbr.com.
HANDELSBLATT, Dienstag, 10. Juli 2007, 07:00 Uhr
Tabakkonzern testet neue Produkte
Anleger setzen auf Altria
Von Anette Kiefer
Die Zahl der Raucher in den Industrienationen sinkt. Trotzdem verdienen die großen Tabakkonzerne prächtig. Der US-Riese Altria zum Beispiel, dem Philip Morris und damit die meistgerauchte US-Zigarettenmarke Marlboro gehört, hat seinen Aktienkurs seit Januar 2000 fast vervierfacht.
STUTTGART. Die Zahl der Raucher in den Industrienationen sinkt. Trotzdem verdienen die großen Tabakkonzerne prächtig. Der US-Riese Altria zum Beispiel, dem Philip Morris und damit die meistgerauchte US-Zigarettenmarke Marlboro gehört, hat seinen Aktienkurs seit Januar 2000 fast vervierfacht.
Analysten halten weiter große Stücke auf die Aktie: „Kaufen!“ empfiehlt Citigroup-Analystin Bonnie Herzog; auch Raymond Mathis von Standard & Poor’s erwartet eine überdurchschnittliche Entwicklung und setzt sein Kursziel auf 85 Dollar. Das wäre ein weiteres Plus von mehr als 20 Prozent.
Besonders enthusiastisch wird von Analysten und Anlegern derzeit die Frage diskutiert, ob Altria eine Ausgliederung des internationalen Tabakgeschäfts Philip Morris International (PMI) vorbereitet. Altrias ehemaliges Tochterunternehmen Kraft Foods steht schon seit März auf eigenen Füßen; viele Experten glauben, dass PMI bald folgen soll. „Wie die Dinge im Moment stehen, gibt es starke Argumente für eine solche Abspaltung“, sagt Jonathan Leinster von UBS. Als möglicher Bekanntgabetermin entsprechender Pläne wird die nächste Aufsichtsratsitzung am 29. August gehandelt. Mark Greenberg von der Deutschen Bank erwartet, dass entsprechende Nachrichten eine milde Rally auslösen werden.
Angeheizt hat die Spekulationen Altrias Ankündigung, in den kommenden vier Jahren die Zigarettenproduktion für das internationale Geschäft aus den USA nach Europa zu verlegen. Damit will der Konzern bis 2011 etwa 335 Mill. Dollar sparen. In Amerika sollen dann nur noch die Zigaretten gefertigt werden, die auch für den dortigen Markt bestimmt sind. Im vergangenen Jahr verkaufte Philip Morris in den USA knapp 185 Mrd. Zigaretten, im Rest der Welt mehr als 830 Mrd. Die geplante Produktionsverlagerung „wird PMI zweierlei Kosteneinsparungen bringen“, erwartet Mark Greenberg. „Einerseits stärkt dies die Leistungsfähigkeit der Marke in Europa, und zweitens entfallen so die Versandkosten.“
Während ein Großteil des Markts eine Abspaltung offenbar befürwortet, gibt es allerdings auch Gegenstimmen. „Noch ist dieser Schritt unserer Meinung nach nicht beschlossen“, sagt Filippe Goossens von Credit Suisse. Es gebe noch eine Reihe anderer Möglichkeiten, „den Unternehmenswert zu steigern, ohne dabei Altrias strategische Positionierung zu schwächen: zum Beispiel durch Aktienrückkäufe, Kosteneinsparungen oder eine Expansion in Schwellenländern“.
Tatsächlich unternimmt der Konzern derzeit große Anstrengungen in diesem Bereich. Vor wenigen Tagen gab die Geschäftsführung bekannt, man werde in Indonesien unter der Marlboro-Marke eine Zigarette mit Nelkenaroma einführen. Mit dieser ungewöhnlichen Geschmacksrichtung sind in Indonesien etwa 90 Prozent der verkauften Zigaretten versehen.
Als fünftgrößter Tabakmarkt der Welt hat das Land eine große Bedeutung für die Branche – insbesondere weil dort Schätzungen zufolge zwei Drittel aller erwachsenen Männer rauchen, verglichen mit rund 25 Prozent in den USA. Und die Zahl dürfte wie in anderen Schwellenländern weiter steigen, weil durch den schwunghaften Zigarettenschmuggel die Ware immer billiger wird, erwartet die Weltgesundheitsorganisation WHO.
In den USA und Teilen Europas dagegen sinkt die Zahl der Raucher. In den vergangenen zehn Jahren sei der Zigarettenkonsum in den USA um jährlich etwa zwei Prozent zurückgegangen, schätzt Philip Morris. Abhilfe schaffen soll eine neue Produktlinie so genannter Snus, also rauchfreier Tabakprodukte. Diese ähneln winzigen Teebeuteln und werden im Mund zwischen Wange und Zahnfleisch geklemmt.
Ein kleiner Bruder für das iPhone
Hat wirklich jemand geglaubt, über das iPhone wäre alles gesagt und geschrieben worden? Weit gefehlt. Nach den Geschichten über Camper vor dem Apple Store, über Frust und Freude mit dem Internet-iPod-Handy, nach Schlagzeilen von hunderttausenden verkauften Geräten bahnt sich eine weitere Sensation an: das iPhone Nano.
Die Analysten von J.P. Morgan gehen davon aus, dass Apple noch bis Ende dieses Jahres dem iPhone einen kleinen Bruder zur Seite stellen wird – ganz wie man das ja schon beim iPod erfolgreich getan hatte. Wer den schicken mp3-Spieler mochte, aber zu teuer fand, schlug bald beim kleineren Nano zu, und beim iPhone dürfte das ganz genau so funktionieren.
Wichtigstes Argument der iPhone-Gegner war schließlich von Anfang an der Preis. 500 Dollar für die kleinere und 600 Dollar for die größere Ausführung, das ist ein Happen, den nicht jeder Handy- und Hightech-Fan schlucken kann. Insofern hält sich unter Experten wacker die Einstellung, dass sich das iPhone zwar einen gewissen Marktanteil sichern aber niemals zum Massenobjekt aufsteigen könnte.
Außer… ja, außer Apple senkt den Preis, und das wäre mit dem iPhone Nano der Fall. J.P. Morgan rechnet mit einem Preis von etwa 300 Dollar, womit man mitten in der Kategorie der Blackberrys und Treos wäre und ganz neue Kundenschichten erobern könnte.
Inwiefern das dem Apple-Partner AT&T nutzen würde, ist zur Zeit unklar. Denn der müsste nicht zwingend die Mobilfunklizenz für das Nano bekommen, nur weil er exklusiv das große iPhone verkauft. Nach dem Ärger vieler Kunden mit langen Freischalt-Fristen und ungenügender Netzdeckung ist es sogar nicht unwahrscheinlich, dass sich Apple für die Massenausführung einen stärkeren Partner sucht.
J.P. Morgan rechnet schon in den nächsten Wochen mit einer entsprechenden Ankündigung von Apple. Immerhin habe man sich das iPhone Nano nicht aus der Luft gegriffen. Im Gegenteil: Apple scheint entsprechende Pläne zum Patentschutz angemeldet zu haben und entsprechend mitten in der Planung sein. Vielleicht wird diese jetzt noch beschleunigt, nachdem die Analysten ihre Verkaufsschätzungen für das Klein-Gadget veröffentlicht haben: Sie rechnen mit 30 bis 40 Millionen verkauften Geräten bis Ende 2008.
Lars Halter -
Gemstar-TV Guide International Inc.
10.07.07 20:48 Uhr
5,982 USD
+12,02 % [+0,642
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GMST.NAS&lColors=0x000000&sSym=GMST.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GMST.NAS&lColors=0x000000&sSym=GMST.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GMST.NAS&lColors=0x000000&sSym=GMST.NAS&hcmask=
Börse
NASDAQ
Aktuell
5,982 USD
Zeit
10.07.07 20:48
Diff. Vortag
+12,02 %
Tages-Vol.
122,27 Mio.
Gehandelte Stück
25 Mio
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GMST.NAS&lColors=0x000000&sSym=GMST.NAS&hcmask=
Gemstar-TV Guide International Announces Review of Strategic Alternatives
LOS ANGELES, Jul 09, 2007 (BUSINESS WIRE) -- Gemstar-TV Guide International, Inc. (NASDAQ: GMST), a leading media, entertainment and technology company, announced today that its Board of Directors has authorized the Company and its advisors to explore strategic alternatives intended to maximize shareholder value, which may include a sale of the Company.
Anthea Disney, Chairman of the Board of the Company, said, "The Company has made significant improvements throughout its businesses and the Board is very pleased with the growth and strategic direction under CEO Richard Battista. We are now poised to investigate the range of available strategic alternatives for continuing to build shareholder value."
The Board of Directors will work with the Company's management team and its legal and financial advisors to evaluate the Company's available alternatives and identify the course of action it believes is in the best interests of all its shareholders. UBS Investment Bank is acting as financial advisor to the Company, and Wachtell, Lipton, Rosen & Katz is acting as legal advisor.
In making the announcement, the Company stated there can be no assurance that the exploration of strategic alternatives will result in any transaction. The Company undertakes no obligation to make any further announcements regarding the exploration of strategic alternatives unless and until a final decision is made.
About Gemstar-TV Guide
Gemstar-TV Guide International, Inc. (the "Company") (NASDAQ: GMST) is a leading global media, entertainment, and technology company that develops, licenses, markets and distributes products and services that maximize the video guidance and entertainment experience for consumers. The Company's businesses include: television, publishing, and new media properties; interactive program guide services and products; and intellectual property licensing. Additional information about the Company can be found at www.gemstartvguide.com.
Depomed, Inc.
10.07.07 21:10 Uhr
2,03 USD
-58,82 % [-2,90]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=DEPO.NAS&lColors=0x000000&sSym=DEPO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=DEPO.NAS&lColors=0x000000&sSym=DEPO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DEPO.NAS&lColors=0x000000&sSym=DEPO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=DEPO.NAS&lColors=0x000000&sSym=DEPO.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,03 USD
Zeit
10.07.07 21:10
Diff. Vortag
-58,82 %
Tages-Vol.
35,00 Mio.
Gehandelte Stück
21 Mio
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
MENLO PARK, Calif., Jul 10, 2007 (BUSINESS WIRE) -- Depomed, Inc. (NASDAQ: DEPO) today announced results from its Phase 3 clinical trial of Gabapentin GR, an investigational extended release tablet for the treatment of patients with postherpetic neuralgia (PHN). PHN is a persistent neuropathic pain condition caused by nerve damage after a shingles, or herpes zoster, viral infection. Results from the trial did not demonstrate statistically significant efficacy relative to placebo in patients receiving an 1800mg total daily dose of Gabapentin GR given once- or twice-daily.
The randomized, double-blind, placebo-controlled, multi-center trial involved 407 PHN patients. Patients were randomized into one of three treatment groups for ten weeks of treatment: Gabapentin GR once-daily, Gabapentin GR twice-daily (each with 1800 mg total daily-dose) and placebo. The primary endpoint of the study was to assess the efficacy of Gabapentin GR compared to placebo in reducing average daily pain scores from baseline to endpoint. Secondary objectives included generating data on safety, sleep interference and global impressions of changes in pain by investigators and patients.
Results
The primary endpoint was not achieved with statistical significance for either active treatment regimen, as compared to placebo, over the ten-week treatment period. The mean reductions in average daily pain scores from baseline to end of study were 1.83 (once-daily), 1.72 (twice-daily) and 1.43 (placebo). However, statistical significance relative to placebo was achieved in each of the first six weeks for the once-daily treatment arm and in each of the first five weeks for the twice-daily treatment arm. Pain scores in the placebo group continued to improve in the last four weeks of the study.
The secondary endpoints of sleep interference, Clinical Global Impression of Change or CGIC (a scale used by physicians for overall assessment of patient improvement) and Patient Global Impression of Change or PGIC (a scale used by patients to report their overall assessment of change) were all statistically significant for the once-daily treatment compared to placebo over the ten week study period. Sleep interference scores were reduced by 2.01 points with Gabapentin GR compared to -1.39 with placebo (p=0.014). Physicians reported that 48.0% of patients taking Gabapentin once-daily were "very much improved" or "much improved" compared to 27.1% of the patients who received placebo (p is less than0.001), as measured by the CGIC. Similar results were observed for the PGIC in the once-daily and placebo arms (p=0.009).
The most common side effect observed was dizziness, which is commonly associated with gabapentin. In the trial, the incidence of dizziness for Gabapentin GR was 10.1% (once-daily) and 14.9% (twice-daily) as compared to 3.0% for placebo. Somnolence was observed in 2.9% of once-daily treated patients and 6.7% of twice-daily treated patients, compared to 2.3% of patients on placebo. Peripheral edema occurred in 5.1% of the once-daily treated population and 4.5% in the twice-daily population compared to no incidents of peripheral edema in the placebo group.
"The Phase 3 results we received today were very surprising and disappointing to us in light of the encouraging safety and efficacy data that we observed in our phase 2 clinical trial, in which we achieved statistically significant results in a four-week period as compared to placebo." said John W. Fara, Ph.D., chairman, president and chief executive officer of Depomed. "We are particularly surprised to see a high placebo effect that persisted throughout the trial as compared to other large published PHN trials. We saw clinically meaningful and statistically significant reductions in pain scores from baseline to the ten-week endpoint in both active treatment arms. However, the unexpected improvements in the pain scores of the placebo group during the last four weeks of the study prevented the achievement of statistical significance in the primary endpoint that is required by the FDA."
"We will be evaluating these results internally and with potential partners to determine how best to proceed with Gabapentin GR in pain indications," said Carl Pelzel, Depomed's executive vice president and chief operating officer. "We do not expect these results to have an impact on our ongoing clinical development program in menopausal hot flashes."
About Gabapentin GR
Gabapentin GR is an investigational extended release and gastric retained formulation of gabapentin, an FDA-approved product for the treatment of PHN. Formulated with Depomed's proprietary AcuForm(TM) drug delivery technology, Gabapentin GR holds the potential to offer patients the pain-relief benefits provided by immediate release formulations of gabapentin, with fewer side effects and a more convenient once- or twice-daily dosing regimen. The formulation of once- or twice-daily Gabapentin is particularly challenging since Gabapentin is absorbed through an active transport mechanism which is concentrated in the upper gastrointestinal tract. Therefore a gastric retained formulation of Gabapentin, such as Gabapentin GR, may demonstrate an improvement in delivering drug to these active transport sites compared to a more traditional extended release technology. In 2006, 16.3 million prescriptions for gabapentin were dispensed.
About Postherpetic Neuralgia
Neuropathic pain affects approximately 2.6 million individuals in the United States. Postherpetic neuralgia (PHN) is a persistent neuropathic pain condition caused by nerve damage after a shingles, or herpes zoster, viral infection. It afflicts approximately one in five patients diagnosed with shingles, or approximately 150,000 individuals in the United States. The incidence of PHN increases in elderly patients, with 75 percent of those over 70 years old who have shingles, developing PHN. The pain associated with PHN reportedly can be so severe that patients are unable to resume normal activities for months. Since there is currently no cure for PHN, treatments are focused on relieving pain.
About Depomed
Depomed, Inc., is a specialty pharmaceutical company with two approved products on the market and multiple product candidates in its pipeline. The company utilizes its proven, proprietary AcuForm(TM) drug delivery technology to improve existing oral medications, allowing for extended, controlled release of medications to the upper gastrointestinal tract. Benefits of AcuForm-enhanced pharmaceuticals include the convenience of once-daily administration, improved treatment tolerability and enhanced compliance and efficacy. Glumetza(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United States by King Pharmaceuticals and in Canada by Biovail Corporation. ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary tract infections. Depomed's product candidate Gabapentin GR(TM) is currently in Phase 3 and Phase 2 clinical development for the treatment of two pain indications, postherpetic neuralgia and diabetic peripheral neuropathy, respectively. A Phase 2 clinical trial of Gabapentin GR in menopausal hot flashes is also under way. Additional information about Depomed may be found on its web site, www.depomedinc.com.
Fonar Corporation
10.07.07 21:19 Uhr
7,7616 USD
+84,45 % [+3,5536
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=FONR.NAS&lColors=0x000000&sSym=FONR.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=FONR.NAS&lColors=0x000000&sSym=FONR.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=FONR.NAS&lColors=0x000000&sSym=FONR.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=FONR.NAS&lColors=0x000000&sSym=FONR.NAS&hcmask=
Börse
NASDAQ
Aktuell
7,7616 USD
Zeit
10.07.07 21:19
Diff. Vortag
+84,45 %
Tages-Vol.
11,35 Mio.
Gehandelte Stück
1,4 Mio.
FONAR Upright(TM) MRI Sales Take Off - 7 Sales in 2 Weeks - While Competitor Recumbent MRI Sales Decline
MELVILLE, N.Y., Jul 10, 2007 (BUSINESS WIRE) -- FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning(TM), reported today that the company has sold Seven UPRIGHT(TM) Multi-Position(TM) MRIs during the previous two weeks. By contrast, since this year began, sales by other MRI manufacturers have declined, with one major company reporting a quarterly imaging sales decline including MRI of $150 million.
A June 26, 2007, article in the Wall Street Journal online titled "Medicare Cuts Hurt Sales of Imaging Equipment," indicated that "the Medicare payment changes... sent sales of scanners (including MRI) made by GE, Siemens AG, Toshiba Corp. and others tumbling more than 20% last quarter, according to data provided by an industry group." See: http://online.wsj.com/article/BT-CO-20070625-711291.html and http://blogs.wsj.com/health/2007/06/26/medicare-cuts-hurt-sales-of-Ima ging-equipment/ (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.).
In recent weeks, FONAR has noted an overall increase in interest in its UPRIGHT(TM) MRI product. Raymond V. Damadian, president and founder of FONAR said, "A noticeable surge in interest and activity has come our way. It concluded with seven new sales that occurred in the last two weeks."
"I think," said Dr. Damadian, "that the dramatic spike in FONAR UPRIGHT(TM) sales reflects the realization by current MRI users that when competing for scans the FONAR UPRIGHT(TM) has a unique advantage that distinguishes it from the great majority of other MRI scanners, which are recumbent only. These scanners cannot achieve the needed UPRIGHT(TM) Multi-Position images that the FONAR scanner can. This advantage is significant in light of the reduced reimbursement reported by the Wall Street Journal for MRI scans in general."
"I think it's clear," said Dr. Damadian, "that for those medical professionals who recognize the need for FONAR's UPRIGHT(TM) Multi-Position(TM) technology, the current depression in the sales of recumbent MRI scanners reported by the Wall Street Journal is irrelevant. The reason is, the FONAR UPRIGHT(TM) is essential to good spine surgery outcomes and patient care. A traditional recumbent non-weight-bearing MRI will often miss a patient's spine pathology. A surgeon who knows he needs 'electric lights' to see the patient's problem realizes the depressed sales of 'gas lights' (recumbent MRIs) are not relevant."
"Approximately 1,000,000 patients undergo spine surgery in the U.S. each year," said Dr. Damadian. "In my view all of these patients should be imaged in an UPRIGHT(TM) MRI scanner before surgery, in order to be sure important pathology is not being missed that could cause the wrong surgery to be performed."
The sales also followed the designation of the UPRIGHT(TM) MRI as the 2007 invention of the year by the Intellectual Property Owners Education Foundation. Previous winners include the Jarvik artificial heart and the Bose stereo speakers.
Among the recent FONAR sales was an UPRIGHT(TM) MRI sale in London, as reported on July 5.
By the end of the June, FONAR had sold 150 UPRIGHT(TM) Multi-Position(TM) MRIs. In addition, 120 UPRIGHT(TM) MRIs had been installed.
About FONAR
The 2007 National Inventor of the Year Award was presented to president and founder Raymond Damadian, M.D., by the Intellectual Property Owners Education Foundation ( www.ipoef.org ) for the INVENTION of the FONAR UPRIGHT(TM) Multi-Position(TM) MRI (also known as the STAND-UP(TM) MRI). It's the world's only whole-body MRI that scans patients in numerous weight-bearing positions; i.e., standing, sitting, flexion, extension, and lateral bending, as well as the conventional lie-down position. An abundance of peer-reviewed literature reporting the essentiality of Upright Imaging for accurately diagnosing the human body can be found at: www.uprightmripublications.com and www.fonar.com/research_index.htm
With one half million patients scanned, the patient-friendly FONAR UPRIGHT(TM) Multi-Position(TM) MRI has a near zero claustrophobic rejection rate by patients. Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. Another MRI, the FONAR 360(TM), is a room-size recumbent scanner that optimizes openness while facilitating physician access to the patient.
The FONAR legacy began in 1970 when company founder Raymond V. Damadian, M.D., discovered marked T1 and T2 signal differences between normal tissues and cancer tissues and between various kinds of normal tissues.
This discovery gave rise to the idea by Dr. Damadian to build a body scanner based on NMR (MR) to search for cancer deposits* within the human body. His discovery of the MR scanner and the first method to achieve an MR scan was patented by him in 1972 and protected by the United States Supreme Court in 1997.
Thirty years ago, on July 3, 1977, Dr. Damadian, along with the assistance of his two graduate students, Larry Minkoff, Ph.D., and Michael Goldsmith, Ph.D., achieved the world's first MRI image of a live human being on the world's first MRI scanner which they built and named 'Indomitable.' FONAR, which built and installed the world's first commercial MRI in 1980, is celebrating 30 years of technological leadership in the MRI industry. Visit: www.fonar.com/history.htm
FONAR is headquartered on Long Island, New York, and has approximately 400 employees.
Pantry, Inc. (The)
10.07.07 21:27 Uhr
39,96 USD
-14,38 % [-6,71]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=PTRY.NAS&lColors=0x000000&sSym=PTRY.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=PTRY.NAS&lColors=0x000000&sSym=PTRY.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PTRY.NAS&lColors=0x000000&sSym=PTRY.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=30y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=PTRY.NAS&lColors=0x000000&sSym=PTRY.NAS&hcmask=
Börse
NASDAQ
Aktuell
39,96 USD
Zeit
10.07.07 21:27
Diff. Vortag
-14,38 %
Tages-Vol.
110,23 Mio.
Gehandelte Stück
3 Mio
The Pantry Announces Preliminary Third Quarter Financial Results and Lowers Fiscal 2007 EPS Guidance Provides Preliminary Fiscal 2008 EPS Outlook
SANFORD, N.C., Jul 10, 2007 (BUSINESS WIRE) -- The Pantry, Inc. (NASDAQ: PTRY), the leading independently operated convenience store chain in the southeastern U.S., today announced preliminary financial results for its third fiscal quarter ended June 28, 2007.
Subject to final adjustments, the Company expects to report diluted earnings per share for the quarter in a range between $0.45 and $0.50, compared with earnings of $0.86 per share in the corresponding period last year. Results for the third quarter of fiscal 2007 will include a charge of approximately $0.06 per share for deferred financing costs in connection with the Company's refinancing of its credit facilities.
Chairman and Chief Executive Officer Peter J. Sodini said, "These preliminary results primarily reflect our relatively low gasoline margins during the quarter as compared to the prior year quarter. This period was characterized by upward pricing pressure due to production constraints at U.S. refineries. We now expect earnings per share for the full fiscal year to be between $1.65 and $1.80, which is below our previous guidance range. EBITDA for fiscal 2007 is estimated at a range of $234 million to $240 million."
Mr. Sodini continued, "Although fiscal 2007 has been a challenging year, we do not believe there has been a material change in the long-term fundamentals of our business. In fact, our competitive position in the marketplace has clearly improved with the strategic acquisitions we have completed this year. In fiscal 2008, assuming average gasoline margins are more in line with historical performance in the mid to high 12 cents per gallon, we would expect earnings per share and EBITDA, excluding future acquisitions, in a range between $2.70 to $3.00 and $304 to $316 million, respectively."
10.07.2007 21:55
SYMANTEC - Was geht jetzt?
SYMANTEC (Nachrichten) - Kürzel: SYMC - ISIN: US8715031089
Börse: Nasdaq in USD / Kursstand: 18,88 $
Kursverlauf vom 15.03.2004 bis 10.07.2007 (log. Kerzenchartdarstellung / 1 Kerze = 1 Tag)
Kurz-Kommentierung: Die SYMANTEC Aktie fällt unter die charttechnische Horizontalunterstützung bei 19,63 $ zurück. Mit dieser Bewegung verschlechtert sich das Gesamtbild etwas. Es besteht jetzt die Möglichkeit, dass die Aktie znächst das Gap (Kurslücke) schließt. Dies dürfte dann Kursabgaben bis 18,00 $ mit sich bringen. In diesem Bereich wird dann entschieden, ob es zu weiteren Kursabschlägen bis 16,00 $ kommt. Dieser Belastungstest ist aktuell noch nicht ersichtlich.
https://ssl.godmode-trader.de/charts/30/2005/abc6766.gif
Genentech übertrifft Erwartungen
(Instock) Genentech (NYSE: DNA) steigert den Gewinn im zweiten Quartal von 531 auf 747 Millionen US-Dollar. Der Gewinn je Aktie legte von 49 auf 70 Cents zu. Vor Sonderposten übertraf der Gewinn je Aktie mit 78 Cents die Erwartungen von 71 Cents. Der Umsatz der Roche-Tochter legte ebenfalls stärker als erwartet von 2,2 auf 3 Milliarden Dollar zu (Prognose: 2,8 Milliarden Dollar). Im Gesamtjahr soll der Gewinn je Aktie statt 2,79 bis 2,90 Dollar nun 2,85 bis 2,95 Dollar erreichen.
[11.07.2007 22:20:21]